{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Authors: Phu Dang and Diane Dinh\n",
    "\n",
    "Purpose: Pedal ROI Data Analysis\n",
    "\n",
    "Date: 05.11.2023\n",
    "\n",
    "Number of projects per investment pillar (AG-AK) (Phu & Diane) (done in Tableau) \\\n",
    "Name of project title and clinical trials(DA-DG) (Phu & Diane) (done in Tableau) \\\n",
    "Number of peer-reviewed publications (DM) (Phu & Diane) \\\n",
    "Name of project titles that will lead to improvements in health policy (FD, FL) (Phu & Diane)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 551,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Importing libraries and packages\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np \n",
    "import matplotlib.pyplot as plt \n",
    "import seaborn as sns\n",
    "import plotly.express as px\n",
    "import os\n",
    "import re\n",
    "\n",
    "# pd.set_option('display.max_rows', None)\n",
    "# Adjust dataframe display options to view full output\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.width', None)\n",
    "\n",
    "# Reset to default ~ comment 2 lines above and \n",
    "# uncomment 2 lines below, run all before pushing to GitHub\n",
    "# pd.set_option('display.max_columns', 20)\n",
    "# pd.set_option('display.width', 80)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 552,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read datasets\n",
    "\n",
    "os.chdir('../data')\n",
    "fp = os.path.join('interim', '2022_Pedal_Progress_Report.csv').replace(\"\\\\\",\"/\")\n",
    "pr = pd.read_csv(fp, index_col=0)\n",
    "\n",
    "fp = os.path.join('interim', '2022_Pedal_ROI.csv').replace(\"\\\\\",\"/\")\n",
    "roi = pd.read_csv(fp, index_col=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 553,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0  3.0  Progress Report #1                  NaN          NaN   \n",
       "1  4.0  Progress Report #1                  NaN          NaN   \n",
       "2  5.0  Progress Report #1                  NaN          NaN   \n",
       "3  6.0  Progress Report #1                  NaN          NaN   \n",
       "4  8.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "  Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                  NaN         NaN                  NaN         NaN   \n",
       "1                  NaN         NaN                  NaN         NaN   \n",
       "2                  NaN         NaN                  NaN         NaN   \n",
       "3                  NaN         NaN                  NaN         NaN   \n",
       "4                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "  Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                  NaN           NaN                  NaN          NaN   \n",
       "1                  NaN           NaN                  NaN          NaN   \n",
       "2                  NaN           NaN                  NaN          NaN   \n",
       "3                  NaN           NaN                  NaN          NaN   \n",
       "4                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                  NaN         NaN                   NaN         NaN   \n",
       "1                  NaN         NaN                   NaN         NaN   \n",
       "2                  NaN         NaN                   NaN         NaN   \n",
       "3                  NaN         NaN                   NaN         NaN   \n",
       "4                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                 Pedal Non-Peer Pubs  \\\n",
       "0                                                NaN   \n",
       "1       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                       None to date   \n",
       "3                                                NaN   \n",
       "4  8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "\n",
       "                               Other Accomplishments Health Benefits  \\\n",
       "0                                                NaN             Yes   \n",
       "1                                                NaN             Yes   \n",
       "2  additional funding provided by Padres Pedal th...             Yes   \n",
       "3                  See above in the progress report.             Yes   \n",
       "4  2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "\n",
       "   International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0          False     False  False           False                     False   \n",
       "1           True     False  False           False                     False   \n",
       "2           True     False  False           False                     False   \n",
       "3           True      True  False           False                     False   \n",
       "4          False     False  False           False                     False   \n",
       "\n",
       "   Patients  Patient Families Policy Influence  International (pol)  \\\n",
       "0      True             False               No                False   \n",
       "1     False             False               No                False   \n",
       "2     False             False               No                False   \n",
       "3      True              True               No                False   \n",
       "4      True             False               No                False   \n",
       "\n",
       "   National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0           False        False                 False   \n",
       "1           False        False                 False   \n",
       "2           False        False                 False   \n",
       "3           False        False                 False   \n",
       "4           False        False                 False   \n",
       "\n",
       "   Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                           False           False                   False   \n",
       "1                           False           False                   False   \n",
       "2                           False           False                   False   \n",
       "3                           False           False                   False   \n",
       "4                           False           False                   False   \n",
       "\n",
       "  Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                         NaN                No                 False   \n",
       "1                         NaN                No                 False   \n",
       "2                         NaN               Yes                 False   \n",
       "3                         NaN               Yes                  True   \n",
       "4                         NaN                No                 False   \n",
       "\n",
       "   National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0            False         False                  False   \n",
       "1            False         False                  False   \n",
       "2             True         False                  False   \n",
       "3             True         False                  False   \n",
       "4            False         False                  False   \n",
       "\n",
       "   Healthcare Professionals (econ)  Patients (econ)  Patient Families (econ)  \\\n",
       "0                            False            False                    False   \n",
       "1                            False            False                    False   \n",
       "2                            False            False                    False   \n",
       "3                            False             True                     True   \n",
       "4                            False            False                    False   \n",
       "\n",
       "                       Economic Benefits Description Equity Benefits  \\\n",
       "0                                                NaN              No   \n",
       "1                                                NaN              No   \n",
       "2  The combination of cabozantinib with 13-cis-re...              No   \n",
       "3  Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                NaN             Yes   \n",
       "\n",
       "   International (equity)  National (equity)  Local (equity)  \\\n",
       "0                   False              False           False   \n",
       "1                   False              False           False   \n",
       "2                   False              False           False   \n",
       "3                    True               True           False   \n",
       "4                   False              False           False   \n",
       "\n",
       "   General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                    False                              False   \n",
       "1                    False                              False   \n",
       "2                    False                              False   \n",
       "3                    False                              False   \n",
       "4                    False                              False   \n",
       "\n",
       "   Patients (equity)  Patient Families (equity)  \\\n",
       "0              False                      False   \n",
       "1              False                      False   \n",
       "2              False                      False   \n",
       "3               True                       True   \n",
       "4               True                      False   \n",
       "\n",
       "                         Equity Benefits Description  \\\n",
       "0                                                NaN   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3  At risk oral cancer patients are often part of...   \n",
       "4  Trial focused on all demographic of prostate c...   \n",
       "\n",
       "  Additional Funding Achieved First AFS Status  \\\n",
       "0                         One          Awarded   \n",
       "1                        Five          Awarded   \n",
       "2                         One          Awarded   \n",
       "3                         One        Submitted   \n",
       "4                         One          Awarded   \n",
       "\n",
       "                    First AFS Name and Project Title  First AFS Amount  \\\n",
       "0  NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                            the Hartwell Foundation          300000.0   \n",
       "2                                     Exelixis, Inc.          250000.0   \n",
       "3                NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                         Oncternal           377000.0   \n",
       "\n",
       "  Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1           Awarded            Padres Pedal the Cause           100000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0              NaN                                   NaN               NaN   \n",
       "1        Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2              NaN                                   NaN               NaN   \n",
       "3              NaN                                   NaN               NaN   \n",
       "4              NaN                                   NaN               NaN   \n",
       "\n",
       "  Fourth AFS Status Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1         Submitted                NIH R03CA273629-01           150000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                NaN                   \n",
       "1                   Tower Cancer Research Foundation                   \n",
       "2                                                NaN                   \n",
       "3                                                NaN                   \n",
       "4                                                NaN                   \n",
       "\n",
       "  Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0              NaN               NaN                             Yes   \n",
       "1        Submitted          500000.0                             Yes   \n",
       "2              NaN               NaN                             Yes   \n",
       "3              NaN               NaN                             Yes   \n",
       "4              NaN               NaN                             Yes   \n",
       "\n",
       "             Additional Funding Benefits Description  \\\n",
       "0  Additional funding would enable the applicatio...   \n",
       "1  Additional funding support would allow us to p...   \n",
       "2  Additional funding support would allow us to e...   \n",
       "3  For advancing the planned clinical trial and c...   \n",
       "4  This is a grass roots project. It is a single ...   \n",
       "\n",
       "  Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                               Yes   \n",
       "1                                               Yes   \n",
       "2                                               Yes   \n",
       "3                                               Yes   \n",
       "4                                                No   \n",
       "\n",
       "  Additional Funding Benefits Description (clinical stages)  \\\n",
       "0  In addition, funding could allow us to do more...          \n",
       "1  Additional funding support would allow us to p...          \n",
       "2  Additional funding support would allow us to p...          \n",
       "3  Identification of biomarkers predicting clinic...          \n",
       "4                                                NaN          \n",
       "\n",
       "                               Participated in Pedal  \\\n",
       "0  Yes, I have participated as a rider every year...   \n",
       "1  I have participated as both a virtual particip...   \n",
       "2  I have participated as both a virtual particip...   \n",
       "3                                                Yes   \n",
       "4                                      Yes, runner.    \n",
       "\n",
       "  Further Research Contributions Success Stories  \\\n",
       "0                             No              No   \n",
       "1                            Yes              No   \n",
       "2                            Yes             Yes   \n",
       "3                             No              No   \n",
       "4                            Yes              No   \n",
       "\n",
       "  Major Scientific Breakthroughs  \\\n",
       "0                            NaN   \n",
       "1                            NaN   \n",
       "2                            Yes   \n",
       "3                            NaN   \n",
       "4                            NaN   \n",
       "\n",
       "                                 Additional Comments  Complete  \\\n",
       "0                                                NaN      True   \n",
       "1  Funding from Padres Pedal the Cause has been i...      True   \n",
       "2  Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                Many thanks for all your support!!!      True   \n",
       "4                                                NaN      True   \n",
       "\n",
       "  Publication Status 1 First DOI # Publication Status 2 Second DOI #  \\\n",
       "0             Accepted         NaN                  NaN          NaN   \n",
       "1             Accepted         NaN            Submitted          NaN   \n",
       "2            Published         NaN                  NaN          NaN   \n",
       "3          In progress         NaN          In progress          NaN   \n",
       "4                  NaN         NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 3 Third DOI #  \n",
       "0                  NaN         NaN  \n",
       "1                  NaN         NaN  \n",
       "2                  NaN         NaN  \n",
       "3                  NaN         NaN  \n",
       "4                  NaN         NaN  "
      ]
     },
     "execution_count": 553,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 554,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>3.1</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify genes that are dysregulated in neurob...</td>\n",
       "      <td>Identify and characterize de novo germline and...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved knowledge of the genetic mutations th...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PPTC funding allowed a postdoctoral resear...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>4.1</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the functional role of NME1 expressio...</td>\n",
       "      <td>Evaluate the functional role of NME1 histidine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>5.1</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the safety, dose-limiting toxicities...</td>\n",
       "      <td>Identify biomarkers predictive of patient resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk and recurrent solid tu...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>8.1</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To investigate the safety and tolerability of ...</td>\n",
       "      <td>To evaluate the anti-tumor activity of cirmtuz...</td>\n",
       "      <td>To prospectively interrogate the Wnt signaling...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic castration resistant prostate cance...</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>2020-01-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes this grant was supporting the infrastructu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID Event Name  Award ID  \\\n",
       "0  3.0    Initial       3.1   \n",
       "2  4.0    Initial       4.1   \n",
       "4  5.0    Initial       5.1   \n",
       "6  6.0    Initial       6.1   \n",
       "8  8.0    Initial       8.1   \n",
       "\n",
       "                                       Project Title        PI Institution  \\\n",
       "0  Detecting dysregulated genes in neuroblastoma ...        Salk Institute   \n",
       "2  Functional Roles for Histidine Kinase Signalin...       Rady Children's   \n",
       "4  A National Phase I Study of Cabozantinib in Co...       Rady Children's   \n",
       "6  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "8  A Phase 1B, Nonrandomized Trial Investigating ...  Moores Cancer Center   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "2               NaN                            False   \n",
       "4               NaN                            False   \n",
       "6               NaN                            False   \n",
       "8               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "2                                           False   \n",
       "4                                           False   \n",
       "6                                           False   \n",
       "8                                            True   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "2                                      False                          False   \n",
       "4                                      False                          False   \n",
       "6                                      False                          False   \n",
       "8                                      False                          False   \n",
       "\n",
       "   Pediatric cancers        Specific Aims  \\\n",
       "0               True    Two Specific Aims   \n",
       "2               True    Two Specific Aims   \n",
       "4               True    Two Specific Aims   \n",
       "6              False  Three Specific Aims   \n",
       "8              False  Three Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Identify genes that are dysregulated in neurob...   \n",
       "2  Evaluate the functional role of NME1 expressio...   \n",
       "4  Determine the safety, dose-limiting toxicities...   \n",
       "6  Improve outcomes for HNSCC by expanding our un...   \n",
       "8  To investigate the safety and tolerability of ...   \n",
       "\n",
       "                                               Aim 2  \\\n",
       "0  Identify and characterize de novo germline and...   \n",
       "2  Evaluate the functional role of NME1 histidine...   \n",
       "4  Identify biomarkers predictive of patient resp...   \n",
       "6  Leverage our administrative, biostatistics, co...   \n",
       "8  To evaluate the anti-tumor activity of cirmtuz...   \n",
       "\n",
       "                                               Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0                                                NaN   NaN   NaN   NaN   \n",
       "2                                                NaN   NaN   NaN   NaN   \n",
       "4                                                NaN   NaN   NaN   NaN   \n",
       "6  Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "8  To prospectively interrogate the Wnt signaling...   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Improved knowledge of the genetic mutations th...      100000.0   \n",
       "2  Children with aggressive neuroblastoma have po...      100000.0   \n",
       "4  Children with high-risk and recurrent solid tu...      200000.0   \n",
       "6  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "8  Metastatic castration resistant prostate cance...      150000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2019-07-15      2021-07-14  Complete      True   \n",
       "2        2019-07-15      2020-07-14  Complete     False   \n",
       "4        2021-07-01      2023-06-30  Complete     False   \n",
       "6        2021-07-01      2022-06-30  Complete     False   \n",
       "8        2020-01-01      2021-12-31  Complete     False   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                 False   \n",
       "2                   False                                 False   \n",
       "4                   False                                 False   \n",
       "6                   False                                  True   \n",
       "8                   False                                  True   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                           False   \n",
       "2                   True                           False   \n",
       "4                   True                           False   \n",
       "6                  False                            True   \n",
       "8                   True                            True   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                  False   \n",
       "2                   False                                  False   \n",
       "4                   False                                  False   \n",
       "6                   False                                   True   \n",
       "8                   False                                   True   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "2                    False               False                       False   \n",
       "4                    False               False                       False   \n",
       "6                    False               False                       False   \n",
       "8                    False               False                       False   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "2                     False                                    False   \n",
       "4                     False                                    False   \n",
       "6                     False                                    False   \n",
       "8                     False                                    False   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "2                False                                  False   \n",
       "4                False                                  False   \n",
       "6                False                                  False   \n",
       "8                False                                  False   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "2                                   True                           False   \n",
       "4                                  False                           False   \n",
       "6                                  False                           False   \n",
       "8                                  False                           False   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "2                    False   \n",
       "4                    False   \n",
       "6                    False   \n",
       "8                    False   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "2                                                Yes       \n",
       "4                                                Yes       \n",
       "6                                                Yes       \n",
       "8                                                Yes       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  The PPTC funding allowed a postdoctoral resear...                   NaN   \n",
       "2  The availability of funding from Padres Pedal ...                   NaN   \n",
       "4  The availability of funding from Padres Pedal ...                   NaN   \n",
       "6  Opportunity to develop an immune modulatory ap...                   NaN   \n",
       "8  Yes this grant was supporting the infrastructu...                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted  \\\n",
       "0                       0.0   \n",
       "2                       0.0   \n",
       "4                       1.0   \n",
       "6                       1.0   \n",
       "8                       1.0   \n",
       "\n",
       "                                First Clinical Trial  \\\n",
       "0                                                NaN   \n",
       "2                                                NaN   \n",
       "4  A National Phase I Study of Cabozantinib in Co...   \n",
       "6           Metformin for oral cancer prevention 2.0   \n",
       "8  Phase 1B, Nonrandomized Trial Investigating Do...   \n",
       "\n",
       "   First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                 NaN                   NaN   \n",
       "2                                 NaN                   NaN   \n",
       "4                                 6.0                   NaN   \n",
       "6                                80.0                   NaN   \n",
       "8                                 0.0                   NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN              None            No   \n",
       "2                                  NaN              none            No   \n",
       "4                                  NaN              None            No   \n",
       "6                                  NaN                No            No   \n",
       "8                                  NaN         Oncternal            No   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              One  \n",
       "2            NaN                              Two  \n",
       "4            NaN                              One  \n",
       "6            NaN                              Two  \n",
       "8            NaN                             Zero  "
      ]
     },
     "execution_count": 554,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 555,
   "metadata": {},
   "outputs": [],
   "source": [
    "roi['Project Title'] = roi['Project Title'].apply(lambda x: re.sub(r\"[\\s]{2}\", \" \", x))\\\n",
    "    .apply(lambda x: re.sub(\"pacreatic\", \"pancreatic\", x))\\\n",
    "    .apply(lambda x: re.sub(\"Rhabdoid\", \"rhabdoid\", x))\\\n",
    "    .replace('Transcriptomic and epigenomic profiling to reveal TIL and microglia functional phenotype and clonality in pediatric brain tumors',\n",
    "    'Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 556,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors',\n",
       "       'A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis',\n",
       "       'A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer',\n",
       "       'A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers',\n",
       "       'A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer',\n",
       "       'A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma',\n",
       "       'An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)',\n",
       "       'An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target',\n",
       "       'Applying p38 MAPK inhibitors to tackle breast cancer metastasis',\n",
       "       'Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic',\n",
       "       'Cytotoxic Breast Cancer Treatment Effects on Aging',\n",
       "       'Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse',\n",
       "       'Decoding Colon Cancers Using Boolean Principles',\n",
       "       'Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models',\n",
       "       'Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients',\n",
       "       'Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients ',\n",
       "       'Detecting dysregulated genes in neuroblastoma using allele-specific expression',\n",
       "       'Developing targeted therapy for Ewing sarcoma metastasis',\n",
       "       'Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials',\n",
       "       'Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C',\n",
       "       'Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma',\n",
       "       'Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression',\n",
       "       'Epigenetic basis of platinum drug resistance in ovarian cancer',\n",
       "       'Epigenetic profiling of endometrial cancer',\n",
       "       'Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures',\n",
       "       'Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC',\n",
       "       'FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma',\n",
       "       'Fake Project to Test',\n",
       "       'Functional Roles for Histidine Kinase Signaling in Neuroblastoma',\n",
       "       'Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs',\n",
       "       'Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies',\n",
       "       'Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling',\n",
       "       'Identification of therapeutic targets of B-ALL using Boolean logic',\n",
       "       'Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer',\n",
       "       'Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain',\n",
       "       'In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy',\n",
       "       'Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot',\n",
       "       'Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation',\n",
       "       'Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer',\n",
       "       'Irreversible electroporation as an In Situ vaccine for pancreatic cancer',\n",
       "       'Junk', 'Junk2',\n",
       "       'KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts',\n",
       "       'Knowledge-based planning and treatment decision-making for gynecologic brachytherapy',\n",
       "       'Low Dose Chemotherapy for Immuno-activation in Lung Cancer',\n",
       "       'Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk',\n",
       "       'Microbe-Associated Colorectal Cancer (M.A.C.S)',\n",
       "       'Natural Killer Cells for Treatment of Medulloblastoma',\n",
       "       'Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC',\n",
       "       'New Therapies for Myeloid Leukemia',\n",
       "       'Novel Pathways Regulated by NME1 in Neuroblastoma',\n",
       "       'Novel kinase inhibitors in combination with retinoic acide for neuroblastoma',\n",
       "       'Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L',\n",
       "       'Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer',\n",
       "       'Precision Interception of Gastric Cancers',\n",
       "       'Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer',\n",
       "       'Responses of Melanoma Patients to Checkpoint Immunotherapy',\n",
       "       'Science',\n",
       "       'Small molecule screen for inhibitors of the GOLPH3 pathway',\n",
       "       'Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy',\n",
       "       'Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors',\n",
       "       'Targeting CD114 Signaling in Pediatric Medulloblastoma',\n",
       "       'Targeting FZD7 in human cancers',\n",
       "       'Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs',\n",
       "       'Targeting Stem Cell Signals in Cancer Development and Progression',\n",
       "       'Targeting cellular mechanotransduction in breast cancer metastasis',\n",
       "       'Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer',\n",
       "       'Targeting imatinib-resistant, KIT-negative cells in human GISTs',\n",
       "       'Test title',\n",
       "       'The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies',\n",
       "       'Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)',\n",
       "       'Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors',\n",
       "       'Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors',\n",
       "       'UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer',\n",
       "       'Understanding and Targeting NRF2 in Pancreatic Cancer'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 556,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test = roi['Project Title'].unique()\n",
    "test.sort()\n",
    "test\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 557,
   "metadata": {},
   "outputs": [],
   "source": [
    "five_pillars = ['Prevention and diagnostic tools', \n",
    "                'Novel approaches and new therapeutic platforms',\n",
    "                'Immunotherapies and personalized vaccines',\n",
    "                'Addressing cancer disparities',\n",
    "                'Pediatric cancers']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 558,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "190\n",
      "False    153\n",
      "True      37\n",
      "Name: Prevention and diagnostic tools, dtype: int64\n",
      "\n",
      "190\n",
      "False    123\n",
      "True      67\n",
      "Name: Novel approaches and new therapeutic platforms, dtype: int64\n",
      "\n",
      "190\n",
      "False    154\n",
      "True      36\n",
      "Name: Immunotherapies and personalized vaccines, dtype: int64\n",
      "\n",
      "190\n",
      "False    187\n",
      "True       3\n",
      "Name: Addressing cancer disparities, dtype: int64\n",
      "\n",
      "190\n",
      "False    143\n",
      "True      47\n",
      "Name: Pediatric cancers, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for col in five_pillars:\n",
    "    print(roi[col].value_counts().sum())\n",
    "    print(roi[col].value_counts())\n",
    "    print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 559,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   0\n",
       "Novel approaches and new therapeutic platforms    0\n",
       "Immunotherapies and personalized vaccines         0\n",
       "Addressing cancer disparities                     0\n",
       "Pediatric cancers                                 0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 559,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[five_pillars].isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 560,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "190\n",
      "190\n"
     ]
    }
   ],
   "source": [
    "print(len(roi['ID'].unique()))\n",
    "print(roi.shape[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 561,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.0    174\n",
       "1.0     15\n",
       "2.0      1\n",
       "Name: Clinical Trials Resulted, dtype: int64"
      ]
     },
     "execution_count": 561,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi['Clinical Trials Resulted'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 562,
   "metadata": {},
   "outputs": [],
   "source": [
    "value_map = {'No Trials': 0, 'One Trial': 1, 'Two Trials': 2, np.nan: 0}\n",
    "\n",
    "roi['Clinical Trials Resulted'] = roi['Clinical Trials Resulted'].replace(\n",
    "    value_map\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 563,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                               2\n",
       "Metformin for oral cancer prevention 2.0                                                                                                                                                                             1\n",
       "Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                     1\n",
       "Individualized therapy for refractory medulloblastoma                                                                                                                                                                1\n",
       "NCT05153304  Protocol PCV-001  A Phase I/II Safety and Feasibility Study of Personalized Immunotherapy in Adults with Upper Gastrointestinal Tract Cancers.                                                          1\n",
       "Trial Name:    Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor  NCT#: NCT03556384                                                                       1\n",
       "A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)                                                                  1\n",
       "Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NSCLC)    NCT04043195                                                                                        1\n",
       "Ruxolitinib with or without navitoxlax (Abbvie)                                                                                                                                                                      1\n",
       "Neoadjuvant Immunoradiotherapy in Head & Neck Cancer                                                                                                                                                                 1\n",
       "A Phase 1b Trial of Cirmtuzumab and Paclitaxel in Metastatic or Locally Advanced, Unresectable Breast Cancer                                                                                                         1\n",
       "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)                                                         1\n",
       "NCI10096 ClinicalTrials.gov Identifier:  NCT03317392  Title:  A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)    1\n",
       "NIVOLUMAB (ANTI-PD1 ANTIBODY) AND IPILIMUMAB (ANTI-CTLA4 ANTIBODY) IN COMBINATION WITH IMMUNOGENIC CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER                                                1\n",
       "Discovery and translation of precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) stem cell targets                                                                                                                 1\n",
       "Name: First Clinical Trial, dtype: int64"
      ]
     },
     "execution_count": 563,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[\"First Clinical Trial\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 564,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                               2\n",
       "Metformin for oral cancer prevention 2.0                                                                                                                                                                             1\n",
       "Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                     1\n",
       "Individualized therapy for refractory medulloblastoma                                                                                                                                                                1\n",
       "NCT05153304  Protocol PCV-001  A Phase I/II Safety and Feasibility Study of Personalized Immunotherapy in Adults with Upper Gastrointestinal Tract Cancers.                                                          1\n",
       "Trial Name:    Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor  NCT#: NCT03556384                                                                       1\n",
       "A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)                                                                  1\n",
       "Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NSCLC)    NCT04043195                                                                                        1\n",
       "Ruxolitinib with or without navitoxlax (Abbvie)                                                                                                                                                                      1\n",
       "Neoadjuvant Immunoradiotherapy in Head & Neck Cancer                                                                                                                                                                 1\n",
       "A Phase 1b Trial of Cirmtuzumab and Paclitaxel in Metastatic or Locally Advanced, Unresectable Breast Cancer                                                                                                         1\n",
       "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)                                                         1\n",
       "NCI10096 ClinicalTrials.gov Identifier:  NCT03317392  Title:  A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)    1\n",
       "NIVOLUMAB (ANTI-PD1 ANTIBODY) AND IPILIMUMAB (ANTI-CTLA4 ANTIBODY) IN COMBINATION WITH IMMUNOGENIC CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER                                                1\n",
       "Discovery and translation of precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) stem cell targets                                                                                                                 1\n",
       "Name: First Clinical Trial, dtype: int64"
      ]
     },
     "execution_count": 564,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[\"First Clinical Trial\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 565,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0      Detecting dysregulated genes in neuroblastoma ...\n",
       "2      Functional Roles for Histidine Kinase Signalin...\n",
       "10                    New Therapies for Myeloid Leukemia\n",
       "12     Peptide Targeted Delivery of Epigenetic Therap...\n",
       "14             Precision Interception of Gastric Cancers\n",
       "16     Examination of inhibitors of the ULK1 autophag...\n",
       "18     Neoantigen-specific T cell responses in except...\n",
       "20     Defining the mechanisms of pancreatic cancer s...\n",
       "22     Elucidating the role of Syk kinase and Syk inh...\n",
       "26     Improved Echocardiographic Diagnosis of Anthra...\n",
       "28     Novel Pathways Regulated by NME1 in Neuroblastoma\n",
       "30     Characterization of a GOLPH3 Pathway Inhibitor...\n",
       "32        Microbe-Associated Colorectal Cancer (M.A.C.S)\n",
       "34     Identification of regulatory programs for glio...\n",
       "36     Evaluation of carcinogen exposure via genome-w...\n",
       "38     Impact of Metformin on Clonal Hematopoiesis an...\n",
       "40      FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma\n",
       "42     Inhibiting Liver Cancer Stem Cells to Improve ...\n",
       "44     Knowledge-based planning and treatment decisio...\n",
       "46     Targeting CD114 Signaling in Pediatric Medullo...\n",
       "48     Natural Killer Cells for Treatment of Medullob...\n",
       "49                       Targeting FZD7 in human cancers\n",
       "51     Inducing Cytosolic Chromatin Fragments in Canc...\n",
       "53     Responses of Melanoma Patients to Checkpoint I...\n",
       "55     Enhanced Breast Cancer Risk Prediction from Im...\n",
       "57     Understanding and Targeting NRF2 in Pancreatic...\n",
       "59     Targeting A Therapeutic Vulnerability in PTEN-...\n",
       "61            Epigenetic profiling of endometrial cancer\n",
       "63     Development and Implementation of a Peer-Navig...\n",
       "65     Transcriptomic, epigenomic profiling to reveal...\n",
       "69     A Phase 1b pilot clinical trial of cirmtuzumab...\n",
       "77     Irreversible electroporation as an In Situ vac...\n",
       "79     Oncogenic Regulation of B-Lymphomagenesis by t...\n",
       "81     An over-expressed GPCR in pancreatic cancer as...\n",
       "83     Targeting cellular mechanotransduction in brea...\n",
       "85       Decoding Colon Cancers Using Boolean Principles\n",
       "87     Tissue-specific role of SMARCB1 in pediatric r...\n",
       "91     Discovery of non-coding oncogenic mutations in...\n",
       "93     Identification of therapeutic targets of B-ALL...\n",
       "95     Developing targeted therapy for Ewing sarcoma ...\n",
       "99                                            Test title\n",
       "101    Functional Roles for Histidine Kinase Signalin...\n",
       "102    A National Phase I Study of Cabozantinib in Co...\n",
       "105    UCSD-UCSF Specialized Program of Research Exce...\n",
       "106                   New Therapies for Myeloid Leukemia\n",
       "108                   New Therapies for Myeloid Leukemia\n",
       "110    Peptide Targeted Delivery of Epigenetic Therap...\n",
       "112                                 Fake Project to Test\n",
       "114            Precision Interception of Gastric Cancers\n",
       "116    Examination of inhibitors of the ULK1 autophag...\n",
       "118    Examination of inhibitors of the ULK1 autophag...\n",
       "120    Neoantigen-specific T cell responses in except...\n",
       "121    Neoantigen-specific T cell responses in except...\n",
       "123    Defining the mechanisms of pancreatic cancer s...\n",
       "125    Elucidating the role of Syk kinase and Syk inh...\n",
       "127    A pilot trial to test the benefit of real time...\n",
       "129    Improved Echocardiographic Diagnosis of Anthra...\n",
       "131    Improved Echocardiographic Diagnosis of Anthra...\n",
       "132    Novel Pathways Regulated by NME1 in Neuroblastoma\n",
       "133    Detecting dysregulated genes in neuroblastoma ...\n",
       "135    Characterization of a GOLPH3 Pathway Inhibitor...\n",
       "137    Identification of regulatory programs for glio...\n",
       "138    Identification of regulatory programs for glio...\n",
       "140    Evaluation of carcinogen exposure via genome-w...\n",
       "142    Impact of Metformin on Clonal Hematopoiesis an...\n",
       "144     FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma\n",
       "146     FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma\n",
       "148    Inhibiting Liver Cancer Stem Cells to Improve ...\n",
       "150    Inhibiting Liver Cancer Stem Cells to Improve ...\n",
       "152    Knowledge-based planning and treatment decisio...\n",
       "154    Knowledge-based planning and treatment decisio...\n",
       "156    Targeting CD114 Signaling in Pediatric Medullo...\n",
       "158    Targeting CD114 Signaling in Pediatric Medullo...\n",
       "159    Natural Killer Cells for Treatment of Medullob...\n",
       "161                      Targeting FZD7 in human cancers\n",
       "163    Inducing Cytosolic Chromatin Fragments in Canc...\n",
       "165    Responses of Melanoma Patients to Checkpoint I...\n",
       "167    Enhanced Breast Cancer Risk Prediction from Im...\n",
       "169    Understanding and Targeting NRF2 in Pancreatic...\n",
       "171    Understanding and Targeting NRF2 in Pancreatic...\n",
       "172                                                 Junk\n",
       "173                                                Junk2\n",
       "174       Microbe-Associated Colorectal Cancer (M.A.C.S)\n",
       "176    Targeting A Therapeutic Vulnerability in PTEN-...\n",
       "177           Epigenetic profiling of endometrial cancer\n",
       "179    Development and Implementation of a Peer-Navig...\n",
       "181    Transcriptomic, epigenomic profiling to reveal...\n",
       "183    A Phase 1b Safety and Feasibility Study of Per...\n",
       "184    A Phase 1b Safety and Feasibility Study of Per...\n",
       "193    Irreversible electroporation as an In Situ vac...\n",
       "195    Irreversible electroporation as an In Situ vac...\n",
       "196    Oncogenic Regulation of B-Lymphomagenesis by t...\n",
       "198    An over-expressed GPCR in pancreatic cancer as...\n",
       "200    Identification of genes critical for the produ...\n",
       "202    Targeting cellular mechanotransduction in brea...\n",
       "204      Decoding Colon Cancers Using Boolean Principles\n",
       "206      Decoding Colon Cancers Using Boolean Principles\n",
       "208    Tissue-specific role of SMARCB1 in pediatric r...\n",
       "210    Deciphering the role of RNA editing in leukemi...\n",
       "211    Discovery of non-coding oncogenic mutations in...\n",
       "213    Discovery of non-coding oncogenic mutations in...\n",
       "217    Developing targeted therapy for Ewing sarcoma ...\n",
       "219    Defining the mechanisms of pancreatic cancer s...\n",
       "221            Precision Interception of Gastric Cancers\n",
       "222    A Novel Role for Histidine Kinase Activity in ...\n",
       "224    A Novel Role for Histidine Kinase Activity in ...\n",
       "226    Targeting fibroblast heterogeneity to improve ...\n",
       "227    Targeting fibroblast heterogeneity to improve ...\n",
       "228    Protein Kinase C as a Novel Biomarker and Targ...\n",
       "229    Protein Kinase C as a Novel Biomarker and Targ...\n",
       "230    Small molecule screen for inhibitors of the GO...\n",
       "231    Small molecule screen for inhibitors of the GO...\n",
       "232    Applying p38 MAPK inhibitors to tackle breast ...\n",
       "233    Applying p38 MAPK inhibitors to tackle breast ...\n",
       "234    Stromal reprogramming to enhance the effective...\n",
       "235    Stromal reprogramming to enhance the effective...\n",
       "236    Targeting imatinib-resistant, KIT-negative cel...\n",
       "237    Targeting imatinib-resistant, KIT-negative cel...\n",
       "238    Demonstrating the Clinical Utility of Whole Ex...\n",
       "239    Demonstrating the Clinical Utility of Whole Ex...\n",
       "240    Highly selective, synthetic, cleavage specific...\n",
       "241    Highly selective, synthetic, cleavage specific...\n",
       "242    Highly selective, synthetic, cleavage specific...\n",
       "243    Cytotoxic Breast Cancer Treatment Effects on A...\n",
       "244    Cytotoxic Breast Cancer Treatment Effects on A...\n",
       "245    In Vivo Modeling of Anti-Tumor Responses of Hu...\n",
       "246    In Vivo Modeling of Anti-Tumor Responses of Hu...\n",
       "247    Therapeutic Reprogramming of Pancreatic Cancer...\n",
       "248    Therapeutic Reprogramming of Pancreatic Cancer...\n",
       "249    Therapeutic Reprogramming of Pancreatic Cancer...\n",
       "250    Therapeutic Reprogramming of Pancreatic Cancer...\n",
       "251    KRAS Addiction and Protein Biomarkers of Respo...\n",
       "252    KRAS Addiction and Protein Biomarkers of Respo...\n",
       "253    Targeting KRAS mutant lung cancer with biphosp...\n",
       "254    Targeting KRAS mutant lung cancer with biphosp...\n",
       "255    Epigenetic basis of platinum drug resistance i...\n",
       "256    Epigenetic basis of platinum drug resistance i...\n",
       "257    Epigenetic basis of platinum drug resistance i...\n",
       "258    Targeting Stem Cell Signals in Cancer Developm...\n",
       "259    Targeting Stem Cell Signals in Cancer Developm...\n",
       "260    Mechanisms Linking Prolonged Nightly Fasting w...\n",
       "261    Mechanisms Linking Prolonged Nightly Fasting w...\n",
       "262    Mechanisms Linking Prolonged Nightly Fasting w...\n",
       "263    Detecting Correlates of Vaccine Responses in A...\n",
       "264    Detecting Correlates of Vaccine Responses in A...\n",
       "265    The GNAS-PKA Onco-Signaling Network in Colorec...\n",
       "266    The GNAS-PKA Onco-Signaling Network in Colorec...\n",
       "267    The GNAS-PKA Onco-Signaling Network in Colorec...\n",
       "268    Irreversible electroporation as an In Situ vac...\n",
       "269    Irreversible electroporation as an In Situ vac...\n",
       "270    Irreversible electroporation as an In Situ vac...\n",
       "271    Oncogenic Regulation of B-Lymphomagenesis by t...\n",
       "272    Oncogenic Regulation of B-Lymphomagenesis by t...\n",
       "273    An over-expressed GPCR in pancreatic cancer as...\n",
       "274    An over-expressed GPCR in pancreatic cancer as...\n",
       "275    Targeting cellular mechanotransduction in brea...\n",
       "276    Targeting cellular mechanotransduction in brea...\n",
       "277    Identification of genes critical for the produ...\n",
       "278    Identification of genes critical for the produ...\n",
       "279      Decoding Colon Cancers Using Boolean Principles\n",
       "280      Decoding Colon Cancers Using Boolean Principles\n",
       "281      Decoding Colon Cancers Using Boolean Principles\n",
       "282    Tissue-specific role of SMARCB1 in pediatric r...\n",
       "283    Tissue-specific role of SMARCB1 in pediatric r...\n",
       "284    Deciphering the role of RNA editing in leukemi...\n",
       "285    Deciphering the role of RNA editing in leukemi...\n",
       "286    Discovery of non-coding oncogenic mutations in...\n",
       "287    Discovery of non-coding oncogenic mutations in...\n",
       "288    Discovery of non-coding oncogenic mutations in...\n",
       "289    Identification of therapeutic targets of B-ALL...\n",
       "290    Identification of therapeutic targets of B-ALL...\n",
       "291    Developing targeted therapy for Ewing sarcoma ...\n",
       "292    Developing targeted therapy for Ewing sarcoma ...\n",
       "293                                              Science\n",
       "Name: Project Title, dtype: object"
      ]
     },
     "execution_count": 565,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[roi['First Clinical Trial'].isna()]['Project Title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 566,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dtype('float64')"
      ]
     },
     "execution_count": 566,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi.dtypes['Clinical Trials Resulted']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 567,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>41.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.1</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PTC funding lead to preliminary data for a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Trial Name:    Temozolomide (TMZ) In Advanced ...</td>\n",
       "      <td>13.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>118.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.2</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID  \\\n",
       "71    41.0    Initial      41.1   \n",
       "187  118.0    Initial      41.2   \n",
       "\n",
       "                                         Project Title        PI Institution  \\\n",
       "71   An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "187  An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "\n",
       "    Other Institution  Prevention and diagnostic tools  \\\n",
       "71                NaN                            False   \n",
       "187               NaN                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "71                                             True   \n",
       "187                                            True   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "71                                       False                          False   \n",
       "187                                      False                          False   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "71               False  Three Specific Aims   \n",
       "187              False  Three Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "71   Primary objective: To determine overall respon...   \n",
       "187  Primary objective: To determine overall respon...   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "71   Secondary objective: To determine progression-...   \n",
       "187  Secondary objective: To determine progression-...   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "71   Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "187  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "71   Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "187  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "71         2019-01-01      2020-12-31  Complete     False   \n",
       "187        2019-01-01      2020-12-31  Complete     False   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "71                    False                                  True   \n",
       "187                   False                                  True   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "71                    True                            True   \n",
       "187                   True                            True   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "71                    False                                  False   \n",
       "187                   False                                  False   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "71                     False               False                       False   \n",
       "187                    False               False                       False   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "71                      False                                    False   \n",
       "187                     False                                    False   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "71                 False                                  False   \n",
       "187                False                                  False   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "71                                   False                           False   \n",
       "187                                  False                           False   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "71                     False   \n",
       "187                    False   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "71                                                 Yes       \n",
       "187                                                 No       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "71   The PTC funding lead to preliminary data for a...                   NaN   \n",
       "187                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "71                        1.0   \n",
       "187                       1.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "71   Trial Name:    Temozolomide (TMZ) In Advanced ...   \n",
       "187  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "\n",
       "     First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "71                                 13.0                   NaN   \n",
       "187                                18.0                   NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "71                                   NaN              None            No   \n",
       "187                                  NaN               NaN            No   \n",
       "\n",
       "    Patent Details Peer-Reviewed Publications Count  \n",
       "71             NaN                            Three  \n",
       "187            NaN                              One  "
      ]
     },
     "execution_count": 567,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[roi['Project Title'].str.contains('An Open')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 568,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Readjust the clinical trials name columns to plot in Tableau\n",
    "\n",
    "def adjust_cli_trials_names(data, title):\n",
    "\n",
    "    \"\"\"\n",
    "        df (DataFrame): subject dataframe\n",
    "        title (str): the title of the project to adjust clinical trials names\n",
    "\n",
    "    \"\"\"\n",
    "\n",
    "    df = data[data['Project Title'] == title].reset_index(drop=True)\n",
    "    num_trials = df['Clinical Trials Resulted'].sum()\n",
    "    first = df['First Clinical Trial'].reset_index(drop=True)\n",
    "    second = df['Second Clinical Trial'].reset_index(drop=True)\n",
    "\n",
    "    if num_trials <= 1:\n",
    "        return df\n",
    "\n",
    "    while len(first[~first.isna()]) > 1:\n",
    "        first_nonnull_index = first[~first.isna()].index[-1]\n",
    "        to_move = first.iloc[first_nonnull_index]\n",
    "        first_null_index = second[second.isna()].index[0]\n",
    "        second.iloc[first_null_index] = to_move\n",
    "        first[first_nonnull_index] = np.NaN\n",
    "\n",
    "    df['First Clinical Trial'] = first\n",
    "    df['Second Clinical Trial'] = second\n",
    "    return df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 569,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>Neoadjuvant Immunoradiotherapy in Head &amp; Neck ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>61.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.2</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding out un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>62.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.3</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     ID Event Name  Award ID  \\\n",
       "0   6.0    Initial       6.1   \n",
       "1  61.0    Initial       6.2   \n",
       "2  62.0    Initial       6.3   \n",
       "\n",
       "                                       Project Title        PI Institution  \\\n",
       "0  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "1  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "2  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "1               NaN                            False   \n",
       "2               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "1                                           False   \n",
       "2                                           False   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "1                                       True                          False   \n",
       "2                                       True                          False   \n",
       "\n",
       "   Pediatric cancers        Specific Aims  \\\n",
       "0              False  Three Specific Aims   \n",
       "1              False    Two Specific Aims   \n",
       "2              False    Two Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Improve outcomes for HNSCC by expanding our un...   \n",
       "1  Improve outcomes for HNSCC by expanding out un...   \n",
       "2  Leverage our administrative, biostatistics, co...   \n",
       "\n",
       "                                               Aim 2  \\\n",
       "0  Leverage our administrative, biostatistics, co...   \n",
       "1  Leverage our administrative, biostatistics, co...   \n",
       "2  Develop emerging, novel, high quality translat...   \n",
       "\n",
       "                                               Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0  Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "1                                                NaN   NaN   NaN   NaN   \n",
       "2                                                NaN   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "1  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "2  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2021-07-01      2022-06-30  Complete     False   \n",
       "1        2021-07-01      2022-06-30  Complete     False   \n",
       "2        2021-07-01      2022-06-30  Complete       NaN   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                  True   \n",
       "1                   False                                  True   \n",
       "2                     NaN                                   NaN   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                            True   \n",
       "1                   True                            True   \n",
       "2                    NaN                             NaN   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                   True   \n",
       "1                    True                                  False   \n",
       "2                     NaN                                    NaN   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "1                    False                True                        True   \n",
       "2                      NaN                 NaN                         NaN   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "1                      True                                    False   \n",
       "2                       NaN                                      NaN   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "1                False                                  False   \n",
       "2                  NaN                                    NaN   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "1                                  False                           False   \n",
       "2                                    NaN                             NaN   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "1                    False   \n",
       "2                      NaN   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "1                                                 No       \n",
       "2                                                NaN       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  Opportunity to develop an immune modulatory ap...                   NaN   \n",
       "1                                                NaN                   NaN   \n",
       "2                                                NaN                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted                      First Clinical Trial  \\\n",
       "0                       1.0  Metformin for oral cancer prevention 2.0   \n",
       "1                       1.0                                       NaN   \n",
       "2                       0.0                                       NaN   \n",
       "\n",
       "   First Clinical Trial Patient Count  \\\n",
       "0                                80.0   \n",
       "1                                 0.0   \n",
       "2                                 NaN   \n",
       "\n",
       "                               Second Clinical Trial  \\\n",
       "0  Neoadjuvant Immunoradiotherapy in Head & Neck ...   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN                No            No   \n",
       "1                                  NaN               NaN            No   \n",
       "2                                  NaN               NaN           NaN   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              Two  \n",
       "1            NaN                              Two  \n",
       "2            NaN                              NaN  "
      ]
     },
     "execution_count": 569,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "adjust_cli_trials_names(roi, 'UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 570,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C\n",
      "Decoding Colon Cancers Using Boolean Principles\n",
      "Irreversible electroporation as an In Situ vaccine for pancreatic cancer\n",
      "Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors\n",
      "Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)\n",
      "Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse\n",
      "Identification of therapeutic targets of B-ALL using Boolean logic\n",
      "Developing targeted therapy for Ewing sarcoma metastasis\n",
      "Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L\n",
      "An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target\n",
      "Targeting cellular mechanotransduction in breast cancer metastasis\n",
      "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma\n",
      "Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies\n",
      "A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers\n",
      "Understanding and Targeting NRF2 in Pancreatic Cancer\n",
      "Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs\n",
      "Targeting CD114 Signaling in Pediatric Medulloblastoma\n",
      "Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation\n",
      "Knowledge-based planning and treatment decision-making for gynecologic brachytherapy\n",
      "Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling\n",
      "The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies\n",
      "UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer\n",
      "Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain\n",
      "New Therapies for Myeloid Leukemia\n",
      "Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk\n",
      "Precision Interception of Gastric Cancers\n",
      "Epigenetic basis of platinum drug resistance in ovarian cancer\n",
      "Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC\n",
      "Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC\n",
      "Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models\n",
      "Cytotoxic Breast Cancer Treatment Effects on Aging\n",
      "Targeting Stem Cell Signals in Cancer Development and Progression\n",
      "Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients \n",
      "Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer\n",
      "A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis\n",
      "In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy\n",
      "Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer\n",
      "Small molecule screen for inhibitors of the GOLPH3 pathway\n",
      "Applying p38 MAPK inhibitors to tackle breast cancer metastasis\n",
      "Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy\n",
      "Targeting imatinib-resistant, KIT-negative cells in human GISTs\n",
      "Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients\n",
      "Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs\n",
      "KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts\n",
      "Detecting dysregulated genes in neuroblastoma using allele-specific expression\n",
      "Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer\n",
      "Low Dose Chemotherapy for Immuno-activation in Lung Cancer\n",
      "Functional Roles for Histidine Kinase Signaling in Neuroblastoma\n",
      "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors\n",
      "Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer\n",
      "Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma\n",
      "A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma\n",
      "Novel Pathways Regulated by NME1 in Neuroblastoma\n",
      "Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic\n",
      "Microbe-Associated Colorectal Cancer (M.A.C.S)\n",
      "Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures\n",
      "Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer\n",
      "Natural Killer Cells for Treatment of Medulloblastoma\n",
      "Targeting FZD7 in human cancers\n",
      "Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot\n",
      "Responses of Melanoma Patients to Checkpoint Immunotherapy\n",
      "Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression\n",
      "Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors\n",
      "Epigenetic profiling of endometrial cancer\n",
      "Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials\n",
      "Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors\n",
      "A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer\n",
      "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)\n",
      "Junk2\n",
      "Junk\n",
      "Fake Project to Test\n",
      "Test title\n",
      "Novel kinase inhibitors in combination with retinoic acide for neuroblastoma\n",
      "A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer\n",
      "Science\n"
     ]
    }
   ],
   "source": [
    "for i in roi['Project Title'].value_counts().index:\n",
    "    print(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 571,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Remove dummy/test projects\n",
    "\n",
    "roi = roi[~roi['Project Title'].isin(['Junk2', 'Junk', 'Fake Project to Test', 'Test title'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 572,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C',\n",
       "       'Decoding Colon Cancers Using Boolean Principles',\n",
       "       'Irreversible electroporation as an In Situ vaccine for pancreatic cancer',\n",
       "       'Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors',\n",
       "       'Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)',\n",
       "       'Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse',\n",
       "       'Identification of therapeutic targets of B-ALL using Boolean logic',\n",
       "       'Developing targeted therapy for Ewing sarcoma metastasis',\n",
       "       'Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L',\n",
       "       'An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target',\n",
       "       'Targeting cellular mechanotransduction in breast cancer metastasis',\n",
       "       'FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma',\n",
       "       'Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies',\n",
       "       'A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers',\n",
       "       'Understanding and Targeting NRF2 in Pancreatic Cancer',\n",
       "       'Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs',\n",
       "       'Targeting CD114 Signaling in Pediatric Medulloblastoma',\n",
       "       'Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation',\n",
       "       'Knowledge-based planning and treatment decision-making for gynecologic brachytherapy',\n",
       "       'Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling',\n",
       "       'The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies',\n",
       "       'UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer',\n",
       "       'Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain',\n",
       "       'New Therapies for Myeloid Leukemia',\n",
       "       'Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk',\n",
       "       'Precision Interception of Gastric Cancers',\n",
       "       'Epigenetic basis of platinum drug resistance in ovarian cancer',\n",
       "       'Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC',\n",
       "       'Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC',\n",
       "       'Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models',\n",
       "       'Cytotoxic Breast Cancer Treatment Effects on Aging',\n",
       "       'Targeting Stem Cell Signals in Cancer Development and Progression',\n",
       "       'Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients ',\n",
       "       'Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer',\n",
       "       'A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis',\n",
       "       'In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy',\n",
       "       'Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer',\n",
       "       'Small molecule screen for inhibitors of the GOLPH3 pathway',\n",
       "       'Applying p38 MAPK inhibitors to tackle breast cancer metastasis',\n",
       "       'Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy',\n",
       "       'Targeting imatinib-resistant, KIT-negative cells in human GISTs',\n",
       "       'Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients',\n",
       "       'Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs',\n",
       "       'KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts',\n",
       "       'Detecting dysregulated genes in neuroblastoma using allele-specific expression',\n",
       "       'A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer',\n",
       "       'Low Dose Chemotherapy for Immuno-activation in Lung Cancer',\n",
       "       'Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer',\n",
       "       'A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors',\n",
       "       'Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer',\n",
       "       'Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma',\n",
       "       'A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma',\n",
       "       'Novel Pathways Regulated by NME1 in Neuroblastoma',\n",
       "       'Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic',\n",
       "       'Microbe-Associated Colorectal Cancer (M.A.C.S)',\n",
       "       'Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures',\n",
       "       'Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer',\n",
       "       'Natural Killer Cells for Treatment of Medulloblastoma',\n",
       "       'Targeting FZD7 in human cancers',\n",
       "       'Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot',\n",
       "       'Responses of Melanoma Patients to Checkpoint Immunotherapy',\n",
       "       'Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression',\n",
       "       'Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors',\n",
       "       'Epigenetic profiling of endometrial cancer',\n",
       "       'Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials',\n",
       "       'Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors',\n",
       "       'Functional Roles for Histidine Kinase Signaling in Neuroblastoma',\n",
       "       'An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)',\n",
       "       'Novel kinase inhibitors in combination with retinoic acide for neuroblastoma',\n",
       "       'A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer',\n",
       "       'Science'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 572,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi['Project Title'].value_counts().index"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 573,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>50.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This grant and the publication that resulted (...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>129.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>196.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>197.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      ID Event Name  Award ID  \\\n",
       "0   50.0    Initial      50.1   \n",
       "1  129.0    Initial      50.2   \n",
       "2  196.0    Initial     196.1   \n",
       "3  197.0    Initial     196.2   \n",
       "\n",
       "                                       Project Title  \\\n",
       "0  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "1  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "2  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "3  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "\n",
       "                                PI Institution Other Institution  \\\n",
       "0                         Moores Cancer Center               NaN   \n",
       "1                              Rady Children's               NaN   \n",
       "2  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "3  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "   Prevention and diagnostic tools  \\\n",
       "0                            False   \n",
       "1                            False   \n",
       "2                            False   \n",
       "3                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "1                                           False   \n",
       "2                                           False   \n",
       "3                                           False   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "1                                      False                          False   \n",
       "2                                      False                          False   \n",
       "3                                      False                          False   \n",
       "\n",
       "   Pediatric cancers      Specific Aims  \\\n",
       "0               True  Two Specific Aims   \n",
       "1               True  Two Specific Aims   \n",
       "2               True  Two Specific Aims   \n",
       "3               True  Two Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Determine cellular constraints on the ability ...   \n",
       "1  Determine cellular constraints on the ability ...   \n",
       "2   Determine cellular constraints on the ability...   \n",
       "3  Determine cellular constraints on the ability ...   \n",
       "\n",
       "                                               Aim 2 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "1  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "2  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "3  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  This project aims to identify the mechanisms u...       75000.0   \n",
       "1  This project aims to identify the mechanisms u...       75000.0   \n",
       "2  This project aims to identify the mechanisms u...       75000.0   \n",
       "3  This project aims to identify the mechanisms u...       75000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2017-06-01      2018-05-31  Complete     False   \n",
       "1        2017-06-01      2018-05-31  Complete      True   \n",
       "2        2017-06-01      2018-05-31  Complete       NaN   \n",
       "3        2017-06-01      2018-05-31  Complete       NaN   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                 False   \n",
       "1                   False                                 False   \n",
       "2                     NaN                                   NaN   \n",
       "3                     NaN                                   NaN   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                           False   \n",
       "1                  False                           False   \n",
       "2                    NaN                             NaN   \n",
       "3                    NaN                             NaN   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                   True   \n",
       "1                   False                                  False   \n",
       "2                     NaN                                    NaN   \n",
       "3                     NaN                                    NaN   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False                True                       False   \n",
       "1                    False               False                       False   \n",
       "2                      NaN                 NaN                         NaN   \n",
       "3                      NaN                 NaN                         NaN   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "1                     False                                    False   \n",
       "2                       NaN                                      NaN   \n",
       "3                       NaN                                      NaN   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "1                False                                  False   \n",
       "2                  NaN                                    NaN   \n",
       "3                  NaN                                    NaN   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "1                                  False                           False   \n",
       "2                                    NaN                             NaN   \n",
       "3                                    NaN                             NaN   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "1                    False   \n",
       "2                      NaN   \n",
       "3                      NaN   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "1                                                 No       \n",
       "2                                                NaN       \n",
       "3                                                NaN       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  This grant and the publication that resulted (...                   NaN   \n",
       "1                                                NaN                   NaN   \n",
       "2                                                NaN                   NaN   \n",
       "3                                                NaN                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted First Clinical Trial  \\\n",
       "0                       0.0                  NaN   \n",
       "1                       0.0                  NaN   \n",
       "2                       0.0                  NaN   \n",
       "3                       0.0                  NaN   \n",
       "\n",
       "   First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                 NaN                   NaN   \n",
       "1                                 NaN                   NaN   \n",
       "2                                 NaN                   NaN   \n",
       "3                                 NaN                   NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN              none            No   \n",
       "1                                  NaN               NaN            No   \n",
       "2                                  NaN               NaN           NaN   \n",
       "3                                  NaN               NaN           NaN   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              One  \n",
       "1            NaN                              One  \n",
       "2            NaN                              NaN  \n",
       "3            NaN                              NaN  "
      ]
     },
     "execution_count": 573,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Apply clinical trial names adjustment function to all projects\n",
    "\n",
    "projs = roi['Project Title'].value_counts().index\n",
    "proj_data = []\n",
    "for p in projs:\n",
    "    df = adjust_cli_trials_names(roi, p)\n",
    "    proj_data.append(df)\n",
    "proj_data[3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 574,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>52.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The funding for this project and the data gene...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>131.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Obtaining funding is important for career adva...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.3</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding for this project enhanced innovative c...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>200.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>201.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>202.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.3</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>49.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>49.1</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>my appointment track does not value intramural...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Six - Ten</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>127.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>49.2</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt.</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Pedal the Cause motivated the students.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2020-135Human-centered drug discovery: A metho...</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>128.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>49.3</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt.</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Please see description of the atypical situati...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>193.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>193.1</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>194.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>193.2</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>195.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>193.3</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>44.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>44.1</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To determine whether IRE induces neoantigen-sp...</td>\n",
       "      <td>To examine the effects of IRE on the tumor mic...</td>\n",
       "      <td>To augment IRE-induced tumor-specific T-cell r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approximately 40,000 people are diagnosed with...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>These pilot projects were critical for generat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>121.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>44.2</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "      <td>LJI</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To determine whether IRE induces neoantigen-sp...</td>\n",
       "      <td>To examine the effects of IRE on the tumor mic...</td>\n",
       "      <td>To augment IRE-induced tumor-specific T-cell r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approximately 40,000 people are diagnosed with...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Pedal the Cause funding enabled me to particip...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>122.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>44.3</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To determine whether IRE induces neoantigen-sp...</td>\n",
       "      <td>To examine the effects of IRE on the tumor mic...</td>\n",
       "      <td>To augment IRE-induced tumor-specific T-cell r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approximately 40,000 people are diagnosed with...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>182.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>182.1</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To determine whether IRE induces neoantigen-sp...</td>\n",
       "      <td>To examine the effects of IRE on the tumor mic...</td>\n",
       "      <td>To augment IRE-induced tumor-specific T-cell r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approximately 40,000 people are diagnosed with...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>183.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>182.2</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "      <td>LJI</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To determine whether IRE induces neoantigen-sp...</td>\n",
       "      <td>To examine the effects of IRE on the tumor mic...</td>\n",
       "      <td>To augment IRE-induced tumor-specific T-cell r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approximately 40,000 people are diagnosed with...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>184.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>182.3</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To determine whether IRE induces neoantigen-sp...</td>\n",
       "      <td>To examine the effects of IRE on the tumor mic...</td>\n",
       "      <td>To augment IRE-induced tumor-specific T-cell r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Approximately 40,000 people are diagnosed with...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>50.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This grant and the publication that resulted (...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>129.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>196.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>197.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>161.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>161.1</td>\n",
       "      <td>Therapeutic Reprogramming of Pancreatic Cancer...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>1a. Effect of p62 or p53 stromal deficiency on...</td>\n",
       "      <td>Identify modulators of p62 or p35 activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer remains the most deadly comm...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>162.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>161.2</td>\n",
       "      <td>Therapeutic Reprogramming of Pancreatic Cancer...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>1a. Effect of p62 or p53 stromal deficiency on...</td>\n",
       "      <td>Identify modulators of p62 or p35 activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer remains the most deadly comm...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>163.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>161.3</td>\n",
       "      <td>Therapeutic Reprogramming of Pancreatic Cancer...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>1a. Effect of p62 or p53 stromal deficiency on...</td>\n",
       "      <td>Identify modulators of p62 or p35 activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer remains the most deadly comm...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>164.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>161.4</td>\n",
       "      <td>Therapeutic Reprogramming of Pancreatic Cancer...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>1a. Effect of p62 or p53 stromal deficiency on...</td>\n",
       "      <td>Identify modulators of p62 or p35 activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer remains the most deadly comm...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>51.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>51.1</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>To determine the functional significance of AD...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute lymphoblastic leukemia (ALL) is the comm...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Pedal the cause helped us to recruit five facu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Ruxolitinib with or without navitoxlax (Abbvie)</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Ruxolitinib with or without BET inhibitors (CPI)</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Aspera Biomedicines</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Please see justia patents:  https://patents.ju...</td>\n",
       "      <td>More than Ten</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>130.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>51.2</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>To determine the functional significance of AD...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute lymphoblastic leukemia (ALL) is the comm...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>198.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>198.1</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>Deciphering the Role of RNA Editing in Leukemi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute lymphoblastic leukemia (ALL) is the comm...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>199.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>198.2</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>Deciphering the Role of RNA Editing in Leukemi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute lymphoblastic leukemia (ALL) is the comm...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>53.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>53.1</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop a computational model of differentiati...</td>\n",
       "      <td>Predict and validate risk stratification in B-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>B-cell acute lymphoblastic leukemia (B-ALL) is...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Pedal the Cause motivated people to focus on r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>133.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>53.2</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop a computational model of differentiati...</td>\n",
       "      <td>Predict and validate risk stratification in B-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>B-cell acute lymphoblastic leukemia (B-ALL) is...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Discovery and translation of precursor B-cell ...</td>\n",
       "      <td>25.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>203.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>203.1</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop a computational model of differentiati...</td>\n",
       "      <td>Predict and validate risk stratification in B-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>B-cell acute lymphoblastic leukemia (B-ALL) is...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>204.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>203.2</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop a computational model of differentiati...</td>\n",
       "      <td>Predict and validate risk stratification in B-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>B-cell acute lymphoblastic leukemia (B-ALL) is...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>54.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>54.1</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>Determine the effects of targeting the neural ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ewing's sarcoma is a malignant tumor that comm...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No.</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>134.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>54.2</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>Determine the effects of targeting the neural ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ewing's sarcoma is a malignant tumor that comm...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Through this grant I was able to continue my r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>205.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>205.1</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>Determine the effects of targeting the neural ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ewing's sarcoma is a malignant tumor that comm...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>206.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>205.2</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>Determine the effects of targeting the neural ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>years of age. About 25% of patients present wi...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>45.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>45.1</td>\n",
       "      <td>Oncogenic Regulation of B-Lymphomagenesis by t...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Defining the role of DOT1L in B-lymphoma patho...</td>\n",
       "      <td>Determining the mechanistic basis of  DOT1L ac...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The epigenome is an exciting new frontier for ...</td>\n",
       "      <td>74881.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Pedal the Cause was critical to recruit and re...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>123.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>45.2</td>\n",
       "      <td>Oncogenic Regulation of B-Lymphomagenesis by t...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Defining the role of DOT1L in B-lymphoma patho...</td>\n",
       "      <td>Determining the mechanistic basis of DOT1L act...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The epigenome is an exciting new frontier for ...</td>\n",
       "      <td>74881.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Pedal the cause helped me to get my first larg...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>185.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>185.1</td>\n",
       "      <td>Oncogenic Regulation of B-Lymphomagenesis by t...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Defining the role of DOT1L in B-lymphoma patho...</td>\n",
       "      <td>Determining the mechanistic basis of  DOT1L ac...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The epigenome is an exciting new frontier for ...</td>\n",
       "      <td>74881.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>186.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>185.2</td>\n",
       "      <td>Oncogenic Regulation of B-Lymphomagenesis by t...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Defining the role of DOT1L in B-lymphoma patho...</td>\n",
       "      <td>Determining the mechanistic basis of  DOT1L ac...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The epigenome is an exciting new frontier for ...</td>\n",
       "      <td>74881.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>46.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>46.1</td>\n",
       "      <td>An over-expressed GPCR in pancreatic cancer as...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Define PCAF activities in response to GPCR act...</td>\n",
       "      <td>Develop and validate an assay to find inhibito...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic ductal adenocarcinoma (PDAC) is the...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-05-01</td>\n",
       "      <td>2018-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Data from the Pedal the Cause project encourag...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No name yet but in the process of founding a c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>A PCT was submitted in 2018: \"GPCRs in Cancer-...</td>\n",
       "      <td>Four</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>124.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>46.2</td>\n",
       "      <td>An over-expressed GPCR in pancreatic cancer as...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Define PCAF activities in response to GPCR act...</td>\n",
       "      <td>Develop and validate an assay to find inhibito...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic ductal adenocarcinoma (PDAC) is the...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-05-01</td>\n",
       "      <td>2018-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>no role in recruitment, retention or advancement</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>187.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>187.1</td>\n",
       "      <td>An over-expressed GPCR in pancreatic cancer as...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Define PCAF activities in response to GPCR act...</td>\n",
       "      <td>Develop and validate an assay to find inhibito...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic ductal adenocarcinoma (PDAC) is the...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-05-01</td>\n",
       "      <td>2018-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>188.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>187.2</td>\n",
       "      <td>An over-expressed GPCR in pancreatic cancer as...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Define PCAF activities in response to GPCR act...</td>\n",
       "      <td>Develop and validate an assay to find inhibito...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic ductal adenocarcinoma (PDAC) is the...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-05-01</td>\n",
       "      <td>2018-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>48.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>48.1</td>\n",
       "      <td>Targeting cellular mechanotransduction in brea...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the role of EPHA2 in cellular mechan...</td>\n",
       "      <td>Determine the involvement of EPHA2 and Lyn in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Breast tumors are frequently detected through ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The seed fund allow us to published and obtain...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No.</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>126.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>48.2</td>\n",
       "      <td>Targeting cellular mechanotransduction in brea...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the role of EPHA2 in cellular mechan...</td>\n",
       "      <td>Determine the involvement of EPHA2 and Lyn in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Breast tumors are frequently detected through ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Enabled initial work that eventually led to a ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>189.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>189.1</td>\n",
       "      <td>Targeting cellular mechanotransduction in brea...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the role of EPHA2 in cellular mechan...</td>\n",
       "      <td>Determine the involvement of EPHA2 and Lyn in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Breast tumors are frequently detected through ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>190.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>189.2</td>\n",
       "      <td>Targeting cellular mechanotransduction in brea...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the role of EPHA2 in cellular mechan...</td>\n",
       "      <td>Determine the involvement of EPHA2 and Lyn in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Breast tumors are frequently detected through ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>25.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>25.1</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To Determine the Response of a Panel of Ewing ...</td>\n",
       "      <td>To Investigate the Response of Ewing Sarcoma C...</td>\n",
       "      <td>To Investigate the Role of EWS-FLI1 Fusion Gen...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ewing sarcoma (ES) is a bone cancer that affec...</td>\n",
       "      <td>99988.00</td>\n",
       "      <td>2019-06-01</td>\n",
       "      <td>2020-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The Pedal the Cause funding was instrumental f...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>89.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>25.2</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To Determine the Response of a Panel of Ewing ...</td>\n",
       "      <td>To Investigate the Response of Ewing Sarcoma C...</td>\n",
       "      <td>To Investigate the Role of EWS-FLI1 Fusion Gen...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ewing sarcoma (ES) is a bone cancer that affec...</td>\n",
       "      <td>99988.00</td>\n",
       "      <td>2019-06-01</td>\n",
       "      <td>2020-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>It was an important for initiating a research ...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>90.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>25.3</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To Determine the Response of a Panel of Ewing ...</td>\n",
       "      <td>To Investigate the Response of Ewing Sarcoma C...</td>\n",
       "      <td>To Investigate the Role of EWS-FLI1 Fusion Gen...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Ewing sarcoma (ES) is a bone cancer that affec...</td>\n",
       "      <td>99988.00</td>\n",
       "      <td>2019-06-01</td>\n",
       "      <td>2020-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>125.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>47.2</td>\n",
       "      <td>Identification of genes critical for the produ...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Use a genome-wide CRISPR-Cas9 screen in hESC c...</td>\n",
       "      <td>Validate and assess tumor-killing capacity of ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>While anti-cancer therapies continue to improv...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>It was beneficial to the recruitment of person...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>191.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>191.1</td>\n",
       "      <td>Identification of genes critical for the produ...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Use a genome-wide CRISPR-Cas9 screen in hESC c...</td>\n",
       "      <td>Validate and assess tumor killing capacity of ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>While anti-cancer therapies continue to improv...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>192.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>191.2</td>\n",
       "      <td>Identification of genes critical for the produ...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Use a genome-wide CRISPR-Cas9 screen in hESC c...</td>\n",
       "      <td>Validate and assess tumor killing capacity of ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>While anti-cancer therapies continue to improv...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>39.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>39.1</td>\n",
       "      <td>A Phase 1b Safety and Feasibility Study of Per...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Conduct a phase 1b clinical trial to assess do...</td>\n",
       "      <td>Characterize the vaccine contribution to T cel...</td>\n",
       "      <td>Determine the extent of epitope spreading seco...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immunotherapy has produced a paradigm shift in...</td>\n",
       "      <td>150000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The funds were critical in advancing the caree...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NCT05153304  Protocol PCV-001  A Phase I/II Sa...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, Lykeion</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Patent filed for the neoantigen discovery and ...</td>\n",
       "      <td>Six - Ten</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>114.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>39.2</td>\n",
       "      <td>A Phase 1b Safety and Feasibility Study of Per...</td>\n",
       "      <td>LJI</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Conduct a phase 1b clinical trial to assess do...</td>\n",
       "      <td>Characterize the vaccine contribution to T cel...</td>\n",
       "      <td>Determine the extent of epitope spreading seco...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immunotherapy has produced a paradigm shift in...</td>\n",
       "      <td>150000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>115.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>39.3</td>\n",
       "      <td>A Phase 1b Safety and Feasibility Study of Per...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Conduct a phase 1b clinical trial to assess do...</td>\n",
       "      <td>Characterize the vaccine contribution to T cel...</td>\n",
       "      <td>Determine the extent of epitope spreading seco...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immunotherapy has produced a paradigm shift in...</td>\n",
       "      <td>150000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>34.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>34.1</td>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine how NRF2 shapes pancreatic cancer ce...</td>\n",
       "      <td>Examine the ability of MDM2 inhibitors to indu...</td>\n",
       "      <td>Examine whether bioreactive prodrugs that are ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>We have identified a protein that is called NR...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Track Code: 2020-263-2PCT  Application Number:...</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>103.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>34.2</td>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine how NRF2 shapes pancreatic cancer ce...</td>\n",
       "      <td>Examine the ability of MDM2 inhibitors to indu...</td>\n",
       "      <td>Examine whether bioreactive prodrugs that are ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>We have identified a protein that is called NR...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>104.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>34.3</td>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine how NRF2 shapes pancreatic cancer ce...</td>\n",
       "      <td>Examine the ability of MDM2 inhibitors to indu...</td>\n",
       "      <td>Examine whether bioreactive prodrugs that are ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>We have identified a protein that is called NR...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>154.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>154.1</td>\n",
       "      <td>Highly selective, synthetic, cleavage specific...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Design and test the QD-FRET MMP-8 and MMP-9 na...</td>\n",
       "      <td>Demonstrate low levels, if any, of the off-tar...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>There is consensus among professionals that ma...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>155.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>154.2</td>\n",
       "      <td>Highly selective, synthetic, cleavage specific...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Design and test the QD-FRET MMP-8 and MMP-9 na...</td>\n",
       "      <td>Demonstrate low levels, if any, of the off-tar...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>There is consensus among professionals that ma...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>156.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>154.3</td>\n",
       "      <td>Highly selective, synthetic, cleavage specific...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Design and test the QD-FRET MMP-8 and MMP-9 na...</td>\n",
       "      <td>Demonstrate low levels, if any, of the off-tar...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>There is consensus among professionals that ma...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-16</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>28.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>28.1</td>\n",
       "      <td>Targeting CD114 Signaling in Pediatric Medullo...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the prognostic relevance of CD114 exp...</td>\n",
       "      <td>Evaluate the efficacy of targeting intracellul...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk, aggressive forms of m...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>96.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>28.2</td>\n",
       "      <td>Targeting CD114 Signaling in Pediatric Medullo...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the prognostic relevance of CD114 exp...</td>\n",
       "      <td>Evaluate the efficacy of targeting intracellul...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk, aggressive forms of m...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>97.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>28.3</td>\n",
       "      <td>Targeting CD114 Signaling in Pediatric Medullo...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the prognostic relevance of CD114 exp...</td>\n",
       "      <td>Evaluate the efficacy of targeting intracellul...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk, aggressive forms of m...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>26.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>26.1</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To test the hypothesis that the heat shock fro...</td>\n",
       "      <td>To test the hypothesis that combining iPTA wit...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Liver cancer, or hepatocellular carcinoma (HCC...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>It enabled me to continue and advance my resea...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>92.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>26.2</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To test the hypothesis that the heat shock fro...</td>\n",
       "      <td>To test the hypothesis that combining iPTA wit...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Liver cancer, or hepatocellular carcinoma (HCC...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Two Radiology residents who worked on the proj...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>93.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>26.3</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To test the hypothesis that the heat shock fro...</td>\n",
       "      <td>To test the hypothesis that combining iPTA wit...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Liver cancer, or hepatocellular carcinoma (HCC...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The fund allowed a BS/MS student complete the ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>27.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>27.1</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To prepare the ML training pipeline, we will p...</td>\n",
       "      <td>We will utilize established ML methods to trai...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brachytherapy is a treatment in which radiatio...</td>\n",
       "      <td>71979.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>It allowed me to a hire a programmer just out ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Four</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>94.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>27.2</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To prepare the ML training pipeline, we will p...</td>\n",
       "      <td>We will utilize established ML methods to trai...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brachytherapy is a treatment in which radiatio...</td>\n",
       "      <td>71979.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>It allowed us to a hire a programmer just out ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Four</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>95.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>27.3</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To prepare the ML training pipeline, we will p...</td>\n",
       "      <td>We will utilize established ML methods to trai...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brachytherapy is a treatment in which radiatio...</td>\n",
       "      <td>71979.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Collaboration with Sandra Meyers PhD physics i...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Four</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>22.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>22.1</td>\n",
       "      <td>Identification of regulatory programs for glio...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify the regulatory programs that distingu...</td>\n",
       "      <td>Uncover the chromatin architecture dynamics of...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cell type heterogeneity is a major contributor...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The project was carried out by my technical staff</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>84.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>22.2</td>\n",
       "      <td>Identification of regulatory programs for glio...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify the regulatory programs that distingu...</td>\n",
       "      <td>Uncover the chromatin architecture dynamics of...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cell type heterogeneity is a major contributor...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>85.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>22.3</td>\n",
       "      <td>Identification of regulatory programs for glio...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify the regulatory programs that distingu...</td>\n",
       "      <td>Uncover the chromatin architecture dynamics of...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cell type heterogeneity is a major contributor...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>I think obtaining funding is important for car...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>179.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>179.1</td>\n",
       "      <td>The GNAS-PKA Onco-Signaling Network in Colorec...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>We will define the contribution of the GNAS-PK...</td>\n",
       "      <td>We will perform a structure/function analysis ...</td>\n",
       "      <td>We will establish the PKA oncogenic transcript...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Every year &gt;135,000 Americans and more than 1....</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>180.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>179.2</td>\n",
       "      <td>The GNAS-PKA Onco-Signaling Network in Colorec...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>We will define the contribution of the GNAS-PK...</td>\n",
       "      <td>We will perform a structure/function analysis ...</td>\n",
       "      <td>We will establish the PKA oncogenic transcript...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Every year &gt;135,000 Americans and more than 1....</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>181.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>179.3</td>\n",
       "      <td>The GNAS-PKA Onco-Signaling Network in Colorec...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>We will define the contribution of the GNAS-PK...</td>\n",
       "      <td>We will perform a structure/function analysis ...</td>\n",
       "      <td>We will establish the PKA oncogenic transcript...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Every year &gt;135,000 Americans and more than 1....</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>Neoadjuvant Immunoradiotherapy in Head &amp; Neck ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>61.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.2</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding out un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>62.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.3</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>17.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>17.1</td>\n",
       "      <td>Improved Echocardiographic Diagnosis of Anthra...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To determine the utility of GLS in conjunction...</td>\n",
       "      <td>To explore the association of MRI-LVEF with GL...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Due to high survival rates and long life expec...</td>\n",
       "      <td>99992.00</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2021-08-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Pedal the Cause funding has allowed me to gene...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Four</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>78.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>17.2</td>\n",
       "      <td>Improved Echocardiographic Diagnosis of Anthra...</td>\n",
       "      <td>Other</td>\n",
       "      <td>City of Hope</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To determine the utility of GLS in conjunction...</td>\n",
       "      <td>To explore the association of MRI-LVEF with GL...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Due to high survival rates and long life expec...</td>\n",
       "      <td>99992.00</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2021-08-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This is not applicable to me. It's more applic...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>79.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>17.3</td>\n",
       "      <td>Improved Echocardiographic Diagnosis of Anthra...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To determine the utility of GLS in conjunction...</td>\n",
       "      <td>To explore the association of MRI-LVEF with GL...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Due to high survival rates and long life expec...</td>\n",
       "      <td>99992.00</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2021-08-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>9.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>9.1</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine if inhibitory Tspan3 mAb impairs the...</td>\n",
       "      <td>Identify biomarkers predictive of response to ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Myelogenous Leukemia (AML) is a cancer m...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2020-02-01</td>\n",
       "      <td>2021-01-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>timeline not applicable</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>65.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>9.2</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine if inhibitory Tspan3 mAb impairs the...</td>\n",
       "      <td>Identify biomarkers predictive of response to ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Myelogenous Leukemia (AML) is a cancer m...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2020-02-01</td>\n",
       "      <td>2021-01-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>66.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>9.3</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine if inhibitory Tspan3 mAb impairs the...</td>\n",
       "      <td>Identify biomarkers predictive of response to ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Myelogenous Leukemia (AML) is a cancer m...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2020-02-01</td>\n",
       "      <td>2021-01-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>My role on this project is to help with patien...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>174.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>174.1</td>\n",
       "      <td>Mechanisms Linking Prolonged Nightly Fasting w...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>fasting insulin concentration and glycemic reg...</td>\n",
       "      <td>inflammation (CRP)</td>\n",
       "      <td>body mass index, sleep duration and quality, a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Obesity is epidemic, thus, identification and ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>175.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>174.2</td>\n",
       "      <td>Mechanisms Linking Prolonged Nightly Fasting w...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>fasting insulin concentration and glycemic reg...</td>\n",
       "      <td>inflammation (CRP)</td>\n",
       "      <td>body mass index, sleep duration and quality, a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Obesity is epidemic, thus, identification and ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>176.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>174.3</td>\n",
       "      <td>Mechanisms Linking Prolonged Nightly Fasting w...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>fasting insulin concentration and glycemic reg...</td>\n",
       "      <td>inflammation (CRP)</td>\n",
       "      <td>body mass index, sleep duration and quality, a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Obesity is epidemic, thus, identification and ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>11.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>11.1</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Network-guided target Identification and prior...</td>\n",
       "      <td>Validation of network-prioritized targets usin...</td>\n",
       "      <td>Phase '0' proof-of-concept trials testing the ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A team of researchers comprised of engineers, ...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>69.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>11.2</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Network-guided target Identification and prior...</td>\n",
       "      <td>Validation of network-prioritized targets usin...</td>\n",
       "      <td>Phase '0' proof-of-concept trials testing the ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A team of researchers comprised of engineers, ...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>I was recently promoted to Professor Step 9.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>N/A.</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>137.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>11.3</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Network-guided target identification and prior...</td>\n",
       "      <td>Validation of network-prioritized targets usin...</td>\n",
       "      <td>Phase '0' proof-of-concept trials testing the ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A team of researchers comprised of engineers, ...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Incomplete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>169.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>169.1</td>\n",
       "      <td>Epigenetic basis of platinum drug resistance i...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify regions differentially methylated in ...</td>\n",
       "      <td>Validate resistance-associated regulatory chan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Platinum drug resistance is a serious clinical...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>170.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>169.2</td>\n",
       "      <td>Epigenetic basis of platinum drug resistance i...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify regions differentially methylated in ...</td>\n",
       "      <td>Validate resistance-associated regulatory chan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Platinum drug resistance is a serious clinical...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>171.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>169.3</td>\n",
       "      <td>Epigenetic basis of platinum drug resistance i...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify regions differentially methylated in ...</td>\n",
       "      <td>Validate resistance-associated regulatory chan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Platinum drug resistance is a serious clinical...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>12.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>12.1</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To test ULK1 inhibitor +/- standard of care fo...</td>\n",
       "      <td>To test ULK1 inhibitor +/- standard of care ch...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lung cancer is the number 1 cause of cancer de...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Provided an opportunity for continue research ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>70.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>12.2</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To test ULK1 inhibitor +/- standard of care fo...</td>\n",
       "      <td>To test ULK1 inhibitor +/- standard of care ch...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lung cancer is the number 1 cause of cancer de...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>A new graduate student joined my lab in 2021 a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Endeavor Biomedicines licensed this program an...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>71.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>12.3</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To test ULK1 inhibitor +/- standard of care fo...</td>\n",
       "      <td>To test ULK1 inhibitor +/- standard of care ch...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lung cancer is the number 1 cause of cancer de...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>I was already tenured and Director of the Salk...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Endeavor Biomedicines licensed this program an...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>13.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>13.1</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To identify NeoAntigen (NeoAg)-specific CD4+ a...</td>\n",
       "      <td>To characterize the TCR repertoires of NeoAg-s...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A breakthrough in cancer treatment are drugs a...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>I was recruited to Salk prior to the obtaining...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>72.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>13.2</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "      <td>LJI</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To identify NeoAntigen (NeoAg)-specific CD4+ a...</td>\n",
       "      <td>To characterize the TCR repertoires of NeoAg-s...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A breakthrough in cancer treatment are drugs a...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>73.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>13.3</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To identify NeoAntigen (NeoAg)-specific CD4+ a...</td>\n",
       "      <td>To characterize the TCR repertoires of NeoAg-s...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A breakthrough in cancer treatment are drugs a...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>I was recruited to Salk prior to the obtaining...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No companies</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>14.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>14.1</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Delineate unique molecular features of chronic...</td>\n",
       "      <td>Define transformation potential in the backgro...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer (PDA) is a deadly malignancy...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is an important project for our research ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>75.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>14.3</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Delineate unique molecular features of chronic...</td>\n",
       "      <td>Define transformation potential in the backgro...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer (PDA) is a deadly malignancy...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>It is an important part of my advancement and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>136.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>14.2</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Incomplete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This funding was important for my midterm eval...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>157.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>157.1</td>\n",
       "      <td>Cytotoxic Breast Cancer Treatment Effects on A...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To compare the change of laboratory-based bloo...</td>\n",
       "      <td>To investigate the effects of breast cancer ch...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>With a growing aging U.S. population and an ex...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>158.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>157.2</td>\n",
       "      <td>Cytotoxic Breast Cancer Treatment Effects on A...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To compare the change of laboratory-based bloo...</td>\n",
       "      <td>To investigate the effects of breast cancer ch...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>With a growing aging U.S. population and an ex...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>172.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>172.1</td>\n",
       "      <td>Targeting Stem Cell Signals in Cancer Developm...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Perform high throughput screening of targeted ...</td>\n",
       "      <td>Test the efficacy of compounds on AML growth</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To identify new therapeutic targets for cancer...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>173.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>172.2</td>\n",
       "      <td>Targeting Stem Cell Signals in Cancer Developm...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Perform high throughput screening of targeted ...</td>\n",
       "      <td>Test the efficacy of compounds on AML growth</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To identify new therapeutic targets for cancer...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>177.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>177.1</td>\n",
       "      <td>Detecting Correlates of Vaccine Responses in A...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine the dynamics of the antibody respons...</td>\n",
       "      <td>Determine the dynamics of germinal center acti...</td>\n",
       "      <td>Determine the vaccine-specific CD4+ T cell res...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Vaccines decrease the risk of infection by wor...</td>\n",
       "      <td>74999.51</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>178.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>177.2</td>\n",
       "      <td>Detecting Correlates of Vaccine Responses in A...</td>\n",
       "      <td>LJI</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine the dynamics of the antibody respons...</td>\n",
       "      <td>Determine the dynamics of germinal center acti...</td>\n",
       "      <td>Determine the vaccine-specific CD4+ T cell res...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Vaccines decrease the risk of infection by wor...</td>\n",
       "      <td>74999.51</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>140.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>140.1</td>\n",
       "      <td>Targeting fibroblast heterogeneity to improve ...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Improving outcomes for fluorescence-guided sur...</td>\n",
       "      <td>Determine the contribution of fibroblast heter...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Currently, the only curative treatment for pan...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-18</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>141.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>140.2</td>\n",
       "      <td>Targeting fibroblast heterogeneity to improve ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Improving outcomes for fluorescence-guided sur...</td>\n",
       "      <td>Determine the contribution of fibroblast heter...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Currently, the only curative treatment for pan...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>138.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>138.1</td>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the prognostic relevance of NME1 exp...</td>\n",
       "      <td>Evaluate the functional role of NME1 histidine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>139.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>138.2</td>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the prognostic relevance of NME1 exp...</td>\n",
       "      <td>Evaluate the functional role of NME1 histidine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>159.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>159.1</td>\n",
       "      <td>In Vivo Modeling of Anti-Tumor Responses of Hu...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To assess the anti-tumor responses of melanoma...</td>\n",
       "      <td>To address the impact of immunotherapy with mA...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Melanoma skin cancer is a deadly disease that ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>160.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>159.2</td>\n",
       "      <td>In Vivo Modeling of Anti-Tumor Responses of Hu...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To assess the anti-tumor responses of melanoma...</td>\n",
       "      <td>To address the impact of immunotherapy with mA...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Melanoma skin cancer is a deadly disease that ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>142.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>142.1</td>\n",
       "      <td>Protein Kinase C as a Novel Biomarker and Targ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Does enhancing PKC protein levels inhibit viab...</td>\n",
       "      <td>What is the mechanism by which high PKC protei...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer remains one of the deadliest...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2020-01-15</td>\n",
       "      <td>2021-01-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>143.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>142.2</td>\n",
       "      <td>Protein Kinase C as a Novel Biomarker and Targ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Does enhancing PKC protein levels inhibit viab...</td>\n",
       "      <td>What is the mechanism by which high PKC protei...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer remains one of the deadliest...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2020-01-15</td>\n",
       "      <td>2021-01-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>144.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>144.1</td>\n",
       "      <td>Small molecule screen for inhibitors of the GO...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Use the current moderate throughput assay to s...</td>\n",
       "      <td>Re-tool the assay for a HTS in the CLS C3 shar...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To more effectively combat cancer we need new ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2014-05-01</td>\n",
       "      <td>2015-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>145.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>144.2</td>\n",
       "      <td>Small molecule screen for inhibitors of the GO...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Use the current moderate throughput assay to s...</td>\n",
       "      <td>Re-tool the assay for a HTS in the CLS C3 shar...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To more effectively combat cancer we need new ...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2014-05-01</td>\n",
       "      <td>2015-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>146.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>146.1</td>\n",
       "      <td>Applying p38 MAPK inhibitors to tackle breast ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Investigate the mechanisms through which Ubc13...</td>\n",
       "      <td>Define metastasis gene signatures that are con...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The spread of cancer cells from the primary tu...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2014-08-01</td>\n",
       "      <td>2015-07-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>147.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>146.2</td>\n",
       "      <td>Applying p38 MAPK inhibitors to tackle breast ...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Investigate the mechanisms through which Ubc13...</td>\n",
       "      <td>Define metastasis gene signatures that are con...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The spread of cancer cells from the primary tu...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2014-08-01</td>\n",
       "      <td>2015-07-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>148.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>148.1</td>\n",
       "      <td>Stromal reprogramming to enhance the effective...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine the impact of stromal p53 activation...</td>\n",
       "      <td>Determine whether PCs reduce p53 activation in...</td>\n",
       "      <td>Test the therapeutic benefit of stromal reprog...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Our project, \"Reprogramming the stroma of panc...</td>\n",
       "      <td>74757.00</td>\n",
       "      <td>2014-05-01</td>\n",
       "      <td>2015-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>149.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>148.2</td>\n",
       "      <td>Stromal reprogramming to enhance the effective...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine the impact of stromal p53 activation...</td>\n",
       "      <td>Determine whether PCs reduce p53 activation in...</td>\n",
       "      <td>Test the therapeutic benefit of stromal reprog...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Our project, \"Reprogramming the stroma of panc...</td>\n",
       "      <td>74757.00</td>\n",
       "      <td>2014-05-01</td>\n",
       "      <td>2015-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>150.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>150.1</td>\n",
       "      <td>Targeting imatinib-resistant, KIT-negative cel...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine whether imatinib-resistant, KITneg c...</td>\n",
       "      <td>Define the molecular properties of imatinib-r...</td>\n",
       "      <td>Identify strategies for targeting imatinib-res...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal Stromal Tumor (GIST) is a can...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2014-06-01</td>\n",
       "      <td>2015-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>151.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>150.2</td>\n",
       "      <td>Targeting imatinib-resistant, KIT-negative cel...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine whether imatinib-resistant, KITneg c...</td>\n",
       "      <td>Define the molecular properties of imatinib-re...</td>\n",
       "      <td>Identify strategies for targeting imatinib-res...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal Stromal Tumor (GIST) is a can...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2014-06-01</td>\n",
       "      <td>2015-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>152.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>152.1</td>\n",
       "      <td>Demonstrating the Clinical Utility of Whole Ex...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Successfully sequence the exomes of a UCSD pat...</td>\n",
       "      <td>Use state of the art bioinformatics methods to...</td>\n",
       "      <td>Translate the finding to clinical care by havi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Breast cancer in young women often has a genet...</td>\n",
       "      <td>18288.00</td>\n",
       "      <td>2014-05-01</td>\n",
       "      <td>2015-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>153.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>152.2</td>\n",
       "      <td>Demonstrating the Clinical Utility of Whole Ex...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Successfully sequence the exomes of a UCSD pat...</td>\n",
       "      <td>Use state of the art bioinformatics methods to...</td>\n",
       "      <td>Translate the finding to clinical care by havi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Breast cancer in young women often has a genet...</td>\n",
       "      <td>18288.00</td>\n",
       "      <td>2014-05-01</td>\n",
       "      <td>2015-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>167.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>167.1</td>\n",
       "      <td>Targeting KRAS mutant lung cancer with biphosp...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Phase II pilot study of zoledronate in combina...</td>\n",
       "      <td>Investigation of bisphosphonates/statins and r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lung cancer is the most common human malignanc...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>168.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>167.2</td>\n",
       "      <td>Targeting KRAS mutant lung cancer with biphosp...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Phase II pilot study of zoledronate in combina...</td>\n",
       "      <td>Investigation of bisphosphonates/statins and r...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Lung cancer is the most common human malignanc...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>2017-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>165.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>165.1</td>\n",
       "      <td>KRAS Addiction and Protein Biomarkers of Respo...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Investigate the effects of mut-KRAS inhibition...</td>\n",
       "      <td>To investigate the in vivo antitumor and bioma...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In approximately 25% of lung cancer, the speci...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>166.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>165.2</td>\n",
       "      <td>KRAS Addiction and Protein Biomarkers of Respo...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Investigate the effects of mut-KRAS inhibition...</td>\n",
       "      <td>To investigate the in vivo antitumor and bioma...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In approximately 25% of lung cancer, the speci...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>2016-04-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>3.1</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify genes that are dysregulated in neurob...</td>\n",
       "      <td>Identify and characterize de novo germline and...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved knowledge of the genetic mutations th...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PPTC funding allowed a postdoctoral resear...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>82.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>3.2</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify genes that are dysregulated in neurob...</td>\n",
       "      <td>Identify and characterize de novo germline and...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Neuroblastoma is a devastating cancer of the s...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Working on this grant and project has been par...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>40.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>40.1</td>\n",
       "      <td>A Phase 1b pilot clinical trial of cirmtuzumab...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To determine the safety and tolerability durin...</td>\n",
       "      <td>To determine the safety and tolerability of ci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Despite recent advances as of 2018, breast can...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This collaboration emerged from development of...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>117.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>40.2</td>\n",
       "      <td>A Phase 1b pilot clinical trial of cirmtuzumab...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To determine the safety and tolerability durin...</td>\n",
       "      <td>To determine the safety and tolerability of ci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Despite recent advances as of 2018, breast can...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2022-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>I applied for accelerated advancement from Ass...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A Phase 1b Trial of Cirmtuzumab and Paclitaxel...</td>\n",
       "      <td>15.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No companies were founded as a result of my tr...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>43.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>43.1</td>\n",
       "      <td>Low Dose Chemotherapy for Immuno-activation in...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To investigate the effects of low dose immunog...</td>\n",
       "      <td>To investigate the patient-derived samples for...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immune checkpoint inhibitors are a new class o...</td>\n",
       "      <td>150000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Provided an opportunity to continue research g...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Nivolumab and Ipilimumab in Combination With I...</td>\n",
       "      <td>19.0</td>\n",
       "      <td>NIVOLUMAB (ANTI-PD1 ANTIBODY) AND IPILIMUMAB (...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>120.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>43.2</td>\n",
       "      <td>Low Dose Chemotherapy for Immuno-activation in...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To investigate the effects of low dose immunog...</td>\n",
       "      <td>To investigate the patient-derived samples for...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immune checkpoint inhibitors are a new class o...</td>\n",
       "      <td>150000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>19.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None.</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>42.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>42.1</td>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To investigate the safety and efficacy of radi...</td>\n",
       "      <td>To prospectively characterize germline and som...</td>\n",
       "      <td>To phenotypically and molecularly profile chan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic castration-resistant prostate cance...</td>\n",
       "      <td>150000.00</td>\n",
       "      <td>2018-11-01</td>\n",
       "      <td>2020-10-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A Phase 1/2 Study of Combination Olaparib and ...</td>\n",
       "      <td>72.0</td>\n",
       "      <td>NCI10096 ClinicalTrials.gov Identifier:  NCT03...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>119.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>42.2</td>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To investigate the safety and efficacy of radi...</td>\n",
       "      <td>To prospectively characterize germline and som...</td>\n",
       "      <td>To phenotypically and molecularly profile chan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic castration-resistant prostate cance...</td>\n",
       "      <td>150000.00</td>\n",
       "      <td>2018-11-01</td>\n",
       "      <td>2020-10-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>5.1</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the safety, dose-limiting toxicities...</td>\n",
       "      <td>Identify biomarkers predictive of patient resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk and recurrent solid tu...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>60.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>5.2</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the safety, dose-limiting toxicities...</td>\n",
       "      <td>Identify biomarkers predictive of patient resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk and recurrent solid tu...</td>\n",
       "      <td>200000.00</td>\n",
       "      <td>2020-12-01</td>\n",
       "      <td>2022-11-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>10.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>10.1</td>\n",
       "      <td>Peptide Targeted Delivery of Epigenetic Therap...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Tumor-targeted delivery of bromodomain inhibit...</td>\n",
       "      <td>Overcome immunosuppression through peptide tar...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer is a devastating disease wit...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2021-08-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>67.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>10.2</td>\n",
       "      <td>Peptide Targeted Delivery of Epigenetic Therap...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Tumor-targeted delivery of bromodomain inhibit...</td>\n",
       "      <td>Overcome immunosuppression through peptide tar...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pancreatic cancer is a devastating disease wit...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-09-01</td>\n",
       "      <td>2021-08-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None at this time</td>\n",
       "      <td>Yes</td>\n",
       "      <td>N/A</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>15.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>15.1</td>\n",
       "      <td>Elucidating the role of Syk kinase and Syk inh...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>We will dissect the role of macrophage Syk Kin...</td>\n",
       "      <td>We will determine if inhibition of Syk kinase ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Neuroblastoma is a cancer that develops in cer...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Mehreen Ishfaq was a visiting graduate student...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>76.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>15.2</td>\n",
       "      <td>Elucidating the role of Syk kinase and Syk inh...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>We will dissect the role of macrophage Syk Kin...</td>\n",
       "      <td>We will determine if inhibition of Syk kinase ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Neuroblastoma is a cancer that develops in cer...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>16.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>16.1</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the feasibility, safety and efficacy...</td>\n",
       "      <td>Test whether patient-derived xenografts can be...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medulloblastoma is the most common malignant b...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The grant was critical in my initial retention...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Individualized therapy for refractory medullob...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>77.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>16.2</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the feasibility, safety and efficacy...</td>\n",
       "      <td>Test whether patient-derived xenografts can be...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Medulloblastoma is the most common malignant b...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>18.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>18.1</td>\n",
       "      <td>Novel Pathways Regulated by NME1 in Neuroblastoma</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify and validate genes and intracellular ...</td>\n",
       "      <td>Evaluate the functional role of NME1 and NME1-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma tumors ...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>80.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>18.2</td>\n",
       "      <td>Novel Pathways Regulated by NME1 in Neuroblastoma</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify and validate genes and intracellular ...</td>\n",
       "      <td>Evaluate the functional role of NME1 and NME1-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma tumors ...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2020-07-01</td>\n",
       "      <td>2021-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>20.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>20.1</td>\n",
       "      <td>Characterization of a GOLPH3 Pathway Inhibitor...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine the critical kinase target of MLS1377</td>\n",
       "      <td>Develop more potent, specific, and drug-like s...</td>\n",
       "      <td>Determine ADME/PK for improved analogs of MLS1377</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To more effectively combat cancer we need new ...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-07-01</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>83.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>20.2</td>\n",
       "      <td>Characterization of a GOLPH3 Pathway Inhibitor...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Determine the critical kinase target of MLS1377</td>\n",
       "      <td>Develop more potent, specific, and drug-like s...</td>\n",
       "      <td>Determine ADME/PK for improved analogs of MLS1377</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To more effectively combat cancer we need new ...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-07-01</td>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>21.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>21.1</td>\n",
       "      <td>Microbe-Associated Colorectal Cancer (M.A.C.S)</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Model infection-inflammation-driven polyp-to-C...</td>\n",
       "      <td>Determine the prognostic impact of the MACS vi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This proposal revolves around the discovery, c...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>108.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>21.2</td>\n",
       "      <td>Microbe-Associated Colorectal Cancer (M.A.C.S)</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Model infection-inflammation-driven polyp-to-C...</td>\n",
       "      <td>Determine the prognostic impact of the MACS vi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This proposal revolves around the discovery, c...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The opportunity to set up collaborations with ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>23.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>23.1</td>\n",
       "      <td>Evaluation of carcinogen exposure via genome-w...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop a model to predict exposure from Ad-Se...</td>\n",
       "      <td>Associate specimen Ad-Seq profiles to risk fac...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Multiple organs of the body are constantly exp...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Any grant award helps with Advancement and aca...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>86.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>23.2</td>\n",
       "      <td>Evaluation of carcinogen exposure via genome-w...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop a model to predict exposure from Ad-Se...</td>\n",
       "      <td>Associate specimen Ad-Seq profiles to risk fac...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Multiple organs of the body are constantly exp...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>24.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>24.1</td>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Characterize the burden and genetic profile of...</td>\n",
       "      <td>Examine the effect of metformin on the clonal ...</td>\n",
       "      <td>Describe the clinical significance of therapy-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clonal hematopoiesis describes a common pre-ca...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-03-02</td>\n",
       "      <td>2020-03-01</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>It provided the sole support for this project ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>88.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>24.2</td>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Characterize the burden and genetic profile of...</td>\n",
       "      <td>Examine the effect of metformin on the clonal ...</td>\n",
       "      <td>Describe the clinical significance of therapy-...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Clonal hematopoiesis describes a common pre-ca...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-03-02</td>\n",
       "      <td>2020-03-01</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>29.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>29.1</td>\n",
       "      <td>Natural Killer Cells for Treatment of Medullob...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine whether MB cells are susceptible to ...</td>\n",
       "      <td>Test whether NK cells can be used for immunoth...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immunotherapy is emerging as a powerful approa...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>98.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>29.2</td>\n",
       "      <td>Natural Killer Cells for Treatment of Medullob...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine whether MB cells are susceptible to ...</td>\n",
       "      <td>Test whether NK cells can be used for immunoth...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immunotherapy is emerging as a powerful approa...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>30.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>30.1</td>\n",
       "      <td>Targeting FZD7 in human cancers</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Characterizing the anti-FZD7 antibody and FZD7...</td>\n",
       "      <td>Using the anti-FZD7 antibody to block growth o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A major shortcoming of current cancer therapie...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The initial studies supported by Pedal the Cau...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Patent No.: US 10,766,962</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>99.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>30.2</td>\n",
       "      <td>Targeting FZD7 in human cancers</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Characterizing the anti-FZD7 antibody and FZD7...</td>\n",
       "      <td>Using the anti-FZD7 antibody to block growth o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A major shortcoming of current cancer therapie...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Myan Do, a PhD candidate at UCSD, was the firs...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No, because product is licensed to Pfizer</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The epitope and the sequence of the antibody w...</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>31.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>31.1</td>\n",
       "      <td>Inducing Cytosolic Chromatin Fragments in Canc...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify compounds that induce CCF and anti-tu...</td>\n",
       "      <td>Determine the in vivo impact of low and high C...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immune therapy is a method to treat cancer usi...</td>\n",
       "      <td>124972.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>It helped support my laboratory and provide br...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>100.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>31.2</td>\n",
       "      <td>Inducing Cytosolic Chromatin Fragments in Canc...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify compounds that induce CCF and anti-tu...</td>\n",
       "      <td>Determine the in vivo impact of low and high C...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immune therapy is a method to treat cancer usi...</td>\n",
       "      <td>124972.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Progress made was able to support a successful...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>32.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>32.1</td>\n",
       "      <td>Responses of Melanoma Patients to Checkpoint I...</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To assess the anti-tumor responses of melanoma...</td>\n",
       "      <td>To determine if PSGL-1 can be targeted in huma...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Advances in immunotherapy for cancer have yiel...</td>\n",
       "      <td>119768.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This funding allowed a senior postdoctoral fel...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No companies have been established.</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>101.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>32.2</td>\n",
       "      <td>Responses of Melanoma Patients to Checkpoint I...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>To assess the anti-tumor responses of melanoma...</td>\n",
       "      <td>To determine if PSGL-1 can be targeted in huma...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Advances in immunotherapy for cancer have yiel...</td>\n",
       "      <td>119768.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Supports my academic advancement</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Patent was filed prior to study. \"L. Bradley a...</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>33.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>33.1</td>\n",
       "      <td>Enhanced Breast Cancer Risk Prediction from Im...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify genes and regulatory network modules ...</td>\n",
       "      <td>Develop a network-informed genetic risk score ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Early detection remains the strongest determin...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This grant was mentioned in my my tenure packa...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>102.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>33.2</td>\n",
       "      <td>Enhanced Breast Cancer Risk Prediction from Im...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify genes and regulatory network modules ...</td>\n",
       "      <td>Develop a network-informed genetic risk score ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Early detection remains the strongest determin...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The Carter and McVicker laboratories were able...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>35.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>35.1</td>\n",
       "      <td>Targeting A Therapeutic Vulnerability in PTEN-...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop intracellular DAXX-H3.3 Protein-Protei...</td>\n",
       "      <td>Interrogate DAXX-H3.3 PPI through peptide-medi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Glioblastoma (GBM), the most common primary br...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This grant was part of my portfolio for a 2 st...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>110.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>35.2</td>\n",
       "      <td>Targeting A Therapeutic Vulnerability in PTEN-...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop intracellular DAXX-H3.3 Protein-Protei...</td>\n",
       "      <td>Interrogate DAXX-H3.3 PPI through peptide-medi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Glioblastoma (GBM), the most common primary br...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>36.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>36.1</td>\n",
       "      <td>Epigenetic profiling of endometrial cancer</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover and define molecular subtypes in EC t...</td>\n",
       "      <td>Discover transcriptional networks in ECs throu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Endometrial Cancer is the fourth most common c...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>111.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>36.2</td>\n",
       "      <td>Epigenetic profiling of endometrial cancer</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover and define molecular subtypes in EC t...</td>\n",
       "      <td>Discover transcriptional networks in ECs throu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Endometrial Cancer is the fourth most common c...</td>\n",
       "      <td>125000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This grant funding helped catalyze my collabor...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>37.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>37.1</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop and pilot test COMPRENDO, a tailored P...</td>\n",
       "      <td>Compare the preliminary effectiveness of COMPR...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Whereas Hispanic children will comprise 33% of...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes, funding has been instrumental to advance ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>na</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Six - Ten</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>112.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>37.2</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Develop and pilot test COMPRENDO, a tailored P...</td>\n",
       "      <td>Compare the preliminary effectiveness of COMPR...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Whereas Hispanic children will comprise 33% of...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Serving as mentor to Dr. Aristizabal.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Six - Ten</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>38.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>38.1</td>\n",
       "      <td>Transcriptomic, epigenomic profiling to reveal...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Tumor-infiltrating CD4+ T cell, CD8+ T cell an...</td>\n",
       "      <td>Tumor-associated microglia and other key immun...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brain tumors are a leading cause of death amon...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>During my hematology oncology fellowship, I un...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>113.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>38.2</td>\n",
       "      <td>Transcriptomic, epigenomic profiling to reveal...</td>\n",
       "      <td>LJI</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Tumor-infiltrating CD4+ T cell, CD8+ T cell an...</td>\n",
       "      <td>Tumor-associated microglia and other key immun...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brain tumors are a leading cause of death amon...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The Pedal The Cause funding was an important f...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>4.1</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the functional role of NME1 expressio...</td>\n",
       "      <td>Evaluate the functional role of NME1 histidine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>58.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>4.2</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the functional role of NME1 expressio...</td>\n",
       "      <td>Evaluate the functional role of NME1 histidine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>100000.00</td>\n",
       "      <td>2019-06-01</td>\n",
       "      <td>2020-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>41.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.1</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PTC funding lead to preliminary data for a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Trial Name:    Temozolomide (TMZ) In Advanced ...</td>\n",
       "      <td>13.0</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>118.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.2</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.00</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>55.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>55.1</td>\n",
       "      <td>Novel kinase inhibitors in combination with re...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the efficacy of CRA treatment combin...</td>\n",
       "      <td>Evaluate the functional role of the RAS-MAPK p...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>8.1</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To investigate the safety and tolerability of ...</td>\n",
       "      <td>To evaluate the anti-tumor activity of cirmtuz...</td>\n",
       "      <td>To prospectively interrogate the Wnt signaling...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic castration resistant prostate cance...</td>\n",
       "      <td>150000.00</td>\n",
       "      <td>2020-01-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes this grant was supporting the infrastructu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>207.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Science</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>science project</td>\n",
       "      <td>Health Project</td>\n",
       "      <td>Both</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>diana</td>\n",
       "      <td>75000.00</td>\n",
       "      <td>2022-08-01</td>\n",
       "      <td>2022-08-31</td>\n",
       "      <td>Incomplete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID  \\\n",
       "0     52.0    Initial      52.1   \n",
       "1    131.0    Initial      52.2   \n",
       "2    132.0    Initial      52.3   \n",
       "3    200.0    Initial     200.1   \n",
       "4    201.0    Initial     200.2   \n",
       "5    202.0    Initial     200.3   \n",
       "6     49.0    Initial      49.1   \n",
       "7    127.0    Initial      49.2   \n",
       "8    128.0    Initial      49.3   \n",
       "9    193.0    Initial     193.1   \n",
       "10   194.0    Initial     193.2   \n",
       "11   195.0    Initial     193.3   \n",
       "12    44.0    Initial      44.1   \n",
       "13   121.0    Initial      44.2   \n",
       "14   122.0    Initial      44.3   \n",
       "15   182.0    Initial     182.1   \n",
       "16   183.0    Initial     182.2   \n",
       "17   184.0    Initial     182.3   \n",
       "18    50.0    Initial      50.1   \n",
       "19   129.0    Initial      50.2   \n",
       "20   196.0    Initial     196.1   \n",
       "21   197.0    Initial     196.2   \n",
       "22   161.0    Initial     161.1   \n",
       "23   162.0    Initial     161.2   \n",
       "24   163.0    Initial     161.3   \n",
       "25   164.0    Initial     161.4   \n",
       "26    51.0    Initial      51.1   \n",
       "27   130.0    Initial      51.2   \n",
       "28   198.0    Initial     198.1   \n",
       "29   199.0    Initial     198.2   \n",
       "30    53.0    Initial      53.1   \n",
       "31   133.0    Initial      53.2   \n",
       "32   203.0    Initial     203.1   \n",
       "33   204.0    Initial     203.2   \n",
       "34    54.0    Initial      54.1   \n",
       "35   134.0    Initial      54.2   \n",
       "36   205.0    Initial     205.1   \n",
       "37   206.0    Initial     205.2   \n",
       "38    45.0    Initial      45.1   \n",
       "39   123.0    Initial      45.2   \n",
       "40   185.0    Initial     185.1   \n",
       "41   186.0    Initial     185.2   \n",
       "42    46.0    Initial      46.1   \n",
       "43   124.0    Initial      46.2   \n",
       "44   187.0    Initial     187.1   \n",
       "45   188.0    Initial     187.2   \n",
       "46    48.0    Initial      48.1   \n",
       "47   126.0    Initial      48.2   \n",
       "48   189.0    Initial     189.1   \n",
       "49   190.0    Initial     189.2   \n",
       "50    25.0    Initial      25.1   \n",
       "51    89.0    Initial      25.2   \n",
       "52    90.0    Initial      25.3   \n",
       "53   125.0    Initial      47.2   \n",
       "54   191.0    Initial     191.1   \n",
       "55   192.0    Initial     191.2   \n",
       "56    39.0    Initial      39.1   \n",
       "57   114.0    Initial      39.2   \n",
       "58   115.0    Initial      39.3   \n",
       "59    34.0    Initial      34.1   \n",
       "60   103.0    Initial      34.2   \n",
       "61   104.0    Initial      34.3   \n",
       "62   154.0    Initial     154.1   \n",
       "63   155.0    Initial     154.2   \n",
       "64   156.0    Initial     154.3   \n",
       "65    28.0    Initial      28.1   \n",
       "66    96.0    Initial      28.2   \n",
       "67    97.0    Initial      28.3   \n",
       "68    26.0    Initial      26.1   \n",
       "69    92.0    Initial      26.2   \n",
       "70    93.0    Initial      26.3   \n",
       "71    27.0    Initial      27.1   \n",
       "72    94.0    Initial      27.2   \n",
       "73    95.0    Initial      27.3   \n",
       "74    22.0    Initial      22.1   \n",
       "75    84.0    Initial      22.2   \n",
       "76    85.0    Initial      22.3   \n",
       "77   179.0    Initial     179.1   \n",
       "78   180.0    Initial     179.2   \n",
       "79   181.0    Initial     179.3   \n",
       "80     6.0    Initial       6.1   \n",
       "81    61.0    Initial       6.2   \n",
       "82    62.0    Initial       6.3   \n",
       "83    17.0    Initial      17.1   \n",
       "84    78.0    Initial      17.2   \n",
       "85    79.0    Initial      17.3   \n",
       "86     9.0    Initial       9.1   \n",
       "87    65.0    Initial       9.2   \n",
       "88    66.0    Initial       9.3   \n",
       "89   174.0    Initial     174.1   \n",
       "90   175.0    Initial     174.2   \n",
       "91   176.0    Initial     174.3   \n",
       "92    11.0    Initial      11.1   \n",
       "93    69.0    Initial      11.2   \n",
       "94   137.0    Initial      11.3   \n",
       "95   169.0    Initial     169.1   \n",
       "96   170.0    Initial     169.2   \n",
       "97   171.0    Initial     169.3   \n",
       "98    12.0    Initial      12.1   \n",
       "99    70.0    Initial      12.2   \n",
       "100   71.0    Initial      12.3   \n",
       "101   13.0    Initial      13.1   \n",
       "102   72.0    Initial      13.2   \n",
       "103   73.0    Initial      13.3   \n",
       "104   14.0    Initial      14.1   \n",
       "105   75.0    Initial      14.3   \n",
       "106  136.0    Initial      14.2   \n",
       "107  157.0    Initial     157.1   \n",
       "108  158.0    Initial     157.2   \n",
       "109  172.0    Initial     172.1   \n",
       "110  173.0    Initial     172.2   \n",
       "111  177.0    Initial     177.1   \n",
       "112  178.0    Initial     177.2   \n",
       "113  140.0    Initial     140.1   \n",
       "114  141.0    Initial     140.2   \n",
       "115  138.0    Initial     138.1   \n",
       "116  139.0    Initial     138.2   \n",
       "117  159.0    Initial     159.1   \n",
       "118  160.0    Initial     159.2   \n",
       "119  142.0    Initial     142.1   \n",
       "120  143.0    Initial     142.2   \n",
       "121  144.0    Initial     144.1   \n",
       "122  145.0    Initial     144.2   \n",
       "123  146.0    Initial     146.1   \n",
       "124  147.0    Initial     146.2   \n",
       "125  148.0    Initial     148.1   \n",
       "126  149.0    Initial     148.2   \n",
       "127  150.0    Initial     150.1   \n",
       "128  151.0    Initial     150.2   \n",
       "129  152.0    Initial     152.1   \n",
       "130  153.0    Initial     152.2   \n",
       "131  167.0    Initial     167.1   \n",
       "132  168.0    Initial     167.2   \n",
       "133  165.0    Initial     165.1   \n",
       "134  166.0    Initial     165.2   \n",
       "135    3.0    Initial       3.1   \n",
       "136   82.0    Initial       3.2   \n",
       "137   40.0    Initial      40.1   \n",
       "138  117.0    Initial      40.2   \n",
       "139   43.0    Initial      43.1   \n",
       "140  120.0    Initial      43.2   \n",
       "141   42.0    Initial      42.1   \n",
       "142  119.0    Initial      42.2   \n",
       "143    5.0    Initial       5.1   \n",
       "144   60.0    Initial       5.2   \n",
       "145   10.0    Initial      10.1   \n",
       "146   67.0    Initial      10.2   \n",
       "147   15.0    Initial      15.1   \n",
       "148   76.0    Initial      15.2   \n",
       "149   16.0    Initial      16.1   \n",
       "150   77.0    Initial      16.2   \n",
       "151   18.0    Initial      18.1   \n",
       "152   80.0    Initial      18.2   \n",
       "153   20.0    Initial      20.1   \n",
       "154   83.0    Initial      20.2   \n",
       "155   21.0    Initial      21.1   \n",
       "156  108.0    Initial      21.2   \n",
       "157   23.0    Initial      23.1   \n",
       "158   86.0    Initial      23.2   \n",
       "159   24.0    Initial      24.1   \n",
       "160   88.0    Initial      24.2   \n",
       "161   29.0    Initial      29.1   \n",
       "162   98.0    Initial      29.2   \n",
       "163   30.0    Initial      30.1   \n",
       "164   99.0    Initial      30.2   \n",
       "165   31.0    Initial      31.1   \n",
       "166  100.0    Initial      31.2   \n",
       "167   32.0    Initial      32.1   \n",
       "168  101.0    Initial      32.2   \n",
       "169   33.0    Initial      33.1   \n",
       "170  102.0    Initial      33.2   \n",
       "171   35.0    Initial      35.1   \n",
       "172  110.0    Initial      35.2   \n",
       "173   36.0    Initial      36.1   \n",
       "174  111.0    Initial      36.2   \n",
       "175   37.0    Initial      37.1   \n",
       "176  112.0    Initial      37.2   \n",
       "177   38.0    Initial      38.1   \n",
       "178  113.0    Initial      38.2   \n",
       "179    4.0    Initial       4.1   \n",
       "180   58.0    Initial       4.2   \n",
       "181   41.0    Initial      41.1   \n",
       "182  118.0    Initial      41.2   \n",
       "183   55.0    Initial      55.1   \n",
       "184    8.0    Initial       8.1   \n",
       "185  207.0    Initial       NaN   \n",
       "\n",
       "                                         Project Title  \\\n",
       "0    Discovery of non-coding oncogenic mutations in...   \n",
       "1    Discovery of non-coding oncogenic mutations in...   \n",
       "2    Discovery of non-coding oncogenic mutations in...   \n",
       "3    Discovery of non-coding oncogenic mutations in...   \n",
       "4    Discovery of non-coding oncogenic mutations in...   \n",
       "5    Discovery of non-coding oncogenic mutations in...   \n",
       "6      Decoding Colon Cancers Using Boolean Principles   \n",
       "7      Decoding Colon Cancers Using Boolean Principles   \n",
       "8      Decoding Colon Cancers Using Boolean Principles   \n",
       "9      Decoding Colon Cancers Using Boolean Principles   \n",
       "10     Decoding Colon Cancers Using Boolean Principles   \n",
       "11     Decoding Colon Cancers Using Boolean Principles   \n",
       "12   Irreversible electroporation as an In Situ vac...   \n",
       "13   Irreversible electroporation as an In Situ vac...   \n",
       "14   Irreversible electroporation as an In Situ vac...   \n",
       "15   Irreversible electroporation as an In Situ vac...   \n",
       "16   Irreversible electroporation as an In Situ vac...   \n",
       "17   Irreversible electroporation as an In Situ vac...   \n",
       "18   Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "19   Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "20   Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "21   Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "22   Therapeutic Reprogramming of Pancreatic Cancer...   \n",
       "23   Therapeutic Reprogramming of Pancreatic Cancer...   \n",
       "24   Therapeutic Reprogramming of Pancreatic Cancer...   \n",
       "25   Therapeutic Reprogramming of Pancreatic Cancer...   \n",
       "26   Deciphering the role of RNA editing in leukemi...   \n",
       "27   Deciphering the role of RNA editing in leukemi...   \n",
       "28   Deciphering the role of RNA editing in leukemi...   \n",
       "29   Deciphering the role of RNA editing in leukemi...   \n",
       "30   Identification of therapeutic targets of B-ALL...   \n",
       "31   Identification of therapeutic targets of B-ALL...   \n",
       "32   Identification of therapeutic targets of B-ALL...   \n",
       "33   Identification of therapeutic targets of B-ALL...   \n",
       "34   Developing targeted therapy for Ewing sarcoma ...   \n",
       "35   Developing targeted therapy for Ewing sarcoma ...   \n",
       "36   Developing targeted therapy for Ewing sarcoma ...   \n",
       "37   Developing targeted therapy for Ewing sarcoma ...   \n",
       "38   Oncogenic Regulation of B-Lymphomagenesis by t...   \n",
       "39   Oncogenic Regulation of B-Lymphomagenesis by t...   \n",
       "40   Oncogenic Regulation of B-Lymphomagenesis by t...   \n",
       "41   Oncogenic Regulation of B-Lymphomagenesis by t...   \n",
       "42   An over-expressed GPCR in pancreatic cancer as...   \n",
       "43   An over-expressed GPCR in pancreatic cancer as...   \n",
       "44   An over-expressed GPCR in pancreatic cancer as...   \n",
       "45   An over-expressed GPCR in pancreatic cancer as...   \n",
       "46   Targeting cellular mechanotransduction in brea...   \n",
       "47   Targeting cellular mechanotransduction in brea...   \n",
       "48   Targeting cellular mechanotransduction in brea...   \n",
       "49   Targeting cellular mechanotransduction in brea...   \n",
       "50    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma   \n",
       "51    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma   \n",
       "52    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma   \n",
       "53   Identification of genes critical for the produ...   \n",
       "54   Identification of genes critical for the produ...   \n",
       "55   Identification of genes critical for the produ...   \n",
       "56   A Phase 1b Safety and Feasibility Study of Per...   \n",
       "57   A Phase 1b Safety and Feasibility Study of Per...   \n",
       "58   A Phase 1b Safety and Feasibility Study of Per...   \n",
       "59   Understanding and Targeting NRF2 in Pancreatic...   \n",
       "60   Understanding and Targeting NRF2 in Pancreatic...   \n",
       "61   Understanding and Targeting NRF2 in Pancreatic...   \n",
       "62   Highly selective, synthetic, cleavage specific...   \n",
       "63   Highly selective, synthetic, cleavage specific...   \n",
       "64   Highly selective, synthetic, cleavage specific...   \n",
       "65   Targeting CD114 Signaling in Pediatric Medullo...   \n",
       "66   Targeting CD114 Signaling in Pediatric Medullo...   \n",
       "67   Targeting CD114 Signaling in Pediatric Medullo...   \n",
       "68   Inhibiting Liver Cancer Stem Cells to Improve ...   \n",
       "69   Inhibiting Liver Cancer Stem Cells to Improve ...   \n",
       "70   Inhibiting Liver Cancer Stem Cells to Improve ...   \n",
       "71   Knowledge-based planning and treatment decisio...   \n",
       "72   Knowledge-based planning and treatment decisio...   \n",
       "73   Knowledge-based planning and treatment decisio...   \n",
       "74   Identification of regulatory programs for glio...   \n",
       "75   Identification of regulatory programs for glio...   \n",
       "76   Identification of regulatory programs for glio...   \n",
       "77   The GNAS-PKA Onco-Signaling Network in Colorec...   \n",
       "78   The GNAS-PKA Onco-Signaling Network in Colorec...   \n",
       "79   The GNAS-PKA Onco-Signaling Network in Colorec...   \n",
       "80   UCSD-UCSF Specialized Program of Research Exce...   \n",
       "81   UCSD-UCSF Specialized Program of Research Exce...   \n",
       "82   UCSD-UCSF Specialized Program of Research Exce...   \n",
       "83   Improved Echocardiographic Diagnosis of Anthra...   \n",
       "84   Improved Echocardiographic Diagnosis of Anthra...   \n",
       "85   Improved Echocardiographic Diagnosis of Anthra...   \n",
       "86                  New Therapies for Myeloid Leukemia   \n",
       "87                  New Therapies for Myeloid Leukemia   \n",
       "88                  New Therapies for Myeloid Leukemia   \n",
       "89   Mechanisms Linking Prolonged Nightly Fasting w...   \n",
       "90   Mechanisms Linking Prolonged Nightly Fasting w...   \n",
       "91   Mechanisms Linking Prolonged Nightly Fasting w...   \n",
       "92           Precision Interception of Gastric Cancers   \n",
       "93           Precision Interception of Gastric Cancers   \n",
       "94           Precision Interception of Gastric Cancers   \n",
       "95   Epigenetic basis of platinum drug resistance i...   \n",
       "96   Epigenetic basis of platinum drug resistance i...   \n",
       "97   Epigenetic basis of platinum drug resistance i...   \n",
       "98   Examination of inhibitors of the ULK1 autophag...   \n",
       "99   Examination of inhibitors of the ULK1 autophag...   \n",
       "100  Examination of inhibitors of the ULK1 autophag...   \n",
       "101  Neoantigen-specific T cell responses in except...   \n",
       "102  Neoantigen-specific T cell responses in except...   \n",
       "103  Neoantigen-specific T cell responses in except...   \n",
       "104  Defining the mechanisms of pancreatic cancer s...   \n",
       "105  Defining the mechanisms of pancreatic cancer s...   \n",
       "106  Defining the mechanisms of pancreatic cancer s...   \n",
       "107  Cytotoxic Breast Cancer Treatment Effects on A...   \n",
       "108  Cytotoxic Breast Cancer Treatment Effects on A...   \n",
       "109  Targeting Stem Cell Signals in Cancer Developm...   \n",
       "110  Targeting Stem Cell Signals in Cancer Developm...   \n",
       "111  Detecting Correlates of Vaccine Responses in A...   \n",
       "112  Detecting Correlates of Vaccine Responses in A...   \n",
       "113  Targeting fibroblast heterogeneity to improve ...   \n",
       "114  Targeting fibroblast heterogeneity to improve ...   \n",
       "115  A Novel Role for Histidine Kinase Activity in ...   \n",
       "116  A Novel Role for Histidine Kinase Activity in ...   \n",
       "117  In Vivo Modeling of Anti-Tumor Responses of Hu...   \n",
       "118  In Vivo Modeling of Anti-Tumor Responses of Hu...   \n",
       "119  Protein Kinase C as a Novel Biomarker and Targ...   \n",
       "120  Protein Kinase C as a Novel Biomarker and Targ...   \n",
       "121  Small molecule screen for inhibitors of the GO...   \n",
       "122  Small molecule screen for inhibitors of the GO...   \n",
       "123  Applying p38 MAPK inhibitors to tackle breast ...   \n",
       "124  Applying p38 MAPK inhibitors to tackle breast ...   \n",
       "125  Stromal reprogramming to enhance the effective...   \n",
       "126  Stromal reprogramming to enhance the effective...   \n",
       "127  Targeting imatinib-resistant, KIT-negative cel...   \n",
       "128  Targeting imatinib-resistant, KIT-negative cel...   \n",
       "129  Demonstrating the Clinical Utility of Whole Ex...   \n",
       "130  Demonstrating the Clinical Utility of Whole Ex...   \n",
       "131  Targeting KRAS mutant lung cancer with biphosp...   \n",
       "132  Targeting KRAS mutant lung cancer with biphosp...   \n",
       "133  KRAS Addiction and Protein Biomarkers of Respo...   \n",
       "134  KRAS Addiction and Protein Biomarkers of Respo...   \n",
       "135  Detecting dysregulated genes in neuroblastoma ...   \n",
       "136  Detecting dysregulated genes in neuroblastoma ...   \n",
       "137  A Phase 1b pilot clinical trial of cirmtuzumab...   \n",
       "138  A Phase 1b pilot clinical trial of cirmtuzumab...   \n",
       "139  Low Dose Chemotherapy for Immuno-activation in...   \n",
       "140  Low Dose Chemotherapy for Immuno-activation in...   \n",
       "141  Investigating the Efficacy of radium-223 with ...   \n",
       "142  Investigating the Efficacy of radium-223 with ...   \n",
       "143  A National Phase I Study of Cabozantinib in Co...   \n",
       "144  A National Phase I Study of Cabozantinib in Co...   \n",
       "145  Peptide Targeted Delivery of Epigenetic Therap...   \n",
       "146  Peptide Targeted Delivery of Epigenetic Therap...   \n",
       "147  Elucidating the role of Syk kinase and Syk inh...   \n",
       "148  Elucidating the role of Syk kinase and Syk inh...   \n",
       "149  A pilot trial to test the benefit of real time...   \n",
       "150  A pilot trial to test the benefit of real time...   \n",
       "151  Novel Pathways Regulated by NME1 in Neuroblastoma   \n",
       "152  Novel Pathways Regulated by NME1 in Neuroblastoma   \n",
       "153  Characterization of a GOLPH3 Pathway Inhibitor...   \n",
       "154  Characterization of a GOLPH3 Pathway Inhibitor...   \n",
       "155     Microbe-Associated Colorectal Cancer (M.A.C.S)   \n",
       "156     Microbe-Associated Colorectal Cancer (M.A.C.S)   \n",
       "157  Evaluation of carcinogen exposure via genome-w...   \n",
       "158  Evaluation of carcinogen exposure via genome-w...   \n",
       "159  Impact of Metformin on Clonal Hematopoiesis an...   \n",
       "160  Impact of Metformin on Clonal Hematopoiesis an...   \n",
       "161  Natural Killer Cells for Treatment of Medullob...   \n",
       "162  Natural Killer Cells for Treatment of Medullob...   \n",
       "163                    Targeting FZD7 in human cancers   \n",
       "164                    Targeting FZD7 in human cancers   \n",
       "165  Inducing Cytosolic Chromatin Fragments in Canc...   \n",
       "166  Inducing Cytosolic Chromatin Fragments in Canc...   \n",
       "167  Responses of Melanoma Patients to Checkpoint I...   \n",
       "168  Responses of Melanoma Patients to Checkpoint I...   \n",
       "169  Enhanced Breast Cancer Risk Prediction from Im...   \n",
       "170  Enhanced Breast Cancer Risk Prediction from Im...   \n",
       "171  Targeting A Therapeutic Vulnerability in PTEN-...   \n",
       "172  Targeting A Therapeutic Vulnerability in PTEN-...   \n",
       "173         Epigenetic profiling of endometrial cancer   \n",
       "174         Epigenetic profiling of endometrial cancer   \n",
       "175  Development and Implementation of a Peer-Navig...   \n",
       "176  Development and Implementation of a Peer-Navig...   \n",
       "177  Transcriptomic, epigenomic profiling to reveal...   \n",
       "178  Transcriptomic, epigenomic profiling to reveal...   \n",
       "179  Functional Roles for Histidine Kinase Signalin...   \n",
       "180  Functional Roles for Histidine Kinase Signalin...   \n",
       "181  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "182  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "183  Novel kinase inhibitors in combination with re...   \n",
       "184  A Phase 1B, Nonrandomized Trial Investigating ...   \n",
       "185                                            Science   \n",
       "\n",
       "                                  PI Institution Other Institution  \\\n",
       "0                                 Salk Institute               NaN   \n",
       "1                                 Salk Institute               NaN   \n",
       "2                                Rady Children's               NaN   \n",
       "3                                 Salk Institute               NaN   \n",
       "4                                 Salk Institute               NaN   \n",
       "5                                Rady Children's               NaN   \n",
       "6                           Moores Cancer Center               NaN   \n",
       "7                           Moores Cancer Center               NaN   \n",
       "8                                 Sanford Burnum               NaN   \n",
       "9                           Moores Cancer Center               NaN   \n",
       "10                          Moores Cancer Center               NaN   \n",
       "11                                Sanford Burnum               NaN   \n",
       "12                          Moores Cancer Center               NaN   \n",
       "13                                           LJI               NaN   \n",
       "14                          Moores Cancer Center               NaN   \n",
       "15   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "16                                           LJI               NaN   \n",
       "17   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "18                          Moores Cancer Center               NaN   \n",
       "19                               Rady Children's               NaN   \n",
       "20   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "21   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "22                                Salk Institute               NaN   \n",
       "23                                Sanford Burnum               NaN   \n",
       "24                                Sanford Burnum               NaN   \n",
       "25   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "26                          Moores Cancer Center               NaN   \n",
       "27                               Rady Children's               NaN   \n",
       "28                               Rady Children's               NaN   \n",
       "29   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "30                          Moores Cancer Center               NaN   \n",
       "31                               Rady Children's               NaN   \n",
       "32   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "33                               Rady Children's               NaN   \n",
       "34                          Moores Cancer Center               NaN   \n",
       "35                               Rady Children's               NaN   \n",
       "36   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "37   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "38                          Moores Cancer Center               NaN   \n",
       "39                                Sanford Burnum               NaN   \n",
       "40                                Sanford Burnum               NaN   \n",
       "41   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "42                          Moores Cancer Center               NaN   \n",
       "43                                Sanford Burnum               NaN   \n",
       "44                          Moores Cancer Center               NaN   \n",
       "45                                Sanford Burnum               NaN   \n",
       "46                          Moores Cancer Center               NaN   \n",
       "47                                Sanford Burnum               NaN   \n",
       "48   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "49                                Sanford Burnum               NaN   \n",
       "50                          Moores Cancer Center               NaN   \n",
       "51                          Moores Cancer Center               NaN   \n",
       "52                          Moores Cancer Center               NaN   \n",
       "53                                Sanford Burnum               NaN   \n",
       "54   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "55                                Sanford Burnum               NaN   \n",
       "56                          Moores Cancer Center               NaN   \n",
       "57                                           LJI               NaN   \n",
       "58                          Moores Cancer Center               NaN   \n",
       "59                          Moores Cancer Center               NaN   \n",
       "60                          Moores Cancer Center               NaN   \n",
       "61                                Sanford Burnum               NaN   \n",
       "62                                Sanford Burnum               NaN   \n",
       "63   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "64   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "65                          Moores Cancer Center               NaN   \n",
       "66                                Sanford Burnum               NaN   \n",
       "67                          Moores Cancer Center               NaN   \n",
       "68                          Moores Cancer Center               NaN   \n",
       "69                          Moores Cancer Center               NaN   \n",
       "70                          Moores Cancer Center               NaN   \n",
       "71                          Moores Cancer Center               NaN   \n",
       "72   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "73                          Moores Cancer Center               NaN   \n",
       "74                                Salk Institute               NaN   \n",
       "75   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "76                                Salk Institute               NaN   \n",
       "77                          Moores Cancer Center               NaN   \n",
       "78                                Salk Institute               NaN   \n",
       "79   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "80                          Moores Cancer Center               NaN   \n",
       "81                          Moores Cancer Center               NaN   \n",
       "82                          Moores Cancer Center               NaN   \n",
       "83                               Rady Children's               NaN   \n",
       "84                                         Other      City of Hope   \n",
       "85                          Moores Cancer Center               NaN   \n",
       "86                          Moores Cancer Center               NaN   \n",
       "87                          Moores Cancer Center               NaN   \n",
       "88                          Moores Cancer Center               NaN   \n",
       "89   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "90   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "91                                Salk Institute               NaN   \n",
       "92                          Moores Cancer Center               NaN   \n",
       "93                          Moores Cancer Center               NaN   \n",
       "94                                Sanford Burnum               NaN   \n",
       "95   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "96                                Salk Institute               NaN   \n",
       "97   UCSD - not a member of Moores Cancer Center               NaN   \n",
       "98                          Moores Cancer Center               NaN   \n",
       "99                                Sanford Burnum               NaN   \n",
       "100                               Salk Institute               NaN   \n",
       "101                               Salk Institute               NaN   \n",
       "102                                          LJI               NaN   \n",
       "103                         Moores Cancer Center               NaN   \n",
       "104                         Moores Cancer Center               NaN   \n",
       "105  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "106                               Salk Institute               NaN   \n",
       "107                         Moores Cancer Center               NaN   \n",
       "108                               Salk Institute               NaN   \n",
       "109  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "110                               Sanford Burnum               NaN   \n",
       "111  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "112                                          LJI               NaN   \n",
       "113                               Salk Institute               NaN   \n",
       "114                         Moores Cancer Center               NaN   \n",
       "115                         Moores Cancer Center               NaN   \n",
       "116                               Salk Institute               NaN   \n",
       "117                               Sanford Burnum               NaN   \n",
       "118                         Moores Cancer Center               NaN   \n",
       "119                         Moores Cancer Center               NaN   \n",
       "120                         Moores Cancer Center               NaN   \n",
       "121                         Moores Cancer Center               NaN   \n",
       "122                               Sanford Burnum               NaN   \n",
       "123                         Moores Cancer Center               NaN   \n",
       "124                               Salk Institute               NaN   \n",
       "125                         Moores Cancer Center               NaN   \n",
       "126                               Salk Institute               NaN   \n",
       "127                         Moores Cancer Center               NaN   \n",
       "128                               Sanford Burnum               NaN   \n",
       "129  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "130                               Salk Institute               NaN   \n",
       "131                               Salk Institute               NaN   \n",
       "132                         Moores Cancer Center               NaN   \n",
       "133                         Moores Cancer Center               NaN   \n",
       "134                               Sanford Burnum               NaN   \n",
       "135                               Salk Institute               NaN   \n",
       "136                         Moores Cancer Center               NaN   \n",
       "137                         Moores Cancer Center               NaN   \n",
       "138                         Moores Cancer Center               NaN   \n",
       "139                         Moores Cancer Center               NaN   \n",
       "140                         Moores Cancer Center               NaN   \n",
       "141                         Moores Cancer Center               NaN   \n",
       "142                         Moores Cancer Center               NaN   \n",
       "143                              Rady Children's               NaN   \n",
       "144                         Moores Cancer Center               NaN   \n",
       "145                         Moores Cancer Center               NaN   \n",
       "146                         Moores Cancer Center               NaN   \n",
       "147                         Moores Cancer Center               NaN   \n",
       "148                         Moores Cancer Center               NaN   \n",
       "149                              Rady Children's               NaN   \n",
       "150                               Sanford Burnum               NaN   \n",
       "151                         Moores Cancer Center               NaN   \n",
       "152                               Salk Institute               NaN   \n",
       "153                         Moores Cancer Center               NaN   \n",
       "154                               Sanford Burnum               NaN   \n",
       "155                         Moores Cancer Center               NaN   \n",
       "156                               Sanford Burnum               NaN   \n",
       "157                         Moores Cancer Center               NaN   \n",
       "158                         Moores Cancer Center               NaN   \n",
       "159                         Moores Cancer Center               NaN   \n",
       "160                         Moores Cancer Center               NaN   \n",
       "161                         Moores Cancer Center               NaN   \n",
       "162                               Sanford Burnum               NaN   \n",
       "163                         Moores Cancer Center               NaN   \n",
       "164                         Moores Cancer Center               NaN   \n",
       "165                         Moores Cancer Center               NaN   \n",
       "166                               Sanford Burnum               NaN   \n",
       "167                               Sanford Burnum               NaN   \n",
       "168                         Moores Cancer Center               NaN   \n",
       "169                         Moores Cancer Center               NaN   \n",
       "170                               Salk Institute               NaN   \n",
       "171                         Moores Cancer Center               NaN   \n",
       "172                               Salk Institute               NaN   \n",
       "173                               Salk Institute               NaN   \n",
       "174                         Moores Cancer Center               NaN   \n",
       "175                              Rady Children's               NaN   \n",
       "176                         Moores Cancer Center               NaN   \n",
       "177                              Rady Children's               NaN   \n",
       "178                                          LJI               NaN   \n",
       "179                              Rady Children's               NaN   \n",
       "180                               Salk Institute               NaN   \n",
       "181                         Moores Cancer Center               NaN   \n",
       "182                         Moores Cancer Center               NaN   \n",
       "183                              Rady Children's               NaN   \n",
       "184                         Moores Cancer Center               NaN   \n",
       "185  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "     Prevention and diagnostic tools  \\\n",
       "0                              False   \n",
       "1                              False   \n",
       "2                              False   \n",
       "3                              False   \n",
       "4                              False   \n",
       "5                              False   \n",
       "6                               True   \n",
       "7                               True   \n",
       "8                               True   \n",
       "9                               True   \n",
       "10                              True   \n",
       "11                              True   \n",
       "12                             False   \n",
       "13                             False   \n",
       "14                             False   \n",
       "15                             False   \n",
       "16                             False   \n",
       "17                             False   \n",
       "18                             False   \n",
       "19                             False   \n",
       "20                             False   \n",
       "21                             False   \n",
       "22                             False   \n",
       "23                             False   \n",
       "24                             False   \n",
       "25                             False   \n",
       "26                             False   \n",
       "27                             False   \n",
       "28                             False   \n",
       "29                             False   \n",
       "30                             False   \n",
       "31                             False   \n",
       "32                             False   \n",
       "33                             False   \n",
       "34                             False   \n",
       "35                             False   \n",
       "36                             False   \n",
       "37                             False   \n",
       "38                             False   \n",
       "39                             False   \n",
       "40                             False   \n",
       "41                             False   \n",
       "42                             False   \n",
       "43                             False   \n",
       "44                             False   \n",
       "45                             False   \n",
       "46                             False   \n",
       "47                             False   \n",
       "48                             False   \n",
       "49                             False   \n",
       "50                             False   \n",
       "51                             False   \n",
       "52                             False   \n",
       "53                             False   \n",
       "54                             False   \n",
       "55                             False   \n",
       "56                             False   \n",
       "57                             False   \n",
       "58                             False   \n",
       "59                             False   \n",
       "60                             False   \n",
       "61                             False   \n",
       "62                              True   \n",
       "63                              True   \n",
       "64                              True   \n",
       "65                             False   \n",
       "66                             False   \n",
       "67                             False   \n",
       "68                             False   \n",
       "69                             False   \n",
       "70                             False   \n",
       "71                              True   \n",
       "72                              True   \n",
       "73                              True   \n",
       "74                             False   \n",
       "75                             False   \n",
       "76                             False   \n",
       "77                             False   \n",
       "78                             False   \n",
       "79                             False   \n",
       "80                             False   \n",
       "81                             False   \n",
       "82                             False   \n",
       "83                             False   \n",
       "84                             False   \n",
       "85                             False   \n",
       "86                             False   \n",
       "87                             False   \n",
       "88                             False   \n",
       "89                              True   \n",
       "90                              True   \n",
       "91                              True   \n",
       "92                             False   \n",
       "93                             False   \n",
       "94                             False   \n",
       "95                              True   \n",
       "96                              True   \n",
       "97                              True   \n",
       "98                             False   \n",
       "99                             False   \n",
       "100                            False   \n",
       "101                            False   \n",
       "102                            False   \n",
       "103                            False   \n",
       "104                             True   \n",
       "105                             True   \n",
       "106                            False   \n",
       "107                             True   \n",
       "108                             True   \n",
       "109                            False   \n",
       "110                            False   \n",
       "111                             True   \n",
       "112                             True   \n",
       "113                            False   \n",
       "114                            False   \n",
       "115                            False   \n",
       "116                            False   \n",
       "117                            False   \n",
       "118                            False   \n",
       "119                            False   \n",
       "120                            False   \n",
       "121                            False   \n",
       "122                            False   \n",
       "123                            False   \n",
       "124                            False   \n",
       "125                            False   \n",
       "126                            False   \n",
       "127                            False   \n",
       "128                            False   \n",
       "129                             True   \n",
       "130                             True   \n",
       "131                            False   \n",
       "132                            False   \n",
       "133                            False   \n",
       "134                            False   \n",
       "135                            False   \n",
       "136                            False   \n",
       "137                            False   \n",
       "138                            False   \n",
       "139                            False   \n",
       "140                            False   \n",
       "141                            False   \n",
       "142                            False   \n",
       "143                            False   \n",
       "144                            False   \n",
       "145                            False   \n",
       "146                            False   \n",
       "147                            False   \n",
       "148                            False   \n",
       "149                            False   \n",
       "150                            False   \n",
       "151                            False   \n",
       "152                            False   \n",
       "153                            False   \n",
       "154                            False   \n",
       "155                            False   \n",
       "156                            False   \n",
       "157                             True   \n",
       "158                             True   \n",
       "159                             True   \n",
       "160                             True   \n",
       "161                            False   \n",
       "162                            False   \n",
       "163                            False   \n",
       "164                            False   \n",
       "165                            False   \n",
       "166                            False   \n",
       "167                            False   \n",
       "168                            False   \n",
       "169                             True   \n",
       "170                             True   \n",
       "171                            False   \n",
       "172                            False   \n",
       "173                             True   \n",
       "174                             True   \n",
       "175                            False   \n",
       "176                            False   \n",
       "177                            False   \n",
       "178                            False   \n",
       "179                            False   \n",
       "180                            False   \n",
       "181                            False   \n",
       "182                            False   \n",
       "183                            False   \n",
       "184                            False   \n",
       "185                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "0                                             False   \n",
       "1                                             False   \n",
       "2                                             False   \n",
       "3                                             False   \n",
       "4                                             False   \n",
       "5                                             False   \n",
       "6                                             False   \n",
       "7                                             False   \n",
       "8                                             False   \n",
       "9                                             False   \n",
       "10                                            False   \n",
       "11                                            False   \n",
       "12                                            False   \n",
       "13                                            False   \n",
       "14                                            False   \n",
       "15                                            False   \n",
       "16                                            False   \n",
       "17                                            False   \n",
       "18                                            False   \n",
       "19                                            False   \n",
       "20                                            False   \n",
       "21                                            False   \n",
       "22                                             True   \n",
       "23                                             True   \n",
       "24                                             True   \n",
       "25                                             True   \n",
       "26                                            False   \n",
       "27                                            False   \n",
       "28                                            False   \n",
       "29                                            False   \n",
       "30                                            False   \n",
       "31                                            False   \n",
       "32                                            False   \n",
       "33                                            False   \n",
       "34                                            False   \n",
       "35                                            False   \n",
       "36                                            False   \n",
       "37                                            False   \n",
       "38                                             True   \n",
       "39                                             True   \n",
       "40                                             True   \n",
       "41                                             True   \n",
       "42                                             True   \n",
       "43                                             True   \n",
       "44                                             True   \n",
       "45                                             True   \n",
       "46                                             True   \n",
       "47                                             True   \n",
       "48                                             True   \n",
       "49                                             True   \n",
       "50                                            False   \n",
       "51                                            False   \n",
       "52                                            False   \n",
       "53                                            False   \n",
       "54                                            False   \n",
       "55                                            False   \n",
       "56                                            False   \n",
       "57                                            False   \n",
       "58                                            False   \n",
       "59                                             True   \n",
       "60                                             True   \n",
       "61                                             True   \n",
       "62                                            False   \n",
       "63                                            False   \n",
       "64                                            False   \n",
       "65                                            False   \n",
       "66                                            False   \n",
       "67                                            False   \n",
       "68                                             True   \n",
       "69                                             True   \n",
       "70                                             True   \n",
       "71                                            False   \n",
       "72                                            False   \n",
       "73                                            False   \n",
       "74                                             True   \n",
       "75                                             True   \n",
       "76                                             True   \n",
       "77                                             True   \n",
       "78                                             True   \n",
       "79                                             True   \n",
       "80                                            False   \n",
       "81                                            False   \n",
       "82                                            False   \n",
       "83                                            False   \n",
       "84                                            False   \n",
       "85                                            False   \n",
       "86                                             True   \n",
       "87                                             True   \n",
       "88                                             True   \n",
       "89                                            False   \n",
       "90                                            False   \n",
       "91                                            False   \n",
       "92                                             True   \n",
       "93                                             True   \n",
       "94                                             True   \n",
       "95                                            False   \n",
       "96                                            False   \n",
       "97                                            False   \n",
       "98                                             True   \n",
       "99                                             True   \n",
       "100                                            True   \n",
       "101                                           False   \n",
       "102                                           False   \n",
       "103                                           False   \n",
       "104                                           False   \n",
       "105                                           False   \n",
       "106                                           False   \n",
       "107                                           False   \n",
       "108                                           False   \n",
       "109                                            True   \n",
       "110                                            True   \n",
       "111                                           False   \n",
       "112                                           False   \n",
       "113                                            True   \n",
       "114                                            True   \n",
       "115                                           False   \n",
       "116                                           False   \n",
       "117                                           False   \n",
       "118                                           False   \n",
       "119                                            True   \n",
       "120                                            True   \n",
       "121                                            True   \n",
       "122                                            True   \n",
       "123                                            True   \n",
       "124                                            True   \n",
       "125                                            True   \n",
       "126                                            True   \n",
       "127                                            True   \n",
       "128                                            True   \n",
       "129                                           False   \n",
       "130                                           False   \n",
       "131                                            True   \n",
       "132                                            True   \n",
       "133                                            True   \n",
       "134                                            True   \n",
       "135                                           False   \n",
       "136                                           False   \n",
       "137                                           False   \n",
       "138                                           False   \n",
       "139                                           False   \n",
       "140                                           False   \n",
       "141                                            True   \n",
       "142                                            True   \n",
       "143                                           False   \n",
       "144                                           False   \n",
       "145                                           False   \n",
       "146                                           False   \n",
       "147                                           False   \n",
       "148                                           False   \n",
       "149                                           False   \n",
       "150                                           False   \n",
       "151                                           False   \n",
       "152                                           False   \n",
       "153                                            True   \n",
       "154                                            True   \n",
       "155                                            True   \n",
       "156                                            True   \n",
       "157                                           False   \n",
       "158                                           False   \n",
       "159                                           False   \n",
       "160                                           False   \n",
       "161                                           False   \n",
       "162                                           False   \n",
       "163                                           False   \n",
       "164                                           False   \n",
       "165                                           False   \n",
       "166                                           False   \n",
       "167                                           False   \n",
       "168                                           False   \n",
       "169                                           False   \n",
       "170                                           False   \n",
       "171                                            True   \n",
       "172                                            True   \n",
       "173                                           False   \n",
       "174                                           False   \n",
       "175                                           False   \n",
       "176                                           False   \n",
       "177                                           False   \n",
       "178                                           False   \n",
       "179                                           False   \n",
       "180                                           False   \n",
       "181                                            True   \n",
       "182                                            True   \n",
       "183                                           False   \n",
       "184                                            True   \n",
       "185                                           False   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                        False                          False   \n",
       "1                                        False                          False   \n",
       "2                                        False                          False   \n",
       "3                                        False                          False   \n",
       "4                                        False                          False   \n",
       "5                                        False                          False   \n",
       "6                                        False                          False   \n",
       "7                                        False                          False   \n",
       "8                                        False                          False   \n",
       "9                                        False                          False   \n",
       "10                                       False                          False   \n",
       "11                                       False                          False   \n",
       "12                                        True                          False   \n",
       "13                                        True                          False   \n",
       "14                                        True                          False   \n",
       "15                                        True                          False   \n",
       "16                                        True                          False   \n",
       "17                                        True                          False   \n",
       "18                                       False                          False   \n",
       "19                                       False                          False   \n",
       "20                                       False                          False   \n",
       "21                                       False                          False   \n",
       "22                                       False                          False   \n",
       "23                                       False                          False   \n",
       "24                                       False                          False   \n",
       "25                                       False                          False   \n",
       "26                                       False                          False   \n",
       "27                                       False                          False   \n",
       "28                                       False                          False   \n",
       "29                                       False                          False   \n",
       "30                                       False                          False   \n",
       "31                                       False                          False   \n",
       "32                                       False                          False   \n",
       "33                                       False                          False   \n",
       "34                                       False                          False   \n",
       "35                                       False                          False   \n",
       "36                                       False                          False   \n",
       "37                                       False                          False   \n",
       "38                                       False                          False   \n",
       "39                                       False                          False   \n",
       "40                                       False                          False   \n",
       "41                                       False                          False   \n",
       "42                                       False                          False   \n",
       "43                                       False                          False   \n",
       "44                                       False                          False   \n",
       "45                                       False                          False   \n",
       "46                                       False                          False   \n",
       "47                                       False                          False   \n",
       "48                                       False                          False   \n",
       "49                                       False                          False   \n",
       "50                                       False                          False   \n",
       "51                                       False                          False   \n",
       "52                                       False                          False   \n",
       "53                                        True                          False   \n",
       "54                                        True                          False   \n",
       "55                                        True                          False   \n",
       "56                                        True                          False   \n",
       "57                                        True                          False   \n",
       "58                                        True                          False   \n",
       "59                                       False                          False   \n",
       "60                                       False                          False   \n",
       "61                                       False                          False   \n",
       "62                                       False                          False   \n",
       "63                                       False                          False   \n",
       "64                                       False                          False   \n",
       "65                                       False                          False   \n",
       "66                                       False                          False   \n",
       "67                                       False                          False   \n",
       "68                                       False                          False   \n",
       "69                                       False                          False   \n",
       "70                                       False                          False   \n",
       "71                                       False                          False   \n",
       "72                                       False                          False   \n",
       "73                                       False                          False   \n",
       "74                                       False                          False   \n",
       "75                                       False                          False   \n",
       "76                                       False                          False   \n",
       "77                                       False                          False   \n",
       "78                                       False                          False   \n",
       "79                                       False                          False   \n",
       "80                                       False                          False   \n",
       "81                                        True                          False   \n",
       "82                                        True                          False   \n",
       "83                                       False                          False   \n",
       "84                                       False                          False   \n",
       "85                                       False                          False   \n",
       "86                                       False                          False   \n",
       "87                                       False                          False   \n",
       "88                                       False                          False   \n",
       "89                                       False                          False   \n",
       "90                                       False                          False   \n",
       "91                                       False                          False   \n",
       "92                                       False                          False   \n",
       "93                                       False                          False   \n",
       "94                                       False                          False   \n",
       "95                                       False                          False   \n",
       "96                                       False                          False   \n",
       "97                                       False                          False   \n",
       "98                                       False                          False   \n",
       "99                                       False                          False   \n",
       "100                                      False                          False   \n",
       "101                                       True                          False   \n",
       "102                                       True                          False   \n",
       "103                                       True                          False   \n",
       "104                                      False                          False   \n",
       "105                                      False                          False   \n",
       "106                                      False                          False   \n",
       "107                                      False                          False   \n",
       "108                                      False                          False   \n",
       "109                                      False                          False   \n",
       "110                                      False                          False   \n",
       "111                                      False                          False   \n",
       "112                                      False                          False   \n",
       "113                                      False                          False   \n",
       "114                                      False                          False   \n",
       "115                                      False                          False   \n",
       "116                                      False                          False   \n",
       "117                                       True                          False   \n",
       "118                                       True                          False   \n",
       "119                                      False                          False   \n",
       "120                                      False                          False   \n",
       "121                                      False                          False   \n",
       "122                                      False                          False   \n",
       "123                                      False                          False   \n",
       "124                                      False                          False   \n",
       "125                                      False                          False   \n",
       "126                                      False                          False   \n",
       "127                                      False                          False   \n",
       "128                                      False                          False   \n",
       "129                                      False                          False   \n",
       "130                                      False                          False   \n",
       "131                                      False                          False   \n",
       "132                                      False                          False   \n",
       "133                                      False                          False   \n",
       "134                                      False                          False   \n",
       "135                                      False                          False   \n",
       "136                                      False                          False   \n",
       "137                                       True                          False   \n",
       "138                                       True                          False   \n",
       "139                                       True                          False   \n",
       "140                                       True                          False   \n",
       "141                                      False                          False   \n",
       "142                                      False                          False   \n",
       "143                                      False                          False   \n",
       "144                                      False                          False   \n",
       "145                                       True                          False   \n",
       "146                                       True                          False   \n",
       "147                                      False                          False   \n",
       "148                                      False                          False   \n",
       "149                                      False                          False   \n",
       "150                                      False                          False   \n",
       "151                                      False                          False   \n",
       "152                                      False                          False   \n",
       "153                                      False                          False   \n",
       "154                                      False                          False   \n",
       "155                                      False                          False   \n",
       "156                                      False                          False   \n",
       "157                                      False                          False   \n",
       "158                                      False                          False   \n",
       "159                                      False                          False   \n",
       "160                                      False                          False   \n",
       "161                                       True                          False   \n",
       "162                                       True                          False   \n",
       "163                                       True                          False   \n",
       "164                                       True                          False   \n",
       "165                                       True                          False   \n",
       "166                                       True                          False   \n",
       "167                                       True                          False   \n",
       "168                                       True                          False   \n",
       "169                                      False                          False   \n",
       "170                                      False                          False   \n",
       "171                                      False                          False   \n",
       "172                                      False                          False   \n",
       "173                                      False                          False   \n",
       "174                                      False                          False   \n",
       "175                                      False                           True   \n",
       "176                                      False                           True   \n",
       "177                                       True                          False   \n",
       "178                                       True                          False   \n",
       "179                                      False                          False   \n",
       "180                                      False                          False   \n",
       "181                                      False                          False   \n",
       "182                                      False                          False   \n",
       "183                                      False                          False   \n",
       "184                                      False                          False   \n",
       "185                                      False                           True   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "0                 True    Two Specific Aims   \n",
       "1                 True    Two Specific Aims   \n",
       "2                 True    Two Specific Aims   \n",
       "3                 True    Two Specific Aims   \n",
       "4                 True    Two Specific Aims   \n",
       "5                 True    Two Specific Aims   \n",
       "6                False  Three Specific Aims   \n",
       "7                False  Three Specific Aims   \n",
       "8                False  Three Specific Aims   \n",
       "9                False  Three Specific Aims   \n",
       "10               False  Three Specific Aims   \n",
       "11               False  Three Specific Aims   \n",
       "12               False  Three Specific Aims   \n",
       "13               False  Three Specific Aims   \n",
       "14               False  Three Specific Aims   \n",
       "15               False  Three Specific Aims   \n",
       "16               False  Three Specific Aims   \n",
       "17               False  Three Specific Aims   \n",
       "18                True    Two Specific Aims   \n",
       "19                True    Two Specific Aims   \n",
       "20                True    Two Specific Aims   \n",
       "21                True    Two Specific Aims   \n",
       "22               False    Two Specific Aims   \n",
       "23               False    Two Specific Aims   \n",
       "24               False    Two Specific Aims   \n",
       "25               False    Two Specific Aims   \n",
       "26                True     One Specific Aim   \n",
       "27                True     One Specific Aim   \n",
       "28                True     One Specific Aim   \n",
       "29                True     One Specific Aim   \n",
       "30                True    Two Specific Aims   \n",
       "31                True    Two Specific Aims   \n",
       "32                True    Two Specific Aims   \n",
       "33                True    Two Specific Aims   \n",
       "34                True     One Specific Aim   \n",
       "35                True     One Specific Aim   \n",
       "36                True     One Specific Aim   \n",
       "37                True     One Specific Aim   \n",
       "38               False    Two Specific Aims   \n",
       "39               False    Two Specific Aims   \n",
       "40               False    Two Specific Aims   \n",
       "41               False    Two Specific Aims   \n",
       "42               False    Two Specific Aims   \n",
       "43               False    Two Specific Aims   \n",
       "44               False    Two Specific Aims   \n",
       "45               False    Two Specific Aims   \n",
       "46               False    Two Specific Aims   \n",
       "47               False    Two Specific Aims   \n",
       "48               False    Two Specific Aims   \n",
       "49               False    Two Specific Aims   \n",
       "50                True  Three Specific Aims   \n",
       "51                True  Three Specific Aims   \n",
       "52                True  Three Specific Aims   \n",
       "53               False    Two Specific Aims   \n",
       "54               False    Two Specific Aims   \n",
       "55               False    Two Specific Aims   \n",
       "56               False  Three Specific Aims   \n",
       "57               False  Three Specific Aims   \n",
       "58               False  Three Specific Aims   \n",
       "59               False  Three Specific Aims   \n",
       "60               False  Three Specific Aims   \n",
       "61               False  Three Specific Aims   \n",
       "62               False    Two Specific Aims   \n",
       "63               False    Two Specific Aims   \n",
       "64               False    Two Specific Aims   \n",
       "65                True    Two Specific Aims   \n",
       "66                True    Two Specific Aims   \n",
       "67                True    Two Specific Aims   \n",
       "68               False    Two Specific Aims   \n",
       "69               False    Two Specific Aims   \n",
       "70               False    Two Specific Aims   \n",
       "71               False    Two Specific Aims   \n",
       "72               False    Two Specific Aims   \n",
       "73               False    Two Specific Aims   \n",
       "74               False    Two Specific Aims   \n",
       "75               False    Two Specific Aims   \n",
       "76               False    Two Specific Aims   \n",
       "77               False  Three Specific Aims   \n",
       "78               False  Three Specific Aims   \n",
       "79               False  Three Specific Aims   \n",
       "80               False  Three Specific Aims   \n",
       "81               False    Two Specific Aims   \n",
       "82               False    Two Specific Aims   \n",
       "83                True    Two Specific Aims   \n",
       "84                True    Two Specific Aims   \n",
       "85                True    Two Specific Aims   \n",
       "86               False    Two Specific Aims   \n",
       "87               False    Two Specific Aims   \n",
       "88               False    Two Specific Aims   \n",
       "89               False  Three Specific Aims   \n",
       "90               False  Three Specific Aims   \n",
       "91               False  Three Specific Aims   \n",
       "92               False  Three Specific Aims   \n",
       "93               False  Three Specific Aims   \n",
       "94               False  Three Specific Aims   \n",
       "95               False    Two Specific Aims   \n",
       "96               False    Two Specific Aims   \n",
       "97               False    Two Specific Aims   \n",
       "98               False    Two Specific Aims   \n",
       "99               False    Two Specific Aims   \n",
       "100              False    Two Specific Aims   \n",
       "101              False    Two Specific Aims   \n",
       "102              False    Two Specific Aims   \n",
       "103              False    Two Specific Aims   \n",
       "104              False    Two Specific Aims   \n",
       "105              False    Two Specific Aims   \n",
       "106              False                  NaN   \n",
       "107              False    Two Specific Aims   \n",
       "108              False    Two Specific Aims   \n",
       "109              False    Two Specific Aims   \n",
       "110              False    Two Specific Aims   \n",
       "111              False  Three Specific Aims   \n",
       "112              False  Three Specific Aims   \n",
       "113              False    Two Specific Aims   \n",
       "114              False    Two Specific Aims   \n",
       "115               True    Two Specific Aims   \n",
       "116               True    Two Specific Aims   \n",
       "117              False    Two Specific Aims   \n",
       "118              False    Two Specific Aims   \n",
       "119              False    Two Specific Aims   \n",
       "120              False    Two Specific Aims   \n",
       "121              False    Two Specific Aims   \n",
       "122              False    Two Specific Aims   \n",
       "123              False    Two Specific Aims   \n",
       "124              False    Two Specific Aims   \n",
       "125              False  Three Specific Aims   \n",
       "126              False  Three Specific Aims   \n",
       "127              False  Three Specific Aims   \n",
       "128              False  Three Specific Aims   \n",
       "129              False  Three Specific Aims   \n",
       "130              False  Three Specific Aims   \n",
       "131              False    Two Specific Aims   \n",
       "132              False    Two Specific Aims   \n",
       "133              False    Two Specific Aims   \n",
       "134              False    Two Specific Aims   \n",
       "135               True    Two Specific Aims   \n",
       "136               True    Two Specific Aims   \n",
       "137              False    Two Specific Aims   \n",
       "138              False    Two Specific Aims   \n",
       "139              False    Two Specific Aims   \n",
       "140              False    Two Specific Aims   \n",
       "141              False  Three Specific Aims   \n",
       "142              False  Three Specific Aims   \n",
       "143               True    Two Specific Aims   \n",
       "144               True    Two Specific Aims   \n",
       "145              False    Two Specific Aims   \n",
       "146              False    Two Specific Aims   \n",
       "147               True    Two Specific Aims   \n",
       "148               True    Two Specific Aims   \n",
       "149               True    Two Specific Aims   \n",
       "150               True    Two Specific Aims   \n",
       "151               True    Two Specific Aims   \n",
       "152               True    Two Specific Aims   \n",
       "153              False  Three Specific Aims   \n",
       "154              False  Three Specific Aims   \n",
       "155              False    Two Specific Aims   \n",
       "156              False    Two Specific Aims   \n",
       "157              False    Two Specific Aims   \n",
       "158              False    Two Specific Aims   \n",
       "159              False  Three Specific Aims   \n",
       "160              False  Three Specific Aims   \n",
       "161              False    Two Specific Aims   \n",
       "162              False    Two Specific Aims   \n",
       "163              False    Two Specific Aims   \n",
       "164              False    Two Specific Aims   \n",
       "165              False    Two Specific Aims   \n",
       "166              False    Two Specific Aims   \n",
       "167              False    Two Specific Aims   \n",
       "168              False    Two Specific Aims   \n",
       "169              False    Two Specific Aims   \n",
       "170              False    Two Specific Aims   \n",
       "171              False    Two Specific Aims   \n",
       "172              False    Two Specific Aims   \n",
       "173              False    Two Specific Aims   \n",
       "174              False    Two Specific Aims   \n",
       "175              False    Two Specific Aims   \n",
       "176              False    Two Specific Aims   \n",
       "177              False    Two Specific Aims   \n",
       "178              False    Two Specific Aims   \n",
       "179               True    Two Specific Aims   \n",
       "180               True    Two Specific Aims   \n",
       "181              False  Three Specific Aims   \n",
       "182              False  Three Specific Aims   \n",
       "183               True    Two Specific Aims   \n",
       "184              False  Three Specific Aims   \n",
       "185              False  Three Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "0    Discover non-coding regulatory mutations in AL...   \n",
       "1    Discover non-coding regulatory mutations in AL...   \n",
       "2    Discover non-coding regulatory mutations in AL...   \n",
       "3    Discover non-coding regulatory mutations in AL...   \n",
       "4    Discover non-coding regulatory mutations in AL...   \n",
       "5    Discover non-coding regulatory mutations in AL...   \n",
       "6                          Build a virtual colon crypt   \n",
       "7                         Build a virtual colon crypt.   \n",
       "8                         Build a virtual colon crypt.   \n",
       "9                          Build a virtual colon crypt   \n",
       "10                         Build a virtual colon crypt   \n",
       "11                         Build a virtual colon crypt   \n",
       "12   To determine whether IRE induces neoantigen-sp...   \n",
       "13   To determine whether IRE induces neoantigen-sp...   \n",
       "14   To determine whether IRE induces neoantigen-sp...   \n",
       "15   To determine whether IRE induces neoantigen-sp...   \n",
       "16   To determine whether IRE induces neoantigen-sp...   \n",
       "17   To determine whether IRE induces neoantigen-sp...   \n",
       "18   Determine cellular constraints on the ability ...   \n",
       "19   Determine cellular constraints on the ability ...   \n",
       "20    Determine cellular constraints on the ability...   \n",
       "21   Determine cellular constraints on the ability ...   \n",
       "22   1a. Effect of p62 or p53 stromal deficiency on...   \n",
       "23   1a. Effect of p62 or p53 stromal deficiency on...   \n",
       "24   1a. Effect of p62 or p53 stromal deficiency on...   \n",
       "25   1a. Effect of p62 or p53 stromal deficiency on...   \n",
       "26   To determine the functional significance of AD...   \n",
       "27   To determine the functional significance of AD...   \n",
       "28   Deciphering the Role of RNA Editing in Leukemi...   \n",
       "29   Deciphering the Role of RNA Editing in Leukemi...   \n",
       "30   Develop a computational model of differentiati...   \n",
       "31   Develop a computational model of differentiati...   \n",
       "32   Develop a computational model of differentiati...   \n",
       "33   Develop a computational model of differentiati...   \n",
       "34   Determine the effects of targeting the neural ...   \n",
       "35   Determine the effects of targeting the neural ...   \n",
       "36   Determine the effects of targeting the neural ...   \n",
       "37   Determine the effects of targeting the neural ...   \n",
       "38   Defining the role of DOT1L in B-lymphoma patho...   \n",
       "39   Defining the role of DOT1L in B-lymphoma patho...   \n",
       "40   Defining the role of DOT1L in B-lymphoma patho...   \n",
       "41   Defining the role of DOT1L in B-lymphoma patho...   \n",
       "42   Define PCAF activities in response to GPCR act...   \n",
       "43   Define PCAF activities in response to GPCR act...   \n",
       "44   Define PCAF activities in response to GPCR act...   \n",
       "45   Define PCAF activities in response to GPCR act...   \n",
       "46   Determine the role of EPHA2 in cellular mechan...   \n",
       "47   Determine the role of EPHA2 in cellular mechan...   \n",
       "48   Determine the role of EPHA2 in cellular mechan...   \n",
       "49   Determine the role of EPHA2 in cellular mechan...   \n",
       "50   To Determine the Response of a Panel of Ewing ...   \n",
       "51   To Determine the Response of a Panel of Ewing ...   \n",
       "52   To Determine the Response of a Panel of Ewing ...   \n",
       "53   Use a genome-wide CRISPR-Cas9 screen in hESC c...   \n",
       "54   Use a genome-wide CRISPR-Cas9 screen in hESC c...   \n",
       "55   Use a genome-wide CRISPR-Cas9 screen in hESC c...   \n",
       "56   Conduct a phase 1b clinical trial to assess do...   \n",
       "57   Conduct a phase 1b clinical trial to assess do...   \n",
       "58   Conduct a phase 1b clinical trial to assess do...   \n",
       "59   Determine how NRF2 shapes pancreatic cancer ce...   \n",
       "60   Determine how NRF2 shapes pancreatic cancer ce...   \n",
       "61   Determine how NRF2 shapes pancreatic cancer ce...   \n",
       "62   Design and test the QD-FRET MMP-8 and MMP-9 na...   \n",
       "63   Design and test the QD-FRET MMP-8 and MMP-9 na...   \n",
       "64   Design and test the QD-FRET MMP-8 and MMP-9 na...   \n",
       "65   Evaluate the prognostic relevance of CD114 exp...   \n",
       "66   Evaluate the prognostic relevance of CD114 exp...   \n",
       "67   Evaluate the prognostic relevance of CD114 exp...   \n",
       "68   To test the hypothesis that the heat shock fro...   \n",
       "69   To test the hypothesis that the heat shock fro...   \n",
       "70   To test the hypothesis that the heat shock fro...   \n",
       "71   To prepare the ML training pipeline, we will p...   \n",
       "72   To prepare the ML training pipeline, we will p...   \n",
       "73   To prepare the ML training pipeline, we will p...   \n",
       "74   Identify the regulatory programs that distingu...   \n",
       "75   Identify the regulatory programs that distingu...   \n",
       "76   Identify the regulatory programs that distingu...   \n",
       "77   We will define the contribution of the GNAS-PK...   \n",
       "78   We will define the contribution of the GNAS-PK...   \n",
       "79   We will define the contribution of the GNAS-PK...   \n",
       "80   Improve outcomes for HNSCC by expanding our un...   \n",
       "81   Improve outcomes for HNSCC by expanding out un...   \n",
       "82   Leverage our administrative, biostatistics, co...   \n",
       "83   To determine the utility of GLS in conjunction...   \n",
       "84   To determine the utility of GLS in conjunction...   \n",
       "85   To determine the utility of GLS in conjunction...   \n",
       "86   Determine if inhibitory Tspan3 mAb impairs the...   \n",
       "87   Determine if inhibitory Tspan3 mAb impairs the...   \n",
       "88   Determine if inhibitory Tspan3 mAb impairs the...   \n",
       "89   fasting insulin concentration and glycemic reg...   \n",
       "90   fasting insulin concentration and glycemic reg...   \n",
       "91   fasting insulin concentration and glycemic reg...   \n",
       "92   Network-guided target Identification and prior...   \n",
       "93   Network-guided target Identification and prior...   \n",
       "94   Network-guided target identification and prior...   \n",
       "95   Identify regions differentially methylated in ...   \n",
       "96   Identify regions differentially methylated in ...   \n",
       "97   Identify regions differentially methylated in ...   \n",
       "98   To test ULK1 inhibitor +/- standard of care fo...   \n",
       "99   To test ULK1 inhibitor +/- standard of care fo...   \n",
       "100  To test ULK1 inhibitor +/- standard of care fo...   \n",
       "101  To identify NeoAntigen (NeoAg)-specific CD4+ a...   \n",
       "102  To identify NeoAntigen (NeoAg)-specific CD4+ a...   \n",
       "103  To identify NeoAntigen (NeoAg)-specific CD4+ a...   \n",
       "104  Delineate unique molecular features of chronic...   \n",
       "105  Delineate unique molecular features of chronic...   \n",
       "106                                                NaN   \n",
       "107  To compare the change of laboratory-based bloo...   \n",
       "108  To compare the change of laboratory-based bloo...   \n",
       "109  Perform high throughput screening of targeted ...   \n",
       "110  Perform high throughput screening of targeted ...   \n",
       "111  Determine the dynamics of the antibody respons...   \n",
       "112  Determine the dynamics of the antibody respons...   \n",
       "113  Improving outcomes for fluorescence-guided sur...   \n",
       "114  Improving outcomes for fluorescence-guided sur...   \n",
       "115  Determine the prognostic relevance of NME1 exp...   \n",
       "116  Determine the prognostic relevance of NME1 exp...   \n",
       "117  To assess the anti-tumor responses of melanoma...   \n",
       "118  To assess the anti-tumor responses of melanoma...   \n",
       "119  Does enhancing PKC protein levels inhibit viab...   \n",
       "120  Does enhancing PKC protein levels inhibit viab...   \n",
       "121  Use the current moderate throughput assay to s...   \n",
       "122  Use the current moderate throughput assay to s...   \n",
       "123  Investigate the mechanisms through which Ubc13...   \n",
       "124  Investigate the mechanisms through which Ubc13...   \n",
       "125  Determine the impact of stromal p53 activation...   \n",
       "126  Determine the impact of stromal p53 activation...   \n",
       "127  Determine whether imatinib-resistant, KITneg c...   \n",
       "128  Determine whether imatinib-resistant, KITneg c...   \n",
       "129  Successfully sequence the exomes of a UCSD pat...   \n",
       "130  Successfully sequence the exomes of a UCSD pat...   \n",
       "131  Phase II pilot study of zoledronate in combina...   \n",
       "132  Phase II pilot study of zoledronate in combina...   \n",
       "133  Investigate the effects of mut-KRAS inhibition...   \n",
       "134  Investigate the effects of mut-KRAS inhibition...   \n",
       "135  Identify genes that are dysregulated in neurob...   \n",
       "136  Identify genes that are dysregulated in neurob...   \n",
       "137  To determine the safety and tolerability durin...   \n",
       "138  To determine the safety and tolerability durin...   \n",
       "139  To investigate the effects of low dose immunog...   \n",
       "140  To investigate the effects of low dose immunog...   \n",
       "141  To investigate the safety and efficacy of radi...   \n",
       "142  To investigate the safety and efficacy of radi...   \n",
       "143  Determine the safety, dose-limiting toxicities...   \n",
       "144  Determine the safety, dose-limiting toxicities...   \n",
       "145  Tumor-targeted delivery of bromodomain inhibit...   \n",
       "146  Tumor-targeted delivery of bromodomain inhibit...   \n",
       "147  We will dissect the role of macrophage Syk Kin...   \n",
       "148  We will dissect the role of macrophage Syk Kin...   \n",
       "149  Determine the feasibility, safety and efficacy...   \n",
       "150  Determine the feasibility, safety and efficacy...   \n",
       "151  Identify and validate genes and intracellular ...   \n",
       "152  Identify and validate genes and intracellular ...   \n",
       "153    Determine the critical kinase target of MLS1377   \n",
       "154    Determine the critical kinase target of MLS1377   \n",
       "155  Model infection-inflammation-driven polyp-to-C...   \n",
       "156  Model infection-inflammation-driven polyp-to-C...   \n",
       "157  Develop a model to predict exposure from Ad-Se...   \n",
       "158  Develop a model to predict exposure from Ad-Se...   \n",
       "159  Characterize the burden and genetic profile of...   \n",
       "160  Characterize the burden and genetic profile of...   \n",
       "161  Determine whether MB cells are susceptible to ...   \n",
       "162  Determine whether MB cells are susceptible to ...   \n",
       "163  Characterizing the anti-FZD7 antibody and FZD7...   \n",
       "164  Characterizing the anti-FZD7 antibody and FZD7...   \n",
       "165  Identify compounds that induce CCF and anti-tu...   \n",
       "166  Identify compounds that induce CCF and anti-tu...   \n",
       "167  To assess the anti-tumor responses of melanoma...   \n",
       "168  To assess the anti-tumor responses of melanoma...   \n",
       "169  Identify genes and regulatory network modules ...   \n",
       "170  Identify genes and regulatory network modules ...   \n",
       "171  Develop intracellular DAXX-H3.3 Protein-Protei...   \n",
       "172  Develop intracellular DAXX-H3.3 Protein-Protei...   \n",
       "173  Discover and define molecular subtypes in EC t...   \n",
       "174  Discover and define molecular subtypes in EC t...   \n",
       "175  Develop and pilot test COMPRENDO, a tailored P...   \n",
       "176  Develop and pilot test COMPRENDO, a tailored P...   \n",
       "177  Tumor-infiltrating CD4+ T cell, CD8+ T cell an...   \n",
       "178  Tumor-infiltrating CD4+ T cell, CD8+ T cell an...   \n",
       "179  Evaluate the functional role of NME1 expressio...   \n",
       "180  Evaluate the functional role of NME1 expressio...   \n",
       "181  Primary objective: To determine overall respon...   \n",
       "182  Primary objective: To determine overall respon...   \n",
       "183  Determine the efficacy of CRA treatment combin...   \n",
       "184  To investigate the safety and tolerability of ...   \n",
       "185                                    science project   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "0    Discover large-scale structural mutations and ...   \n",
       "1    Discover large-scale structural mutations and ...   \n",
       "2    Discover large-scale structural mutations and ...   \n",
       "3    Discover large-scale structural mutations and ...   \n",
       "4    Discover large-scale structural mutations and ...   \n",
       "5    Discover large-scale structural mutations and ...   \n",
       "6    Visualize the altered organization of crypts i...   \n",
       "7    Visualize the altered organization of crypts i...   \n",
       "8    Visualize the altered organization of crypts i...   \n",
       "9    Visualize the altered organization of crypts i...   \n",
       "10   Visualize the altered organization of crypts i...   \n",
       "11   Visualize the altered organization of crypts i...   \n",
       "12   To examine the effects of IRE on the tumor mic...   \n",
       "13   To examine the effects of IRE on the tumor mic...   \n",
       "14   To examine the effects of IRE on the tumor mic...   \n",
       "15   To examine the effects of IRE on the tumor mic...   \n",
       "16   To examine the effects of IRE on the tumor mic...   \n",
       "17   To examine the effects of IRE on the tumor mic...   \n",
       "18   Investigate mechanisms underlying tissue-speci...   \n",
       "19   Investigate mechanisms underlying tissue-speci...   \n",
       "20   Investigate mechanisms underlying tissue-speci...   \n",
       "21   Investigate mechanisms underlying tissue-speci...   \n",
       "22   Identify modulators of p62 or p35 activity in ...   \n",
       "23   Identify modulators of p62 or p35 activity in ...   \n",
       "24   Identify modulators of p62 or p35 activity in ...   \n",
       "25   Identify modulators of p62 or p35 activity in ...   \n",
       "26                                                 NaN   \n",
       "27                                                 NaN   \n",
       "28                                                 NaN   \n",
       "29                                                 NaN   \n",
       "30   Predict and validate risk stratification in B-...   \n",
       "31   Predict and validate risk stratification in B-...   \n",
       "32   Predict and validate risk stratification in B-...   \n",
       "33   Predict and validate risk stratification in B-...   \n",
       "34                                                 NaN   \n",
       "35                                                 NaN   \n",
       "36                                                 NaN   \n",
       "37                                                 NaN   \n",
       "38   Determining the mechanistic basis of  DOT1L ac...   \n",
       "39   Determining the mechanistic basis of DOT1L act...   \n",
       "40   Determining the mechanistic basis of  DOT1L ac...   \n",
       "41   Determining the mechanistic basis of  DOT1L ac...   \n",
       "42   Develop and validate an assay to find inhibito...   \n",
       "43   Develop and validate an assay to find inhibito...   \n",
       "44   Develop and validate an assay to find inhibito...   \n",
       "45   Develop and validate an assay to find inhibito...   \n",
       "46   Determine the involvement of EPHA2 and Lyn in ...   \n",
       "47   Determine the involvement of EPHA2 and Lyn in ...   \n",
       "48   Determine the involvement of EPHA2 and Lyn in ...   \n",
       "49   Determine the involvement of EPHA2 and Lyn in ...   \n",
       "50   To Investigate the Response of Ewing Sarcoma C...   \n",
       "51   To Investigate the Response of Ewing Sarcoma C...   \n",
       "52   To Investigate the Response of Ewing Sarcoma C...   \n",
       "53   Validate and assess tumor-killing capacity of ...   \n",
       "54   Validate and assess tumor killing capacity of ...   \n",
       "55   Validate and assess tumor killing capacity of ...   \n",
       "56   Characterize the vaccine contribution to T cel...   \n",
       "57   Characterize the vaccine contribution to T cel...   \n",
       "58   Characterize the vaccine contribution to T cel...   \n",
       "59   Examine the ability of MDM2 inhibitors to indu...   \n",
       "60   Examine the ability of MDM2 inhibitors to indu...   \n",
       "61   Examine the ability of MDM2 inhibitors to indu...   \n",
       "62   Demonstrate low levels, if any, of the off-tar...   \n",
       "63   Demonstrate low levels, if any, of the off-tar...   \n",
       "64   Demonstrate low levels, if any, of the off-tar...   \n",
       "65   Evaluate the efficacy of targeting intracellul...   \n",
       "66   Evaluate the efficacy of targeting intracellul...   \n",
       "67   Evaluate the efficacy of targeting intracellul...   \n",
       "68   To test the hypothesis that combining iPTA wit...   \n",
       "69   To test the hypothesis that combining iPTA wit...   \n",
       "70   To test the hypothesis that combining iPTA wit...   \n",
       "71   We will utilize established ML methods to trai...   \n",
       "72   We will utilize established ML methods to trai...   \n",
       "73   We will utilize established ML methods to trai...   \n",
       "74   Uncover the chromatin architecture dynamics of...   \n",
       "75   Uncover the chromatin architecture dynamics of...   \n",
       "76   Uncover the chromatin architecture dynamics of...   \n",
       "77   We will perform a structure/function analysis ...   \n",
       "78   We will perform a structure/function analysis ...   \n",
       "79   We will perform a structure/function analysis ...   \n",
       "80   Leverage our administrative, biostatistics, co...   \n",
       "81   Leverage our administrative, biostatistics, co...   \n",
       "82   Develop emerging, novel, high quality translat...   \n",
       "83   To explore the association of MRI-LVEF with GL...   \n",
       "84   To explore the association of MRI-LVEF with GL...   \n",
       "85   To explore the association of MRI-LVEF with GL...   \n",
       "86   Identify biomarkers predictive of response to ...   \n",
       "87   Identify biomarkers predictive of response to ...   \n",
       "88   Identify biomarkers predictive of response to ...   \n",
       "89                                  inflammation (CRP)   \n",
       "90                                  inflammation (CRP)   \n",
       "91                                  inflammation (CRP)   \n",
       "92   Validation of network-prioritized targets usin...   \n",
       "93   Validation of network-prioritized targets usin...   \n",
       "94   Validation of network-prioritized targets usin...   \n",
       "95   Validate resistance-associated regulatory chan...   \n",
       "96   Validate resistance-associated regulatory chan...   \n",
       "97   Validate resistance-associated regulatory chan...   \n",
       "98   To test ULK1 inhibitor +/- standard of care ch...   \n",
       "99   To test ULK1 inhibitor +/- standard of care ch...   \n",
       "100  To test ULK1 inhibitor +/- standard of care ch...   \n",
       "101  To characterize the TCR repertoires of NeoAg-s...   \n",
       "102  To characterize the TCR repertoires of NeoAg-s...   \n",
       "103  To characterize the TCR repertoires of NeoAg-s...   \n",
       "104  Define transformation potential in the backgro...   \n",
       "105  Define transformation potential in the backgro...   \n",
       "106                                                NaN   \n",
       "107  To investigate the effects of breast cancer ch...   \n",
       "108  To investigate the effects of breast cancer ch...   \n",
       "109       Test the efficacy of compounds on AML growth   \n",
       "110       Test the efficacy of compounds on AML growth   \n",
       "111  Determine the dynamics of germinal center acti...   \n",
       "112  Determine the dynamics of germinal center acti...   \n",
       "113  Determine the contribution of fibroblast heter...   \n",
       "114  Determine the contribution of fibroblast heter...   \n",
       "115  Evaluate the functional role of NME1 histidine...   \n",
       "116  Evaluate the functional role of NME1 histidine...   \n",
       "117  To address the impact of immunotherapy with mA...   \n",
       "118  To address the impact of immunotherapy with mA...   \n",
       "119  What is the mechanism by which high PKC protei...   \n",
       "120  What is the mechanism by which high PKC protei...   \n",
       "121  Re-tool the assay for a HTS in the CLS C3 shar...   \n",
       "122  Re-tool the assay for a HTS in the CLS C3 shar...   \n",
       "123  Define metastasis gene signatures that are con...   \n",
       "124  Define metastasis gene signatures that are con...   \n",
       "125  Determine whether PCs reduce p53 activation in...   \n",
       "126  Determine whether PCs reduce p53 activation in...   \n",
       "127   Define the molecular properties of imatinib-r...   \n",
       "128  Define the molecular properties of imatinib-re...   \n",
       "129  Use state of the art bioinformatics methods to...   \n",
       "130  Use state of the art bioinformatics methods to...   \n",
       "131  Investigation of bisphosphonates/statins and r...   \n",
       "132  Investigation of bisphosphonates/statins and r...   \n",
       "133  To investigate the in vivo antitumor and bioma...   \n",
       "134  To investigate the in vivo antitumor and bioma...   \n",
       "135  Identify and characterize de novo germline and...   \n",
       "136  Identify and characterize de novo germline and...   \n",
       "137  To determine the safety and tolerability of ci...   \n",
       "138  To determine the safety and tolerability of ci...   \n",
       "139  To investigate the patient-derived samples for...   \n",
       "140  To investigate the patient-derived samples for...   \n",
       "141  To prospectively characterize germline and som...   \n",
       "142  To prospectively characterize germline and som...   \n",
       "143  Identify biomarkers predictive of patient resp...   \n",
       "144  Identify biomarkers predictive of patient resp...   \n",
       "145  Overcome immunosuppression through peptide tar...   \n",
       "146  Overcome immunosuppression through peptide tar...   \n",
       "147  We will determine if inhibition of Syk kinase ...   \n",
       "148  We will determine if inhibition of Syk kinase ...   \n",
       "149  Test whether patient-derived xenografts can be...   \n",
       "150  Test whether patient-derived xenografts can be...   \n",
       "151  Evaluate the functional role of NME1 and NME1-...   \n",
       "152  Evaluate the functional role of NME1 and NME1-...   \n",
       "153  Develop more potent, specific, and drug-like s...   \n",
       "154  Develop more potent, specific, and drug-like s...   \n",
       "155  Determine the prognostic impact of the MACS vi...   \n",
       "156  Determine the prognostic impact of the MACS vi...   \n",
       "157  Associate specimen Ad-Seq profiles to risk fac...   \n",
       "158  Associate specimen Ad-Seq profiles to risk fac...   \n",
       "159  Examine the effect of metformin on the clonal ...   \n",
       "160  Examine the effect of metformin on the clonal ...   \n",
       "161  Test whether NK cells can be used for immunoth...   \n",
       "162  Test whether NK cells can be used for immunoth...   \n",
       "163  Using the anti-FZD7 antibody to block growth o...   \n",
       "164  Using the anti-FZD7 antibody to block growth o...   \n",
       "165  Determine the in vivo impact of low and high C...   \n",
       "166  Determine the in vivo impact of low and high C...   \n",
       "167  To determine if PSGL-1 can be targeted in huma...   \n",
       "168  To determine if PSGL-1 can be targeted in huma...   \n",
       "169  Develop a network-informed genetic risk score ...   \n",
       "170  Develop a network-informed genetic risk score ...   \n",
       "171  Interrogate DAXX-H3.3 PPI through peptide-medi...   \n",
       "172  Interrogate DAXX-H3.3 PPI through peptide-medi...   \n",
       "173  Discover transcriptional networks in ECs throu...   \n",
       "174  Discover transcriptional networks in ECs throu...   \n",
       "175  Compare the preliminary effectiveness of COMPR...   \n",
       "176  Compare the preliminary effectiveness of COMPR...   \n",
       "177  Tumor-associated microglia and other key immun...   \n",
       "178  Tumor-associated microglia and other key immun...   \n",
       "179  Evaluate the functional role of NME1 histidine...   \n",
       "180  Evaluate the functional role of NME1 histidine...   \n",
       "181  Secondary objective: To determine progression-...   \n",
       "182  Secondary objective: To determine progression-...   \n",
       "183  Evaluate the functional role of the RAS-MAPK p...   \n",
       "184  To evaluate the anti-tumor activity of cirmtuz...   \n",
       "185                                     Health Project   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0                                                  NaN   NaN   NaN   NaN   \n",
       "1                                                  NaN   NaN   NaN   NaN   \n",
       "2                                                  NaN   NaN   NaN   NaN   \n",
       "3                                                  NaN   NaN   NaN   NaN   \n",
       "4                                                  NaN   NaN   NaN   NaN   \n",
       "5                                                  NaN   NaN   NaN   NaN   \n",
       "6    Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "7    Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "8    Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "9    Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "10   Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "11   Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "12   To augment IRE-induced tumor-specific T-cell r...   NaN   NaN   NaN   \n",
       "13   To augment IRE-induced tumor-specific T-cell r...   NaN   NaN   NaN   \n",
       "14   To augment IRE-induced tumor-specific T-cell r...   NaN   NaN   NaN   \n",
       "15   To augment IRE-induced tumor-specific T-cell r...   NaN   NaN   NaN   \n",
       "16   To augment IRE-induced tumor-specific T-cell r...   NaN   NaN   NaN   \n",
       "17   To augment IRE-induced tumor-specific T-cell r...   NaN   NaN   NaN   \n",
       "18                                                 NaN   NaN   NaN   NaN   \n",
       "19                                                 NaN   NaN   NaN   NaN   \n",
       "20                                                 NaN   NaN   NaN   NaN   \n",
       "21                                                 NaN   NaN   NaN   NaN   \n",
       "22                                                 NaN   NaN   NaN   NaN   \n",
       "23                                                 NaN   NaN   NaN   NaN   \n",
       "24                                                 NaN   NaN   NaN   NaN   \n",
       "25                                                 NaN   NaN   NaN   NaN   \n",
       "26                                                 NaN   NaN   NaN   NaN   \n",
       "27                                                 NaN   NaN   NaN   NaN   \n",
       "28                                                 NaN   NaN   NaN   NaN   \n",
       "29                                                 NaN   NaN   NaN   NaN   \n",
       "30                                                 NaN   NaN   NaN   NaN   \n",
       "31                                                 NaN   NaN   NaN   NaN   \n",
       "32                                                 NaN   NaN   NaN   NaN   \n",
       "33                                                 NaN   NaN   NaN   NaN   \n",
       "34                                                 NaN   NaN   NaN   NaN   \n",
       "35                                                 NaN   NaN   NaN   NaN   \n",
       "36                                                 NaN   NaN   NaN   NaN   \n",
       "37                                                 NaN   NaN   NaN   NaN   \n",
       "38                                                 NaN   NaN   NaN   NaN   \n",
       "39                                                 NaN   NaN   NaN   NaN   \n",
       "40                                                 NaN   NaN   NaN   NaN   \n",
       "41                                                 NaN   NaN   NaN   NaN   \n",
       "42                                                 NaN   NaN   NaN   NaN   \n",
       "43                                                 NaN   NaN   NaN   NaN   \n",
       "44                                                 NaN   NaN   NaN   NaN   \n",
       "45                                                 NaN   NaN   NaN   NaN   \n",
       "46                                                 NaN   NaN   NaN   NaN   \n",
       "47                                                 NaN   NaN   NaN   NaN   \n",
       "48                                                 NaN   NaN   NaN   NaN   \n",
       "49                                                 NaN   NaN   NaN   NaN   \n",
       "50   To Investigate the Role of EWS-FLI1 Fusion Gen...   NaN   NaN   NaN   \n",
       "51   To Investigate the Role of EWS-FLI1 Fusion Gen...   NaN   NaN   NaN   \n",
       "52   To Investigate the Role of EWS-FLI1 Fusion Gen...   NaN   NaN   NaN   \n",
       "53                                                 NaN   NaN   NaN   NaN   \n",
       "54                                                 NaN   NaN   NaN   NaN   \n",
       "55                                                 NaN   NaN   NaN   NaN   \n",
       "56   Determine the extent of epitope spreading seco...   NaN   NaN   NaN   \n",
       "57   Determine the extent of epitope spreading seco...   NaN   NaN   NaN   \n",
       "58   Determine the extent of epitope spreading seco...   NaN   NaN   NaN   \n",
       "59   Examine whether bioreactive prodrugs that are ...   NaN   NaN   NaN   \n",
       "60   Examine whether bioreactive prodrugs that are ...   NaN   NaN   NaN   \n",
       "61   Examine whether bioreactive prodrugs that are ...   NaN   NaN   NaN   \n",
       "62                                                 NaN   NaN   NaN   NaN   \n",
       "63                                                 NaN   NaN   NaN   NaN   \n",
       "64                                                 NaN   NaN   NaN   NaN   \n",
       "65                                                 NaN   NaN   NaN   NaN   \n",
       "66                                                 NaN   NaN   NaN   NaN   \n",
       "67                                                 NaN   NaN   NaN   NaN   \n",
       "68                                                 NaN   NaN   NaN   NaN   \n",
       "69                                                 NaN   NaN   NaN   NaN   \n",
       "70                                                 NaN   NaN   NaN   NaN   \n",
       "71                                                 NaN   NaN   NaN   NaN   \n",
       "72                                                 NaN   NaN   NaN   NaN   \n",
       "73                                                 NaN   NaN   NaN   NaN   \n",
       "74                                                 NaN   NaN   NaN   NaN   \n",
       "75                                                 NaN   NaN   NaN   NaN   \n",
       "76                                                 NaN   NaN   NaN   NaN   \n",
       "77   We will establish the PKA oncogenic transcript...   NaN   NaN   NaN   \n",
       "78   We will establish the PKA oncogenic transcript...   NaN   NaN   NaN   \n",
       "79   We will establish the PKA oncogenic transcript...   NaN   NaN   NaN   \n",
       "80   Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "81                                                 NaN   NaN   NaN   NaN   \n",
       "82                                                 NaN   NaN   NaN   NaN   \n",
       "83                                                 NaN   NaN   NaN   NaN   \n",
       "84                                                 NaN   NaN   NaN   NaN   \n",
       "85                                                 NaN   NaN   NaN   NaN   \n",
       "86                                                 NaN   NaN   NaN   NaN   \n",
       "87                                                 NaN   NaN   NaN   NaN   \n",
       "88                                                 NaN   NaN   NaN   NaN   \n",
       "89   body mass index, sleep duration and quality, a...   NaN   NaN   NaN   \n",
       "90   body mass index, sleep duration and quality, a...   NaN   NaN   NaN   \n",
       "91   body mass index, sleep duration and quality, a...   NaN   NaN   NaN   \n",
       "92   Phase '0' proof-of-concept trials testing the ...   NaN   NaN   NaN   \n",
       "93   Phase '0' proof-of-concept trials testing the ...   NaN   NaN   NaN   \n",
       "94   Phase '0' proof-of-concept trials testing the ...   NaN   NaN   NaN   \n",
       "95                                                 NaN   NaN   NaN   NaN   \n",
       "96                                                 NaN   NaN   NaN   NaN   \n",
       "97                                                 NaN   NaN   NaN   NaN   \n",
       "98                                                 NaN   NaN   NaN   NaN   \n",
       "99                                                 NaN   NaN   NaN   NaN   \n",
       "100                                                NaN   NaN   NaN   NaN   \n",
       "101                                                NaN   NaN   NaN   NaN   \n",
       "102                                                NaN   NaN   NaN   NaN   \n",
       "103                                                NaN   NaN   NaN   NaN   \n",
       "104                                                NaN   NaN   NaN   NaN   \n",
       "105                                                NaN   NaN   NaN   NaN   \n",
       "106                                                NaN   NaN   NaN   NaN   \n",
       "107                                                NaN   NaN   NaN   NaN   \n",
       "108                                                NaN   NaN   NaN   NaN   \n",
       "109                                                NaN   NaN   NaN   NaN   \n",
       "110                                                NaN   NaN   NaN   NaN   \n",
       "111  Determine the vaccine-specific CD4+ T cell res...   NaN   NaN   NaN   \n",
       "112  Determine the vaccine-specific CD4+ T cell res...   NaN   NaN   NaN   \n",
       "113                                                NaN   NaN   NaN   NaN   \n",
       "114                                                NaN   NaN   NaN   NaN   \n",
       "115                                                NaN   NaN   NaN   NaN   \n",
       "116                                                NaN   NaN   NaN   NaN   \n",
       "117                                                NaN   NaN   NaN   NaN   \n",
       "118                                                NaN   NaN   NaN   NaN   \n",
       "119                                                NaN   NaN   NaN   NaN   \n",
       "120                                                NaN   NaN   NaN   NaN   \n",
       "121                                                NaN   NaN   NaN   NaN   \n",
       "122                                                NaN   NaN   NaN   NaN   \n",
       "123                                                NaN   NaN   NaN   NaN   \n",
       "124                                                NaN   NaN   NaN   NaN   \n",
       "125  Test the therapeutic benefit of stromal reprog...   NaN   NaN   NaN   \n",
       "126  Test the therapeutic benefit of stromal reprog...   NaN   NaN   NaN   \n",
       "127  Identify strategies for targeting imatinib-res...   NaN   NaN   NaN   \n",
       "128  Identify strategies for targeting imatinib-res...   NaN   NaN   NaN   \n",
       "129  Translate the finding to clinical care by havi...   NaN   NaN   NaN   \n",
       "130  Translate the finding to clinical care by havi...   NaN   NaN   NaN   \n",
       "131                                                NaN   NaN   NaN   NaN   \n",
       "132                                                NaN   NaN   NaN   NaN   \n",
       "133                                                NaN   NaN   NaN   NaN   \n",
       "134                                                NaN   NaN   NaN   NaN   \n",
       "135                                                NaN   NaN   NaN   NaN   \n",
       "136                                                NaN   NaN   NaN   NaN   \n",
       "137                                                NaN   NaN   NaN   NaN   \n",
       "138                                                NaN   NaN   NaN   NaN   \n",
       "139                                                NaN   NaN   NaN   NaN   \n",
       "140                                                NaN   NaN   NaN   NaN   \n",
       "141  To phenotypically and molecularly profile chan...   NaN   NaN   NaN   \n",
       "142  To phenotypically and molecularly profile chan...   NaN   NaN   NaN   \n",
       "143                                                NaN   NaN   NaN   NaN   \n",
       "144                                                NaN   NaN   NaN   NaN   \n",
       "145                                                NaN   NaN   NaN   NaN   \n",
       "146                                                NaN   NaN   NaN   NaN   \n",
       "147                                                NaN   NaN   NaN   NaN   \n",
       "148                                                NaN   NaN   NaN   NaN   \n",
       "149                                                NaN   NaN   NaN   NaN   \n",
       "150                                                NaN   NaN   NaN   NaN   \n",
       "151                                                NaN   NaN   NaN   NaN   \n",
       "152                                                NaN   NaN   NaN   NaN   \n",
       "153  Determine ADME/PK for improved analogs of MLS1377   NaN   NaN   NaN   \n",
       "154  Determine ADME/PK for improved analogs of MLS1377   NaN   NaN   NaN   \n",
       "155                                                NaN   NaN   NaN   NaN   \n",
       "156                                                NaN   NaN   NaN   NaN   \n",
       "157                                                NaN   NaN   NaN   NaN   \n",
       "158                                                NaN   NaN   NaN   NaN   \n",
       "159  Describe the clinical significance of therapy-...   NaN   NaN   NaN   \n",
       "160  Describe the clinical significance of therapy-...   NaN   NaN   NaN   \n",
       "161                                                NaN   NaN   NaN   NaN   \n",
       "162                                                NaN   NaN   NaN   NaN   \n",
       "163                                                NaN   NaN   NaN   NaN   \n",
       "164                                                NaN   NaN   NaN   NaN   \n",
       "165                                                NaN   NaN   NaN   NaN   \n",
       "166                                                NaN   NaN   NaN   NaN   \n",
       "167                                                NaN   NaN   NaN   NaN   \n",
       "168                                                NaN   NaN   NaN   NaN   \n",
       "169                                                NaN   NaN   NaN   NaN   \n",
       "170                                                NaN   NaN   NaN   NaN   \n",
       "171                                                NaN   NaN   NaN   NaN   \n",
       "172                                                NaN   NaN   NaN   NaN   \n",
       "173                                                NaN   NaN   NaN   NaN   \n",
       "174                                                NaN   NaN   NaN   NaN   \n",
       "175                                                NaN   NaN   NaN   NaN   \n",
       "176                                                NaN   NaN   NaN   NaN   \n",
       "177                                                NaN   NaN   NaN   NaN   \n",
       "178                                                NaN   NaN   NaN   NaN   \n",
       "179                                                NaN   NaN   NaN   NaN   \n",
       "180                                                NaN   NaN   NaN   NaN   \n",
       "181  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "182  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "183                                                NaN   NaN   NaN   NaN   \n",
       "184  To prospectively interrogate the Wnt signaling...   NaN   NaN   NaN   \n",
       "185                                               Both   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "0    Acute Lymphoblastic Leukemia (ALL) is the most...      75000.00   \n",
       "1    Acute Lymphoblastic Leukemia (ALL) is the most...      75000.00   \n",
       "2    Acute Lymphoblastic Leukemia (ALL) is the most...      75000.00   \n",
       "3    Acute Lymphoblastic Leukemia (ALL) is the most...      75000.00   \n",
       "4    Acute Lymphoblastic Leukemia (ALL) is the most...      75000.00   \n",
       "5    Acute Lymphoblastic Leukemia (ALL) is the most...      75000.00   \n",
       "6    Colorectal cancer is the 3rd most common cance...      75000.00   \n",
       "7    Colorectal cancer is the 3rd most common cance...      75000.00   \n",
       "8    Colorectal cancer is the 3rd most common cance...      75000.00   \n",
       "9    Colorectal cancer is the 3rd most common cance...      75000.00   \n",
       "10   Colorectal cancer is the 3rd most common cance...      75000.00   \n",
       "11   Colorectal cancer is the 3rd most common cance...      75000.00   \n",
       "12   Approximately 40,000 people are diagnosed with...      75000.00   \n",
       "13   Approximately 40,000 people are diagnosed with...      75000.00   \n",
       "14   Approximately 40,000 people are diagnosed with...      75000.00   \n",
       "15   Approximately 40,000 people are diagnosed with...      75000.00   \n",
       "16   Approximately 40,000 people are diagnosed with...      75000.00   \n",
       "17   Approximately 40,000 people are diagnosed with...      75000.00   \n",
       "18   This project aims to identify the mechanisms u...      75000.00   \n",
       "19   This project aims to identify the mechanisms u...      75000.00   \n",
       "20   This project aims to identify the mechanisms u...      75000.00   \n",
       "21   This project aims to identify the mechanisms u...      75000.00   \n",
       "22   Pancreatic cancer remains the most deadly comm...     300000.00   \n",
       "23   Pancreatic cancer remains the most deadly comm...     300000.00   \n",
       "24   Pancreatic cancer remains the most deadly comm...     300000.00   \n",
       "25   Pancreatic cancer remains the most deadly comm...     300000.00   \n",
       "26   Acute lymphoblastic leukemia (ALL) is the comm...      75000.00   \n",
       "27   Acute lymphoblastic leukemia (ALL) is the comm...      75000.00   \n",
       "28   Acute lymphoblastic leukemia (ALL) is the comm...      75000.00   \n",
       "29   Acute lymphoblastic leukemia (ALL) is the comm...      75000.00   \n",
       "30   B-cell acute lymphoblastic leukemia (B-ALL) is...      75000.00   \n",
       "31   B-cell acute lymphoblastic leukemia (B-ALL) is...      75000.00   \n",
       "32   B-cell acute lymphoblastic leukemia (B-ALL) is...      75000.00   \n",
       "33   B-cell acute lymphoblastic leukemia (B-ALL) is...      75000.00   \n",
       "34   Ewing's sarcoma is a malignant tumor that comm...      75000.00   \n",
       "35   Ewing's sarcoma is a malignant tumor that comm...      75000.00   \n",
       "36   Ewing's sarcoma is a malignant tumor that comm...      75000.00   \n",
       "37   years of age. About 25% of patients present wi...      75000.00   \n",
       "38   The epigenome is an exciting new frontier for ...      74881.00   \n",
       "39   The epigenome is an exciting new frontier for ...      74881.00   \n",
       "40   The epigenome is an exciting new frontier for ...      74881.00   \n",
       "41   The epigenome is an exciting new frontier for ...      74881.00   \n",
       "42   Pancreatic ductal adenocarcinoma (PDAC) is the...      75000.00   \n",
       "43   Pancreatic ductal adenocarcinoma (PDAC) is the...      75000.00   \n",
       "44   Pancreatic ductal adenocarcinoma (PDAC) is the...      75000.00   \n",
       "45   Pancreatic ductal adenocarcinoma (PDAC) is the...      75000.00   \n",
       "46   Breast tumors are frequently detected through ...      75000.00   \n",
       "47   Breast tumors are frequently detected through ...      75000.00   \n",
       "48   Breast tumors are frequently detected through ...      75000.00   \n",
       "49   Breast tumors are frequently detected through ...      75000.00   \n",
       "50   Ewing sarcoma (ES) is a bone cancer that affec...      99988.00   \n",
       "51   Ewing sarcoma (ES) is a bone cancer that affec...      99988.00   \n",
       "52   Ewing sarcoma (ES) is a bone cancer that affec...      99988.00   \n",
       "53   While anti-cancer therapies continue to improv...      75000.00   \n",
       "54   While anti-cancer therapies continue to improv...      75000.00   \n",
       "55   While anti-cancer therapies continue to improv...      75000.00   \n",
       "56   Immunotherapy has produced a paradigm shift in...     150000.00   \n",
       "57   Immunotherapy has produced a paradigm shift in...     150000.00   \n",
       "58   Immunotherapy has produced a paradigm shift in...     150000.00   \n",
       "59   We have identified a protein that is called NR...     125000.00   \n",
       "60   We have identified a protein that is called NR...     125000.00   \n",
       "61   We have identified a protein that is called NR...     125000.00   \n",
       "62   There is consensus among professionals that ma...      75000.00   \n",
       "63   There is consensus among professionals that ma...      75000.00   \n",
       "64   There is consensus among professionals that ma...      75000.00   \n",
       "65   Children with high-risk, aggressive forms of m...     125000.00   \n",
       "66   Children with high-risk, aggressive forms of m...     125000.00   \n",
       "67   Children with high-risk, aggressive forms of m...     125000.00   \n",
       "68   Liver cancer, or hepatocellular carcinoma (HCC...     125000.00   \n",
       "69   Liver cancer, or hepatocellular carcinoma (HCC...     125000.00   \n",
       "70   Liver cancer, or hepatocellular carcinoma (HCC...     125000.00   \n",
       "71   Brachytherapy is a treatment in which radiatio...      71979.00   \n",
       "72   Brachytherapy is a treatment in which radiatio...      71979.00   \n",
       "73   Brachytherapy is a treatment in which radiatio...      71979.00   \n",
       "74   Cell type heterogeneity is a major contributor...     125000.00   \n",
       "75   Cell type heterogeneity is a major contributor...     125000.00   \n",
       "76   Cell type heterogeneity is a major contributor...     125000.00   \n",
       "77   Every year >135,000 Americans and more than 1....      75000.00   \n",
       "78   Every year >135,000 Americans and more than 1....      75000.00   \n",
       "79   Every year >135,000 Americans and more than 1....      75000.00   \n",
       "80   Cancer immunotherapies have led to major treat...     200000.00   \n",
       "81   Cancer immunotherapies have led to major treat...     200000.00   \n",
       "82   Cancer immunotherapies have led to major treat...     200000.00   \n",
       "83   Due to high survival rates and long life expec...      99992.00   \n",
       "84   Due to high survival rates and long life expec...      99992.00   \n",
       "85   Due to high survival rates and long life expec...      99992.00   \n",
       "86   Acute Myelogenous Leukemia (AML) is a cancer m...     200000.00   \n",
       "87   Acute Myelogenous Leukemia (AML) is a cancer m...     200000.00   \n",
       "88   Acute Myelogenous Leukemia (AML) is a cancer m...     200000.00   \n",
       "89   Obesity is epidemic, thus, identification and ...      75000.00   \n",
       "90   Obesity is epidemic, thus, identification and ...      75000.00   \n",
       "91   Obesity is epidemic, thus, identification and ...      75000.00   \n",
       "92   A team of researchers comprised of engineers, ...     125000.00   \n",
       "93   A team of researchers comprised of engineers, ...     125000.00   \n",
       "94   A team of researchers comprised of engineers, ...     125000.00   \n",
       "95   Platinum drug resistance is a serious clinical...      75000.00   \n",
       "96   Platinum drug resistance is a serious clinical...      75000.00   \n",
       "97   Platinum drug resistance is a serious clinical...      75000.00   \n",
       "98   Lung cancer is the number 1 cause of cancer de...     125000.00   \n",
       "99   Lung cancer is the number 1 cause of cancer de...     125000.00   \n",
       "100  Lung cancer is the number 1 cause of cancer de...     125000.00   \n",
       "101  A breakthrough in cancer treatment are drugs a...     125000.00   \n",
       "102  A breakthrough in cancer treatment are drugs a...     125000.00   \n",
       "103  A breakthrough in cancer treatment are drugs a...     125000.00   \n",
       "104  Pancreatic cancer (PDA) is a deadly malignancy...     125000.00   \n",
       "105  Pancreatic cancer (PDA) is a deadly malignancy...     125000.00   \n",
       "106                                                NaN     125000.00   \n",
       "107  With a growing aging U.S. population and an ex...      75000.00   \n",
       "108  With a growing aging U.S. population and an ex...      75000.00   \n",
       "109  To identify new therapeutic targets for cancer...      75000.00   \n",
       "110  To identify new therapeutic targets for cancer...      75000.00   \n",
       "111  Vaccines decrease the risk of infection by wor...      74999.51   \n",
       "112  Vaccines decrease the risk of infection by wor...      74999.51   \n",
       "113  Currently, the only curative treatment for pan...     125000.00   \n",
       "114  Currently, the only curative treatment for pan...     125000.00   \n",
       "115  Children with aggressive neuroblastoma have po...     100000.00   \n",
       "116  Children with aggressive neuroblastoma have po...     100000.00   \n",
       "117  Melanoma skin cancer is a deadly disease that ...      75000.00   \n",
       "118  Melanoma skin cancer is a deadly disease that ...      75000.00   \n",
       "119  Pancreatic cancer remains one of the deadliest...     200000.00   \n",
       "120  Pancreatic cancer remains one of the deadliest...     200000.00   \n",
       "121  To more effectively combat cancer we need new ...      75000.00   \n",
       "122  To more effectively combat cancer we need new ...      75000.00   \n",
       "123  The spread of cancer cells from the primary tu...      75000.00   \n",
       "124  The spread of cancer cells from the primary tu...      75000.00   \n",
       "125  Our project, \"Reprogramming the stroma of panc...      74757.00   \n",
       "126  Our project, \"Reprogramming the stroma of panc...      74757.00   \n",
       "127  Gastrointestinal Stromal Tumor (GIST) is a can...      75000.00   \n",
       "128  Gastrointestinal Stromal Tumor (GIST) is a can...      75000.00   \n",
       "129  Breast cancer in young women often has a genet...      18288.00   \n",
       "130  Breast cancer in young women often has a genet...      18288.00   \n",
       "131  Lung cancer is the most common human malignanc...      75000.00   \n",
       "132  Lung cancer is the most common human malignanc...      75000.00   \n",
       "133  In approximately 25% of lung cancer, the speci...      75000.00   \n",
       "134  In approximately 25% of lung cancer, the speci...      75000.00   \n",
       "135  Improved knowledge of the genetic mutations th...     100000.00   \n",
       "136  Neuroblastoma is a devastating cancer of the s...     100000.00   \n",
       "137  Despite recent advances as of 2018, breast can...     300000.00   \n",
       "138  Despite recent advances as of 2018, breast can...     300000.00   \n",
       "139  Immune checkpoint inhibitors are a new class o...     150000.00   \n",
       "140  Immune checkpoint inhibitors are a new class o...     150000.00   \n",
       "141  Metastatic castration-resistant prostate cance...     150000.00   \n",
       "142  Metastatic castration-resistant prostate cance...     150000.00   \n",
       "143  Children with high-risk and recurrent solid tu...     200000.00   \n",
       "144  Children with high-risk and recurrent solid tu...     200000.00   \n",
       "145  Pancreatic cancer is a devastating disease wit...     125000.00   \n",
       "146  Pancreatic cancer is a devastating disease wit...     125000.00   \n",
       "147  Neuroblastoma is a cancer that develops in cer...     125000.00   \n",
       "148  Neuroblastoma is a cancer that develops in cer...     125000.00   \n",
       "149  Medulloblastoma is the most common malignant b...     100000.00   \n",
       "150  Medulloblastoma is the most common malignant b...     100000.00   \n",
       "151  Children with aggressive neuroblastoma tumors ...     100000.00   \n",
       "152  Children with aggressive neuroblastoma tumors ...     100000.00   \n",
       "153  To more effectively combat cancer we need new ...     125000.00   \n",
       "154  To more effectively combat cancer we need new ...     125000.00   \n",
       "155  This proposal revolves around the discovery, c...     125000.00   \n",
       "156  This proposal revolves around the discovery, c...     125000.00   \n",
       "157  Multiple organs of the body are constantly exp...     125000.00   \n",
       "158  Multiple organs of the body are constantly exp...     125000.00   \n",
       "159  Clonal hematopoiesis describes a common pre-ca...     125000.00   \n",
       "160  Clonal hematopoiesis describes a common pre-ca...     125000.00   \n",
       "161  Immunotherapy is emerging as a powerful approa...     125000.00   \n",
       "162  Immunotherapy is emerging as a powerful approa...     125000.00   \n",
       "163  A major shortcoming of current cancer therapie...     125000.00   \n",
       "164  A major shortcoming of current cancer therapie...     125000.00   \n",
       "165  Immune therapy is a method to treat cancer usi...     124972.00   \n",
       "166  Immune therapy is a method to treat cancer usi...     124972.00   \n",
       "167  Advances in immunotherapy for cancer have yiel...     119768.00   \n",
       "168  Advances in immunotherapy for cancer have yiel...     119768.00   \n",
       "169  Early detection remains the strongest determin...     125000.00   \n",
       "170  Early detection remains the strongest determin...     125000.00   \n",
       "171  Glioblastoma (GBM), the most common primary br...     125000.00   \n",
       "172  Glioblastoma (GBM), the most common primary br...     125000.00   \n",
       "173  Endometrial Cancer is the fourth most common c...     125000.00   \n",
       "174  Endometrial Cancer is the fourth most common c...     125000.00   \n",
       "175  Whereas Hispanic children will comprise 33% of...     100000.00   \n",
       "176  Whereas Hispanic children will comprise 33% of...     100000.00   \n",
       "177  Brain tumors are a leading cause of death amon...     100000.00   \n",
       "178  Brain tumors are a leading cause of death amon...     100000.00   \n",
       "179  Children with aggressive neuroblastoma have po...     100000.00   \n",
       "180  Children with aggressive neuroblastoma have po...     100000.00   \n",
       "181  Gastrointestinal stromal tumor (GIST) caused b...     300000.00   \n",
       "182  Gastrointestinal stromal tumor (GIST) caused b...     300000.00   \n",
       "183  Children with aggressive neuroblastoma have po...      75000.00   \n",
       "184  Metastatic castration resistant prostate cance...     150000.00   \n",
       "185                                              diana      75000.00   \n",
       "\n",
       "    Grant Start Date: Grant End Date:    Complete SR - None  \\\n",
       "0          2017-06-01      2018-05-31    Complete      True   \n",
       "1          2017-06-01      2018-05-31    Complete      True   \n",
       "2          2017-06-01      2018-05-31    Complete      True   \n",
       "3          2017-06-01      2018-05-31    Complete       NaN   \n",
       "4          2017-06-01      2018-05-31    Complete       NaN   \n",
       "5          2017-06-01      2018-05-31    Complete       NaN   \n",
       "6          2017-06-01      2018-05-31    Complete      True   \n",
       "7          2017-06-01      2018-05-31    Complete      True   \n",
       "8          2017-06-01      2018-05-31    Complete     False   \n",
       "9          2017-06-01      2018-05-31    Complete       NaN   \n",
       "10         2017-06-01      2018-05-31    Complete       NaN   \n",
       "11         2017-06-01      2018-05-31    Complete       NaN   \n",
       "12         2017-06-01      2018-05-31    Complete     False   \n",
       "13         2017-06-01      2018-05-31    Complete     False   \n",
       "14         2017-06-01      2018-05-31    Complete       NaN   \n",
       "15         2017-06-01      2018-05-31    Complete       NaN   \n",
       "16         2017-06-01      2018-05-31    Complete       NaN   \n",
       "17         2017-06-01      2018-05-31    Complete       NaN   \n",
       "18         2017-06-01      2018-05-31    Complete     False   \n",
       "19         2017-06-01      2018-05-31    Complete      True   \n",
       "20         2017-06-01      2018-05-31    Complete       NaN   \n",
       "21         2017-06-01      2018-05-31    Complete       NaN   \n",
       "22         2015-05-01      2017-04-30    Complete       NaN   \n",
       "23         2015-05-01      2017-04-30    Complete       NaN   \n",
       "24         2015-05-01      2017-04-30    Complete       NaN   \n",
       "25         2015-05-01      2017-04-30    Complete       NaN   \n",
       "26         2017-06-01      2018-05-31    Complete     False   \n",
       "27         2017-06-01      2018-05-31    Complete       NaN   \n",
       "28         2017-06-01      2018-05-31    Complete       NaN   \n",
       "29         2017-06-01      2018-05-31    Complete       NaN   \n",
       "30         2017-06-01      2018-05-31    Complete      True   \n",
       "31         2017-06-01      2018-05-31    Complete     False   \n",
       "32         2017-06-01      2018-05-31    Complete       NaN   \n",
       "33         2017-06-01      2018-05-31    Complete       NaN   \n",
       "34         2017-06-01      2018-05-31    Complete     False   \n",
       "35         2017-06-01      2018-05-31    Complete      True   \n",
       "36         2017-06-01      2018-05-31    Complete       NaN   \n",
       "37         2017-06-01      2018-05-31    Complete       NaN   \n",
       "38         2017-06-01      2018-05-31    Complete     False   \n",
       "39         2017-06-01      2018-05-31    Complete     False   \n",
       "40         2017-06-01      2018-05-31    Complete       NaN   \n",
       "41         2017-06-01      2018-05-31    Complete       NaN   \n",
       "42         2017-05-01      2018-04-30    Complete     False   \n",
       "43         2017-05-01      2018-04-30    Complete     False   \n",
       "44         2017-05-01      2018-04-30    Complete       NaN   \n",
       "45         2017-05-01      2018-04-30    Complete       NaN   \n",
       "46         2017-06-01      2018-05-31    Complete     False   \n",
       "47         2017-06-01      2018-05-31    Complete     False   \n",
       "48         2017-06-01      2018-05-31    Complete       NaN   \n",
       "49         2017-06-01      2018-05-31    Complete       NaN   \n",
       "50         2019-06-01      2020-05-31    Complete      True   \n",
       "51         2019-06-01      2020-05-31    Complete     False   \n",
       "52         2019-06-01      2020-05-31    Complete     False   \n",
       "53         2017-06-01      2018-05-31    Complete     False   \n",
       "54         2017-06-01      2018-05-31    Complete       NaN   \n",
       "55         2017-06-01      2018-05-31    Complete       NaN   \n",
       "56         2019-01-01      2019-12-31    Complete     False   \n",
       "57         2019-01-01      2019-12-31    Complete       NaN   \n",
       "58         2019-01-01      2019-12-31    Complete       NaN   \n",
       "59         2018-06-01      2019-05-31    Complete     False   \n",
       "60         2018-06-01      2019-05-31    Complete     False   \n",
       "61         2018-06-01      2019-05-31    Complete       NaN   \n",
       "62         2015-05-01      2016-04-30    Complete       NaN   \n",
       "63         2015-05-01      2016-04-30    Complete       NaN   \n",
       "64         2015-05-01      2016-04-16    Complete       NaN   \n",
       "65         2019-01-01      2019-12-31    Complete     False   \n",
       "66         2019-01-01      2019-12-31    Complete     False   \n",
       "67         2019-01-01      2019-12-31    Complete       NaN   \n",
       "68         2019-01-01      2019-12-31    Complete     False   \n",
       "69         2019-01-01      2019-12-31    Complete     False   \n",
       "70         2019-01-01      2019-12-31    Complete      True   \n",
       "71         2019-01-01      2019-12-31    Complete     False   \n",
       "72         2019-01-01      2019-12-31    Complete     False   \n",
       "73         2019-01-01      2019-12-31    Complete     False   \n",
       "74         2019-07-15      2020-07-14    Complete     False   \n",
       "75         2019-07-15      2020-07-14    Complete       NaN   \n",
       "76         2019-07-15      2020-07-14    Complete      True   \n",
       "77         2016-05-01      2017-04-30    Complete       NaN   \n",
       "78         2016-05-01      2017-04-30    Complete       NaN   \n",
       "79         2016-05-01      2017-04-30    Complete       NaN   \n",
       "80         2021-07-01      2022-06-30    Complete     False   \n",
       "81         2021-07-01      2022-06-30    Complete     False   \n",
       "82         2021-07-01      2022-06-30    Complete       NaN   \n",
       "83         2020-09-01      2021-08-30    Complete      True   \n",
       "84         2020-09-01      2021-08-30    Complete      True   \n",
       "85         2020-09-01      2021-08-30    Complete       NaN   \n",
       "86         2020-02-01      2021-01-31    Complete     False   \n",
       "87         2020-02-01      2021-01-31    Complete     False   \n",
       "88         2020-02-01      2021-01-31    Complete      True   \n",
       "89         2016-05-01      2017-04-30    Complete       NaN   \n",
       "90         2016-05-01      2017-04-30    Complete       NaN   \n",
       "91         2016-05-01      2016-04-30    Complete       NaN   \n",
       "92         2020-07-01      2021-06-30    Complete      True   \n",
       "93         2020-07-01      2021-06-30    Complete     False   \n",
       "94         2020-07-01      2021-06-30  Incomplete       NaN   \n",
       "95         2016-05-01      2017-04-30    Complete       NaN   \n",
       "96         2016-05-01      2017-04-30    Complete       NaN   \n",
       "97         2016-05-01      2017-04-30    Complete       NaN   \n",
       "98         2020-07-01      2021-06-30    Complete      True   \n",
       "99         2020-07-01      2021-06-30    Complete     False   \n",
       "100        2020-07-01      2021-06-30    Complete      True   \n",
       "101        2020-07-01      2021-06-30    Complete     False   \n",
       "102        2020-07-01      2021-06-30    Complete       NaN   \n",
       "103        2020-07-01      2021-06-30    Complete     False   \n",
       "104        2020-07-01      2021-06-30    Complete     False   \n",
       "105        2020-07-01      2021-06-30    Complete     False   \n",
       "106        2020-07-01      2021-06-30  Incomplete     False   \n",
       "107        2015-05-01      2016-04-30    Complete       NaN   \n",
       "108        2015-05-01      2016-04-30    Complete       NaN   \n",
       "109        2016-05-01      2017-04-30    Complete       NaN   \n",
       "110        2016-05-01      2017-04-30    Complete       NaN   \n",
       "111        2016-05-01      2017-04-30    Complete       NaN   \n",
       "112        2016-05-01      2017-04-30    Complete       NaN   \n",
       "113        2018-06-18      2019-05-31    Complete       NaN   \n",
       "114        2018-06-01      2019-05-31    Complete       NaN   \n",
       "115        2018-06-01      2019-05-31    Complete      True   \n",
       "116        2018-06-01      2019-05-31    Complete     False   \n",
       "117        2015-05-01      2016-04-30    Complete       NaN   \n",
       "118        2015-05-01      2016-04-30    Complete       NaN   \n",
       "119        2020-01-15      2021-01-14    Complete       NaN   \n",
       "120        2020-01-15      2021-01-14    Complete       NaN   \n",
       "121        2014-05-01      2015-04-30    Complete       NaN   \n",
       "122        2014-05-01      2015-04-30    Complete       NaN   \n",
       "123        2014-08-01      2015-07-31    Complete       NaN   \n",
       "124        2014-08-01      2015-07-31    Complete       NaN   \n",
       "125        2014-05-01      2015-04-30    Complete       NaN   \n",
       "126        2014-05-01      2015-04-30    Complete       NaN   \n",
       "127        2014-06-01      2015-05-31    Complete       NaN   \n",
       "128        2014-06-01      2015-05-31    Complete       NaN   \n",
       "129        2014-05-01      2015-04-30    Complete       NaN   \n",
       "130        2014-05-01      2015-04-30    Complete       NaN   \n",
       "131        2016-05-01      2017-04-30    Complete       NaN   \n",
       "132        2016-05-01      2017-04-30    Complete       NaN   \n",
       "133        2015-05-01      2016-04-30    Complete       NaN   \n",
       "134        2015-05-01      2016-04-30    Complete       NaN   \n",
       "135        2019-07-15      2021-07-14    Complete      True   \n",
       "136        2019-07-15      2021-07-14    Complete      True   \n",
       "137        2019-01-01      2021-12-31    Complete     False   \n",
       "138        2019-01-01      2022-12-31    Complete     False   \n",
       "139        2019-01-01      2020-12-31    Complete     False   \n",
       "140        2019-01-01      2020-12-31    Complete     False   \n",
       "141        2018-11-01      2020-10-31    Complete     False   \n",
       "142        2018-11-01      2020-10-31    Complete     False   \n",
       "143        2021-07-01      2023-06-30    Complete     False   \n",
       "144        2020-12-01      2022-11-30    Complete       NaN   \n",
       "145        2020-09-01      2021-08-30    Complete      True   \n",
       "146        2020-09-01      2021-08-30    Complete     False   \n",
       "147        2020-07-01      2021-06-30    Complete     False   \n",
       "148        2020-07-01      2021-06-30    Complete     False   \n",
       "149        2020-07-01      2021-06-30    Complete      True   \n",
       "150        2020-07-01      2021-06-30    Complete      True   \n",
       "151        2020-07-01      2021-06-30    Complete     False   \n",
       "152        2020-07-01      2021-06-30    Complete       NaN   \n",
       "153        2019-07-01      2020-06-30    Complete     False   \n",
       "154        2019-07-01      2020-06-30    Complete     False   \n",
       "155        2019-07-15      2020-07-14    Complete      True   \n",
       "156        2019-07-15      2020-07-14    Complete      True   \n",
       "157        2019-01-01      2019-12-31    Complete     False   \n",
       "158        2019-01-01      2019-12-31    Complete      True   \n",
       "159        2019-03-02      2020-03-01    Complete     False   \n",
       "160        2019-03-02      2020-03-01    Complete     False   \n",
       "161        2018-06-01      2019-05-31    Complete       NaN   \n",
       "162        2018-06-01      2019-05-31    Complete     False   \n",
       "163        2019-01-01      2019-12-31    Complete      True   \n",
       "164        2019-01-01      2019-12-31    Complete     False   \n",
       "165        2018-06-01      2019-05-31    Complete      True   \n",
       "166        2018-06-01      2019-05-31    Complete     False   \n",
       "167        2018-06-01      2019-05-31    Complete     False   \n",
       "168        2018-06-01      2019-05-31    Complete     False   \n",
       "169        2018-06-01      2019-05-31    Complete     False   \n",
       "170        2018-06-01      2019-05-31    Complete      True   \n",
       "171        2018-06-01      2019-05-31    Complete     False   \n",
       "172        2018-06-01      2019-05-31    Complete       NaN   \n",
       "173        2018-06-01      2019-05-31    Complete      True   \n",
       "174        2018-06-01      2019-05-31    Complete     False   \n",
       "175        2018-06-01      2019-05-31    Complete      True   \n",
       "176        2018-06-01      2019-05-31    Complete     False   \n",
       "177        2018-06-01      2019-05-31    Complete      True   \n",
       "178        2018-06-01      2019-05-31    Complete      True   \n",
       "179        2019-07-15      2020-07-14    Complete     False   \n",
       "180        2019-06-01      2020-05-31    Complete       NaN   \n",
       "181        2019-01-01      2020-12-31    Complete     False   \n",
       "182        2019-01-01      2020-12-31    Complete     False   \n",
       "183        2017-06-01      2018-05-31    Complete     False   \n",
       "184        2020-01-01      2021-12-31    Complete     False   \n",
       "185        2022-08-01      2022-08-31  Incomplete       NaN   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                     False                                 False   \n",
       "1                     False                                 False   \n",
       "2                     False                                 False   \n",
       "3                       NaN                                   NaN   \n",
       "4                       NaN                                   NaN   \n",
       "5                       NaN                                   NaN   \n",
       "6                     False                                 False   \n",
       "7                     False                                 False   \n",
       "8                     False                                  True   \n",
       "9                       NaN                                   NaN   \n",
       "10                      NaN                                   NaN   \n",
       "11                      NaN                                   NaN   \n",
       "12                    False                                  True   \n",
       "13                    False                                  True   \n",
       "14                      NaN                                   NaN   \n",
       "15                      NaN                                   NaN   \n",
       "16                      NaN                                   NaN   \n",
       "17                      NaN                                   NaN   \n",
       "18                    False                                 False   \n",
       "19                    False                                 False   \n",
       "20                      NaN                                   NaN   \n",
       "21                      NaN                                   NaN   \n",
       "22                      NaN                                   NaN   \n",
       "23                      NaN                                   NaN   \n",
       "24                      NaN                                   NaN   \n",
       "25                      NaN                                   NaN   \n",
       "26                    False                                  True   \n",
       "27                      NaN                                   NaN   \n",
       "28                      NaN                                   NaN   \n",
       "29                      NaN                                   NaN   \n",
       "30                    False                                 False   \n",
       "31                    False                                 False   \n",
       "32                      NaN                                   NaN   \n",
       "33                      NaN                                   NaN   \n",
       "34                    False                                 False   \n",
       "35                    False                                 False   \n",
       "36                      NaN                                   NaN   \n",
       "37                      NaN                                   NaN   \n",
       "38                    False                                 False   \n",
       "39                    False                                 False   \n",
       "40                      NaN                                   NaN   \n",
       "41                      NaN                                   NaN   \n",
       "42                    False                                  True   \n",
       "43                    False                                 False   \n",
       "44                      NaN                                   NaN   \n",
       "45                      NaN                                   NaN   \n",
       "46                    False                                  True   \n",
       "47                    False                                 False   \n",
       "48                      NaN                                   NaN   \n",
       "49                      NaN                                   NaN   \n",
       "50                    False                                 False   \n",
       "51                    False                                 False   \n",
       "52                    False                                  True   \n",
       "53                    False                                 False   \n",
       "54                      NaN                                   NaN   \n",
       "55                      NaN                                   NaN   \n",
       "56                    False                                  True   \n",
       "57                      NaN                                   NaN   \n",
       "58                      NaN                                   NaN   \n",
       "59                    False                                  True   \n",
       "60                    False                                  True   \n",
       "61                      NaN                                   NaN   \n",
       "62                      NaN                                   NaN   \n",
       "63                      NaN                                   NaN   \n",
       "64                      NaN                                   NaN   \n",
       "65                    False                                  True   \n",
       "66                    False                                 False   \n",
       "67                      NaN                                   NaN   \n",
       "68                    False                                 False   \n",
       "69                    False                                  True   \n",
       "70                    False                                 False   \n",
       "71                    False                                 False   \n",
       "72                    False                                 False   \n",
       "73                    False                                 False   \n",
       "74                    False                                 False   \n",
       "75                      NaN                                   NaN   \n",
       "76                    False                                 False   \n",
       "77                      NaN                                   NaN   \n",
       "78                      NaN                                   NaN   \n",
       "79                      NaN                                   NaN   \n",
       "80                    False                                  True   \n",
       "81                    False                                  True   \n",
       "82                      NaN                                   NaN   \n",
       "83                    False                                 False   \n",
       "84                    False                                 False   \n",
       "85                      NaN                                   NaN   \n",
       "86                    False                                  True   \n",
       "87                    False                                  True   \n",
       "88                    False                                 False   \n",
       "89                      NaN                                   NaN   \n",
       "90                      NaN                                   NaN   \n",
       "91                      NaN                                   NaN   \n",
       "92                    False                                 False   \n",
       "93                    False                                  True   \n",
       "94                      NaN                                   NaN   \n",
       "95                      NaN                                   NaN   \n",
       "96                      NaN                                   NaN   \n",
       "97                      NaN                                   NaN   \n",
       "98                    False                                 False   \n",
       "99                    False                                 False   \n",
       "100                   False                                 False   \n",
       "101                   False                                 False   \n",
       "102                     NaN                                   NaN   \n",
       "103                   False                                 False   \n",
       "104                   False                                  True   \n",
       "105                   False                                  True   \n",
       "106                   False                                  True   \n",
       "107                     NaN                                   NaN   \n",
       "108                     NaN                                   NaN   \n",
       "109                     NaN                                   NaN   \n",
       "110                     NaN                                   NaN   \n",
       "111                     NaN                                   NaN   \n",
       "112                     NaN                                   NaN   \n",
       "113                     NaN                                   NaN   \n",
       "114                     NaN                                   NaN   \n",
       "115                   False                                 False   \n",
       "116                   False                                 False   \n",
       "117                     NaN                                   NaN   \n",
       "118                     NaN                                   NaN   \n",
       "119                     NaN                                   NaN   \n",
       "120                     NaN                                   NaN   \n",
       "121                     NaN                                   NaN   \n",
       "122                     NaN                                   NaN   \n",
       "123                     NaN                                   NaN   \n",
       "124                     NaN                                   NaN   \n",
       "125                     NaN                                   NaN   \n",
       "126                     NaN                                   NaN   \n",
       "127                     NaN                                   NaN   \n",
       "128                     NaN                                   NaN   \n",
       "129                     NaN                                   NaN   \n",
       "130                     NaN                                   NaN   \n",
       "131                     NaN                                   NaN   \n",
       "132                     NaN                                   NaN   \n",
       "133                     NaN                                   NaN   \n",
       "134                     NaN                                   NaN   \n",
       "135                   False                                 False   \n",
       "136                   False                                 False   \n",
       "137                   False                                  True   \n",
       "138                   False                                  True   \n",
       "139                   False                                 False   \n",
       "140                   False                                 False   \n",
       "141                   False                                  True   \n",
       "142                   False                                 False   \n",
       "143                   False                                 False   \n",
       "144                     NaN                                   NaN   \n",
       "145                   False                                 False   \n",
       "146                   False                                  True   \n",
       "147                   False                                  True   \n",
       "148                   False                                 False   \n",
       "149                   False                                 False   \n",
       "150                   False                                 False   \n",
       "151                   False                                 False   \n",
       "152                     NaN                                   NaN   \n",
       "153                   False                                 False   \n",
       "154                   False                                 False   \n",
       "155                   False                                 False   \n",
       "156                   False                                 False   \n",
       "157                   False                                  True   \n",
       "158                   False                                 False   \n",
       "159                   False                                 False   \n",
       "160                    True                                 False   \n",
       "161                     NaN                                   NaN   \n",
       "162                   False                                 False   \n",
       "163                   False                                 False   \n",
       "164                   False                                 False   \n",
       "165                   False                                 False   \n",
       "166                   False                                 False   \n",
       "167                   False                                 False   \n",
       "168                   False                                  True   \n",
       "169                   False                                 False   \n",
       "170                   False                                 False   \n",
       "171                   False                                 False   \n",
       "172                     NaN                                   NaN   \n",
       "173                   False                                 False   \n",
       "174                   False                                  True   \n",
       "175                   False                                 False   \n",
       "176                   False                                 False   \n",
       "177                   False                                 False   \n",
       "178                   False                                 False   \n",
       "179                   False                                 False   \n",
       "180                     NaN                                   NaN   \n",
       "181                   False                                  True   \n",
       "182                   False                                  True   \n",
       "183                   False                                  True   \n",
       "184                   False                                  True   \n",
       "185                     NaN                                   NaN   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                    False                           False   \n",
       "1                    False                           False   \n",
       "2                    False                           False   \n",
       "3                      NaN                             NaN   \n",
       "4                      NaN                             NaN   \n",
       "5                      NaN                             NaN   \n",
       "6                    False                           False   \n",
       "7                    False                           False   \n",
       "8                    False                           False   \n",
       "9                      NaN                             NaN   \n",
       "10                     NaN                             NaN   \n",
       "11                     NaN                             NaN   \n",
       "12                    True                           False   \n",
       "13                   False                           False   \n",
       "14                     NaN                             NaN   \n",
       "15                     NaN                             NaN   \n",
       "16                     NaN                             NaN   \n",
       "17                     NaN                             NaN   \n",
       "18                   False                           False   \n",
       "19                   False                           False   \n",
       "20                     NaN                             NaN   \n",
       "21                     NaN                             NaN   \n",
       "22                     NaN                             NaN   \n",
       "23                     NaN                             NaN   \n",
       "24                     NaN                             NaN   \n",
       "25                     NaN                             NaN   \n",
       "26                   False                            True   \n",
       "27                     NaN                             NaN   \n",
       "28                     NaN                             NaN   \n",
       "29                     NaN                             NaN   \n",
       "30                   False                           False   \n",
       "31                   False                            True   \n",
       "32                     NaN                             NaN   \n",
       "33                     NaN                             NaN   \n",
       "34                   False                           False   \n",
       "35                   False                           False   \n",
       "36                     NaN                             NaN   \n",
       "37                     NaN                             NaN   \n",
       "38                   False                           False   \n",
       "39                   False                           False   \n",
       "40                     NaN                             NaN   \n",
       "41                     NaN                             NaN   \n",
       "42                   False                           False   \n",
       "43                   False                           False   \n",
       "44                     NaN                             NaN   \n",
       "45                     NaN                             NaN   \n",
       "46                   False                           False   \n",
       "47                   False                           False   \n",
       "48                     NaN                             NaN   \n",
       "49                     NaN                             NaN   \n",
       "50                   False                           False   \n",
       "51                   False                           False   \n",
       "52                   False                           False   \n",
       "53                   False                           False   \n",
       "54                     NaN                             NaN   \n",
       "55                     NaN                             NaN   \n",
       "56                    True                            True   \n",
       "57                     NaN                             NaN   \n",
       "58                     NaN                             NaN   \n",
       "59                   False                           False   \n",
       "60                   False                           False   \n",
       "61                     NaN                             NaN   \n",
       "62                     NaN                             NaN   \n",
       "63                     NaN                             NaN   \n",
       "64                     NaN                             NaN   \n",
       "65                    True                           False   \n",
       "66                   False                           False   \n",
       "67                     NaN                             NaN   \n",
       "68                    True                           False   \n",
       "69                   False                           False   \n",
       "70                   False                           False   \n",
       "71                   False                           False   \n",
       "72                   False                           False   \n",
       "73                   False                           False   \n",
       "74                   False                           False   \n",
       "75                     NaN                             NaN   \n",
       "76                   False                           False   \n",
       "77                     NaN                             NaN   \n",
       "78                     NaN                             NaN   \n",
       "79                     NaN                             NaN   \n",
       "80                   False                            True   \n",
       "81                    True                            True   \n",
       "82                     NaN                             NaN   \n",
       "83                   False                           False   \n",
       "84                   False                           False   \n",
       "85                     NaN                             NaN   \n",
       "86                   False                           False   \n",
       "87                   False                           False   \n",
       "88                   False                           False   \n",
       "89                     NaN                             NaN   \n",
       "90                     NaN                             NaN   \n",
       "91                     NaN                             NaN   \n",
       "92                   False                           False   \n",
       "93                   False                           False   \n",
       "94                     NaN                             NaN   \n",
       "95                     NaN                             NaN   \n",
       "96                     NaN                             NaN   \n",
       "97                     NaN                             NaN   \n",
       "98                   False                           False   \n",
       "99                   False                           False   \n",
       "100                  False                           False   \n",
       "101                  False                           False   \n",
       "102                    NaN                             NaN   \n",
       "103                  False                           False   \n",
       "104                  False                           False   \n",
       "105                  False                           False   \n",
       "106                  False                           False   \n",
       "107                    NaN                             NaN   \n",
       "108                    NaN                             NaN   \n",
       "109                    NaN                             NaN   \n",
       "110                    NaN                             NaN   \n",
       "111                    NaN                             NaN   \n",
       "112                    NaN                             NaN   \n",
       "113                    NaN                             NaN   \n",
       "114                    NaN                             NaN   \n",
       "115                  False                           False   \n",
       "116                  False                           False   \n",
       "117                    NaN                             NaN   \n",
       "118                    NaN                             NaN   \n",
       "119                    NaN                             NaN   \n",
       "120                    NaN                             NaN   \n",
       "121                    NaN                             NaN   \n",
       "122                    NaN                             NaN   \n",
       "123                    NaN                             NaN   \n",
       "124                    NaN                             NaN   \n",
       "125                    NaN                             NaN   \n",
       "126                    NaN                             NaN   \n",
       "127                    NaN                             NaN   \n",
       "128                    NaN                             NaN   \n",
       "129                    NaN                             NaN   \n",
       "130                    NaN                             NaN   \n",
       "131                    NaN                             NaN   \n",
       "132                    NaN                             NaN   \n",
       "133                    NaN                             NaN   \n",
       "134                    NaN                             NaN   \n",
       "135                  False                           False   \n",
       "136                  False                           False   \n",
       "137                   True                            True   \n",
       "138                   True                            True   \n",
       "139                  False                            True   \n",
       "140                  False                           False   \n",
       "141                   True                            True   \n",
       "142                   True                            True   \n",
       "143                   True                           False   \n",
       "144                    NaN                             NaN   \n",
       "145                  False                           False   \n",
       "146                  False                           False   \n",
       "147                  False                           False   \n",
       "148                  False                           False   \n",
       "149                  False                           False   \n",
       "150                  False                           False   \n",
       "151                   True                           False   \n",
       "152                    NaN                             NaN   \n",
       "153                   True                           False   \n",
       "154                   True                           False   \n",
       "155                  False                           False   \n",
       "156                  False                           False   \n",
       "157                  False                           False   \n",
       "158                  False                           False   \n",
       "159                   True                           False   \n",
       "160                  False                           False   \n",
       "161                    NaN                             NaN   \n",
       "162                  False                           False   \n",
       "163                  False                           False   \n",
       "164                  False                           False   \n",
       "165                  False                           False   \n",
       "166                  False                           False   \n",
       "167                  False                           False   \n",
       "168                  False                           False   \n",
       "169                  False                           False   \n",
       "170                  False                           False   \n",
       "171                  False                           False   \n",
       "172                    NaN                             NaN   \n",
       "173                  False                           False   \n",
       "174                  False                            True   \n",
       "175                  False                           False   \n",
       "176                  False                            True   \n",
       "177                  False                           False   \n",
       "178                  False                           False   \n",
       "179                   True                           False   \n",
       "180                    NaN                             NaN   \n",
       "181                   True                            True   \n",
       "182                   True                            True   \n",
       "183                   True                           False   \n",
       "184                   True                            True   \n",
       "185                    NaN                             NaN   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                     False                                  False   \n",
       "1                     False                                  False   \n",
       "2                     False                                  False   \n",
       "3                       NaN                                    NaN   \n",
       "4                       NaN                                    NaN   \n",
       "5                       NaN                                    NaN   \n",
       "6                     False                                  False   \n",
       "7                     False                                  False   \n",
       "8                     False                                   True   \n",
       "9                       NaN                                    NaN   \n",
       "10                      NaN                                    NaN   \n",
       "11                      NaN                                    NaN   \n",
       "12                    False                                  False   \n",
       "13                     True                                   True   \n",
       "14                      NaN                                    NaN   \n",
       "15                      NaN                                    NaN   \n",
       "16                      NaN                                    NaN   \n",
       "17                      NaN                                    NaN   \n",
       "18                    False                                   True   \n",
       "19                    False                                  False   \n",
       "20                      NaN                                    NaN   \n",
       "21                      NaN                                    NaN   \n",
       "22                      NaN                                    NaN   \n",
       "23                      NaN                                    NaN   \n",
       "24                      NaN                                    NaN   \n",
       "25                      NaN                                    NaN   \n",
       "26                    False                                   True   \n",
       "27                      NaN                                    NaN   \n",
       "28                      NaN                                    NaN   \n",
       "29                      NaN                                    NaN   \n",
       "30                    False                                  False   \n",
       "31                     True                                  False   \n",
       "32                      NaN                                    NaN   \n",
       "33                      NaN                                    NaN   \n",
       "34                    False                                  False   \n",
       "35                    False                                  False   \n",
       "36                      NaN                                    NaN   \n",
       "37                      NaN                                    NaN   \n",
       "38                    False                                  False   \n",
       "39                    False                                  False   \n",
       "40                      NaN                                    NaN   \n",
       "41                      NaN                                    NaN   \n",
       "42                    False                                  False   \n",
       "43                    False                                  False   \n",
       "44                      NaN                                    NaN   \n",
       "45                      NaN                                    NaN   \n",
       "46                    False                                  False   \n",
       "47                    False                                  False   \n",
       "48                      NaN                                    NaN   \n",
       "49                      NaN                                    NaN   \n",
       "50                    False                                  False   \n",
       "51                    False                                   True   \n",
       "52                    False                                  False   \n",
       "53                    False                                  False   \n",
       "54                      NaN                                    NaN   \n",
       "55                      NaN                                    NaN   \n",
       "56                    False                                  False   \n",
       "57                      NaN                                    NaN   \n",
       "58                      NaN                                    NaN   \n",
       "59                    False                                  False   \n",
       "60                    False                                   True   \n",
       "61                      NaN                                    NaN   \n",
       "62                      NaN                                    NaN   \n",
       "63                      NaN                                    NaN   \n",
       "64                      NaN                                    NaN   \n",
       "65                    False                                  False   \n",
       "66                     True                                  False   \n",
       "67                      NaN                                    NaN   \n",
       "68                     True                                  False   \n",
       "69                    False                                  False   \n",
       "70                    False                                  False   \n",
       "71                    False                                  False   \n",
       "72                    False                                  False   \n",
       "73                    False                                  False   \n",
       "74                     True                                  False   \n",
       "75                      NaN                                    NaN   \n",
       "76                    False                                  False   \n",
       "77                      NaN                                    NaN   \n",
       "78                      NaN                                    NaN   \n",
       "79                      NaN                                    NaN   \n",
       "80                    False                                   True   \n",
       "81                     True                                  False   \n",
       "82                      NaN                                    NaN   \n",
       "83                    False                                  False   \n",
       "84                    False                                  False   \n",
       "85                      NaN                                    NaN   \n",
       "86                    False                                  False   \n",
       "87                    False                                  False   \n",
       "88                    False                                  False   \n",
       "89                      NaN                                    NaN   \n",
       "90                      NaN                                    NaN   \n",
       "91                      NaN                                    NaN   \n",
       "92                    False                                  False   \n",
       "93                    False                                  False   \n",
       "94                      NaN                                    NaN   \n",
       "95                      NaN                                    NaN   \n",
       "96                      NaN                                    NaN   \n",
       "97                      NaN                                    NaN   \n",
       "98                    False                                  False   \n",
       "99                    False                                  False   \n",
       "100                   False                                  False   \n",
       "101                    True                                   True   \n",
       "102                     NaN                                    NaN   \n",
       "103                    True                                   True   \n",
       "104                   False                                  False   \n",
       "105                   False                                  False   \n",
       "106                   False                                  False   \n",
       "107                     NaN                                    NaN   \n",
       "108                     NaN                                    NaN   \n",
       "109                     NaN                                    NaN   \n",
       "110                     NaN                                    NaN   \n",
       "111                     NaN                                    NaN   \n",
       "112                     NaN                                    NaN   \n",
       "113                     NaN                                    NaN   \n",
       "114                     NaN                                    NaN   \n",
       "115                   False                                  False   \n",
       "116                   False                                  False   \n",
       "117                     NaN                                    NaN   \n",
       "118                     NaN                                    NaN   \n",
       "119                     NaN                                    NaN   \n",
       "120                     NaN                                    NaN   \n",
       "121                     NaN                                    NaN   \n",
       "122                     NaN                                    NaN   \n",
       "123                     NaN                                    NaN   \n",
       "124                     NaN                                    NaN   \n",
       "125                     NaN                                    NaN   \n",
       "126                     NaN                                    NaN   \n",
       "127                     NaN                                    NaN   \n",
       "128                     NaN                                    NaN   \n",
       "129                     NaN                                    NaN   \n",
       "130                     NaN                                    NaN   \n",
       "131                     NaN                                    NaN   \n",
       "132                     NaN                                    NaN   \n",
       "133                     NaN                                    NaN   \n",
       "134                     NaN                                    NaN   \n",
       "135                   False                                  False   \n",
       "136                   False                                  False   \n",
       "137                    True                                  False   \n",
       "138                    True                                  False   \n",
       "139                   False                                  False   \n",
       "140                   False                                   True   \n",
       "141                   False                                   True   \n",
       "142                    True                                  False   \n",
       "143                   False                                  False   \n",
       "144                     NaN                                    NaN   \n",
       "145                   False                                  False   \n",
       "146                   False                                  False   \n",
       "147                   False                                  False   \n",
       "148                   False                                  False   \n",
       "149                   False                                  False   \n",
       "150                   False                                  False   \n",
       "151                   False                                  False   \n",
       "152                     NaN                                    NaN   \n",
       "153                   False                                  False   \n",
       "154                   False                                  False   \n",
       "155                   False                                  False   \n",
       "156                   False                                  False   \n",
       "157                   False                                  False   \n",
       "158                   False                                  False   \n",
       "159                   False                                  False   \n",
       "160                   False                                  False   \n",
       "161                     NaN                                    NaN   \n",
       "162                    True                                  False   \n",
       "163                   False                                  False   \n",
       "164                   False                                  False   \n",
       "165                   False                                  False   \n",
       "166                   False                                  False   \n",
       "167                   False                                  False   \n",
       "168                   False                                  False   \n",
       "169                   False                                   True   \n",
       "170                   False                                  False   \n",
       "171                   False                                   True   \n",
       "172                     NaN                                    NaN   \n",
       "173                   False                                  False   \n",
       "174                   False                                  False   \n",
       "175                   False                                  False   \n",
       "176                   False                                  False   \n",
       "177                   False                                  False   \n",
       "178                   False                                  False   \n",
       "179                   False                                  False   \n",
       "180                     NaN                                    NaN   \n",
       "181                   False                                  False   \n",
       "182                   False                                  False   \n",
       "183                   False                                  False   \n",
       "184                   False                                   True   \n",
       "185                     NaN                                    NaN   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                      False               False                       False   \n",
       "1                      False               False                       False   \n",
       "2                      False               False                       False   \n",
       "3                        NaN                 NaN                         NaN   \n",
       "4                        NaN                 NaN                         NaN   \n",
       "5                        NaN                 NaN                         NaN   \n",
       "6                      False               False                       False   \n",
       "7                      False               False                       False   \n",
       "8                      False               False                       False   \n",
       "9                        NaN                 NaN                         NaN   \n",
       "10                       NaN                 NaN                         NaN   \n",
       "11                       NaN                 NaN                         NaN   \n",
       "12                     False               False                       False   \n",
       "13                     False               False                       False   \n",
       "14                       NaN                 NaN                         NaN   \n",
       "15                       NaN                 NaN                         NaN   \n",
       "16                       NaN                 NaN                         NaN   \n",
       "17                       NaN                 NaN                         NaN   \n",
       "18                     False                True                       False   \n",
       "19                     False               False                       False   \n",
       "20                       NaN                 NaN                         NaN   \n",
       "21                       NaN                 NaN                         NaN   \n",
       "22                       NaN                 NaN                         NaN   \n",
       "23                       NaN                 NaN                         NaN   \n",
       "24                       NaN                 NaN                         NaN   \n",
       "25                       NaN                 NaN                         NaN   \n",
       "26                     False               False                       False   \n",
       "27                       NaN                 NaN                         NaN   \n",
       "28                       NaN                 NaN                         NaN   \n",
       "29                       NaN                 NaN                         NaN   \n",
       "30                     False               False                       False   \n",
       "31                     False               False                       False   \n",
       "32                       NaN                 NaN                         NaN   \n",
       "33                       NaN                 NaN                         NaN   \n",
       "34                     False                True                       False   \n",
       "35                     False               False                       False   \n",
       "36                       NaN                 NaN                         NaN   \n",
       "37                       NaN                 NaN                         NaN   \n",
       "38                     False               False                       False   \n",
       "39                     False               False                       False   \n",
       "40                       NaN                 NaN                         NaN   \n",
       "41                       NaN                 NaN                         NaN   \n",
       "42                     False               False                       False   \n",
       "43                     False               False                       False   \n",
       "44                       NaN                 NaN                         NaN   \n",
       "45                       NaN                 NaN                         NaN   \n",
       "46                     False                True                       False   \n",
       "47                     False                True                       False   \n",
       "48                       NaN                 NaN                         NaN   \n",
       "49                       NaN                 NaN                         NaN   \n",
       "50                     False               False                       False   \n",
       "51                     False               False                       False   \n",
       "52                     False               False                       False   \n",
       "53                     False               False                       False   \n",
       "54                       NaN                 NaN                         NaN   \n",
       "55                       NaN                 NaN                         NaN   \n",
       "56                     False               False                       False   \n",
       "57                       NaN                 NaN                         NaN   \n",
       "58                       NaN                 NaN                         NaN   \n",
       "59                     False               False                       False   \n",
       "60                     False               False                       False   \n",
       "61                       NaN                 NaN                         NaN   \n",
       "62                       NaN                 NaN                         NaN   \n",
       "63                       NaN                 NaN                         NaN   \n",
       "64                       NaN                 NaN                         NaN   \n",
       "65                     False               False                       False   \n",
       "66                     False               False                       False   \n",
       "67                       NaN                 NaN                         NaN   \n",
       "68                     False                True                       False   \n",
       "69                     False                True                       False   \n",
       "70                     False               False                       False   \n",
       "71                     False               False                        True   \n",
       "72                     False               False                        True   \n",
       "73                     False               False                        True   \n",
       "74                     False               False                       False   \n",
       "75                       NaN                 NaN                         NaN   \n",
       "76                     False               False                       False   \n",
       "77                       NaN                 NaN                         NaN   \n",
       "78                       NaN                 NaN                         NaN   \n",
       "79                       NaN                 NaN                         NaN   \n",
       "80                     False               False                       False   \n",
       "81                     False                True                        True   \n",
       "82                       NaN                 NaN                         NaN   \n",
       "83                     False               False                       False   \n",
       "84                     False               False                       False   \n",
       "85                       NaN                 NaN                         NaN   \n",
       "86                     False               False                       False   \n",
       "87                     False               False                       False   \n",
       "88                     False               False                       False   \n",
       "89                       NaN                 NaN                         NaN   \n",
       "90                       NaN                 NaN                         NaN   \n",
       "91                       NaN                 NaN                         NaN   \n",
       "92                     False               False                       False   \n",
       "93                     False                True                       False   \n",
       "94                       NaN                 NaN                         NaN   \n",
       "95                       NaN                 NaN                         NaN   \n",
       "96                       NaN                 NaN                         NaN   \n",
       "97                       NaN                 NaN                         NaN   \n",
       "98                     False               False                       False   \n",
       "99                     False               False                       False   \n",
       "100                    False               False                       False   \n",
       "101                    False               False                       False   \n",
       "102                      NaN                 NaN                         NaN   \n",
       "103                    False               False                       False   \n",
       "104                    False               False                       False   \n",
       "105                    False               False                       False   \n",
       "106                    False               False                       False   \n",
       "107                      NaN                 NaN                         NaN   \n",
       "108                      NaN                 NaN                         NaN   \n",
       "109                      NaN                 NaN                         NaN   \n",
       "110                      NaN                 NaN                         NaN   \n",
       "111                      NaN                 NaN                         NaN   \n",
       "112                      NaN                 NaN                         NaN   \n",
       "113                      NaN                 NaN                         NaN   \n",
       "114                      NaN                 NaN                         NaN   \n",
       "115                    False               False                       False   \n",
       "116                    False               False                       False   \n",
       "117                      NaN                 NaN                         NaN   \n",
       "118                      NaN                 NaN                         NaN   \n",
       "119                      NaN                 NaN                         NaN   \n",
       "120                      NaN                 NaN                         NaN   \n",
       "121                      NaN                 NaN                         NaN   \n",
       "122                      NaN                 NaN                         NaN   \n",
       "123                      NaN                 NaN                         NaN   \n",
       "124                      NaN                 NaN                         NaN   \n",
       "125                      NaN                 NaN                         NaN   \n",
       "126                      NaN                 NaN                         NaN   \n",
       "127                      NaN                 NaN                         NaN   \n",
       "128                      NaN                 NaN                         NaN   \n",
       "129                      NaN                 NaN                         NaN   \n",
       "130                      NaN                 NaN                         NaN   \n",
       "131                      NaN                 NaN                         NaN   \n",
       "132                      NaN                 NaN                         NaN   \n",
       "133                      NaN                 NaN                         NaN   \n",
       "134                      NaN                 NaN                         NaN   \n",
       "135                    False               False                       False   \n",
       "136                    False               False                       False   \n",
       "137                    False               False                       False   \n",
       "138                     True                True                       False   \n",
       "139                    False               False                       False   \n",
       "140                    False               False                       False   \n",
       "141                    False               False                       False   \n",
       "142                    False               False                       False   \n",
       "143                    False               False                       False   \n",
       "144                      NaN                 NaN                         NaN   \n",
       "145                    False               False                       False   \n",
       "146                    False                True                       False   \n",
       "147                    False               False                        True   \n",
       "148                    False               False                       False   \n",
       "149                    False               False                       False   \n",
       "150                    False               False                       False   \n",
       "151                    False               False                       False   \n",
       "152                      NaN                 NaN                         NaN   \n",
       "153                    False                True                       False   \n",
       "154                    False                True                       False   \n",
       "155                    False               False                       False   \n",
       "156                    False               False                       False   \n",
       "157                    False               False                       False   \n",
       "158                    False               False                       False   \n",
       "159                    False               False                       False   \n",
       "160                    False               False                       False   \n",
       "161                      NaN                 NaN                         NaN   \n",
       "162                     True               False                       False   \n",
       "163                    False               False                       False   \n",
       "164                    False               False                       False   \n",
       "165                    False               False                       False   \n",
       "166                    False                True                       False   \n",
       "167                    False               False                       False   \n",
       "168                    False               False                       False   \n",
       "169                    False               False                       False   \n",
       "170                    False               False                       False   \n",
       "171                    False               False                       False   \n",
       "172                      NaN                 NaN                         NaN   \n",
       "173                    False               False                       False   \n",
       "174                    False               False                       False   \n",
       "175                    False               False                       False   \n",
       "176                    False               False                       False   \n",
       "177                    False               False                       False   \n",
       "178                    False               False                       False   \n",
       "179                    False               False                       False   \n",
       "180                      NaN                 NaN                         NaN   \n",
       "181                    False               False                       False   \n",
       "182                    False               False                       False   \n",
       "183                     True               False                       False   \n",
       "184                    False               False                       False   \n",
       "185                      NaN                 NaN                         NaN   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                       False                                    False   \n",
       "1                       False                                    False   \n",
       "2                       False                                    False   \n",
       "3                         NaN                                      NaN   \n",
       "4                         NaN                                      NaN   \n",
       "5                         NaN                                      NaN   \n",
       "6                       False                                    False   \n",
       "7                       False                                    False   \n",
       "8                       False                                    False   \n",
       "9                         NaN                                      NaN   \n",
       "10                        NaN                                      NaN   \n",
       "11                        NaN                                      NaN   \n",
       "12                      False                                    False   \n",
       "13                      False                                    False   \n",
       "14                        NaN                                      NaN   \n",
       "15                        NaN                                      NaN   \n",
       "16                        NaN                                      NaN   \n",
       "17                        NaN                                      NaN   \n",
       "18                      False                                    False   \n",
       "19                      False                                    False   \n",
       "20                        NaN                                      NaN   \n",
       "21                        NaN                                      NaN   \n",
       "22                        NaN                                      NaN   \n",
       "23                        NaN                                      NaN   \n",
       "24                        NaN                                      NaN   \n",
       "25                        NaN                                      NaN   \n",
       "26                      False                                    False   \n",
       "27                        NaN                                      NaN   \n",
       "28                        NaN                                      NaN   \n",
       "29                        NaN                                      NaN   \n",
       "30                      False                                    False   \n",
       "31                      False                                    False   \n",
       "32                        NaN                                      NaN   \n",
       "33                        NaN                                      NaN   \n",
       "34                      False                                    False   \n",
       "35                      False                                    False   \n",
       "36                        NaN                                      NaN   \n",
       "37                        NaN                                      NaN   \n",
       "38                      False                                    False   \n",
       "39                      False                                    False   \n",
       "40                        NaN                                      NaN   \n",
       "41                        NaN                                      NaN   \n",
       "42                      False                                    False   \n",
       "43                      False                                    False   \n",
       "44                        NaN                                      NaN   \n",
       "45                        NaN                                      NaN   \n",
       "46                      False                                    False   \n",
       "47                      False                                    False   \n",
       "48                        NaN                                      NaN   \n",
       "49                        NaN                                      NaN   \n",
       "50                      False                                    False   \n",
       "51                      False                                    False   \n",
       "52                      False                                    False   \n",
       "53                      False                                    False   \n",
       "54                        NaN                                      NaN   \n",
       "55                        NaN                                      NaN   \n",
       "56                      False                                    False   \n",
       "57                        NaN                                      NaN   \n",
       "58                        NaN                                      NaN   \n",
       "59                      False                                    False   \n",
       "60                      False                                    False   \n",
       "61                        NaN                                      NaN   \n",
       "62                        NaN                                      NaN   \n",
       "63                        NaN                                      NaN   \n",
       "64                        NaN                                      NaN   \n",
       "65                      False                                    False   \n",
       "66                      False                                    False   \n",
       "67                        NaN                                      NaN   \n",
       "68                      False                                    False   \n",
       "69                      False                                    False   \n",
       "70                      False                                    False   \n",
       "71                      False                                    False   \n",
       "72                      False                                    False   \n",
       "73                      False                                    False   \n",
       "74                      False                                    False   \n",
       "75                        NaN                                      NaN   \n",
       "76                      False                                    False   \n",
       "77                        NaN                                      NaN   \n",
       "78                        NaN                                      NaN   \n",
       "79                        NaN                                      NaN   \n",
       "80                      False                                    False   \n",
       "81                       True                                    False   \n",
       "82                        NaN                                      NaN   \n",
       "83                      False                                    False   \n",
       "84                      False                                    False   \n",
       "85                        NaN                                      NaN   \n",
       "86                      False                                    False   \n",
       "87                      False                                    False   \n",
       "88                      False                                    False   \n",
       "89                        NaN                                      NaN   \n",
       "90                        NaN                                      NaN   \n",
       "91                        NaN                                      NaN   \n",
       "92                      False                                    False   \n",
       "93                      False                                    False   \n",
       "94                        NaN                                      NaN   \n",
       "95                        NaN                                      NaN   \n",
       "96                        NaN                                      NaN   \n",
       "97                        NaN                                      NaN   \n",
       "98                      False                                    False   \n",
       "99                      False                                    False   \n",
       "100                     False                                    False   \n",
       "101                      True                                    False   \n",
       "102                       NaN                                      NaN   \n",
       "103                      True                                    False   \n",
       "104                     False                                    False   \n",
       "105                     False                                     True   \n",
       "106                     False                                    False   \n",
       "107                       NaN                                      NaN   \n",
       "108                       NaN                                      NaN   \n",
       "109                       NaN                                      NaN   \n",
       "110                       NaN                                      NaN   \n",
       "111                       NaN                                      NaN   \n",
       "112                       NaN                                      NaN   \n",
       "113                       NaN                                      NaN   \n",
       "114                       NaN                                      NaN   \n",
       "115                     False                                    False   \n",
       "116                     False                                    False   \n",
       "117                       NaN                                      NaN   \n",
       "118                       NaN                                      NaN   \n",
       "119                       NaN                                      NaN   \n",
       "120                       NaN                                      NaN   \n",
       "121                       NaN                                      NaN   \n",
       "122                       NaN                                      NaN   \n",
       "123                       NaN                                      NaN   \n",
       "124                       NaN                                      NaN   \n",
       "125                       NaN                                      NaN   \n",
       "126                       NaN                                      NaN   \n",
       "127                       NaN                                      NaN   \n",
       "128                       NaN                                      NaN   \n",
       "129                       NaN                                      NaN   \n",
       "130                       NaN                                      NaN   \n",
       "131                       NaN                                      NaN   \n",
       "132                       NaN                                      NaN   \n",
       "133                       NaN                                      NaN   \n",
       "134                       NaN                                      NaN   \n",
       "135                     False                                    False   \n",
       "136                     False                                    False   \n",
       "137                      True                                    False   \n",
       "138                      True                                    False   \n",
       "139                     False                                    False   \n",
       "140                     False                                    False   \n",
       "141                     False                                    False   \n",
       "142                     False                                    False   \n",
       "143                     False                                    False   \n",
       "144                       NaN                                      NaN   \n",
       "145                     False                                    False   \n",
       "146                     False                                    False   \n",
       "147                     False                                    False   \n",
       "148                     False                                    False   \n",
       "149                     False                                    False   \n",
       "150                     False                                    False   \n",
       "151                     False                                    False   \n",
       "152                       NaN                                      NaN   \n",
       "153                     False                                    False   \n",
       "154                     False                                    False   \n",
       "155                     False                                    False   \n",
       "156                     False                                    False   \n",
       "157                     False                                    False   \n",
       "158                     False                                    False   \n",
       "159                     False                                    False   \n",
       "160                     False                                    False   \n",
       "161                       NaN                                      NaN   \n",
       "162                     False                                    False   \n",
       "163                     False                                    False   \n",
       "164                      True                                    False   \n",
       "165                     False                                    False   \n",
       "166                     False                                    False   \n",
       "167                     False                                    False   \n",
       "168                     False                                    False   \n",
       "169                     False                                    False   \n",
       "170                     False                                    False   \n",
       "171                     False                                    False   \n",
       "172                       NaN                                      NaN   \n",
       "173                     False                                    False   \n",
       "174                     False                                    False   \n",
       "175                     False                                    False   \n",
       "176                     False                                    False   \n",
       "177                     False                                    False   \n",
       "178                     False                                    False   \n",
       "179                     False                                    False   \n",
       "180                       NaN                                      NaN   \n",
       "181                     False                                    False   \n",
       "182                     False                                    False   \n",
       "183                     False                                    False   \n",
       "184                     False                                    False   \n",
       "185                       NaN                                      NaN   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                  False                                  False   \n",
       "1                  False                                  False   \n",
       "2                  False                                  False   \n",
       "3                    NaN                                    NaN   \n",
       "4                    NaN                                    NaN   \n",
       "5                    NaN                                    NaN   \n",
       "6                  False                                  False   \n",
       "7                  False                                  False   \n",
       "8                  False                                  False   \n",
       "9                    NaN                                    NaN   \n",
       "10                   NaN                                    NaN   \n",
       "11                   NaN                                    NaN   \n",
       "12                 False                                  False   \n",
       "13                 False                                  False   \n",
       "14                   NaN                                    NaN   \n",
       "15                   NaN                                    NaN   \n",
       "16                   NaN                                    NaN   \n",
       "17                   NaN                                    NaN   \n",
       "18                 False                                  False   \n",
       "19                 False                                  False   \n",
       "20                   NaN                                    NaN   \n",
       "21                   NaN                                    NaN   \n",
       "22                   NaN                                    NaN   \n",
       "23                   NaN                                    NaN   \n",
       "24                   NaN                                    NaN   \n",
       "25                   NaN                                    NaN   \n",
       "26                 False                                  False   \n",
       "27                   NaN                                    NaN   \n",
       "28                   NaN                                    NaN   \n",
       "29                   NaN                                    NaN   \n",
       "30                 False                                  False   \n",
       "31                 False                                  False   \n",
       "32                   NaN                                    NaN   \n",
       "33                   NaN                                    NaN   \n",
       "34                 False                                  False   \n",
       "35                 False                                  False   \n",
       "36                   NaN                                    NaN   \n",
       "37                   NaN                                    NaN   \n",
       "38                 False                                  False   \n",
       "39                 False                                  False   \n",
       "40                   NaN                                    NaN   \n",
       "41                   NaN                                    NaN   \n",
       "42                 False                                  False   \n",
       "43                 False                                  False   \n",
       "44                   NaN                                    NaN   \n",
       "45                   NaN                                    NaN   \n",
       "46                 False                                  False   \n",
       "47                 False                                  False   \n",
       "48                   NaN                                    NaN   \n",
       "49                   NaN                                    NaN   \n",
       "50                 False                                  False   \n",
       "51                 False                                  False   \n",
       "52                 False                                  False   \n",
       "53                 False                                  False   \n",
       "54                   NaN                                    NaN   \n",
       "55                   NaN                                    NaN   \n",
       "56                 False                                  False   \n",
       "57                   NaN                                    NaN   \n",
       "58                   NaN                                    NaN   \n",
       "59                 False                                  False   \n",
       "60                 False                                  False   \n",
       "61                   NaN                                    NaN   \n",
       "62                   NaN                                    NaN   \n",
       "63                   NaN                                    NaN   \n",
       "64                   NaN                                    NaN   \n",
       "65                 False                                  False   \n",
       "66                 False                                  False   \n",
       "67                   NaN                                    NaN   \n",
       "68                 False                                  False   \n",
       "69                 False                                  False   \n",
       "70                 False                                  False   \n",
       "71                 False                                  False   \n",
       "72                 False                                  False   \n",
       "73                 False                                  False   \n",
       "74                 False                                  False   \n",
       "75                   NaN                                    NaN   \n",
       "76                 False                                  False   \n",
       "77                   NaN                                    NaN   \n",
       "78                   NaN                                    NaN   \n",
       "79                   NaN                                    NaN   \n",
       "80                 False                                  False   \n",
       "81                 False                                  False   \n",
       "82                   NaN                                    NaN   \n",
       "83                 False                                  False   \n",
       "84                 False                                  False   \n",
       "85                   NaN                                    NaN   \n",
       "86                 False                                  False   \n",
       "87                 False                                  False   \n",
       "88                 False                                  False   \n",
       "89                   NaN                                    NaN   \n",
       "90                   NaN                                    NaN   \n",
       "91                   NaN                                    NaN   \n",
       "92                 False                                  False   \n",
       "93                 False                                  False   \n",
       "94                   NaN                                    NaN   \n",
       "95                   NaN                                    NaN   \n",
       "96                   NaN                                    NaN   \n",
       "97                   NaN                                    NaN   \n",
       "98                 False                                  False   \n",
       "99                 False                                  False   \n",
       "100                False                                  False   \n",
       "101                False                                  False   \n",
       "102                  NaN                                    NaN   \n",
       "103                False                                  False   \n",
       "104                False                                  False   \n",
       "105                False                                  False   \n",
       "106                False                                  False   \n",
       "107                  NaN                                    NaN   \n",
       "108                  NaN                                    NaN   \n",
       "109                  NaN                                    NaN   \n",
       "110                  NaN                                    NaN   \n",
       "111                  NaN                                    NaN   \n",
       "112                  NaN                                    NaN   \n",
       "113                  NaN                                    NaN   \n",
       "114                  NaN                                    NaN   \n",
       "115                False                                  False   \n",
       "116                False                                   True   \n",
       "117                  NaN                                    NaN   \n",
       "118                  NaN                                    NaN   \n",
       "119                  NaN                                    NaN   \n",
       "120                  NaN                                    NaN   \n",
       "121                  NaN                                    NaN   \n",
       "122                  NaN                                    NaN   \n",
       "123                  NaN                                    NaN   \n",
       "124                  NaN                                    NaN   \n",
       "125                  NaN                                    NaN   \n",
       "126                  NaN                                    NaN   \n",
       "127                  NaN                                    NaN   \n",
       "128                  NaN                                    NaN   \n",
       "129                  NaN                                    NaN   \n",
       "130                  NaN                                    NaN   \n",
       "131                  NaN                                    NaN   \n",
       "132                  NaN                                    NaN   \n",
       "133                  NaN                                    NaN   \n",
       "134                  NaN                                    NaN   \n",
       "135                False                                  False   \n",
       "136                False                                  False   \n",
       "137                False                                  False   \n",
       "138                False                                  False   \n",
       "139                False                                  False   \n",
       "140                False                                  False   \n",
       "141                False                                  False   \n",
       "142                False                                  False   \n",
       "143                False                                  False   \n",
       "144                  NaN                                    NaN   \n",
       "145                False                                  False   \n",
       "146                False                                  False   \n",
       "147                False                                  False   \n",
       "148                False                                  False   \n",
       "149                False                                  False   \n",
       "150                False                                  False   \n",
       "151                False                                  False   \n",
       "152                  NaN                                    NaN   \n",
       "153                False                                  False   \n",
       "154                False                                  False   \n",
       "155                False                                  False   \n",
       "156                False                                  False   \n",
       "157                False                                  False   \n",
       "158                False                                  False   \n",
       "159                False                                  False   \n",
       "160                False                                  False   \n",
       "161                  NaN                                    NaN   \n",
       "162                False                                  False   \n",
       "163                False                                  False   \n",
       "164                False                                  False   \n",
       "165                False                                  False   \n",
       "166                False                                  False   \n",
       "167                False                                  False   \n",
       "168                False                                  False   \n",
       "169                False                                  False   \n",
       "170                False                                  False   \n",
       "171                False                                  False   \n",
       "172                  NaN                                    NaN   \n",
       "173                False                                  False   \n",
       "174                False                                  False   \n",
       "175                False                                  False   \n",
       "176                False                                  False   \n",
       "177                False                                  False   \n",
       "178                False                                  False   \n",
       "179                False                                  False   \n",
       "180                  NaN                                    NaN   \n",
       "181                False                                  False   \n",
       "182                False                                  False   \n",
       "183                False                                  False   \n",
       "184                False                                  False   \n",
       "185                  NaN                                    NaN   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                    False                           False   \n",
       "1                                    False                           False   \n",
       "2                                    False                           False   \n",
       "3                                      NaN                             NaN   \n",
       "4                                      NaN                             NaN   \n",
       "5                                      NaN                             NaN   \n",
       "6                                    False                           False   \n",
       "7                                    False                           False   \n",
       "8                                    False                           False   \n",
       "9                                      NaN                             NaN   \n",
       "10                                     NaN                             NaN   \n",
       "11                                     NaN                             NaN   \n",
       "12                                   False                           False   \n",
       "13                                   False                           False   \n",
       "14                                     NaN                             NaN   \n",
       "15                                     NaN                             NaN   \n",
       "16                                     NaN                             NaN   \n",
       "17                                     NaN                             NaN   \n",
       "18                                   False                           False   \n",
       "19                                   False                           False   \n",
       "20                                     NaN                             NaN   \n",
       "21                                     NaN                             NaN   \n",
       "22                                     NaN                             NaN   \n",
       "23                                     NaN                             NaN   \n",
       "24                                     NaN                             NaN   \n",
       "25                                     NaN                             NaN   \n",
       "26                                   False                           False   \n",
       "27                                     NaN                             NaN   \n",
       "28                                     NaN                             NaN   \n",
       "29                                     NaN                             NaN   \n",
       "30                                   False                           False   \n",
       "31                                   False                           False   \n",
       "32                                     NaN                             NaN   \n",
       "33                                     NaN                             NaN   \n",
       "34                                   False                           False   \n",
       "35                                   False                           False   \n",
       "36                                     NaN                             NaN   \n",
       "37                                     NaN                             NaN   \n",
       "38                                    True                            True   \n",
       "39                                   False                            True   \n",
       "40                                     NaN                             NaN   \n",
       "41                                     NaN                             NaN   \n",
       "42                                    True                           False   \n",
       "43                                    True                           False   \n",
       "44                                     NaN                             NaN   \n",
       "45                                     NaN                             NaN   \n",
       "46                                   False                           False   \n",
       "47                                   False                           False   \n",
       "48                                     NaN                             NaN   \n",
       "49                                     NaN                             NaN   \n",
       "50                                   False                           False   \n",
       "51                                   False                           False   \n",
       "52                                   False                           False   \n",
       "53                                   False                            True   \n",
       "54                                     NaN                             NaN   \n",
       "55                                     NaN                             NaN   \n",
       "56                                   False                           False   \n",
       "57                                     NaN                             NaN   \n",
       "58                                     NaN                             NaN   \n",
       "59                                   False                           False   \n",
       "60                                   False                           False   \n",
       "61                                     NaN                             NaN   \n",
       "62                                     NaN                             NaN   \n",
       "63                                     NaN                             NaN   \n",
       "64                                     NaN                             NaN   \n",
       "65                                   False                           False   \n",
       "66                                   False                           False   \n",
       "67                                     NaN                             NaN   \n",
       "68                                   False                           False   \n",
       "69                                   False                           False   \n",
       "70                                   False                           False   \n",
       "71                                   False                           False   \n",
       "72                                   False                           False   \n",
       "73                                   False                           False   \n",
       "74                                   False                           False   \n",
       "75                                     NaN                             NaN   \n",
       "76                                   False                           False   \n",
       "77                                     NaN                             NaN   \n",
       "78                                     NaN                             NaN   \n",
       "79                                     NaN                             NaN   \n",
       "80                                   False                           False   \n",
       "81                                   False                           False   \n",
       "82                                     NaN                             NaN   \n",
       "83                                   False                           False   \n",
       "84                                   False                           False   \n",
       "85                                     NaN                             NaN   \n",
       "86                                   False                           False   \n",
       "87                                   False                           False   \n",
       "88                                   False                           False   \n",
       "89                                     NaN                             NaN   \n",
       "90                                     NaN                             NaN   \n",
       "91                                     NaN                             NaN   \n",
       "92                                   False                           False   \n",
       "93                                   False                           False   \n",
       "94                                     NaN                             NaN   \n",
       "95                                     NaN                             NaN   \n",
       "96                                     NaN                             NaN   \n",
       "97                                     NaN                             NaN   \n",
       "98                                   False                           False   \n",
       "99                                    True                           False   \n",
       "100                                  False                           False   \n",
       "101                                  False                           False   \n",
       "102                                    NaN                             NaN   \n",
       "103                                  False                           False   \n",
       "104                                  False                           False   \n",
       "105                                  False                           False   \n",
       "106                                  False                           False   \n",
       "107                                    NaN                             NaN   \n",
       "108                                    NaN                             NaN   \n",
       "109                                    NaN                             NaN   \n",
       "110                                    NaN                             NaN   \n",
       "111                                    NaN                             NaN   \n",
       "112                                    NaN                             NaN   \n",
       "113                                    NaN                             NaN   \n",
       "114                                    NaN                             NaN   \n",
       "115                                  False                           False   \n",
       "116                                  False                           False   \n",
       "117                                    NaN                             NaN   \n",
       "118                                    NaN                             NaN   \n",
       "119                                    NaN                             NaN   \n",
       "120                                    NaN                             NaN   \n",
       "121                                    NaN                             NaN   \n",
       "122                                    NaN                             NaN   \n",
       "123                                    NaN                             NaN   \n",
       "124                                    NaN                             NaN   \n",
       "125                                    NaN                             NaN   \n",
       "126                                    NaN                             NaN   \n",
       "127                                    NaN                             NaN   \n",
       "128                                    NaN                             NaN   \n",
       "129                                    NaN                             NaN   \n",
       "130                                    NaN                             NaN   \n",
       "131                                    NaN                             NaN   \n",
       "132                                    NaN                             NaN   \n",
       "133                                    NaN                             NaN   \n",
       "134                                    NaN                             NaN   \n",
       "135                                  False                           False   \n",
       "136                                  False                           False   \n",
       "137                                  False                           False   \n",
       "138                                  False                           False   \n",
       "139                                  False                           False   \n",
       "140                                  False                           False   \n",
       "141                                  False                           False   \n",
       "142                                  False                           False   \n",
       "143                                  False                           False   \n",
       "144                                    NaN                             NaN   \n",
       "145                                  False                           False   \n",
       "146                                  False                           False   \n",
       "147                                  False                           False   \n",
       "148                                  False                           False   \n",
       "149                                  False                           False   \n",
       "150                                  False                           False   \n",
       "151                                   True                           False   \n",
       "152                                    NaN                             NaN   \n",
       "153                                   True                           False   \n",
       "154                                   True                           False   \n",
       "155                                  False                           False   \n",
       "156                                  False                           False   \n",
       "157                                  False                           False   \n",
       "158                                  False                           False   \n",
       "159                                  False                           False   \n",
       "160                                  False                           False   \n",
       "161                                    NaN                             NaN   \n",
       "162                                  False                           False   \n",
       "163                                  False                           False   \n",
       "164                                  False                           False   \n",
       "165                                  False                           False   \n",
       "166                                   True                            True   \n",
       "167                                  False                            True   \n",
       "168                                  False                           False   \n",
       "169                                  False                           False   \n",
       "170                                  False                           False   \n",
       "171                                  False                           False   \n",
       "172                                    NaN                             NaN   \n",
       "173                                  False                           False   \n",
       "174                                  False                           False   \n",
       "175                                  False                           False   \n",
       "176                                  False                           False   \n",
       "177                                  False                           False   \n",
       "178                                  False                           False   \n",
       "179                                   True                           False   \n",
       "180                                    NaN                             NaN   \n",
       "181                                  False                           False   \n",
       "182                                  False                           False   \n",
       "183                                  False                           False   \n",
       "184                                  False                           False   \n",
       "185                                    NaN                             NaN   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "0                      False   \n",
       "1                      False   \n",
       "2                      False   \n",
       "3                        NaN   \n",
       "4                        NaN   \n",
       "5                        NaN   \n",
       "6                      False   \n",
       "7                      False   \n",
       "8                      False   \n",
       "9                        NaN   \n",
       "10                       NaN   \n",
       "11                       NaN   \n",
       "12                     False   \n",
       "13                     False   \n",
       "14                       NaN   \n",
       "15                       NaN   \n",
       "16                       NaN   \n",
       "17                       NaN   \n",
       "18                     False   \n",
       "19                     False   \n",
       "20                       NaN   \n",
       "21                       NaN   \n",
       "22                       NaN   \n",
       "23                       NaN   \n",
       "24                       NaN   \n",
       "25                       NaN   \n",
       "26                     False   \n",
       "27                       NaN   \n",
       "28                       NaN   \n",
       "29                       NaN   \n",
       "30                     False   \n",
       "31                     False   \n",
       "32                       NaN   \n",
       "33                       NaN   \n",
       "34                     False   \n",
       "35                     False   \n",
       "36                       NaN   \n",
       "37                       NaN   \n",
       "38                     False   \n",
       "39                     False   \n",
       "40                       NaN   \n",
       "41                       NaN   \n",
       "42                     False   \n",
       "43                     False   \n",
       "44                       NaN   \n",
       "45                       NaN   \n",
       "46                     False   \n",
       "47                     False   \n",
       "48                       NaN   \n",
       "49                       NaN   \n",
       "50                     False   \n",
       "51                     False   \n",
       "52                     False   \n",
       "53                     False   \n",
       "54                       NaN   \n",
       "55                       NaN   \n",
       "56                     False   \n",
       "57                       NaN   \n",
       "58                       NaN   \n",
       "59                      True   \n",
       "60                     False   \n",
       "61                       NaN   \n",
       "62                       NaN   \n",
       "63                       NaN   \n",
       "64                       NaN   \n",
       "65                     False   \n",
       "66                     False   \n",
       "67                       NaN   \n",
       "68                     False   \n",
       "69                     False   \n",
       "70                     False   \n",
       "71                     False   \n",
       "72                     False   \n",
       "73                     False   \n",
       "74                     False   \n",
       "75                       NaN   \n",
       "76                     False   \n",
       "77                       NaN   \n",
       "78                       NaN   \n",
       "79                       NaN   \n",
       "80                     False   \n",
       "81                     False   \n",
       "82                       NaN   \n",
       "83                     False   \n",
       "84                     False   \n",
       "85                       NaN   \n",
       "86                     False   \n",
       "87                     False   \n",
       "88                     False   \n",
       "89                       NaN   \n",
       "90                       NaN   \n",
       "91                       NaN   \n",
       "92                     False   \n",
       "93                     False   \n",
       "94                       NaN   \n",
       "95                       NaN   \n",
       "96                       NaN   \n",
       "97                       NaN   \n",
       "98                     False   \n",
       "99                     False   \n",
       "100                    False   \n",
       "101                    False   \n",
       "102                      NaN   \n",
       "103                    False   \n",
       "104                    False   \n",
       "105                    False   \n",
       "106                    False   \n",
       "107                      NaN   \n",
       "108                      NaN   \n",
       "109                      NaN   \n",
       "110                      NaN   \n",
       "111                      NaN   \n",
       "112                      NaN   \n",
       "113                      NaN   \n",
       "114                      NaN   \n",
       "115                    False   \n",
       "116                    False   \n",
       "117                      NaN   \n",
       "118                      NaN   \n",
       "119                      NaN   \n",
       "120                      NaN   \n",
       "121                      NaN   \n",
       "122                      NaN   \n",
       "123                      NaN   \n",
       "124                      NaN   \n",
       "125                      NaN   \n",
       "126                      NaN   \n",
       "127                      NaN   \n",
       "128                      NaN   \n",
       "129                      NaN   \n",
       "130                      NaN   \n",
       "131                      NaN   \n",
       "132                      NaN   \n",
       "133                      NaN   \n",
       "134                      NaN   \n",
       "135                    False   \n",
       "136                    False   \n",
       "137                    False   \n",
       "138                    False   \n",
       "139                    False   \n",
       "140                    False   \n",
       "141                    False   \n",
       "142                    False   \n",
       "143                    False   \n",
       "144                      NaN   \n",
       "145                    False   \n",
       "146                     True   \n",
       "147                    False   \n",
       "148                    False   \n",
       "149                    False   \n",
       "150                    False   \n",
       "151                    False   \n",
       "152                      NaN   \n",
       "153                    False   \n",
       "154                    False   \n",
       "155                    False   \n",
       "156                    False   \n",
       "157                    False   \n",
       "158                    False   \n",
       "159                    False   \n",
       "160                    False   \n",
       "161                      NaN   \n",
       "162                    False   \n",
       "163                    False   \n",
       "164                    False   \n",
       "165                    False   \n",
       "166                    False   \n",
       "167                    False   \n",
       "168                    False   \n",
       "169                    False   \n",
       "170                    False   \n",
       "171                    False   \n",
       "172                      NaN   \n",
       "173                    False   \n",
       "174                    False   \n",
       "175                    False   \n",
       "176                    False   \n",
       "177                    False   \n",
       "178                    False   \n",
       "179                    False   \n",
       "180                      NaN   \n",
       "181                    False   \n",
       "182                    False   \n",
       "183                    False   \n",
       "184                    False   \n",
       "185                      NaN   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                  Yes       \n",
       "1                                                  Yes       \n",
       "2                                                  Yes       \n",
       "3                                                  NaN       \n",
       "4                                                  NaN       \n",
       "5                                                  NaN       \n",
       "6                                                   No       \n",
       "7                                                  Yes       \n",
       "8                                                   No       \n",
       "9                                                  NaN       \n",
       "10                                                 NaN       \n",
       "11                                                 NaN       \n",
       "12                                                 Yes       \n",
       "13                                                 Yes       \n",
       "14                                                 NaN       \n",
       "15                                                 NaN       \n",
       "16                                                 NaN       \n",
       "17                                                 NaN       \n",
       "18                                                 Yes       \n",
       "19                                                  No       \n",
       "20                                                 NaN       \n",
       "21                                                 NaN       \n",
       "22                                                 NaN       \n",
       "23                                                 NaN       \n",
       "24                                                 NaN       \n",
       "25                                                 NaN       \n",
       "26                                                 Yes       \n",
       "27                                                 NaN       \n",
       "28                                                 NaN       \n",
       "29                                                 NaN       \n",
       "30                                                 Yes       \n",
       "31                                                  No       \n",
       "32                                                 NaN       \n",
       "33                                                 NaN       \n",
       "34                                                  No       \n",
       "35                                                 Yes       \n",
       "36                                                 NaN       \n",
       "37                                                 NaN       \n",
       "38                                                 Yes       \n",
       "39                                                 Yes       \n",
       "40                                                 NaN       \n",
       "41                                                 NaN       \n",
       "42                                                 Yes       \n",
       "43                                                  No       \n",
       "44                                                 NaN       \n",
       "45                                                 NaN       \n",
       "46                                                 Yes       \n",
       "47                                                 Yes       \n",
       "48                                                 NaN       \n",
       "49                                                 NaN       \n",
       "50                                                 Yes       \n",
       "51                                                  No       \n",
       "52                                                  No       \n",
       "53                                                  No       \n",
       "54                                                 NaN       \n",
       "55                                                 NaN       \n",
       "56                                                 Yes       \n",
       "57                                                 NaN       \n",
       "58                                                 NaN       \n",
       "59                                                  No       \n",
       "60                                                  No       \n",
       "61                                                 NaN       \n",
       "62                                                 NaN       \n",
       "63                                                 NaN       \n",
       "64                                                 NaN       \n",
       "65                                                 Yes       \n",
       "66                                                  No       \n",
       "67                                                 NaN       \n",
       "68                                                 Yes       \n",
       "69                                                 Yes       \n",
       "70                                                 Yes       \n",
       "71                                                 Yes       \n",
       "72                                                 Yes       \n",
       "73                                                 Yes       \n",
       "74                                                  No       \n",
       "75                                                 NaN       \n",
       "76                                                 Yes       \n",
       "77                                                 NaN       \n",
       "78                                                 NaN       \n",
       "79                                                 NaN       \n",
       "80                                                 Yes       \n",
       "81                                                  No       \n",
       "82                                                 NaN       \n",
       "83                                                 Yes       \n",
       "84                                                  No       \n",
       "85                                                 NaN       \n",
       "86                                                  No       \n",
       "87                                                  No       \n",
       "88                                                  No       \n",
       "89                                                 NaN       \n",
       "90                                                 NaN       \n",
       "91                                                 NaN       \n",
       "92                                                  No       \n",
       "93                                                 Yes       \n",
       "94                                                 NaN       \n",
       "95                                                 NaN       \n",
       "96                                                 NaN       \n",
       "97                                                 NaN       \n",
       "98                                                 Yes       \n",
       "99                                                 Yes       \n",
       "100                                                 No       \n",
       "101                                                 No       \n",
       "102                                                NaN       \n",
       "103                                                 No       \n",
       "104                                                Yes       \n",
       "105                                                Yes       \n",
       "106                                                Yes       \n",
       "107                                                NaN       \n",
       "108                                                NaN       \n",
       "109                                                NaN       \n",
       "110                                                NaN       \n",
       "111                                                NaN       \n",
       "112                                                NaN       \n",
       "113                                                NaN       \n",
       "114                                                NaN       \n",
       "115                                                Yes       \n",
       "116                                                NaN       \n",
       "117                                                NaN       \n",
       "118                                                NaN       \n",
       "119                                                NaN       \n",
       "120                                                NaN       \n",
       "121                                                NaN       \n",
       "122                                                NaN       \n",
       "123                                                NaN       \n",
       "124                                                NaN       \n",
       "125                                                NaN       \n",
       "126                                                NaN       \n",
       "127                                                NaN       \n",
       "128                                                NaN       \n",
       "129                                                NaN       \n",
       "130                                                NaN       \n",
       "131                                                NaN       \n",
       "132                                                NaN       \n",
       "133                                                NaN       \n",
       "134                                                NaN       \n",
       "135                                                Yes       \n",
       "136                                                Yes       \n",
       "137                                                 No       \n",
       "138                                                Yes       \n",
       "139                                                Yes       \n",
       "140                                                 No       \n",
       "141                                                 No       \n",
       "142                                                Yes       \n",
       "143                                                Yes       \n",
       "144                                                NaN       \n",
       "145                                                 No       \n",
       "146                                                Yes       \n",
       "147                                                Yes       \n",
       "148                                                Yes       \n",
       "149                                                Yes       \n",
       "150                                                 No       \n",
       "151                                                Yes       \n",
       "152                                                NaN       \n",
       "153                                                 No       \n",
       "154                                                 No       \n",
       "155                                                Yes       \n",
       "156                                                Yes       \n",
       "157                                                Yes       \n",
       "158                                                 No       \n",
       "159                                                Yes       \n",
       "160                                                 No       \n",
       "161                                                NaN       \n",
       "162                                                 No       \n",
       "163                                                Yes       \n",
       "164                                                Yes       \n",
       "165                                                Yes       \n",
       "166                                                Yes       \n",
       "167                                                Yes       \n",
       "168                                                Yes       \n",
       "169                                                Yes       \n",
       "170                                                Yes       \n",
       "171                                                Yes       \n",
       "172                                                NaN       \n",
       "173                                                 No       \n",
       "174                                                Yes       \n",
       "175                                                Yes       \n",
       "176                                                Yes       \n",
       "177                                                Yes       \n",
       "178                                                Yes       \n",
       "179                                                Yes       \n",
       "180                                                NaN       \n",
       "181                                                Yes       \n",
       "182                                                 No       \n",
       "183                                                Yes       \n",
       "184                                                Yes       \n",
       "185                                                NaN       \n",
       "\n",
       "                                If yes, please specify  \\\n",
       "0    The funding for this project and the data gene...   \n",
       "1    Obtaining funding is important for career adva...   \n",
       "2    Funding for this project enhanced innovative c...   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "5                                                  NaN   \n",
       "6                                                  NaN   \n",
       "7              Pedal the Cause motivated the students.   \n",
       "8                                                  NaN   \n",
       "9                                                  NaN   \n",
       "10                                                 NaN   \n",
       "11                                                 NaN   \n",
       "12   These pilot projects were critical for generat...   \n",
       "13   Pedal the Cause funding enabled me to particip...   \n",
       "14                                                 NaN   \n",
       "15                                                 NaN   \n",
       "16                                                 NaN   \n",
       "17                                                 NaN   \n",
       "18   This grant and the publication that resulted (...   \n",
       "19                                                 NaN   \n",
       "20                                                 NaN   \n",
       "21                                                 NaN   \n",
       "22                                                 NaN   \n",
       "23                                                 NaN   \n",
       "24                                                 NaN   \n",
       "25                                                 NaN   \n",
       "26   Pedal the cause helped us to recruit five facu...   \n",
       "27                                                 NaN   \n",
       "28                                                 NaN   \n",
       "29                                                 NaN   \n",
       "30   Pedal the Cause motivated people to focus on r...   \n",
       "31                                                 NaN   \n",
       "32                                                 NaN   \n",
       "33                                                 NaN   \n",
       "34                                                 NaN   \n",
       "35   Through this grant I was able to continue my r...   \n",
       "36                                                 NaN   \n",
       "37                                                 NaN   \n",
       "38   Pedal the Cause was critical to recruit and re...   \n",
       "39   Pedal the cause helped me to get my first larg...   \n",
       "40                                                 NaN   \n",
       "41                                                 NaN   \n",
       "42   Data from the Pedal the Cause project encourag...   \n",
       "43                                                 NaN   \n",
       "44                                                 NaN   \n",
       "45                                                 NaN   \n",
       "46   The seed fund allow us to published and obtain...   \n",
       "47   Enabled initial work that eventually led to a ...   \n",
       "48                                                 NaN   \n",
       "49                                                 NaN   \n",
       "50   The Pedal the Cause funding was instrumental f...   \n",
       "51                                                 NaN   \n",
       "52                                                 NaN   \n",
       "53                                                 NaN   \n",
       "54                                                 NaN   \n",
       "55                                                 NaN   \n",
       "56   The funds were critical in advancing the caree...   \n",
       "57                                                 NaN   \n",
       "58                                                 NaN   \n",
       "59                                                 NaN   \n",
       "60                                                 NaN   \n",
       "61                                                 NaN   \n",
       "62                                                 NaN   \n",
       "63                                                 NaN   \n",
       "64                                                 NaN   \n",
       "65   The availability of funding from Padres Pedal ...   \n",
       "66                                                 NaN   \n",
       "67                                                 NaN   \n",
       "68   It enabled me to continue and advance my resea...   \n",
       "69   Two Radiology residents who worked on the proj...   \n",
       "70   The fund allowed a BS/MS student complete the ...   \n",
       "71   It allowed me to a hire a programmer just out ...   \n",
       "72   It allowed us to a hire a programmer just out ...   \n",
       "73   Collaboration with Sandra Meyers PhD physics i...   \n",
       "74                                                 NaN   \n",
       "75                                                 NaN   \n",
       "76   I think obtaining funding is important for car...   \n",
       "77                                                 NaN   \n",
       "78                                                 NaN   \n",
       "79                                                 NaN   \n",
       "80   Opportunity to develop an immune modulatory ap...   \n",
       "81                                                 NaN   \n",
       "82                                                 NaN   \n",
       "83   Pedal the Cause funding has allowed me to gene...   \n",
       "84                                                 NaN   \n",
       "85                                                 NaN   \n",
       "86                                                 NaN   \n",
       "87                                                 NaN   \n",
       "88                                                 NaN   \n",
       "89                                                 NaN   \n",
       "90                                                 NaN   \n",
       "91                                                 NaN   \n",
       "92                                                 NaN   \n",
       "93        I was recently promoted to Professor Step 9.   \n",
       "94                                                 NaN   \n",
       "95                                                 NaN   \n",
       "96                                                 NaN   \n",
       "97                                                 NaN   \n",
       "98   Provided an opportunity for continue research ...   \n",
       "99   A new graduate student joined my lab in 2021 a...   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102                                                NaN   \n",
       "103                                                NaN   \n",
       "104  This is an important project for our research ...   \n",
       "105  It is an important part of my advancement and ...   \n",
       "106  This funding was important for my midterm eval...   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "110                                                NaN   \n",
       "111                                                NaN   \n",
       "112                                                NaN   \n",
       "113                                                NaN   \n",
       "114                                                NaN   \n",
       "115  The availability of funding from Padres Pedal ...   \n",
       "116                                                NaN   \n",
       "117                                                NaN   \n",
       "118                                                NaN   \n",
       "119                                                NaN   \n",
       "120                                                NaN   \n",
       "121                                                NaN   \n",
       "122                                                NaN   \n",
       "123                                                NaN   \n",
       "124                                                NaN   \n",
       "125                                                NaN   \n",
       "126                                                NaN   \n",
       "127                                                NaN   \n",
       "128                                                NaN   \n",
       "129                                                NaN   \n",
       "130                                                NaN   \n",
       "131                                                NaN   \n",
       "132                                                NaN   \n",
       "133                                                NaN   \n",
       "134                                                NaN   \n",
       "135  The PPTC funding allowed a postdoctoral resear...   \n",
       "136  Working on this grant and project has been par...   \n",
       "137                                                NaN   \n",
       "138  I applied for accelerated advancement from Ass...   \n",
       "139  Provided an opportunity to continue research g...   \n",
       "140                                                NaN   \n",
       "141                                                NaN   \n",
       "142                                                NaN   \n",
       "143  The availability of funding from Padres Pedal ...   \n",
       "144                                                NaN   \n",
       "145                                                NaN   \n",
       "146                                                NaN   \n",
       "147  Mehreen Ishfaq was a visiting graduate student...   \n",
       "148                                                NaN   \n",
       "149  The grant was critical in my initial retention...   \n",
       "150                                                NaN   \n",
       "151  The availability of funding from Padres Pedal ...   \n",
       "152                                                NaN   \n",
       "153                                                NaN   \n",
       "154                                                NaN   \n",
       "155                                                NaN   \n",
       "156  The opportunity to set up collaborations with ...   \n",
       "157  Any grant award helps with Advancement and aca...   \n",
       "158                                                NaN   \n",
       "159  It provided the sole support for this project ...   \n",
       "160                                                NaN   \n",
       "161                                                NaN   \n",
       "162                                                NaN   \n",
       "163  The initial studies supported by Pedal the Cau...   \n",
       "164  Myan Do, a PhD candidate at UCSD, was the firs...   \n",
       "165  It helped support my laboratory and provide br...   \n",
       "166  Progress made was able to support a successful...   \n",
       "167  This funding allowed a senior postdoctoral fel...   \n",
       "168                   Supports my academic advancement   \n",
       "169  This grant was mentioned in my my tenure packa...   \n",
       "170  The Carter and McVicker laboratories were able...   \n",
       "171  This grant was part of my portfolio for a 2 st...   \n",
       "172                                                NaN   \n",
       "173                                                NaN   \n",
       "174  This grant funding helped catalyze my collabor...   \n",
       "175  Yes, funding has been instrumental to advance ...   \n",
       "176              Serving as mentor to Dr. Aristizabal.   \n",
       "177  During my hematology oncology fellowship, I un...   \n",
       "178  The Pedal The Cause funding was an important f...   \n",
       "179  The availability of funding from Padres Pedal ...   \n",
       "180                                                NaN   \n",
       "181  The PTC funding lead to preliminary data for a...   \n",
       "182                                                NaN   \n",
       "183  The availability of funding from Padres Pedal ...   \n",
       "184  Yes this grant was supporting the infrastructu...   \n",
       "185                                                NaN   \n",
       "\n",
       "                                 If no, please specify  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "5                                                  NaN   \n",
       "6    my appointment track does not value intramural...   \n",
       "7                                                  NaN   \n",
       "8    Please see description of the atypical situati...   \n",
       "9                                                  NaN   \n",
       "10                                                 NaN   \n",
       "11                                                 NaN   \n",
       "12                                                 NaN   \n",
       "13                                                 NaN   \n",
       "14                                                 NaN   \n",
       "15                                                 NaN   \n",
       "16                                                 NaN   \n",
       "17                                                 NaN   \n",
       "18                                                 NaN   \n",
       "19                                                 NaN   \n",
       "20                                                 NaN   \n",
       "21                                                 NaN   \n",
       "22                                                 NaN   \n",
       "23                                                 NaN   \n",
       "24                                                 NaN   \n",
       "25                                                 NaN   \n",
       "26                                                 NaN   \n",
       "27                                                 NaN   \n",
       "28                                                 NaN   \n",
       "29                                                 NaN   \n",
       "30                                                 NaN   \n",
       "31                                                 NaN   \n",
       "32                                                 NaN   \n",
       "33                                                 NaN   \n",
       "34                                                 NaN   \n",
       "35                                                 NaN   \n",
       "36                                                 NaN   \n",
       "37                                                 NaN   \n",
       "38                                                 NaN   \n",
       "39                                                 NaN   \n",
       "40                                                 NaN   \n",
       "41                                                 NaN   \n",
       "42                                                 NaN   \n",
       "43    no role in recruitment, retention or advancement   \n",
       "44                                                 NaN   \n",
       "45                                                 NaN   \n",
       "46                                                 NaN   \n",
       "47                                                 NaN   \n",
       "48                                                 NaN   \n",
       "49                                                 NaN   \n",
       "50                                                 NaN   \n",
       "51   It was an important for initiating a research ...   \n",
       "52                                                 NaN   \n",
       "53   It was beneficial to the recruitment of person...   \n",
       "54                                                 NaN   \n",
       "55                                                 NaN   \n",
       "56                                                 NaN   \n",
       "57                                                 NaN   \n",
       "58                                                 NaN   \n",
       "59                                                 NaN   \n",
       "60                                                 NaN   \n",
       "61                                                 NaN   \n",
       "62                                                 NaN   \n",
       "63                                                 NaN   \n",
       "64                                                 NaN   \n",
       "65                                                 NaN   \n",
       "66                                                 NaN   \n",
       "67                                                 NaN   \n",
       "68                                                 NaN   \n",
       "69                                                 NaN   \n",
       "70                                                 NaN   \n",
       "71                                                 NaN   \n",
       "72                                                 NaN   \n",
       "73                                                 NaN   \n",
       "74   The project was carried out by my technical staff   \n",
       "75                                                 NaN   \n",
       "76                                                 NaN   \n",
       "77                                                 NaN   \n",
       "78                                                 NaN   \n",
       "79                                                 NaN   \n",
       "80                                                 NaN   \n",
       "81                                                 NaN   \n",
       "82                                                 NaN   \n",
       "83                                                 NaN   \n",
       "84   This is not applicable to me. It's more applic...   \n",
       "85                                                 NaN   \n",
       "86                             timeline not applicable   \n",
       "87                                                 NaN   \n",
       "88   My role on this project is to help with patien...   \n",
       "89                                                 NaN   \n",
       "90                                                 NaN   \n",
       "91                                                 NaN   \n",
       "92                                                 NaN   \n",
       "93                                                 NaN   \n",
       "94                                                 NaN   \n",
       "95                                                 NaN   \n",
       "96                                                 NaN   \n",
       "97                                                 NaN   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100  I was already tenured and Director of the Salk...   \n",
       "101  I was recruited to Salk prior to the obtaining...   \n",
       "102                                                NaN   \n",
       "103  I was recruited to Salk prior to the obtaining...   \n",
       "104                                                NaN   \n",
       "105                                                NaN   \n",
       "106                                                NaN   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "110                                                NaN   \n",
       "111                                                NaN   \n",
       "112                                                NaN   \n",
       "113                                                NaN   \n",
       "114                                                NaN   \n",
       "115                                                NaN   \n",
       "116                                                NaN   \n",
       "117                                                NaN   \n",
       "118                                                NaN   \n",
       "119                                                NaN   \n",
       "120                                                NaN   \n",
       "121                                                NaN   \n",
       "122                                                NaN   \n",
       "123                                                NaN   \n",
       "124                                                NaN   \n",
       "125                                                NaN   \n",
       "126                                                NaN   \n",
       "127                                                NaN   \n",
       "128                                                NaN   \n",
       "129                                                NaN   \n",
       "130                                                NaN   \n",
       "131                                                NaN   \n",
       "132                                                NaN   \n",
       "133                                                NaN   \n",
       "134                                                NaN   \n",
       "135                                                NaN   \n",
       "136                                                NaN   \n",
       "137  This collaboration emerged from development of...   \n",
       "138                                                NaN   \n",
       "139                                                NaN   \n",
       "140                                                NaN   \n",
       "141                                                NaN   \n",
       "142                                                NaN   \n",
       "143                                                NaN   \n",
       "144                                                NaN   \n",
       "145                                                NaN   \n",
       "146                                                NaN   \n",
       "147                                                NaN   \n",
       "148                                                NaN   \n",
       "149                                                NaN   \n",
       "150                                                NaN   \n",
       "151                                                NaN   \n",
       "152                                                NaN   \n",
       "153                                                NaN   \n",
       "154                                                NaN   \n",
       "155                                                NaN   \n",
       "156                                                NaN   \n",
       "157                                                NaN   \n",
       "158                                                NaN   \n",
       "159                                                NaN   \n",
       "160                                                NaN   \n",
       "161                                                NaN   \n",
       "162                                                NaN   \n",
       "163                                                NaN   \n",
       "164                                                NaN   \n",
       "165                                                NaN   \n",
       "166                                                NaN   \n",
       "167                                                NaN   \n",
       "168                                                NaN   \n",
       "169                                                NaN   \n",
       "170                                                NaN   \n",
       "171                                                NaN   \n",
       "172                                                NaN   \n",
       "173                                     Not applicable   \n",
       "174                                                NaN   \n",
       "175                                                NaN   \n",
       "176                                                NaN   \n",
       "177                                                NaN   \n",
       "178                                                NaN   \n",
       "179                                                NaN   \n",
       "180                                                NaN   \n",
       "181                                                NaN   \n",
       "182                                                NaN   \n",
       "183                                                NaN   \n",
       "184                                                NaN   \n",
       "185                                                NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "0                         0.0   \n",
       "1                         0.0   \n",
       "2                         0.0   \n",
       "3                         0.0   \n",
       "4                         0.0   \n",
       "5                         0.0   \n",
       "6                         0.0   \n",
       "7                         0.0   \n",
       "8                         0.0   \n",
       "9                         0.0   \n",
       "10                        0.0   \n",
       "11                        0.0   \n",
       "12                        0.0   \n",
       "13                        0.0   \n",
       "14                        0.0   \n",
       "15                        0.0   \n",
       "16                        0.0   \n",
       "17                        0.0   \n",
       "18                        0.0   \n",
       "19                        0.0   \n",
       "20                        0.0   \n",
       "21                        0.0   \n",
       "22                        0.0   \n",
       "23                        0.0   \n",
       "24                        0.0   \n",
       "25                        0.0   \n",
       "26                        2.0   \n",
       "27                        0.0   \n",
       "28                        0.0   \n",
       "29                        0.0   \n",
       "30                        0.0   \n",
       "31                        1.0   \n",
       "32                        0.0   \n",
       "33                        0.0   \n",
       "34                        0.0   \n",
       "35                        0.0   \n",
       "36                        0.0   \n",
       "37                        0.0   \n",
       "38                        0.0   \n",
       "39                        0.0   \n",
       "40                        0.0   \n",
       "41                        0.0   \n",
       "42                        0.0   \n",
       "43                        0.0   \n",
       "44                        0.0   \n",
       "45                        0.0   \n",
       "46                        0.0   \n",
       "47                        0.0   \n",
       "48                        0.0   \n",
       "49                        0.0   \n",
       "50                        0.0   \n",
       "51                        0.0   \n",
       "52                        0.0   \n",
       "53                        0.0   \n",
       "54                        0.0   \n",
       "55                        0.0   \n",
       "56                        1.0   \n",
       "57                        0.0   \n",
       "58                        0.0   \n",
       "59                        0.0   \n",
       "60                        0.0   \n",
       "61                        0.0   \n",
       "62                        0.0   \n",
       "63                        0.0   \n",
       "64                        0.0   \n",
       "65                        0.0   \n",
       "66                        0.0   \n",
       "67                        0.0   \n",
       "68                        0.0   \n",
       "69                        0.0   \n",
       "70                        0.0   \n",
       "71                        0.0   \n",
       "72                        0.0   \n",
       "73                        0.0   \n",
       "74                        0.0   \n",
       "75                        0.0   \n",
       "76                        0.0   \n",
       "77                        0.0   \n",
       "78                        0.0   \n",
       "79                        0.0   \n",
       "80                        1.0   \n",
       "81                        1.0   \n",
       "82                        0.0   \n",
       "83                        0.0   \n",
       "84                        0.0   \n",
       "85                        0.0   \n",
       "86                        0.0   \n",
       "87                        0.0   \n",
       "88                        0.0   \n",
       "89                        0.0   \n",
       "90                        0.0   \n",
       "91                        0.0   \n",
       "92                        0.0   \n",
       "93                        0.0   \n",
       "94                        0.0   \n",
       "95                        0.0   \n",
       "96                        0.0   \n",
       "97                        0.0   \n",
       "98                        0.0   \n",
       "99                        0.0   \n",
       "100                       0.0   \n",
       "101                       0.0   \n",
       "102                       0.0   \n",
       "103                       0.0   \n",
       "104                       0.0   \n",
       "105                       0.0   \n",
       "106                       0.0   \n",
       "107                       0.0   \n",
       "108                       0.0   \n",
       "109                       0.0   \n",
       "110                       0.0   \n",
       "111                       0.0   \n",
       "112                       0.0   \n",
       "113                       0.0   \n",
       "114                       0.0   \n",
       "115                       0.0   \n",
       "116                       0.0   \n",
       "117                       0.0   \n",
       "118                       0.0   \n",
       "119                       0.0   \n",
       "120                       0.0   \n",
       "121                       0.0   \n",
       "122                       0.0   \n",
       "123                       0.0   \n",
       "124                       0.0   \n",
       "125                       0.0   \n",
       "126                       0.0   \n",
       "127                       0.0   \n",
       "128                       0.0   \n",
       "129                       0.0   \n",
       "130                       0.0   \n",
       "131                       0.0   \n",
       "132                       0.0   \n",
       "133                       0.0   \n",
       "134                       0.0   \n",
       "135                       0.0   \n",
       "136                       0.0   \n",
       "137                       0.0   \n",
       "138                       1.0   \n",
       "139                       1.0   \n",
       "140                       1.0   \n",
       "141                       1.0   \n",
       "142                       1.0   \n",
       "143                       1.0   \n",
       "144                       0.0   \n",
       "145                       0.0   \n",
       "146                       0.0   \n",
       "147                       0.0   \n",
       "148                       0.0   \n",
       "149                       1.0   \n",
       "150                       0.0   \n",
       "151                       0.0   \n",
       "152                       0.0   \n",
       "153                       0.0   \n",
       "154                       0.0   \n",
       "155                       0.0   \n",
       "156                       0.0   \n",
       "157                       0.0   \n",
       "158                       0.0   \n",
       "159                       0.0   \n",
       "160                       0.0   \n",
       "161                       0.0   \n",
       "162                       0.0   \n",
       "163                       0.0   \n",
       "164                       0.0   \n",
       "165                       0.0   \n",
       "166                       0.0   \n",
       "167                       0.0   \n",
       "168                       0.0   \n",
       "169                       0.0   \n",
       "170                       0.0   \n",
       "171                       0.0   \n",
       "172                       0.0   \n",
       "173                       0.0   \n",
       "174                       0.0   \n",
       "175                       0.0   \n",
       "176                       0.0   \n",
       "177                       0.0   \n",
       "178                       0.0   \n",
       "179                       0.0   \n",
       "180                       0.0   \n",
       "181                       1.0   \n",
       "182                       1.0   \n",
       "183                       1.0   \n",
       "184                       1.0   \n",
       "185                       0.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "5                                                  NaN   \n",
       "6                                                  NaN   \n",
       "7                                                  NaN   \n",
       "8                                                  NaN   \n",
       "9                                                  NaN   \n",
       "10                                                 NaN   \n",
       "11                                                 NaN   \n",
       "12                                                 NaN   \n",
       "13                                                 NaN   \n",
       "14                                                 NaN   \n",
       "15                                                 NaN   \n",
       "16                                                 NaN   \n",
       "17                                                 NaN   \n",
       "18                                                 NaN   \n",
       "19                                                 NaN   \n",
       "20                                                 NaN   \n",
       "21                                                 NaN   \n",
       "22                                                 NaN   \n",
       "23                                                 NaN   \n",
       "24                                                 NaN   \n",
       "25                                                 NaN   \n",
       "26     Ruxolitinib with or without navitoxlax (Abbvie)   \n",
       "27                                                 NaN   \n",
       "28                                                 NaN   \n",
       "29                                                 NaN   \n",
       "30                                                 NaN   \n",
       "31   Discovery and translation of precursor B-cell ...   \n",
       "32                                                 NaN   \n",
       "33                                                 NaN   \n",
       "34                                                 NaN   \n",
       "35                                                 NaN   \n",
       "36                                                 NaN   \n",
       "37                                                 NaN   \n",
       "38                                                 NaN   \n",
       "39                                                 NaN   \n",
       "40                                                 NaN   \n",
       "41                                                 NaN   \n",
       "42                                                 NaN   \n",
       "43                                                 NaN   \n",
       "44                                                 NaN   \n",
       "45                                                 NaN   \n",
       "46                                                 NaN   \n",
       "47                                                 NaN   \n",
       "48                                                 NaN   \n",
       "49                                                 NaN   \n",
       "50                                                 NaN   \n",
       "51                                                 NaN   \n",
       "52                                                 NaN   \n",
       "53                                                 NaN   \n",
       "54                                                 NaN   \n",
       "55                                                 NaN   \n",
       "56   NCT05153304  Protocol PCV-001  A Phase I/II Sa...   \n",
       "57                                                 NaN   \n",
       "58                                                 NaN   \n",
       "59                                                 NaN   \n",
       "60                                                 NaN   \n",
       "61                                                 NaN   \n",
       "62                                                 NaN   \n",
       "63                                                 NaN   \n",
       "64                                                 NaN   \n",
       "65                                                 NaN   \n",
       "66                                                 NaN   \n",
       "67                                                 NaN   \n",
       "68                                                 NaN   \n",
       "69                                                 NaN   \n",
       "70                                                 NaN   \n",
       "71                                                 NaN   \n",
       "72                                                 NaN   \n",
       "73                                                 NaN   \n",
       "74                                                 NaN   \n",
       "75                                                 NaN   \n",
       "76                                                 NaN   \n",
       "77                                                 NaN   \n",
       "78                                                 NaN   \n",
       "79                                                 NaN   \n",
       "80            Metformin for oral cancer prevention 2.0   \n",
       "81                                                 NaN   \n",
       "82                                                 NaN   \n",
       "83                                                 NaN   \n",
       "84                                                 NaN   \n",
       "85                                                 NaN   \n",
       "86                                                 NaN   \n",
       "87                                                 NaN   \n",
       "88                                                 NaN   \n",
       "89                                                 NaN   \n",
       "90                                                 NaN   \n",
       "91                                                 NaN   \n",
       "92                                                 NaN   \n",
       "93                                                 NaN   \n",
       "94                                                 NaN   \n",
       "95                                                 NaN   \n",
       "96                                                 NaN   \n",
       "97                                                 NaN   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102                                                NaN   \n",
       "103                                                NaN   \n",
       "104                                                NaN   \n",
       "105                                                NaN   \n",
       "106                                                NaN   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "110                                                NaN   \n",
       "111                                                NaN   \n",
       "112                                                NaN   \n",
       "113                                                NaN   \n",
       "114                                                NaN   \n",
       "115                                                NaN   \n",
       "116                                                NaN   \n",
       "117                                                NaN   \n",
       "118                                                NaN   \n",
       "119                                                NaN   \n",
       "120                                                NaN   \n",
       "121                                                NaN   \n",
       "122                                                NaN   \n",
       "123                                                NaN   \n",
       "124                                                NaN   \n",
       "125                                                NaN   \n",
       "126                                                NaN   \n",
       "127                                                NaN   \n",
       "128                                                NaN   \n",
       "129                                                NaN   \n",
       "130                                                NaN   \n",
       "131                                                NaN   \n",
       "132                                                NaN   \n",
       "133                                                NaN   \n",
       "134                                                NaN   \n",
       "135                                                NaN   \n",
       "136                                                NaN   \n",
       "137                                                NaN   \n",
       "138  A Phase 1b Trial of Cirmtuzumab and Paclitaxel...   \n",
       "139  Nivolumab and Ipilimumab in Combination With I...   \n",
       "140                                                NaN   \n",
       "141  A Phase 1/2 Study of Combination Olaparib and ...   \n",
       "142                                                NaN   \n",
       "143  A National Phase I Study of Cabozantinib in Co...   \n",
       "144                                                NaN   \n",
       "145                                                NaN   \n",
       "146                                                NaN   \n",
       "147                                                NaN   \n",
       "148                                                NaN   \n",
       "149  Individualized therapy for refractory medullob...   \n",
       "150                                                NaN   \n",
       "151                                                NaN   \n",
       "152                                                NaN   \n",
       "153                                                NaN   \n",
       "154                                                NaN   \n",
       "155                                                NaN   \n",
       "156                                                NaN   \n",
       "157                                                NaN   \n",
       "158                                                NaN   \n",
       "159                                                NaN   \n",
       "160                                                NaN   \n",
       "161                                                NaN   \n",
       "162                                                NaN   \n",
       "163                                                NaN   \n",
       "164                                                NaN   \n",
       "165                                                NaN   \n",
       "166                                                NaN   \n",
       "167                                                NaN   \n",
       "168                                                NaN   \n",
       "169                                                NaN   \n",
       "170                                                NaN   \n",
       "171                                                NaN   \n",
       "172                                                NaN   \n",
       "173                                                NaN   \n",
       "174                                                NaN   \n",
       "175                                                NaN   \n",
       "176                                                NaN   \n",
       "177                                                NaN   \n",
       "178                                                NaN   \n",
       "179                                                NaN   \n",
       "180                                                NaN   \n",
       "181  Trial Name:    Temozolomide (TMZ) In Advanced ...   \n",
       "182                                                NaN   \n",
       "183  A National Phase I Study of Cabozantinib in Co...   \n",
       "184  Phase 1B, Nonrandomized Trial Investigating Do...   \n",
       "185                                                NaN   \n",
       "\n",
       "     First Clinical Trial Patient Count  \\\n",
       "0                                   NaN   \n",
       "1                                   NaN   \n",
       "2                                   NaN   \n",
       "3                                   NaN   \n",
       "4                                   NaN   \n",
       "5                                   NaN   \n",
       "6                                   NaN   \n",
       "7                                   NaN   \n",
       "8                                   NaN   \n",
       "9                                   NaN   \n",
       "10                                  NaN   \n",
       "11                                  NaN   \n",
       "12                                  NaN   \n",
       "13                                  NaN   \n",
       "14                                  NaN   \n",
       "15                                  NaN   \n",
       "16                                  NaN   \n",
       "17                                  NaN   \n",
       "18                                  NaN   \n",
       "19                                  NaN   \n",
       "20                                  NaN   \n",
       "21                                  NaN   \n",
       "22                                  NaN   \n",
       "23                                  NaN   \n",
       "24                                  NaN   \n",
       "25                                  NaN   \n",
       "26                                  2.0   \n",
       "27                                  NaN   \n",
       "28                                  NaN   \n",
       "29                                  NaN   \n",
       "30                                  NaN   \n",
       "31                                 25.0   \n",
       "32                                  NaN   \n",
       "33                                  NaN   \n",
       "34                                  NaN   \n",
       "35                                  NaN   \n",
       "36                                  NaN   \n",
       "37                                  NaN   \n",
       "38                                  NaN   \n",
       "39                                  NaN   \n",
       "40                                  NaN   \n",
       "41                                  NaN   \n",
       "42                                  NaN   \n",
       "43                                  NaN   \n",
       "44                                  NaN   \n",
       "45                                  NaN   \n",
       "46                                  NaN   \n",
       "47                                  NaN   \n",
       "48                                  NaN   \n",
       "49                                  NaN   \n",
       "50                                  NaN   \n",
       "51                                  NaN   \n",
       "52                                  NaN   \n",
       "53                                  NaN   \n",
       "54                                  NaN   \n",
       "55                                  NaN   \n",
       "56                                  2.0   \n",
       "57                                  NaN   \n",
       "58                                  NaN   \n",
       "59                                  NaN   \n",
       "60                                  NaN   \n",
       "61                                  NaN   \n",
       "62                                  NaN   \n",
       "63                                  NaN   \n",
       "64                                  NaN   \n",
       "65                                  NaN   \n",
       "66                                  NaN   \n",
       "67                                  NaN   \n",
       "68                                  NaN   \n",
       "69                                  NaN   \n",
       "70                                  NaN   \n",
       "71                                  NaN   \n",
       "72                                  NaN   \n",
       "73                                  NaN   \n",
       "74                                  NaN   \n",
       "75                                  NaN   \n",
       "76                                  NaN   \n",
       "77                                  NaN   \n",
       "78                                  NaN   \n",
       "79                                  NaN   \n",
       "80                                 80.0   \n",
       "81                                  0.0   \n",
       "82                                  NaN   \n",
       "83                                  NaN   \n",
       "84                                  NaN   \n",
       "85                                  NaN   \n",
       "86                                  NaN   \n",
       "87                                  NaN   \n",
       "88                                  NaN   \n",
       "89                                  NaN   \n",
       "90                                  NaN   \n",
       "91                                  NaN   \n",
       "92                                  NaN   \n",
       "93                                  NaN   \n",
       "94                                  NaN   \n",
       "95                                  NaN   \n",
       "96                                  NaN   \n",
       "97                                  NaN   \n",
       "98                                  NaN   \n",
       "99                                  NaN   \n",
       "100                                 NaN   \n",
       "101                                 NaN   \n",
       "102                                 NaN   \n",
       "103                                 NaN   \n",
       "104                                 NaN   \n",
       "105                                 NaN   \n",
       "106                                 NaN   \n",
       "107                                 NaN   \n",
       "108                                 NaN   \n",
       "109                                 NaN   \n",
       "110                                 NaN   \n",
       "111                                 NaN   \n",
       "112                                 NaN   \n",
       "113                                 NaN   \n",
       "114                                 NaN   \n",
       "115                                 NaN   \n",
       "116                                 NaN   \n",
       "117                                 NaN   \n",
       "118                                 NaN   \n",
       "119                                 NaN   \n",
       "120                                 NaN   \n",
       "121                                 NaN   \n",
       "122                                 NaN   \n",
       "123                                 NaN   \n",
       "124                                 NaN   \n",
       "125                                 NaN   \n",
       "126                                 NaN   \n",
       "127                                 NaN   \n",
       "128                                 NaN   \n",
       "129                                 NaN   \n",
       "130                                 NaN   \n",
       "131                                 NaN   \n",
       "132                                 NaN   \n",
       "133                                 NaN   \n",
       "134                                 NaN   \n",
       "135                                 NaN   \n",
       "136                                 NaN   \n",
       "137                                 NaN   \n",
       "138                                15.0   \n",
       "139                                19.0   \n",
       "140                                19.0   \n",
       "141                                72.0   \n",
       "142                                 NaN   \n",
       "143                                 6.0   \n",
       "144                                 NaN   \n",
       "145                                 NaN   \n",
       "146                                 NaN   \n",
       "147                                 NaN   \n",
       "148                                 NaN   \n",
       "149                                 0.0   \n",
       "150                                 NaN   \n",
       "151                                 NaN   \n",
       "152                                 NaN   \n",
       "153                                 NaN   \n",
       "154                                 NaN   \n",
       "155                                 NaN   \n",
       "156                                 NaN   \n",
       "157                                 NaN   \n",
       "158                                 NaN   \n",
       "159                                 NaN   \n",
       "160                                 NaN   \n",
       "161                                 NaN   \n",
       "162                                 NaN   \n",
       "163                                 NaN   \n",
       "164                                 NaN   \n",
       "165                                 NaN   \n",
       "166                                 NaN   \n",
       "167                                 NaN   \n",
       "168                                 NaN   \n",
       "169                                 NaN   \n",
       "170                                 NaN   \n",
       "171                                 NaN   \n",
       "172                                 NaN   \n",
       "173                                 NaN   \n",
       "174                                 NaN   \n",
       "175                                 NaN   \n",
       "176                                 NaN   \n",
       "177                                 NaN   \n",
       "178                                 NaN   \n",
       "179                                 NaN   \n",
       "180                                 NaN   \n",
       "181                                13.0   \n",
       "182                                18.0   \n",
       "183                                 6.0   \n",
       "184                                 0.0   \n",
       "185                                 NaN   \n",
       "\n",
       "                                 Second Clinical Trial  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "5                                                  NaN   \n",
       "6                                                  NaN   \n",
       "7                                                  NaN   \n",
       "8                                                  NaN   \n",
       "9                                                  NaN   \n",
       "10                                                 NaN   \n",
       "11                                                 NaN   \n",
       "12                                                 NaN   \n",
       "13                                                 NaN   \n",
       "14                                                 NaN   \n",
       "15                                                 NaN   \n",
       "16                                                 NaN   \n",
       "17                                                 NaN   \n",
       "18                                                 NaN   \n",
       "19                                                 NaN   \n",
       "20                                                 NaN   \n",
       "21                                                 NaN   \n",
       "22                                                 NaN   \n",
       "23                                                 NaN   \n",
       "24                                                 NaN   \n",
       "25                                                 NaN   \n",
       "26    Ruxolitinib with or without BET inhibitors (CPI)   \n",
       "27                                                 NaN   \n",
       "28                                                 NaN   \n",
       "29                                                 NaN   \n",
       "30                                                 NaN   \n",
       "31                                                 NaN   \n",
       "32                                                 NaN   \n",
       "33                                                 NaN   \n",
       "34                                                 NaN   \n",
       "35                                                 NaN   \n",
       "36                                                 NaN   \n",
       "37                                                 NaN   \n",
       "38                                                 NaN   \n",
       "39                                                 NaN   \n",
       "40                                                 NaN   \n",
       "41                                                 NaN   \n",
       "42                                                 NaN   \n",
       "43                                                 NaN   \n",
       "44                                                 NaN   \n",
       "45                                                 NaN   \n",
       "46                                                 NaN   \n",
       "47                                                 NaN   \n",
       "48                                                 NaN   \n",
       "49                                                 NaN   \n",
       "50                                                 NaN   \n",
       "51                                                 NaN   \n",
       "52                                                 NaN   \n",
       "53                                                 NaN   \n",
       "54                                                 NaN   \n",
       "55                                                 NaN   \n",
       "56                                                 NaN   \n",
       "57                                                 NaN   \n",
       "58                                                 NaN   \n",
       "59                                                 NaN   \n",
       "60                                                 NaN   \n",
       "61                                                 NaN   \n",
       "62                                                 NaN   \n",
       "63                                                 NaN   \n",
       "64                                                 NaN   \n",
       "65                                                 NaN   \n",
       "66                                                 NaN   \n",
       "67                                                 NaN   \n",
       "68                                                 NaN   \n",
       "69                                                 NaN   \n",
       "70                                                 NaN   \n",
       "71                                                 NaN   \n",
       "72                                                 NaN   \n",
       "73                                                 NaN   \n",
       "74                                                 NaN   \n",
       "75                                                 NaN   \n",
       "76                                                 NaN   \n",
       "77                                                 NaN   \n",
       "78                                                 NaN   \n",
       "79                                                 NaN   \n",
       "80   Neoadjuvant Immunoradiotherapy in Head & Neck ...   \n",
       "81                                                 NaN   \n",
       "82                                                 NaN   \n",
       "83                                                 NaN   \n",
       "84                                                 NaN   \n",
       "85                                                 NaN   \n",
       "86                                                 NaN   \n",
       "87                                                 NaN   \n",
       "88                                                 NaN   \n",
       "89                                                 NaN   \n",
       "90                                                 NaN   \n",
       "91                                                 NaN   \n",
       "92                                                 NaN   \n",
       "93                                                 NaN   \n",
       "94                                                 NaN   \n",
       "95                                                 NaN   \n",
       "96                                                 NaN   \n",
       "97                                                 NaN   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102                                                NaN   \n",
       "103                                                NaN   \n",
       "104                                                NaN   \n",
       "105                                                NaN   \n",
       "106                                                NaN   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "110                                                NaN   \n",
       "111                                                NaN   \n",
       "112                                                NaN   \n",
       "113                                                NaN   \n",
       "114                                                NaN   \n",
       "115                                                NaN   \n",
       "116                                                NaN   \n",
       "117                                                NaN   \n",
       "118                                                NaN   \n",
       "119                                                NaN   \n",
       "120                                                NaN   \n",
       "121                                                NaN   \n",
       "122                                                NaN   \n",
       "123                                                NaN   \n",
       "124                                                NaN   \n",
       "125                                                NaN   \n",
       "126                                                NaN   \n",
       "127                                                NaN   \n",
       "128                                                NaN   \n",
       "129                                                NaN   \n",
       "130                                                NaN   \n",
       "131                                                NaN   \n",
       "132                                                NaN   \n",
       "133                                                NaN   \n",
       "134                                                NaN   \n",
       "135                                                NaN   \n",
       "136                                                NaN   \n",
       "137                                                NaN   \n",
       "138                                                NaN   \n",
       "139  NIVOLUMAB (ANTI-PD1 ANTIBODY) AND IPILIMUMAB (...   \n",
       "140                                                NaN   \n",
       "141  NCI10096 ClinicalTrials.gov Identifier:  NCT03...   \n",
       "142                                                NaN   \n",
       "143                                                NaN   \n",
       "144                                                NaN   \n",
       "145                                                NaN   \n",
       "146                                                NaN   \n",
       "147                                                NaN   \n",
       "148                                                NaN   \n",
       "149                                                NaN   \n",
       "150                                                NaN   \n",
       "151                                                NaN   \n",
       "152                                                NaN   \n",
       "153                                                NaN   \n",
       "154                                                NaN   \n",
       "155                                                NaN   \n",
       "156                                                NaN   \n",
       "157                                                NaN   \n",
       "158                                                NaN   \n",
       "159                                                NaN   \n",
       "160                                                NaN   \n",
       "161                                                NaN   \n",
       "162                                                NaN   \n",
       "163                                                NaN   \n",
       "164                                                NaN   \n",
       "165                                                NaN   \n",
       "166                                                NaN   \n",
       "167                                                NaN   \n",
       "168                                                NaN   \n",
       "169                                                NaN   \n",
       "170                                                NaN   \n",
       "171                                                NaN   \n",
       "172                                                NaN   \n",
       "173                                                NaN   \n",
       "174                                                NaN   \n",
       "175                                                NaN   \n",
       "176                                                NaN   \n",
       "177                                                NaN   \n",
       "178                                                NaN   \n",
       "179                                                NaN   \n",
       "180                                                NaN   \n",
       "181  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "182                                                NaN   \n",
       "183                                                NaN   \n",
       "184                                                NaN   \n",
       "185                                                NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count  \\\n",
       "0                                    NaN   \n",
       "1                                    NaN   \n",
       "2                                    NaN   \n",
       "3                                    NaN   \n",
       "4                                    NaN   \n",
       "5                                    NaN   \n",
       "6                                    NaN   \n",
       "7                                    NaN   \n",
       "8                                    NaN   \n",
       "9                                    NaN   \n",
       "10                                   NaN   \n",
       "11                                   NaN   \n",
       "12                                   NaN   \n",
       "13                                   NaN   \n",
       "14                                   NaN   \n",
       "15                                   NaN   \n",
       "16                                   NaN   \n",
       "17                                   NaN   \n",
       "18                                   NaN   \n",
       "19                                   NaN   \n",
       "20                                   NaN   \n",
       "21                                   NaN   \n",
       "22                                   NaN   \n",
       "23                                   NaN   \n",
       "24                                   NaN   \n",
       "25                                   NaN   \n",
       "26                                   2.0   \n",
       "27                                   NaN   \n",
       "28                                   NaN   \n",
       "29                                   NaN   \n",
       "30                                   NaN   \n",
       "31                                   NaN   \n",
       "32                                   NaN   \n",
       "33                                   NaN   \n",
       "34                                   NaN   \n",
       "35                                   NaN   \n",
       "36                                   NaN   \n",
       "37                                   NaN   \n",
       "38                                   NaN   \n",
       "39                                   NaN   \n",
       "40                                   NaN   \n",
       "41                                   NaN   \n",
       "42                                   NaN   \n",
       "43                                   NaN   \n",
       "44                                   NaN   \n",
       "45                                   NaN   \n",
       "46                                   NaN   \n",
       "47                                   NaN   \n",
       "48                                   NaN   \n",
       "49                                   NaN   \n",
       "50                                   NaN   \n",
       "51                                   NaN   \n",
       "52                                   NaN   \n",
       "53                                   NaN   \n",
       "54                                   NaN   \n",
       "55                                   NaN   \n",
       "56                                   NaN   \n",
       "57                                   NaN   \n",
       "58                                   NaN   \n",
       "59                                   NaN   \n",
       "60                                   NaN   \n",
       "61                                   NaN   \n",
       "62                                   NaN   \n",
       "63                                   NaN   \n",
       "64                                   NaN   \n",
       "65                                   NaN   \n",
       "66                                   NaN   \n",
       "67                                   NaN   \n",
       "68                                   NaN   \n",
       "69                                   NaN   \n",
       "70                                   NaN   \n",
       "71                                   NaN   \n",
       "72                                   NaN   \n",
       "73                                   NaN   \n",
       "74                                   NaN   \n",
       "75                                   NaN   \n",
       "76                                   NaN   \n",
       "77                                   NaN   \n",
       "78                                   NaN   \n",
       "79                                   NaN   \n",
       "80                                   NaN   \n",
       "81                                   NaN   \n",
       "82                                   NaN   \n",
       "83                                   NaN   \n",
       "84                                   NaN   \n",
       "85                                   NaN   \n",
       "86                                   NaN   \n",
       "87                                   NaN   \n",
       "88                                   NaN   \n",
       "89                                   NaN   \n",
       "90                                   NaN   \n",
       "91                                   NaN   \n",
       "92                                   NaN   \n",
       "93                                   NaN   \n",
       "94                                   NaN   \n",
       "95                                   NaN   \n",
       "96                                   NaN   \n",
       "97                                   NaN   \n",
       "98                                   NaN   \n",
       "99                                   NaN   \n",
       "100                                  NaN   \n",
       "101                                  NaN   \n",
       "102                                  NaN   \n",
       "103                                  NaN   \n",
       "104                                  NaN   \n",
       "105                                  NaN   \n",
       "106                                  NaN   \n",
       "107                                  NaN   \n",
       "108                                  NaN   \n",
       "109                                  NaN   \n",
       "110                                  NaN   \n",
       "111                                  NaN   \n",
       "112                                  NaN   \n",
       "113                                  NaN   \n",
       "114                                  NaN   \n",
       "115                                  NaN   \n",
       "116                                  NaN   \n",
       "117                                  NaN   \n",
       "118                                  NaN   \n",
       "119                                  NaN   \n",
       "120                                  NaN   \n",
       "121                                  NaN   \n",
       "122                                  NaN   \n",
       "123                                  NaN   \n",
       "124                                  NaN   \n",
       "125                                  NaN   \n",
       "126                                  NaN   \n",
       "127                                  NaN   \n",
       "128                                  NaN   \n",
       "129                                  NaN   \n",
       "130                                  NaN   \n",
       "131                                  NaN   \n",
       "132                                  NaN   \n",
       "133                                  NaN   \n",
       "134                                  NaN   \n",
       "135                                  NaN   \n",
       "136                                  NaN   \n",
       "137                                  NaN   \n",
       "138                                  NaN   \n",
       "139                                  NaN   \n",
       "140                                  NaN   \n",
       "141                                  NaN   \n",
       "142                                  NaN   \n",
       "143                                  NaN   \n",
       "144                                  NaN   \n",
       "145                                  NaN   \n",
       "146                                  NaN   \n",
       "147                                  NaN   \n",
       "148                                  NaN   \n",
       "149                                  NaN   \n",
       "150                                  NaN   \n",
       "151                                  NaN   \n",
       "152                                  NaN   \n",
       "153                                  NaN   \n",
       "154                                  NaN   \n",
       "155                                  NaN   \n",
       "156                                  NaN   \n",
       "157                                  NaN   \n",
       "158                                  NaN   \n",
       "159                                  NaN   \n",
       "160                                  NaN   \n",
       "161                                  NaN   \n",
       "162                                  NaN   \n",
       "163                                  NaN   \n",
       "164                                  NaN   \n",
       "165                                  NaN   \n",
       "166                                  NaN   \n",
       "167                                  NaN   \n",
       "168                                  NaN   \n",
       "169                                  NaN   \n",
       "170                                  NaN   \n",
       "171                                  NaN   \n",
       "172                                  NaN   \n",
       "173                                  NaN   \n",
       "174                                  NaN   \n",
       "175                                  NaN   \n",
       "176                                  NaN   \n",
       "177                                  NaN   \n",
       "178                                  NaN   \n",
       "179                                  NaN   \n",
       "180                                  NaN   \n",
       "181                                  NaN   \n",
       "182                                  NaN   \n",
       "183                                  NaN   \n",
       "184                                  NaN   \n",
       "185                                  NaN   \n",
       "\n",
       "                                     Companies Founded Patents Filed  \\\n",
       "0                                                 None            No   \n",
       "1                                                 None            No   \n",
       "2                                                 None            No   \n",
       "3                                                  NaN           NaN   \n",
       "4                                                  NaN           NaN   \n",
       "5                                                  NaN           NaN   \n",
       "6                                                  NaN            No   \n",
       "7                                                 None           Yes   \n",
       "8                                                 None            No   \n",
       "9                                                  NaN           NaN   \n",
       "10                                                 NaN           NaN   \n",
       "11                                                 NaN           NaN   \n",
       "12                                                None            No   \n",
       "13                                                  No            No   \n",
       "14                                                 NaN           NaN   \n",
       "15                                                 NaN           NaN   \n",
       "16                                                 NaN           NaN   \n",
       "17                                                 NaN           NaN   \n",
       "18                                                none            No   \n",
       "19                                                 NaN            No   \n",
       "20                                                 NaN           NaN   \n",
       "21                                                 NaN           NaN   \n",
       "22                                                 NaN           NaN   \n",
       "23                                                 NaN           NaN   \n",
       "24                                                 NaN           NaN   \n",
       "25                                                 NaN           NaN   \n",
       "26                                 Aspera Biomedicines           Yes   \n",
       "27                                                 NaN           NaN   \n",
       "28                                                 NaN           NaN   \n",
       "29                                                 NaN           NaN   \n",
       "30                                                None            No   \n",
       "31                                      Not applicable            No   \n",
       "32                                                 NaN           NaN   \n",
       "33                                                 NaN           NaN   \n",
       "34                                                 No.            No   \n",
       "35                                                 NaN            No   \n",
       "36                                                 NaN           NaN   \n",
       "37                                                 NaN           NaN   \n",
       "38                                                None            No   \n",
       "39                                                None            No   \n",
       "40                                                 NaN           NaN   \n",
       "41                                                 NaN           NaN   \n",
       "42   No name yet but in the process of founding a c...           Yes   \n",
       "43                                                None            No   \n",
       "44                                                 NaN           NaN   \n",
       "45                                                 NaN           NaN   \n",
       "46                                                 No.            No   \n",
       "47                                                 NaN            No   \n",
       "48                                                 NaN           NaN   \n",
       "49                                                 NaN           NaN   \n",
       "50                                                None            No   \n",
       "51                                                 0.0            No   \n",
       "52                                                None            No   \n",
       "53                                                 NaN            No   \n",
       "54                                                 NaN           NaN   \n",
       "55                                                 NaN           NaN   \n",
       "56                                        Yes, Lykeion           Yes   \n",
       "57                                                 NaN           NaN   \n",
       "58                                                 NaN           NaN   \n",
       "59                                               None.           Yes   \n",
       "60                                                None            No   \n",
       "61                                                 NaN           NaN   \n",
       "62                                                 NaN           NaN   \n",
       "63                                                 NaN           NaN   \n",
       "64                                                 NaN           NaN   \n",
       "65                                                none            No   \n",
       "66                                                 NaN            No   \n",
       "67                                                 NaN           NaN   \n",
       "68                                                none            No   \n",
       "69                                                 NaN            No   \n",
       "70                                                 NaN            No   \n",
       "71                                                 NaN            No   \n",
       "72                                                 NaN            No   \n",
       "73                                                none            No   \n",
       "74                                                none            No   \n",
       "75                                                 NaN           NaN   \n",
       "76                                                None            No   \n",
       "77                                                 NaN           NaN   \n",
       "78                                                 NaN           NaN   \n",
       "79                                                 NaN           NaN   \n",
       "80                                                  No            No   \n",
       "81                                                 NaN            No   \n",
       "82                                                 NaN           NaN   \n",
       "83                                                 NaN            No   \n",
       "84                                                 NaN            No   \n",
       "85                                                 NaN           NaN   \n",
       "86                                                 NaN            No   \n",
       "87                                                 NaN            No   \n",
       "88                                                 NaN            No   \n",
       "89                                                 NaN           NaN   \n",
       "90                                                 NaN           NaN   \n",
       "91                                                 NaN           NaN   \n",
       "92                                                 NaN            No   \n",
       "93                                                N/A.            No   \n",
       "94                                                 NaN           NaN   \n",
       "95                                                 NaN           NaN   \n",
       "96                                                 NaN           NaN   \n",
       "97                                                 NaN           NaN   \n",
       "98                                                none            No   \n",
       "99   Endeavor Biomedicines licensed this program an...            No   \n",
       "100  Endeavor Biomedicines licensed this program an...            No   \n",
       "101                                                NaN            No   \n",
       "102                                                NaN           NaN   \n",
       "103                                       No companies            No   \n",
       "104                                               None            No   \n",
       "105                                                NaN            No   \n",
       "106                                                NaN            No   \n",
       "107                                                NaN           NaN   \n",
       "108                                                NaN           NaN   \n",
       "109                                                NaN           NaN   \n",
       "110                                                NaN           NaN   \n",
       "111                                                NaN           NaN   \n",
       "112                                                NaN           NaN   \n",
       "113                                                NaN           NaN   \n",
       "114                                                NaN           NaN   \n",
       "115                                               none            No   \n",
       "116                                               None            No   \n",
       "117                                                NaN           NaN   \n",
       "118                                                NaN           NaN   \n",
       "119                                                NaN           NaN   \n",
       "120                                                NaN           NaN   \n",
       "121                                                NaN           NaN   \n",
       "122                                                NaN           NaN   \n",
       "123                                                NaN           NaN   \n",
       "124                                                NaN           NaN   \n",
       "125                                                NaN           NaN   \n",
       "126                                                NaN           NaN   \n",
       "127                                                NaN           NaN   \n",
       "128                                                NaN           NaN   \n",
       "129                                                NaN           NaN   \n",
       "130                                                NaN           NaN   \n",
       "131                                                NaN           NaN   \n",
       "132                                                NaN           NaN   \n",
       "133                                                NaN           NaN   \n",
       "134                                                NaN           NaN   \n",
       "135                                               None            No   \n",
       "136                                               none            No   \n",
       "137                                               None            No   \n",
       "138  No companies were founded as a result of my tr...            No   \n",
       "139                                               none            No   \n",
       "140                                              None.            No   \n",
       "141                                               None            No   \n",
       "142                                               None            No   \n",
       "143                                               None            No   \n",
       "144                                                NaN           NaN   \n",
       "145                                                NaN            No   \n",
       "146                                  None at this time           Yes   \n",
       "147                                                NaN            No   \n",
       "148                                                NaN            No   \n",
       "149                                                NaN            No   \n",
       "150                                                NaN            No   \n",
       "151                                               none            No   \n",
       "152                                                NaN           NaN   \n",
       "153                                               None            No   \n",
       "154                                               None            No   \n",
       "155                                                NaN            No   \n",
       "156                                               None            No   \n",
       "157                                               none            No   \n",
       "158                                                NaN            No   \n",
       "159                                               None            No   \n",
       "160                                               none            No   \n",
       "161                                                NaN           NaN   \n",
       "162                                                NaN            No   \n",
       "163                                               none           Yes   \n",
       "164          No, because product is licensed to Pfizer           Yes   \n",
       "165                                               None            No   \n",
       "166                                               none            No   \n",
       "167                No companies have been established.            No   \n",
       "168                                                NaN           Yes   \n",
       "169                                                NaN            No   \n",
       "170                                               None            No   \n",
       "171                                               none            No   \n",
       "172                                                NaN           NaN   \n",
       "173                                               none            No   \n",
       "174                                     Not applicable            No   \n",
       "175                                                 na            No   \n",
       "176                                                NaN            No   \n",
       "177                                               None            No   \n",
       "178                                               None            No   \n",
       "179                                               none            No   \n",
       "180                                                NaN           NaN   \n",
       "181                                               None            No   \n",
       "182                                                NaN            No   \n",
       "183                                               none            No   \n",
       "184                                          Oncternal            No   \n",
       "185                                                NaN           NaN   \n",
       "\n",
       "                                        Patent Details  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "5                                                  NaN   \n",
       "6                                                  NaN   \n",
       "7    2020-135Human-centered drug discovery: A metho...   \n",
       "8                                                  NaN   \n",
       "9                                                  NaN   \n",
       "10                                                 NaN   \n",
       "11                                                 NaN   \n",
       "12                                                 NaN   \n",
       "13                                                 NaN   \n",
       "14                                                 NaN   \n",
       "15                                                 NaN   \n",
       "16                                                 NaN   \n",
       "17                                                 NaN   \n",
       "18                                                 NaN   \n",
       "19                                                 NaN   \n",
       "20                                                 NaN   \n",
       "21                                                 NaN   \n",
       "22                                                 NaN   \n",
       "23                                                 NaN   \n",
       "24                                                 NaN   \n",
       "25                                                 NaN   \n",
       "26   Please see justia patents:  https://patents.ju...   \n",
       "27                                                 NaN   \n",
       "28                                                 NaN   \n",
       "29                                                 NaN   \n",
       "30                                                 NaN   \n",
       "31                                                 NaN   \n",
       "32                                                 NaN   \n",
       "33                                                 NaN   \n",
       "34                                                 NaN   \n",
       "35                                                 NaN   \n",
       "36                                                 NaN   \n",
       "37                                                 NaN   \n",
       "38                                                 NaN   \n",
       "39                                                 NaN   \n",
       "40                                                 NaN   \n",
       "41                                                 NaN   \n",
       "42   A PCT was submitted in 2018: \"GPCRs in Cancer-...   \n",
       "43                                                 NaN   \n",
       "44                                                 NaN   \n",
       "45                                                 NaN   \n",
       "46                                                 NaN   \n",
       "47                                                 NaN   \n",
       "48                                                 NaN   \n",
       "49                                                 NaN   \n",
       "50                                                 NaN   \n",
       "51                                                 NaN   \n",
       "52                                                 NaN   \n",
       "53                                                 NaN   \n",
       "54                                                 NaN   \n",
       "55                                                 NaN   \n",
       "56   Patent filed for the neoantigen discovery and ...   \n",
       "57                                                 NaN   \n",
       "58                                                 NaN   \n",
       "59   Track Code: 2020-263-2PCT  Application Number:...   \n",
       "60                                                 NaN   \n",
       "61                                                 NaN   \n",
       "62                                                 NaN   \n",
       "63                                                 NaN   \n",
       "64                                                 NaN   \n",
       "65                                                 NaN   \n",
       "66                                                 NaN   \n",
       "67                                                 NaN   \n",
       "68                                                 NaN   \n",
       "69                                                 NaN   \n",
       "70                                                 NaN   \n",
       "71                                                 NaN   \n",
       "72                                                 NaN   \n",
       "73                                                 NaN   \n",
       "74                                                 NaN   \n",
       "75                                                 NaN   \n",
       "76                                                 NaN   \n",
       "77                                                 NaN   \n",
       "78                                                 NaN   \n",
       "79                                                 NaN   \n",
       "80                                                 NaN   \n",
       "81                                                 NaN   \n",
       "82                                                 NaN   \n",
       "83                                                 NaN   \n",
       "84                                                 NaN   \n",
       "85                                                 NaN   \n",
       "86                                                 NaN   \n",
       "87                                                 NaN   \n",
       "88                                                 NaN   \n",
       "89                                                 NaN   \n",
       "90                                                 NaN   \n",
       "91                                                 NaN   \n",
       "92                                                 NaN   \n",
       "93                                                 NaN   \n",
       "94                                                 NaN   \n",
       "95                                                 NaN   \n",
       "96                                                 NaN   \n",
       "97                                                 NaN   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102                                                NaN   \n",
       "103                                                NaN   \n",
       "104                                                NaN   \n",
       "105                                                NaN   \n",
       "106                                                NaN   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "110                                                NaN   \n",
       "111                                                NaN   \n",
       "112                                                NaN   \n",
       "113                                                NaN   \n",
       "114                                                NaN   \n",
       "115                                                NaN   \n",
       "116                                                NaN   \n",
       "117                                                NaN   \n",
       "118                                                NaN   \n",
       "119                                                NaN   \n",
       "120                                                NaN   \n",
       "121                                                NaN   \n",
       "122                                                NaN   \n",
       "123                                                NaN   \n",
       "124                                                NaN   \n",
       "125                                                NaN   \n",
       "126                                                NaN   \n",
       "127                                                NaN   \n",
       "128                                                NaN   \n",
       "129                                                NaN   \n",
       "130                                                NaN   \n",
       "131                                                NaN   \n",
       "132                                                NaN   \n",
       "133                                                NaN   \n",
       "134                                                NaN   \n",
       "135                                                NaN   \n",
       "136                                                NaN   \n",
       "137                                                NaN   \n",
       "138                                                NaN   \n",
       "139                                                NaN   \n",
       "140                                                NaN   \n",
       "141                                                NaN   \n",
       "142                                                NaN   \n",
       "143                                                NaN   \n",
       "144                                                NaN   \n",
       "145                                                NaN   \n",
       "146                                              N/A     \n",
       "147                                                NaN   \n",
       "148                                                NaN   \n",
       "149                                                NaN   \n",
       "150                                                NaN   \n",
       "151                                                NaN   \n",
       "152                                                NaN   \n",
       "153                                                NaN   \n",
       "154                                                NaN   \n",
       "155                                                NaN   \n",
       "156                                                NaN   \n",
       "157                                                NaN   \n",
       "158                                                NaN   \n",
       "159                                                NaN   \n",
       "160                                                NaN   \n",
       "161                                                NaN   \n",
       "162                                                NaN   \n",
       "163                          Patent No.: US 10,766,962   \n",
       "164  The epitope and the sequence of the antibody w...   \n",
       "165                                                NaN   \n",
       "166                                                NaN   \n",
       "167                                                NaN   \n",
       "168  Patent was filed prior to study. \"L. Bradley a...   \n",
       "169                                                NaN   \n",
       "170                                                NaN   \n",
       "171                                                NaN   \n",
       "172                                                NaN   \n",
       "173                                                NaN   \n",
       "174                                                NaN   \n",
       "175                                                NaN   \n",
       "176                                                NaN   \n",
       "177                                                NaN   \n",
       "178                                                NaN   \n",
       "179                                                NaN   \n",
       "180                                                NaN   \n",
       "181                                                NaN   \n",
       "182                                                NaN   \n",
       "183                                                NaN   \n",
       "184                                                NaN   \n",
       "185                                                NaN   \n",
       "\n",
       "    Peer-Reviewed Publications Count  \n",
       "0                                Two  \n",
       "1                                One  \n",
       "2                                Two  \n",
       "3                                NaN  \n",
       "4                                NaN  \n",
       "5                                NaN  \n",
       "6                          Six - Ten  \n",
       "7                                Two  \n",
       "8                               Zero  \n",
       "9                                NaN  \n",
       "10                               NaN  \n",
       "11                               NaN  \n",
       "12                               Two  \n",
       "13                               Two  \n",
       "14                               NaN  \n",
       "15                               NaN  \n",
       "16                               NaN  \n",
       "17                               NaN  \n",
       "18                               One  \n",
       "19                               One  \n",
       "20                               NaN  \n",
       "21                               NaN  \n",
       "22                               NaN  \n",
       "23                               NaN  \n",
       "24                               NaN  \n",
       "25                               NaN  \n",
       "26                     More than Ten  \n",
       "27                               NaN  \n",
       "28                               NaN  \n",
       "29                               NaN  \n",
       "30                               One  \n",
       "31                               One  \n",
       "32                               NaN  \n",
       "33                               NaN  \n",
       "34                               One  \n",
       "35                               One  \n",
       "36                               NaN  \n",
       "37                               NaN  \n",
       "38                               One  \n",
       "39                               One  \n",
       "40                               NaN  \n",
       "41                               NaN  \n",
       "42                              Four  \n",
       "43                             Three  \n",
       "44                               NaN  \n",
       "45                               NaN  \n",
       "46                               One  \n",
       "47                               One  \n",
       "48                               NaN  \n",
       "49                               NaN  \n",
       "50                              Zero  \n",
       "51                              Zero  \n",
       "52                              Zero  \n",
       "53                              Zero  \n",
       "54                               NaN  \n",
       "55                               NaN  \n",
       "56                         Six - Ten  \n",
       "57                               NaN  \n",
       "58                               NaN  \n",
       "59                             Three  \n",
       "60                               Two  \n",
       "61                               NaN  \n",
       "62                               NaN  \n",
       "63                               NaN  \n",
       "64                               NaN  \n",
       "65                               Two  \n",
       "66                               One  \n",
       "67                               NaN  \n",
       "68                               Two  \n",
       "69                              Zero  \n",
       "70                              Zero  \n",
       "71                              Four  \n",
       "72                              Four  \n",
       "73                              Four  \n",
       "74                              Zero  \n",
       "75                               NaN  \n",
       "76                              Zero  \n",
       "77                               NaN  \n",
       "78                               NaN  \n",
       "79                               NaN  \n",
       "80                               Two  \n",
       "81                               Two  \n",
       "82                               NaN  \n",
       "83                              Four  \n",
       "84                               One  \n",
       "85                               NaN  \n",
       "86                              Zero  \n",
       "87                              Zero  \n",
       "88                              Zero  \n",
       "89                               NaN  \n",
       "90                               NaN  \n",
       "91                               NaN  \n",
       "92                               One  \n",
       "93                               Two  \n",
       "94                               NaN  \n",
       "95                               NaN  \n",
       "96                               NaN  \n",
       "97                               NaN  \n",
       "98                               One  \n",
       "99                               Two  \n",
       "100                              Two  \n",
       "101                             Zero  \n",
       "102                              NaN  \n",
       "103                             Zero  \n",
       "104                             Zero  \n",
       "105                              One  \n",
       "106                              One  \n",
       "107                              NaN  \n",
       "108                              NaN  \n",
       "109                              NaN  \n",
       "110                              NaN  \n",
       "111                              NaN  \n",
       "112                              NaN  \n",
       "113                              NaN  \n",
       "114                              NaN  \n",
       "115                              Two  \n",
       "116                              One  \n",
       "117                              NaN  \n",
       "118                              NaN  \n",
       "119                              NaN  \n",
       "120                              NaN  \n",
       "121                              NaN  \n",
       "122                              NaN  \n",
       "123                              NaN  \n",
       "124                              NaN  \n",
       "125                              NaN  \n",
       "126                              NaN  \n",
       "127                              NaN  \n",
       "128                              NaN  \n",
       "129                              NaN  \n",
       "130                              NaN  \n",
       "131                              NaN  \n",
       "132                              NaN  \n",
       "133                              NaN  \n",
       "134                              NaN  \n",
       "135                              One  \n",
       "136                              One  \n",
       "137                              Two  \n",
       "138                              One  \n",
       "139                              One  \n",
       "140                              One  \n",
       "141                             Zero  \n",
       "142                              One  \n",
       "143                              One  \n",
       "144                              NaN  \n",
       "145                              Two  \n",
       "146                              Two  \n",
       "147                            Three  \n",
       "148                              Two  \n",
       "149                              One  \n",
       "150                             Zero  \n",
       "151                              Two  \n",
       "152                              NaN  \n",
       "153                            Three  \n",
       "154                             Zero  \n",
       "155                              Two  \n",
       "156                             Zero  \n",
       "157                             Zero  \n",
       "158                             Zero  \n",
       "159                              One  \n",
       "160                              One  \n",
       "161                              NaN  \n",
       "162                             Zero  \n",
       "163                              Two  \n",
       "164                              Two  \n",
       "165                             Zero  \n",
       "166                             Zero  \n",
       "167                              One  \n",
       "168                              One  \n",
       "169                              One  \n",
       "170                              One  \n",
       "171                              One  \n",
       "172                              NaN  \n",
       "173                              Two  \n",
       "174                              One  \n",
       "175                        Six - Ten  \n",
       "176                        Six - Ten  \n",
       "177                              Two  \n",
       "178                              Two  \n",
       "179                              Two  \n",
       "180                              NaN  \n",
       "181                            Three  \n",
       "182                              One  \n",
       "183                            Three  \n",
       "184                             Zero  \n",
       "185                              NaN  "
      ]
     },
     "execution_count": 574,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Concatenate adjusted dataframes into one\n",
    "\n",
    "roi_adj = pd.concat(proj_data, ignore_index=True)\n",
    "roi_adj"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 575,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>41.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.1</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PTC funding lead to preliminary data for a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Trial Name:    Temozolomide (TMZ) In Advanced ...</td>\n",
       "      <td>13.0</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>118.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.2</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID  \\\n",
       "181   41.0    Initial      41.1   \n",
       "182  118.0    Initial      41.2   \n",
       "\n",
       "                                         Project Title        PI Institution  \\\n",
       "181  An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "182  An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "\n",
       "    Other Institution  Prevention and diagnostic tools  \\\n",
       "181               NaN                            False   \n",
       "182               NaN                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "181                                            True   \n",
       "182                                            True   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "181                                      False                          False   \n",
       "182                                      False                          False   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "181              False  Three Specific Aims   \n",
       "182              False  Three Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "181  Primary objective: To determine overall respon...   \n",
       "182  Primary objective: To determine overall respon...   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "181  Secondary objective: To determine progression-...   \n",
       "182  Secondary objective: To determine progression-...   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "181  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "182  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "181  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "182  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "181        2019-01-01      2020-12-31  Complete     False   \n",
       "182        2019-01-01      2020-12-31  Complete     False   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "181                   False                                  True   \n",
       "182                   False                                  True   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "181                   True                            True   \n",
       "182                   True                            True   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "181                   False                                  False   \n",
       "182                   False                                  False   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "181                    False               False                       False   \n",
       "182                    False               False                       False   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "181                     False                                    False   \n",
       "182                     False                                    False   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "181                False                                  False   \n",
       "182                False                                  False   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "181                                  False                           False   \n",
       "182                                  False                           False   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "181                    False   \n",
       "182                    False   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "181                                                Yes       \n",
       "182                                                 No       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "181  The PTC funding lead to preliminary data for a...                   NaN   \n",
       "182                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "181                       1.0   \n",
       "182                       1.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "181  Trial Name:    Temozolomide (TMZ) In Advanced ...   \n",
       "182                                                NaN   \n",
       "\n",
       "     First Clinical Trial Patient Count  \\\n",
       "181                                13.0   \n",
       "182                                18.0   \n",
       "\n",
       "                                 Second Clinical Trial  \\\n",
       "181  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "182                                                NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "181                                  NaN              None            No   \n",
       "182                                  NaN               NaN            No   \n",
       "\n",
       "    Patent Details Peer-Reviewed Publications Count  \n",
       "181            NaN                            Three  \n",
       "182            NaN                              One  "
      ]
     },
     "execution_count": 575,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity checks\n",
    "\n",
    "roi_adj.loc[\n",
    "    roi_adj['Project Title'].apply(lambda x: True if re.match(r'^An Open-Label', x) else False), :\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 576,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Project Title</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Neoadjuvant Immunoradiotherapy in Head &amp; Neck ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>186 rows  3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Project Title  \\\n",
       "169  Understanding and Targeting NRF2 in Pancreatic...   \n",
       "171  Understanding and Targeting NRF2 in Pancreatic...   \n",
       "57   Understanding and Targeting NRF2 in Pancreatic...   \n",
       "103  UCSD-UCSF Specialized Program of Research Exce...   \n",
       "6    UCSD-UCSF Specialized Program of Research Exce...   \n",
       "..                                                 ...   \n",
       "8    A Phase 1B, Nonrandomized Trial Investigating ...   \n",
       "222  A Novel Role for Histidine Kinase Activity in ...   \n",
       "224  A Novel Role for Histidine Kinase Activity in ...   \n",
       "4    A National Phase I Study of Cabozantinib in Co...   \n",
       "102  A National Phase I Study of Cabozantinib in Co...   \n",
       "\n",
       "                                  First Clinical Trial Second Clinical Trial  \n",
       "169                                                NaN                   NaN  \n",
       "171                                                NaN                   NaN  \n",
       "57                                                 NaN                   NaN  \n",
       "103  Neoadjuvant Immunoradiotherapy in Head & Neck ...                   NaN  \n",
       "6             Metformin for oral cancer prevention 2.0                   NaN  \n",
       "..                                                 ...                   ...  \n",
       "8    Phase 1B, Nonrandomized Trial Investigating Do...                   NaN  \n",
       "222                                                NaN                   NaN  \n",
       "224                                                NaN                   NaN  \n",
       "4    A National Phase I Study of Cabozantinib in Co...                   NaN  \n",
       "102                                                NaN                   NaN  \n",
       "\n",
       "[186 rows x 3 columns]"
      ]
     },
     "execution_count": 576,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_rows', 22)\n",
    "roi[['Project Title', 'First Clinical Trial', 'Second Clinical Trial']].sort_values(by='Project Title', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 577,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save cleaned dataframes to csv files in interim\n",
    "# Caution: examine directory before uncomment/run this cell to prevent duplicate\n",
    "# files or unintentional modifications to files\n",
    "\n",
    "wp = os.path.join('interim', 'tableau-datasets', '2022_Pedal_ROI.csv')\n",
    "roi_adj.to_csv(wp)\n",
    "\n",
    "# wp = os.path.join('interim', '2022_Pedal_Progress_Report.csv')\n",
    "# prog_r.to_csv(wp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 578,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>132.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the continued ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, I have participated as a virtual rider ev...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>doi.org/10.1093/nar/gkab621</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>133.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>134.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>136.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funds would enable our team to cont...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, in May 2021 I participated virtually.</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>138.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has  been ...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>102 rows  85 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0      3.0  Progress Report #1                  NaN          NaN   \n",
       "1      4.0  Progress Report #1                  NaN          NaN   \n",
       "2      5.0  Progress Report #1                  NaN          NaN   \n",
       "3      6.0  Progress Report #1                  NaN          NaN   \n",
       "4      8.0  Progress Report #1                  NaN          NaN   \n",
       "..     ...                 ...                  ...          ...   \n",
       "98   132.0  Progress Report #1                  NaN          NaN   \n",
       "99   133.0  Progress Report #1                  NaN          NaN   \n",
       "100  134.0  Progress Report #1                  NaN          NaN   \n",
       "101  136.0  Progress Report #1                  NaN          NaN   \n",
       "102  138.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "    Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                    NaN         NaN                  NaN         NaN   \n",
       "1                    NaN         NaN                  NaN         NaN   \n",
       "2                    NaN         NaN                  NaN         NaN   \n",
       "3                    NaN         NaN                  NaN         NaN   \n",
       "4                    NaN         NaN                  NaN         NaN   \n",
       "..                   ...         ...                  ...         ...   \n",
       "98                   NaN         NaN                  NaN         NaN   \n",
       "99                   NaN         NaN                  NaN         NaN   \n",
       "100                  NaN         NaN                  NaN         NaN   \n",
       "101                  NaN         NaN                  NaN         NaN   \n",
       "102                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "    Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                    NaN           NaN                  NaN          NaN   \n",
       "1                    NaN           NaN                  NaN          NaN   \n",
       "2                    NaN           NaN                  NaN          NaN   \n",
       "3                    NaN           NaN                  NaN          NaN   \n",
       "4                    NaN           NaN                  NaN          NaN   \n",
       "..                   ...           ...                  ...          ...   \n",
       "98                   NaN           NaN                  NaN          NaN   \n",
       "99                   NaN           NaN                  NaN          NaN   \n",
       "100                  NaN           NaN                  NaN          NaN   \n",
       "101                  NaN           NaN                  NaN          NaN   \n",
       "102                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "    Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                    NaN         NaN                   NaN         NaN   \n",
       "1                    NaN         NaN                   NaN         NaN   \n",
       "2                    NaN         NaN                   NaN         NaN   \n",
       "3                    NaN         NaN                   NaN         NaN   \n",
       "4                    NaN         NaN                   NaN         NaN   \n",
       "..                   ...         ...                   ...         ...   \n",
       "98                   NaN         NaN                   NaN         NaN   \n",
       "99                   NaN         NaN                   NaN         NaN   \n",
       "100                  NaN         NaN                   NaN         NaN   \n",
       "101                  NaN         NaN                   NaN         NaN   \n",
       "102                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                   Pedal Non-Peer Pubs  \\\n",
       "0                                                  NaN   \n",
       "1         Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                         None to date   \n",
       "3                                                  NaN   \n",
       "4    8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "..                                                 ...   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "\n",
       "                                 Other Accomplishments Health Benefits  \\\n",
       "0                                                  NaN             Yes   \n",
       "1                                                  NaN             Yes   \n",
       "2    additional funding provided by Padres Pedal th...             Yes   \n",
       "3                    See above in the progress report.             Yes   \n",
       "4    2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "..                                                 ...             ...   \n",
       "98                                                 NaN             Yes   \n",
       "99                                      Not applicable             Yes   \n",
       "100                                                NaN             Yes   \n",
       "101                                                NaN             Yes   \n",
       "102                                                NaN             Yes   \n",
       "\n",
       "     International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0            False     False  False           False                     False   \n",
       "1             True     False  False           False                     False   \n",
       "2             True     False  False           False                     False   \n",
       "3             True      True  False           False                     False   \n",
       "4            False     False  False           False                     False   \n",
       "..             ...       ...    ...             ...                       ...   \n",
       "98           False     False  False           False                     False   \n",
       "99           False     False  False           False                     False   \n",
       "100          False     False  False           False                     False   \n",
       "101          False     False  False           False                     False   \n",
       "102           True     False  False           False                     False   \n",
       "\n",
       "     Patients  Patient Families  Policy Influence  International (pol)  \\\n",
       "0        True             False              True                False   \n",
       "1       False             False              True                False   \n",
       "2       False             False              True                False   \n",
       "3        True              True              True                False   \n",
       "4        True             False              True                False   \n",
       "..        ...               ...               ...                  ...   \n",
       "98       True             False              True                False   \n",
       "99       True             False              True                False   \n",
       "100      True             False              True                False   \n",
       "101      True             False              True                False   \n",
       "102     False             False              True                False   \n",
       "\n",
       "     National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0             False        False                 False   \n",
       "1             False        False                 False   \n",
       "2             False        False                 False   \n",
       "3             False        False                 False   \n",
       "4             False        False                 False   \n",
       "..              ...          ...                   ...   \n",
       "98            False        False                 False   \n",
       "99            False        False                 False   \n",
       "100           False        False                 False   \n",
       "101           False        False                 False   \n",
       "102           False        False                 False   \n",
       "\n",
       "     Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                             False           False                   False   \n",
       "1                             False           False                   False   \n",
       "2                             False           False                   False   \n",
       "3                             False           False                   False   \n",
       "4                             False           False                   False   \n",
       "..                              ...             ...                     ...   \n",
       "98                            False           False                   False   \n",
       "99                            False           False                   False   \n",
       "100                           False           False                   False   \n",
       "101                           False           False                   False   \n",
       "102                           False           False                   False   \n",
       "\n",
       "    Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                           NaN                No                 False   \n",
       "1                           NaN                No                 False   \n",
       "2                           NaN               Yes                 False   \n",
       "3                           NaN               Yes                  True   \n",
       "4                           NaN                No                 False   \n",
       "..                          ...               ...                   ...   \n",
       "98                          NaN                No                 False   \n",
       "99                          NaN                No                 False   \n",
       "100                         NaN                No                 False   \n",
       "101                         NaN                No                 False   \n",
       "102                         NaN                No                 False   \n",
       "\n",
       "     National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0              False         False                  False   \n",
       "1              False         False                  False   \n",
       "2               True         False                  False   \n",
       "3               True         False                  False   \n",
       "4              False         False                  False   \n",
       "..               ...           ...                    ...   \n",
       "98             False         False                  False   \n",
       "99             False         False                  False   \n",
       "100            False         False                  False   \n",
       "101            False         False                  False   \n",
       "102            False         False                  False   \n",
       "\n",
       "     Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "0                              False            False   \n",
       "1                              False            False   \n",
       "2                              False            False   \n",
       "3                              False             True   \n",
       "4                              False            False   \n",
       "..                               ...              ...   \n",
       "98                             False            False   \n",
       "99                             False            False   \n",
       "100                            False            False   \n",
       "101                            False            False   \n",
       "102                            False            False   \n",
       "\n",
       "     Patient Families (econ)  \\\n",
       "0                      False   \n",
       "1                      False   \n",
       "2                      False   \n",
       "3                       True   \n",
       "4                      False   \n",
       "..                       ...   \n",
       "98                     False   \n",
       "99                     False   \n",
       "100                    False   \n",
       "101                    False   \n",
       "102                    False   \n",
       "\n",
       "                         Economic Benefits Description Equity Benefits  \\\n",
       "0                                                  NaN              No   \n",
       "1                                                  NaN              No   \n",
       "2    The combination of cabozantinib with 13-cis-re...              No   \n",
       "3    Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                  NaN             Yes   \n",
       "..                                                 ...             ...   \n",
       "98                                                 NaN              No   \n",
       "99                                                 NaN              No   \n",
       "100                                                NaN              No   \n",
       "101                                                NaN              No   \n",
       "102                                                NaN              No   \n",
       "\n",
       "     International (equity)  National (equity)  Local (equity)  \\\n",
       "0                     False              False           False   \n",
       "1                     False              False           False   \n",
       "2                     False              False           False   \n",
       "3                      True               True           False   \n",
       "4                     False              False           False   \n",
       "..                      ...                ...             ...   \n",
       "98                    False              False           False   \n",
       "99                    False              False           False   \n",
       "100                   False              False           False   \n",
       "101                   False              False           False   \n",
       "102                   False              False           False   \n",
       "\n",
       "     General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                      False                              False   \n",
       "1                      False                              False   \n",
       "2                      False                              False   \n",
       "3                      False                              False   \n",
       "4                      False                              False   \n",
       "..                       ...                                ...   \n",
       "98                     False                              False   \n",
       "99                     False                              False   \n",
       "100                    False                              False   \n",
       "101                    False                              False   \n",
       "102                    False                              False   \n",
       "\n",
       "     Patients (equity)  Patient Families (equity)  \\\n",
       "0                False                      False   \n",
       "1                False                      False   \n",
       "2                False                      False   \n",
       "3                 True                       True   \n",
       "4                 True                      False   \n",
       "..                 ...                        ...   \n",
       "98               False                      False   \n",
       "99               False                      False   \n",
       "100              False                      False   \n",
       "101              False                      False   \n",
       "102              False                      False   \n",
       "\n",
       "                           Equity Benefits Description  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3    At risk oral cancer patients are often part of...   \n",
       "4    Trial focused on all demographic of prostate c...   \n",
       "..                                                 ...   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102                                                NaN   \n",
       "\n",
       "       Additional Funding Achieved First AFS Status  \\\n",
       "0                              One          Awarded   \n",
       "1                             Five          Awarded   \n",
       "2                              One          Awarded   \n",
       "3                              One        Submitted   \n",
       "4                              One          Awarded   \n",
       "..                             ...              ...   \n",
       "98   No additional funding sources              NaN   \n",
       "99   No additional funding sources              NaN   \n",
       "100  No additional funding sources              NaN   \n",
       "101  No additional funding sources              NaN   \n",
       "102                           Five          Awarded   \n",
       "\n",
       "                      First AFS Name and Project Title  First AFS Amount  \\\n",
       "0    NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                              the Hartwell Foundation          300000.0   \n",
       "2                                       Exelixis, Inc.          250000.0   \n",
       "3                  NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                           Oncternal           377000.0   \n",
       "..                                                 ...               ...   \n",
       "98                                                 NaN               NaN   \n",
       "99                                                 NaN               NaN   \n",
       "100                                                NaN               NaN   \n",
       "101                                                NaN               NaN   \n",
       "102                            the Hartwell Foundation          300000.0   \n",
       "\n",
       "    Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0                 NaN                               NaN                NaN   \n",
       "1             Awarded            Padres Pedal the Cause           100000.0   \n",
       "2                 NaN                               NaN                NaN   \n",
       "3                 NaN                               NaN                NaN   \n",
       "4                 NaN                               NaN                NaN   \n",
       "..                ...                               ...                ...   \n",
       "98                NaN                               NaN                NaN   \n",
       "99                NaN                               NaN                NaN   \n",
       "100               NaN                               NaN                NaN   \n",
       "101               NaN                               NaN                NaN   \n",
       "102           Awarded            Padres Pedal the Cause           100000.0   \n",
       "\n",
       "    Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0                NaN                                   NaN               NaN   \n",
       "1          Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2                NaN                                   NaN               NaN   \n",
       "3                NaN                                   NaN               NaN   \n",
       "4                NaN                                   NaN               NaN   \n",
       "..               ...                                   ...               ...   \n",
       "98               NaN                                   NaN               NaN   \n",
       "99               NaN                                   NaN               NaN   \n",
       "100              NaN                                   NaN               NaN   \n",
       "101              NaN                                   NaN               NaN   \n",
       "102          Awarded                Padres Pedal the Cause          100000.0   \n",
       "\n",
       "    Fourth AFS Status     Fourth AFS Name and Project Title  \\\n",
       "0                 NaN                                   NaN   \n",
       "1           Submitted                    NIH R03CA273629-01   \n",
       "2                 NaN                                   NaN   \n",
       "3                 NaN                                   NaN   \n",
       "4                 NaN                                   NaN   \n",
       "..                ...                                   ...   \n",
       "98                NaN                                   NaN   \n",
       "99                NaN                                   NaN   \n",
       "100               NaN                                   NaN   \n",
       "101               NaN                                   NaN   \n",
       "102         Submitted  Pediatric Cancer Research Foundation   \n",
       "\n",
       "     Fourth AFS Amount  \\\n",
       "0                  NaN   \n",
       "1             150000.0   \n",
       "2                  NaN   \n",
       "3                  NaN   \n",
       "4                  NaN   \n",
       "..                 ...   \n",
       "98                 NaN   \n",
       "99                 NaN   \n",
       "100                NaN   \n",
       "101                NaN   \n",
       "102           750000.0   \n",
       "\n",
       "    Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                  NaN                   \n",
       "1                     Tower Cancer Research Foundation                   \n",
       "2                                                  NaN                   \n",
       "3                                                  NaN                   \n",
       "4                                                  NaN                   \n",
       "..                                                 ...                   \n",
       "98                                                 NaN                   \n",
       "99                                                 NaN                   \n",
       "100                                                NaN                   \n",
       "101                                                NaN                   \n",
       "102                                 NIH R03CA273629-01                   \n",
       "\n",
       "    Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0                NaN               NaN                             Yes   \n",
       "1          Submitted          500000.0                             Yes   \n",
       "2                NaN               NaN                             Yes   \n",
       "3                NaN               NaN                             Yes   \n",
       "4                NaN               NaN                             Yes   \n",
       "..               ...               ...                             ...   \n",
       "98               NaN               NaN                             Yes   \n",
       "99               NaN               NaN                              No   \n",
       "100              NaN               NaN                              No   \n",
       "101              NaN               NaN                             Yes   \n",
       "102        Submitted          150000.0                             Yes   \n",
       "\n",
       "               Additional Funding Benefits Description  \\\n",
       "0    Additional funding would enable the applicatio...   \n",
       "1    Additional funding support would allow us to p...   \n",
       "2    Additional funding support would allow us to e...   \n",
       "3    For advancing the planned clinical trial and c...   \n",
       "4    This is a grass roots project. It is a single ...   \n",
       "..                                                 ...   \n",
       "98   Additional funding would enable the continued ...   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101  Additional funds would enable our team to cont...   \n",
       "102  Additional funding support would allow us to p...   \n",
       "\n",
       "    Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                                 Yes   \n",
       "1                                                 Yes   \n",
       "2                                                 Yes   \n",
       "3                                                 Yes   \n",
       "4                                                  No   \n",
       "..                                                ...   \n",
       "98                                                 No   \n",
       "99                                                 No   \n",
       "100                                                No   \n",
       "101                                                No   \n",
       "102                                               Yes   \n",
       "\n",
       "    Additional Funding Benefits Description (clinical stages)  \\\n",
       "0    In addition, funding could allow us to do more...          \n",
       "1    Additional funding support would allow us to p...          \n",
       "2    Additional funding support would allow us to p...          \n",
       "3    Identification of biomarkers predicting clinic...          \n",
       "4                                                  NaN          \n",
       "..                                                 ...          \n",
       "98                                                 NaN          \n",
       "99                                                 NaN          \n",
       "100                                                NaN          \n",
       "101                                                NaN          \n",
       "102  Additional funding support would allow us to p...          \n",
       "\n",
       "                                 Participated in Pedal  \\\n",
       "0    Yes, I have participated as a rider every year...   \n",
       "1    I have participated as both a virtual particip...   \n",
       "2    I have participated as both a virtual particip...   \n",
       "3                                                  Yes   \n",
       "4                                        Yes, runner.    \n",
       "..                                                 ...   \n",
       "98   Yes, I have participated as a virtual rider ev...   \n",
       "99                                                  No   \n",
       "100                                                NaN   \n",
       "101         Yes, in May 2021 I participated virtually.   \n",
       "102  I have participated as both a virtual particip...   \n",
       "\n",
       "    Further Research Contributions Success Stories  \\\n",
       "0                               No              No   \n",
       "1                              Yes              No   \n",
       "2                              Yes             Yes   \n",
       "3                               No              No   \n",
       "4                              Yes              No   \n",
       "..                             ...             ...   \n",
       "98                              No              No   \n",
       "99                              No              No   \n",
       "100                            NaN             NaN   \n",
       "101                             No              No   \n",
       "102                            Yes              No   \n",
       "\n",
       "    Major Scientific Breakthroughs  \\\n",
       "0                              NaN   \n",
       "1                              NaN   \n",
       "2                              Yes   \n",
       "3                              NaN   \n",
       "4                              NaN   \n",
       "..                             ...   \n",
       "98                             NaN   \n",
       "99                             NaN   \n",
       "100                            NaN   \n",
       "101                            NaN   \n",
       "102                            NaN   \n",
       "\n",
       "                                   Additional Comments  Complete  \\\n",
       "0                                                  NaN      True   \n",
       "1    Funding from Padres Pedal the Cause has been i...      True   \n",
       "2    Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                  Many thanks for all your support!!!      True   \n",
       "4                                                  NaN      True   \n",
       "..                                                 ...       ...   \n",
       "98                                                 NaN      True   \n",
       "99                                                  No      True   \n",
       "100                                                NaN      True   \n",
       "101                                                NaN      True   \n",
       "102  Funding from Padres Pedal the Cause has  been ...      True   \n",
       "\n",
       "    Publication Status 1                  First DOI # Publication Status 2  \\\n",
       "0               Accepted                          NaN                  NaN   \n",
       "1               Accepted                          NaN            Submitted   \n",
       "2              Published                          NaN                  NaN   \n",
       "3            In progress                          NaN          In progress   \n",
       "4                    NaN                          NaN                  NaN   \n",
       "..                   ...                          ...                  ...   \n",
       "98              Accepted  doi.org/10.1093/nar/gkab621          In progress   \n",
       "99           In progress                          NaN                  NaN   \n",
       "100            Published                          NaN                  NaN   \n",
       "101          In progress                          NaN                  NaN   \n",
       "102            Published                          NaN          In progress   \n",
       "\n",
       "    Second DOI # Publication Status 3 Third DOI #  \n",
       "0            NaN                  NaN         NaN  \n",
       "1            NaN                  NaN         NaN  \n",
       "2            NaN                  NaN         NaN  \n",
       "3            NaN                  NaN         NaN  \n",
       "4            NaN                  NaN         NaN  \n",
       "..           ...                  ...         ...  \n",
       "98           NaN                  NaN         NaN  \n",
       "99           NaN                  NaN         NaN  \n",
       "100          NaN                  NaN         NaN  \n",
       "101          NaN                  NaN         NaN  \n",
       "102          NaN                  NaN         NaN  \n",
       "\n",
       "[102 rows x 85 columns]"
      ]
     },
     "execution_count": 578,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr['Policy Influence'] = pr['Policy Influence'].fillna(False).astype(bool)\n",
    "\n",
    "pr[pr['Policy Influence']]"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Number of peer-reviewed publications (DM)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 579,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Published      30\n",
      "In progress    28\n",
      "Accepted       16\n",
      "Submitted       2\n",
      "Name: Publication Status 1, dtype: int64\n",
      "\n",
      "In progress    21\n",
      "Published      11\n",
      "Submitted       5\n",
      "Accepted        4\n",
      "Name: Publication Status 2, dtype: int64\n",
      "\n",
      "Published      6\n",
      "In progress    5\n",
      "Accepted       3\n",
      "Submitted      1\n",
      "Name: Publication Status 3, dtype: int64\n",
      "\n",
      "Published      6\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Name: Publication Status 4, dtype: int64\n",
      "\n",
      "Accepted     2\n",
      "Published    2\n",
      "Submitted    1\n",
      "Name: Publication Status 5, dtype: int64\n",
      "\n",
      "Submitted    2\n",
      "Accepted     1\n",
      "Published    1\n",
      "Name: Publication Status 6, dtype: int64\n",
      "\n",
      "Submitted    2\n",
      "Accepted     1\n",
      "Published    1\n",
      "Name: Publication Status 7, dtype: int64\n",
      "\n",
      "Accepted       1\n",
      "Submitted      1\n",
      "In progress    1\n",
      "Published      1\n",
      "Name: Publication Status 8, dtype: int64\n",
      "\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Published      1\n",
      "Name: Publication Status 9, dtype: int64\n",
      "\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Published      1\n",
      "Name: Publication Status 10, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i in range(1, 11):\n",
    "    print(pr[f'Publication Status {i}'].value_counts())\n",
    "    print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 580,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Published      30\n",
       "In progress    28\n",
       "Accepted       16\n",
       "Submitted       2\n",
       "Name: Publication Status 1, dtype: int64"
      ]
     },
     "execution_count": 580,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "to_plot = pr['Publication Status 1'].value_counts()\n",
    "to_plot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 581,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "hovertemplate": "variable=Publication Status 1<br>index=%{x}<br>value=%{y}<extra></extra>",
         "legendgroup": "Publication Status 1",
         "marker": {
          "color": "#636efa",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication Status 1",
         "offsetgroup": "Publication Status 1",
         "orientation": "v",
         "showlegend": true,
         "textposition": "auto",
         "type": "bar",
         "x": [
          "Published",
          "In progress",
          "Accepted",
          "Submitted"
         ],
         "xaxis": "x",
         "y": [
          30,
          28,
          16,
          2
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "title": {
          "text": "variable"
         },
         "tracegroupgap": 0
        },
        "margin": {
         "t": 60
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "index"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "value"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "px.bar(to_plot)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 582,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Publication Status 10</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Accepted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>In progress</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>Published</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>104 rows  10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Publication Status 1 Publication Status 2 Publication Status 3  \\\n",
       "0               Accepted                  NaN                  NaN   \n",
       "1               Accepted            Submitted                  NaN   \n",
       "2              Published                  NaN                  NaN   \n",
       "3            In progress          In progress                  NaN   \n",
       "4                    NaN                  NaN                  NaN   \n",
       "..                   ...                  ...                  ...   \n",
       "99           In progress                  NaN                  NaN   \n",
       "100            Published                  NaN                  NaN   \n",
       "101          In progress                  NaN                  NaN   \n",
       "102            Published          In progress                  NaN   \n",
       "103            Published                  NaN                  NaN   \n",
       "\n",
       "    Publication Status 4 Publication Status 5 Publication Status 6  \\\n",
       "0                    NaN                  NaN                  NaN   \n",
       "1                    NaN                  NaN                  NaN   \n",
       "2                    NaN                  NaN                  NaN   \n",
       "3                    NaN                  NaN                  NaN   \n",
       "4                    NaN                  NaN                  NaN   \n",
       "..                   ...                  ...                  ...   \n",
       "99                   NaN                  NaN                  NaN   \n",
       "100                  NaN                  NaN                  NaN   \n",
       "101                  NaN                  NaN                  NaN   \n",
       "102                  NaN                  NaN                  NaN   \n",
       "103                  NaN                  NaN                  NaN   \n",
       "\n",
       "    Publication Status 7 Publication Status 8 Publication Status 9  \\\n",
       "0                    NaN                  NaN                  NaN   \n",
       "1                    NaN                  NaN                  NaN   \n",
       "2                    NaN                  NaN                  NaN   \n",
       "3                    NaN                  NaN                  NaN   \n",
       "4                    NaN                  NaN                  NaN   \n",
       "..                   ...                  ...                  ...   \n",
       "99                   NaN                  NaN                  NaN   \n",
       "100                  NaN                  NaN                  NaN   \n",
       "101                  NaN                  NaN                  NaN   \n",
       "102                  NaN                  NaN                  NaN   \n",
       "103                  NaN                  NaN                  NaN   \n",
       "\n",
       "    Publication Status 10  \n",
       "0                     NaN  \n",
       "1                     NaN  \n",
       "2                     NaN  \n",
       "3                     NaN  \n",
       "4                     NaN  \n",
       "..                    ...  \n",
       "99                    NaN  \n",
       "100                   NaN  \n",
       "101                   NaN  \n",
       "102                   NaN  \n",
       "103                   NaN  \n",
       "\n",
       "[104 rows x 10 columns]"
      ]
     },
     "execution_count": 582,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get all peer-reviewed publication statuses\n",
    "\n",
    "pubs = pr.filter(regex=(r'Publication Status\\s\\d{1}'))\n",
    "pubs = pubs[pubs.columns[-3:].tolist() + pubs.columns[:7].tolist()]\n",
    "pubs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 583,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Publication 1</th>\n",
       "      <th>Publication 2</th>\n",
       "      <th>Publication 3</th>\n",
       "      <th>Publication 4</th>\n",
       "      <th>Publication 5</th>\n",
       "      <th>Publication 6</th>\n",
       "      <th>Publication 7</th>\n",
       "      <th>Publication 8</th>\n",
       "      <th>Publication 9</th>\n",
       "      <th>Publication 10</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Accepted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>In progress</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Publication 1 Publication 2 Publication 3 Publication 4 Publication 5  \\\n",
       "0      Accepted           NaN           NaN           NaN           NaN   \n",
       "1      Accepted     Submitted           NaN           NaN           NaN   \n",
       "2     Published           NaN           NaN           NaN           NaN   \n",
       "3   In progress   In progress           NaN           NaN           NaN   \n",
       "4           NaN           NaN           NaN           NaN           NaN   \n",
       "\n",
       "  Publication 6 Publication 7 Publication 8 Publication 9 Publication 10  \n",
       "0           NaN           NaN           NaN           NaN            NaN  \n",
       "1           NaN           NaN           NaN           NaN            NaN  \n",
       "2           NaN           NaN           NaN           NaN            NaN  \n",
       "3           NaN           NaN           NaN           NaN            NaN  \n",
       "4           NaN           NaN           NaN           NaN            NaN  "
      ]
     },
     "execution_count": 583,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Remove \"Status\" from pubs column names\n",
    "\n",
    "new_cols = []\n",
    "for col in pubs.columns:\n",
    "    new_col = re.sub(r' Status', '', col)\n",
    "    new_cols.append(new_col)\n",
    "\n",
    "pubs.columns = new_cols\n",
    "pubs.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 584,
   "metadata": {},
   "outputs": [],
   "source": [
    "pubs_color_palette = px.colors.qualitative.Bold"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 585,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 1<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 1",
         "marker": {
          "color": "rgb(127, 60, 141)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 1",
         "offsetgroup": "Publication 1",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          "Accepted",
          "Accepted",
          "Published",
          "In progress",
          null,
          null,
          "In progress",
          "In progress",
          "In progress",
          null,
          null,
          "Published",
          "In progress",
          "Accepted",
          "Published",
          "Published",
          "Accepted",
          null,
          null,
          "In progress",
          null,
          "In progress",
          "Published",
          "Accepted",
          "Published",
          null,
          "Submitted",
          "In progress",
          "Published",
          "Published",
          "In progress",
          "Accepted",
          "In progress",
          "Published",
          "In progress",
          "Accepted",
          null,
          "In progress",
          "Published",
          "In progress",
          "Published",
          "Accepted",
          "Accepted",
          "Accepted",
          null,
          "Accepted",
          "In progress",
          "Published",
          "Published",
          null,
          "In progress",
          null,
          null,
          "In progress",
          null,
          "Accepted",
          "Published",
          "Published",
          null,
          "In progress",
          "Published",
          null,
          "In progress",
          "Accepted",
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          "Published",
          "Published",
          "Published",
          null,
          "Published",
          null,
          "Submitted",
          "In progress",
          "Published",
          null,
          "In progress",
          "Published",
          "In progress",
          "In progress",
          "Published",
          "In progress",
          "Published",
          "Accepted",
          "In progress",
          "Published",
          null,
          "Published",
          "Published",
          null,
          "Accepted",
          "In progress",
          "Accepted",
          "In progress",
          "Published",
          "In progress",
          "Published",
          "Published"
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 2<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 2",
         "marker": {
          "color": "rgb(17, 165, 121)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 2",
         "offsetgroup": "Publication 2",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          "Submitted",
          null,
          "In progress",
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          "Published",
          null,
          "Accepted",
          "Submitted",
          "Submitted",
          "In progress",
          null,
          null,
          null,
          null,
          "In progress",
          "Published",
          "In progress",
          "Published",
          null,
          null,
          null,
          "Submitted",
          null,
          "In progress",
          "Accepted",
          "In progress",
          "Published",
          "In progress",
          "In progress",
          null,
          null,
          "In progress",
          null,
          "Published",
          null,
          "Accepted",
          null,
          null,
          "In progress",
          null,
          null,
          "Published",
          null,
          "In progress",
          null,
          null,
          "In progress",
          null,
          "In progress",
          "In progress",
          "In progress",
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          "Accepted",
          null,
          null,
          "Published",
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          "Published",
          "In progress",
          null,
          null,
          null,
          null,
          "In progress",
          null,
          "Published",
          null,
          null,
          "Published",
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          "In progress",
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 3<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 3",
         "marker": {
          "color": "rgb(57, 105, 172)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 3",
         "offsetgroup": "Publication 3",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          "In progress",
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          "Accepted",
          null,
          "Published",
          null,
          "In progress",
          null,
          null,
          null,
          null,
          "Published",
          null,
          "Accepted",
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          "Accepted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 4<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 4",
         "marker": {
          "color": "rgb(242, 183, 1)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 4",
         "offsetgroup": "Publication 4",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          "Accepted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 5<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 5",
         "marker": {
          "color": "rgb(231, 63, 116)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 5",
         "offsetgroup": "Publication 5",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          "Accepted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 6<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 6",
         "marker": {
          "color": "rgb(128, 186, 90)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 6",
         "offsetgroup": "Publication 6",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 7<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 7",
         "marker": {
          "color": "rgb(230, 131, 16)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 7",
         "offsetgroup": "Publication 7",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 8<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 8",
         "marker": {
          "color": "rgb(0, 134, 149)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 8",
         "offsetgroup": "Publication 8",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 9<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 9",
         "marker": {
          "color": "rgb(207, 28, 144)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 9",
         "offsetgroup": "Publication 9",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 10<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 10",
         "marker": {
          "color": "rgb(249, 123, 114)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 10",
         "offsetgroup": "Publication 10",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "title": {
          "text": "publication #"
         },
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "2022 Peer-Reviewed Publication Percentages by Status"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "status"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "percent"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot the publication distribution, subset by status\n",
    "\n",
    "publications_fig = px.histogram(pubs, color_discrete_sequence=pubs_color_palette, \\\n",
    "    title='2022 Peer-Reviewed Publication Percentages by Status', histnorm='percent',\n",
    "    labels={'variable': 'publication #', 'value': 'status'})\n",
    "publications_fig.update_layout(xaxis_title='status')\n",
    "# publications_fig.update_traces(\n",
    "#     hovertemplate='publiction #: %{}<br>status: %{x}<br>percent: %{y:.2f}',\n",
    "# )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 586,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Export viz\n",
    "\n",
    "viz_dir = \"C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\src\\\\visualization\"\n",
    "wp = os.path.join(viz_dir, 'publications_fig.html')\n",
    "publications_fig.write_html(wp)#, include_plotlyjs='cdn')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 587,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "166"
      ]
     },
     "execution_count": 587,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get total number of peer-reviewed publications\n",
    "\n",
    "num_pubs = 0\n",
    "for col in pubs.columns:\n",
    "    num_pub = len(pubs[col]) - pubs[col].isna().sum()\n",
    "    num_pubs += num_pub\n",
    "\n",
    "num_pubs\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 588,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 588,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity check\n",
    "\n",
    "pr.shape[0] == pr['ID'].nunique()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Name of project titles that will lead to improvements in health policy (FD, FL)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 596,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Merge project titles to progress report\n",
    "\n",
    "titles = roi[['ID', 'Project Title']]\n",
    "pr = pr.merge(titles, on='ID')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 597,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_35096\\3271432832.py:4: SettingWithCopyWarning:\n",
      "\n",
      "\n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Policy Influence  International (pol)  National (pol)  Local (pol)  \\\n",
       "0              True                False           False        False   \n",
       "1              True                False           False        False   \n",
       "2              True                False           False        False   \n",
       "3              True                False           False        False   \n",
       "4              True                False           False        False   \n",
       "\n",
       "   General Public (pol)  Healthcare Professionals (pol)  Patients (pol)  \\\n",
       "0                 False                           False           False   \n",
       "1                 False                           False           False   \n",
       "2                 False                           False           False   \n",
       "3                 False                           False           False   \n",
       "4                 False                           False           False   \n",
       "\n",
       "   Patient Families (pol) Policy Benefits Description  \\\n",
       "0                   False                         NaN   \n",
       "1                   False                         NaN   \n",
       "2                   False                         NaN   \n",
       "3                   False                         NaN   \n",
       "4                   False                         NaN   \n",
       "\n",
       "                                       Project Title  \n",
       "0  Detecting dysregulated genes in neuroblastoma ...  \n",
       "1  Functional Roles for Histidine Kinase Signalin...  \n",
       "2  A National Phase I Study of Cabozantinib in Co...  \n",
       "3  UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4  A Phase 1B, Nonrandomized Trial Investigating ...  "
      ]
     },
     "execution_count": 597,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get all columns related health policy / health decision making\n",
    "\n",
    "poli = pr.filter(regex=(r'pol|Pol'))\n",
    "poli['Project Title'] = pr['Project Title']\n",
    "poli.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 598,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0  3.0  Progress Report #1                  NaN          NaN   \n",
       "1  4.0  Progress Report #1                  NaN          NaN   \n",
       "2  5.0  Progress Report #1                  NaN          NaN   \n",
       "3  6.0  Progress Report #1                  NaN          NaN   \n",
       "4  8.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "  Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                  NaN         NaN                  NaN         NaN   \n",
       "1                  NaN         NaN                  NaN         NaN   \n",
       "2                  NaN         NaN                  NaN         NaN   \n",
       "3                  NaN         NaN                  NaN         NaN   \n",
       "4                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "  Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                  NaN           NaN                  NaN          NaN   \n",
       "1                  NaN           NaN                  NaN          NaN   \n",
       "2                  NaN           NaN                  NaN          NaN   \n",
       "3                  NaN           NaN                  NaN          NaN   \n",
       "4                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                  NaN         NaN                   NaN         NaN   \n",
       "1                  NaN         NaN                   NaN         NaN   \n",
       "2                  NaN         NaN                   NaN         NaN   \n",
       "3                  NaN         NaN                   NaN         NaN   \n",
       "4                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                 Pedal Non-Peer Pubs  \\\n",
       "0                                                NaN   \n",
       "1       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                       None to date   \n",
       "3                                                NaN   \n",
       "4  8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "\n",
       "                               Other Accomplishments Health Benefits  \\\n",
       "0                                                NaN             Yes   \n",
       "1                                                NaN             Yes   \n",
       "2  additional funding provided by Padres Pedal th...             Yes   \n",
       "3                  See above in the progress report.             Yes   \n",
       "4  2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "\n",
       "   International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0          False     False  False           False                     False   \n",
       "1           True     False  False           False                     False   \n",
       "2           True     False  False           False                     False   \n",
       "3           True      True  False           False                     False   \n",
       "4          False     False  False           False                     False   \n",
       "\n",
       "   Patients  Patient Families  Policy Influence  International (pol)  \\\n",
       "0      True             False              True                False   \n",
       "1     False             False              True                False   \n",
       "2     False             False              True                False   \n",
       "3      True              True              True                False   \n",
       "4      True             False              True                False   \n",
       "\n",
       "   National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0           False        False                 False   \n",
       "1           False        False                 False   \n",
       "2           False        False                 False   \n",
       "3           False        False                 False   \n",
       "4           False        False                 False   \n",
       "\n",
       "   Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                           False           False                   False   \n",
       "1                           False           False                   False   \n",
       "2                           False           False                   False   \n",
       "3                           False           False                   False   \n",
       "4                           False           False                   False   \n",
       "\n",
       "  Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                         NaN                No                 False   \n",
       "1                         NaN                No                 False   \n",
       "2                         NaN               Yes                 False   \n",
       "3                         NaN               Yes                  True   \n",
       "4                         NaN                No                 False   \n",
       "\n",
       "   National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0            False         False                  False   \n",
       "1            False         False                  False   \n",
       "2             True         False                  False   \n",
       "3             True         False                  False   \n",
       "4            False         False                  False   \n",
       "\n",
       "   Healthcare Professionals (econ)  Patients (econ)  Patient Families (econ)  \\\n",
       "0                            False            False                    False   \n",
       "1                            False            False                    False   \n",
       "2                            False            False                    False   \n",
       "3                            False             True                     True   \n",
       "4                            False            False                    False   \n",
       "\n",
       "                       Economic Benefits Description Equity Benefits  \\\n",
       "0                                                NaN              No   \n",
       "1                                                NaN              No   \n",
       "2  The combination of cabozantinib with 13-cis-re...              No   \n",
       "3  Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                NaN             Yes   \n",
       "\n",
       "   International (equity)  National (equity)  Local (equity)  \\\n",
       "0                   False              False           False   \n",
       "1                   False              False           False   \n",
       "2                   False              False           False   \n",
       "3                    True               True           False   \n",
       "4                   False              False           False   \n",
       "\n",
       "   General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                    False                              False   \n",
       "1                    False                              False   \n",
       "2                    False                              False   \n",
       "3                    False                              False   \n",
       "4                    False                              False   \n",
       "\n",
       "   Patients (equity)  Patient Families (equity)  \\\n",
       "0              False                      False   \n",
       "1              False                      False   \n",
       "2              False                      False   \n",
       "3               True                       True   \n",
       "4               True                      False   \n",
       "\n",
       "                         Equity Benefits Description  \\\n",
       "0                                                NaN   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3  At risk oral cancer patients are often part of...   \n",
       "4  Trial focused on all demographic of prostate c...   \n",
       "\n",
       "  Additional Funding Achieved First AFS Status  \\\n",
       "0                         One          Awarded   \n",
       "1                        Five          Awarded   \n",
       "2                         One          Awarded   \n",
       "3                         One        Submitted   \n",
       "4                         One          Awarded   \n",
       "\n",
       "                    First AFS Name and Project Title  First AFS Amount  \\\n",
       "0  NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                            the Hartwell Foundation          300000.0   \n",
       "2                                     Exelixis, Inc.          250000.0   \n",
       "3                NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                         Oncternal           377000.0   \n",
       "\n",
       "  Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1           Awarded            Padres Pedal the Cause           100000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0              NaN                                   NaN               NaN   \n",
       "1        Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2              NaN                                   NaN               NaN   \n",
       "3              NaN                                   NaN               NaN   \n",
       "4              NaN                                   NaN               NaN   \n",
       "\n",
       "  Fourth AFS Status Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1         Submitted                NIH R03CA273629-01           150000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                NaN                   \n",
       "1                   Tower Cancer Research Foundation                   \n",
       "2                                                NaN                   \n",
       "3                                                NaN                   \n",
       "4                                                NaN                   \n",
       "\n",
       "  Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0              NaN               NaN                             Yes   \n",
       "1        Submitted          500000.0                             Yes   \n",
       "2              NaN               NaN                             Yes   \n",
       "3              NaN               NaN                             Yes   \n",
       "4              NaN               NaN                             Yes   \n",
       "\n",
       "             Additional Funding Benefits Description  \\\n",
       "0  Additional funding would enable the applicatio...   \n",
       "1  Additional funding support would allow us to p...   \n",
       "2  Additional funding support would allow us to e...   \n",
       "3  For advancing the planned clinical trial and c...   \n",
       "4  This is a grass roots project. It is a single ...   \n",
       "\n",
       "  Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                               Yes   \n",
       "1                                               Yes   \n",
       "2                                               Yes   \n",
       "3                                               Yes   \n",
       "4                                                No   \n",
       "\n",
       "  Additional Funding Benefits Description (clinical stages)  \\\n",
       "0  In addition, funding could allow us to do more...          \n",
       "1  Additional funding support would allow us to p...          \n",
       "2  Additional funding support would allow us to p...          \n",
       "3  Identification of biomarkers predicting clinic...          \n",
       "4                                                NaN          \n",
       "\n",
       "                               Participated in Pedal  \\\n",
       "0  Yes, I have participated as a rider every year...   \n",
       "1  I have participated as both a virtual particip...   \n",
       "2  I have participated as both a virtual particip...   \n",
       "3                                                Yes   \n",
       "4                                      Yes, runner.    \n",
       "\n",
       "  Further Research Contributions Success Stories  \\\n",
       "0                             No              No   \n",
       "1                            Yes              No   \n",
       "2                            Yes             Yes   \n",
       "3                             No              No   \n",
       "4                            Yes              No   \n",
       "\n",
       "  Major Scientific Breakthroughs  \\\n",
       "0                            NaN   \n",
       "1                            NaN   \n",
       "2                            Yes   \n",
       "3                            NaN   \n",
       "4                            NaN   \n",
       "\n",
       "                                 Additional Comments  Complete  \\\n",
       "0                                                NaN      True   \n",
       "1  Funding from Padres Pedal the Cause has been i...      True   \n",
       "2  Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                Many thanks for all your support!!!      True   \n",
       "4                                                NaN      True   \n",
       "\n",
       "  Publication Status 1 First DOI # Publication Status 2 Second DOI #  \\\n",
       "0             Accepted         NaN                  NaN          NaN   \n",
       "1             Accepted         NaN            Submitted          NaN   \n",
       "2            Published         NaN                  NaN          NaN   \n",
       "3          In progress         NaN          In progress          NaN   \n",
       "4                  NaN         NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 3 Third DOI #  \\\n",
       "0                  NaN         NaN   \n",
       "1                  NaN         NaN   \n",
       "2                  NaN         NaN   \n",
       "3                  NaN         NaN   \n",
       "4                  NaN         NaN   \n",
       "\n",
       "                                       Project Title  \n",
       "0  Detecting dysregulated genes in neuroblastoma ...  \n",
       "1  Functional Roles for Histidine Kinase Signalin...  \n",
       "2  A National Phase I Study of Cabozantinib in Co...  \n",
       "3  UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4  A Phase 1B, Nonrandomized Trial Investigating ...  "
      ]
     },
     "execution_count": 598,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 599,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>WIll better delineate the burden of clonal hem...</td>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Potential to influence NCCN guidelines.</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>E cigarette related policies</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Adding genomics to the EMR in Epic.</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The development of tumor specific probes for g...</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>N/a</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>To make brachy more automated and clinical</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially b...</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>These studies on the immune compartment may le...</td>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Policy Influence  International (pol)  National (pol)  Local (pol)  \\\n",
       "9               True                False           False        False   \n",
       "19              True                 True           False        False   \n",
       "22              True                 True            True         True   \n",
       "31              True                False            True         True   \n",
       "35              True                False            True        False   \n",
       "42              True                False           False        False   \n",
       "44              True                False           False        False   \n",
       "53              True                 True            True        False   \n",
       "56              True                False           False        False   \n",
       "59              True                 True            True         True   \n",
       "70              True                 True            True         True   \n",
       "71              True                 True            True         True   \n",
       "81              True                False            True         True   \n",
       "85              True                False            True        False   \n",
       "\n",
       "    General Public (pol)  Healthcare Professionals (pol)  Patients (pol)  \\\n",
       "9                   True                           False            True   \n",
       "19                 False                           False           False   \n",
       "22                 False                            True            True   \n",
       "31                  True                            True            True   \n",
       "35                 False                           False           False   \n",
       "42                  True                           False           False   \n",
       "44                 False                            True           False   \n",
       "53                 False                            True            True   \n",
       "56                  True                           False            True   \n",
       "59                 False                            True           False   \n",
       "70                 False                            True            True   \n",
       "71                  True                           False           False   \n",
       "81                  True                            True            True   \n",
       "85                 False                           False           False   \n",
       "\n",
       "    Patient Families (pol)                        Policy Benefits Description  \\\n",
       "9                    False  Our project could improve guidelines as to how...   \n",
       "19                   False  WIll better delineate the burden of clonal hem...   \n",
       "22                   False  These tools can help healthcare professionals ...   \n",
       "31                    True  The navigation intervention could potentially ...   \n",
       "35                   False            Potential to influence NCCN guidelines.   \n",
       "42                   False                       E cigarette related policies   \n",
       "44                   False                Adding genomics to the EMR in Epic.   \n",
       "53                   False  The development of tumor specific probes for g...   \n",
       "56                   False  Our project could improve guidelines as to how...   \n",
       "59                   False                                                N/a   \n",
       "70                   False  These tools can help healthcare professionals ...   \n",
       "71                   False        To make brachy more automated and clinical    \n",
       "81                    True  The navigator intervention could potentially b...   \n",
       "85                   False  These studies on the immune compartment may le...   \n",
       "\n",
       "                                        Project Title  \n",
       "9   Neoantigen-specific T cell responses in except...  \n",
       "19  Impact of Metformin on Clonal Hematopoiesis an...  \n",
       "22  Knowledge-based planning and treatment decisio...  \n",
       "31  Development and Implementation of a Peer-Navig...  \n",
       "35  An Open-Label, Phase 2 Efficacy Study of Temoz...  \n",
       "42    Decoding Colon Cancers Using Boolean Principles  \n",
       "44  Deciphering the role of RNA editing in leukemi...  \n",
       "53          Precision Interception of Gastric Cancers  \n",
       "56  Neoantigen-specific T cell responses in except...  \n",
       "59  A pilot trial to test the benefit of real time...  \n",
       "70  Knowledge-based planning and treatment decisio...  \n",
       "71  Knowledge-based planning and treatment decisio...  \n",
       "81  Development and Implementation of a Peer-Navig...  \n",
       "85  Investigating the Efficacy of radium-223 with ...  "
      ]
     },
     "execution_count": 599,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "poli[~poli['Policy Benefits Description'].isna()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 600,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_35096\\2581353454.py:3: SettingWithCopyWarning:\n",
      "\n",
      "\n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Policy Influence  International (pol)  National (pol)  Local (pol)  \\\n",
       "0              True                False           False        False   \n",
       "1              True                False           False        False   \n",
       "2              True                False           False        False   \n",
       "3              True                False           False        False   \n",
       "4              True                False           False        False   \n",
       "\n",
       "   General Public (pol)  Healthcare Professionals (pol)  Patients (pol)  \\\n",
       "0                 False                           False           False   \n",
       "1                 False                           False           False   \n",
       "2                 False                           False           False   \n",
       "3                 False                           False           False   \n",
       "4                 False                           False           False   \n",
       "\n",
       "   Patient Families (pol) Policy Benefits Description  \\\n",
       "0                   False                         NaN   \n",
       "1                   False                         NaN   \n",
       "2                   False                         NaN   \n",
       "3                   False                         NaN   \n",
       "4                   False                         NaN   \n",
       "\n",
       "                                       Project Title  \n",
       "0  Detecting dysregulated genes in neuroblastoma ...  \n",
       "1  Functional Roles for Histidine Kinase Signalin...  \n",
       "2  A National Phase I Study of Cabozantinib in Co...  \n",
       "3  UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4  A Phase 1B, Nonrandomized Trial Investigating ...  "
      ]
     },
     "execution_count": 600,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Replace an instance of 'N/a' in pol benefits descr. with nan\n",
    "\n",
    "poli['Policy Benefits Description'] = poli['Policy Benefits Description'].replace('N/a', np.nan)\n",
    "# poli = poli.loc[:, poli.columns[:8].tolist() + ['Description']]\n",
    "poli.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 601,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Policy Influence\n",
      "True     101\n",
      "False      1\n",
      "Name: Policy Influence, dtype: int64\n",
      "\n",
      "International (pol)\n",
      "False    96\n",
      "True      6\n",
      "Name: International (pol), dtype: int64\n",
      "\n",
      "National (pol)\n",
      "False    93\n",
      "True      9\n",
      "Name: National (pol), dtype: int64\n",
      "\n",
      "Local (pol)\n",
      "False    96\n",
      "True      6\n",
      "Name: Local (pol), dtype: int64\n",
      "\n",
      "General Public (pol)\n",
      "False    96\n",
      "True      6\n",
      "Name: General Public (pol), dtype: int64\n",
      "\n",
      "Healthcare Professionals (pol)\n",
      "False    95\n",
      "True      7\n",
      "Name: Healthcare Professionals (pol), dtype: int64\n",
      "\n",
      "Patients (pol)\n",
      "False    95\n",
      "True      7\n",
      "Name: Patients (pol), dtype: int64\n",
      "\n",
      "Patient Families (pol)\n",
      "False    100\n",
      "True       2\n",
      "Name: Patient Families (pol), dtype: int64\n",
      "\n",
      "Policy Benefits Description\n",
      "Our project could improve guidelines as to how patients are treated with immune checkpoint blockade treatment.                                                                                                                                                                                                1\n",
      "WIll better delineate the burden of clonal hematopoiesis in breast cancer patients, informing the risk of developing secondary malignancies and perhaps, risk of breast cancer recurrence associated with this novel biomarker.                                                                               1\n",
      "These tools can help healthcare professionals with decision-making that impacts the quality and length of patient treatments, by helping them select appropriate brachytherapy devices to implant                                                                                                             1\n",
      "The navigation intervention could potentially be translated to bedside clinical care and thus be included in training for all providers involved in informed consent processes for therapeutic and non-therapeutic clinical trials. Results can also be translated to adolescents and adults with cancer.     1\n",
      "Potential to influence NCCN guidelines.                                                                                                                                                                                                                                                                       1\n",
      "E cigarette related policies                                                                                                                                                                                                                                                                                  1\n",
      "Adding genomics to the EMR in Epic.                                                                                                                                                                                                                                                                           1\n",
      "The development of tumor specific probes for gastric cancer may lead to new clinical guidelines for detection and treatment of gastric cancer.                                                                                                                                                                1\n",
      "Our project could improve guidelines as to how patients are treated with immune checkpoint blockade  treatment.                                                                                                                                                                                               1\n",
      "These tools can help healthcare professionals with decision-making that impacts the quality and length  of patient treatments, by helping them select appropriate brachytherapy devices to implant                                                                                                            1\n",
      "To make brachy more automated and clinical                                                                                                                                                                                                                                                                    1\n",
      "The navigator intervention could potentially be translated to bedside clinical care and thus be included in training for all providers involved in informed consent processes for therapeutic and non-therapeutic clinical trials. Results can also be translated to adolescents and adults with cancer.      1\n",
      "These studies on the immune compartment may lead to support for adjusting clinical treatment guidelines for bone metastatic castration resistant prostate cancer to include the new combination treatment of Ra-223 plus olaparib.                                                                            1\n",
      "Name: Policy Benefits Description, dtype: int64\n",
      "\n",
      "Project Title\n",
      "Knowledge-based planning and treatment decision-making for gynecologic brachytherapy                                                                          3\n",
      "Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C                                                 3\n",
      "New Therapies for Myeloid Leukemia                                                                                                                            3\n",
      "Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation                                                                                    3\n",
      "Decoding Colon Cancers Using Boolean Principles                                                                                                               3\n",
      "                                                                                                                                                             ..\n",
      "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                        1\n",
      "Novel kinase inhibitors in combination with retinoic acide for neuroblastoma                                                                                  1\n",
      "Natural Killer Cells for Treatment of Medulloblastoma                                                                                                         1\n",
      "Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies    1\n",
      "Functional Roles for Histidine Kinase Signaling in Neuroblastoma                                                                                              1\n",
      "Name: Project Title, Length: 52, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Check columns values\n",
    "\n",
    "for col in poli.columns:\n",
    "    print(col)\n",
    "    print(poli[col].value_counts())\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 602,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_35096\\801329202.py:4: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "52"
      ]
     },
     "execution_count": 602,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get total number of projects with improvements in health policy\n",
    "\n",
    "pd.set_option('display.max_rows', None)\n",
    "poli.groupby(by='Project Title').max()['Policy Influence'].sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 603,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>50.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This grant and the publication that resulted (...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>129.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>196.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>197.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID Event Name  Award ID  \\\n",
       "18   50.0    Initial      50.1   \n",
       "19  129.0    Initial      50.2   \n",
       "20  196.0    Initial     196.1   \n",
       "21  197.0    Initial     196.2   \n",
       "\n",
       "                                        Project Title  \\\n",
       "18  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "19  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "20  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "21  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "\n",
       "                                 PI Institution Other Institution  \\\n",
       "18                         Moores Cancer Center               NaN   \n",
       "19                              Rady Children's               NaN   \n",
       "20  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "21  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "    Prevention and diagnostic tools  \\\n",
       "18                            False   \n",
       "19                            False   \n",
       "20                            False   \n",
       "21                            False   \n",
       "\n",
       "    Novel approaches and new therapeutic platforms  \\\n",
       "18                                           False   \n",
       "19                                           False   \n",
       "20                                           False   \n",
       "21                                           False   \n",
       "\n",
       "    Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "18                                      False                          False   \n",
       "19                                      False                          False   \n",
       "20                                      False                          False   \n",
       "21                                      False                          False   \n",
       "\n",
       "    Pediatric cancers      Specific Aims  \\\n",
       "18               True  Two Specific Aims   \n",
       "19               True  Two Specific Aims   \n",
       "20               True  Two Specific Aims   \n",
       "21               True  Two Specific Aims   \n",
       "\n",
       "                                                Aim 1  \\\n",
       "18  Determine cellular constraints on the ability ...   \n",
       "19  Determine cellular constraints on the ability ...   \n",
       "20   Determine cellular constraints on the ability...   \n",
       "21  Determine cellular constraints on the ability ...   \n",
       "\n",
       "                                                Aim 2 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "18  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "19  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "20  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "21  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "\n",
       "                           Public Health Significance  Award Amount  \\\n",
       "18  This project aims to identify the mechanisms u...       75000.0   \n",
       "19  This project aims to identify the mechanisms u...       75000.0   \n",
       "20  This project aims to identify the mechanisms u...       75000.0   \n",
       "21  This project aims to identify the mechanisms u...       75000.0   \n",
       "\n",
       "   Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "18        2017-06-01      2018-05-31  Complete     False   \n",
       "19        2017-06-01      2018-05-31  Complete      True   \n",
       "20        2017-06-01      2018-05-31  Complete       NaN   \n",
       "21        2017-06-01      2018-05-31  Complete       NaN   \n",
       "\n",
       "   SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "18                   False                                 False   \n",
       "19                   False                                 False   \n",
       "20                     NaN                                   NaN   \n",
       "21                     NaN                                   NaN   \n",
       "\n",
       "   SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "18                  False                           False   \n",
       "19                  False                           False   \n",
       "20                    NaN                             NaN   \n",
       "21                    NaN                             NaN   \n",
       "\n",
       "   SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "18                   False                                   True   \n",
       "19                   False                                  False   \n",
       "20                     NaN                                    NaN   \n",
       "21                     NaN                                    NaN   \n",
       "\n",
       "   SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "18                    False                True                       False   \n",
       "19                    False               False                       False   \n",
       "20                      NaN                 NaN                         NaN   \n",
       "21                      NaN                 NaN                         NaN   \n",
       "\n",
       "   SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "18                     False                                    False   \n",
       "19                     False                                    False   \n",
       "20                       NaN                                      NaN   \n",
       "21                       NaN                                      NaN   \n",
       "\n",
       "   SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "18                False                                  False   \n",
       "19                False                                  False   \n",
       "20                  NaN                                    NaN   \n",
       "21                  NaN                                    NaN   \n",
       "\n",
       "   SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "18                                  False                           False   \n",
       "19                                  False                           False   \n",
       "20                                    NaN                             NaN   \n",
       "21                                    NaN                             NaN   \n",
       "\n",
       "   Cancer Metabolism SBPMDI  \\\n",
       "18                    False   \n",
       "19                    False   \n",
       "20                      NaN   \n",
       "21                      NaN   \n",
       "\n",
       "   Pedal Importance (recruitment, retention, advancement)  \\\n",
       "18                                                Yes       \n",
       "19                                                 No       \n",
       "20                                                NaN       \n",
       "21                                                NaN       \n",
       "\n",
       "                               If yes, please specify If no, please specify  \\\n",
       "18  This grant and the publication that resulted (...                   NaN   \n",
       "19                                                NaN                   NaN   \n",
       "20                                                NaN                   NaN   \n",
       "21                                                NaN                   NaN   \n",
       "\n",
       "    Clinical Trials Resulted First Clinical Trial  \\\n",
       "18                       0.0                  NaN   \n",
       "19                       0.0                  NaN   \n",
       "20                       0.0                  NaN   \n",
       "21                       0.0                  NaN   \n",
       "\n",
       "    First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "18                                 NaN                   NaN   \n",
       "19                                 NaN                   NaN   \n",
       "20                                 NaN                   NaN   \n",
       "21                                 NaN                   NaN   \n",
       "\n",
       "    Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "18                                  NaN              none            No   \n",
       "19                                  NaN               NaN            No   \n",
       "20                                  NaN               NaN           NaN   \n",
       "21                                  NaN               NaN           NaN   \n",
       "\n",
       "   Patent Details Peer-Reviewed Publications Count  \n",
       "18            NaN                              One  \n",
       "19            NaN                              One  \n",
       "20            NaN                              NaN  \n",
       "21            NaN                              NaN  "
      ]
     },
     "execution_count": 603,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity check\n",
    "\n",
    "roi_adj[roi_adj['Project Title'].str.contains('Tissue-specific')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 604,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Define color schemes\n",
    "\n",
    "red = px.colors.qualitative.Alphabet[17]\n",
    "blue = px.colors.qualitative.Alphabet[18]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 605,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_35096\\2072050918.py:3: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histfunc": "sum",
         "hovertemplate": "x=%{x}<br>sum of y=%{y}<extra></extra>",
         "legendgroup": "",
         "marker": {
          "color": "#F6222E",
          "opacity": 0.81,
          "pattern": {
           "shape": ""
          }
         },
         "name": "",
         "offsetgroup": "",
         "orientation": "v",
         "showlegend": false,
         "texttemplate": "%{value}",
         "type": "histogram",
         "x": [
          "National",
          "Healthcare Professionals",
          "International",
          "General Public",
          "Patients",
          "Local",
          "Patient Families"
         ],
         "xaxis": "x",
         "y": [
          6,
          5,
          4,
          4,
          4,
          3,
          1
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "Distribution of health policy improvements by impact level"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "impact level"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "count"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution of policy impact\n",
    "\n",
    "poli_data = poli.groupby(by='Project Title').max().reset_index(drop=True)\\\n",
    "    .drop(columns=['Policy Influence'])\n",
    "poli_data.columns = poli_data.columns.map(lambda x: re.sub(r' \\(pol\\)', '', x))\n",
    "poli_data = poli_data.sum().sort_values(ascending=False)\n",
    "poli_fig = px.histogram(x=poli_data.index, y=poli_data, text_auto=True, \\\n",
    "    title='Distribution of health policy improvements by impact level', \n",
    "    color_discrete_sequence=[red], opacity=0.81)\n",
    "poli_fig.update_yaxes(title='count')\n",
    "poli_fig.update_xaxes(title='impact level')\n",
    "poli_fig"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 606,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Our project could improve guidelines as to how patients are treated with immune checkpoint blockade treatment.                                                                                                                                                                                                1\n",
       "WIll better delineate the burden of clonal hematopoiesis in breast cancer patients, informing the risk of developing secondary malignancies and perhaps, risk of breast cancer recurrence associated with this novel biomarker.                                                                               1\n",
       "These tools can help healthcare professionals with decision-making that impacts the quality and length of patient treatments, by helping them select appropriate brachytherapy devices to implant                                                                                                             1\n",
       "The navigation intervention could potentially be translated to bedside clinical care and thus be included in training for all providers involved in informed consent processes for therapeutic and non-therapeutic clinical trials. Results can also be translated to adolescents and adults with cancer.     1\n",
       "Potential to influence NCCN guidelines.                                                                                                                                                                                                                                                                       1\n",
       "E cigarette related policies                                                                                                                                                                                                                                                                                  1\n",
       "Adding genomics to the EMR in Epic.                                                                                                                                                                                                                                                                           1\n",
       "The development of tumor specific probes for gastric cancer may lead to new clinical guidelines for detection and treatment of gastric cancer.                                                                                                                                                                1\n",
       "Our project could improve guidelines as to how patients are treated with immune checkpoint blockade  treatment.                                                                                                                                                                                               1\n",
       "These tools can help healthcare professionals with decision-making that impacts the quality and length  of patient treatments, by helping them select appropriate brachytherapy devices to implant                                                                                                            1\n",
       "To make brachy more automated and clinical                                                                                                                                                                                                                                                                    1\n",
       "The navigator intervention could potentially be translated to bedside clinical care and thus be included in training for all providers involved in informed consent processes for therapeutic and non-therapeutic clinical trials. Results can also be translated to adolescents and adults with cancer.      1\n",
       "These studies on the immune compartment may lead to support for adjusting clinical treatment guidelines for bone metastatic castration resistant prostate cancer to include the new combination treatment of Ra-223 plus olaparib.                                                                            1\n",
       "Name: Policy Benefits Description, dtype: int64"
      ]
     },
     "execution_count": 606,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Pass columns back into pr (progress report) dataframe\n",
    "\n",
    "for col in poli.columns:\n",
    "    pr[col] = poli[col]\n",
    "\n",
    "pr['Policy Benefits Description'].value_counts()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Health Benefits\n",
    "- HEALTH GAINS:  Will the findings from your project benefit health (e.g., prevention, detection, and/or treatment of cancer) and/or health behaviors? "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 607,
   "metadata": {},
   "outputs": [],
   "source": [
    "hlth = pr.loc[:, ['Health Benefits', 'International', 'National', 'Local', \\\n",
    "    'General Public', 'Healthcare Professionals', 'Patients', 'Patient Families']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 608,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Health Benefits\n",
      "Yes    86\n",
      "No     15\n",
      "Name: Health Benefits, dtype: int64\n",
      "\n",
      "International\n",
      "False    52\n",
      "True     50\n",
      "Name: International, dtype: int64\n",
      "\n",
      "National\n",
      "False    80\n",
      "True     22\n",
      "Name: National, dtype: int64\n",
      "\n",
      "Local\n",
      "False    88\n",
      "True     14\n",
      "Name: Local, dtype: int64\n",
      "\n",
      "General Public\n",
      "False    88\n",
      "True     14\n",
      "Name: General Public, dtype: int64\n",
      "\n",
      "Healthcare Professionals\n",
      "False    91\n",
      "True     11\n",
      "Name: Healthcare Professionals, dtype: int64\n",
      "\n",
      "Patients\n",
      "False    54\n",
      "True     48\n",
      "Name: Patients, dtype: int64\n",
      "\n",
      "Patient Families\n",
      "False    98\n",
      "True      4\n",
      "Name: Patient Families, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Check columns values\n",
    "\n",
    "for col in hlth.columns:\n",
    "    print(col)\n",
    "    print(hlth[col].value_counts())\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 609,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Yes    86\n",
       "No     15\n",
       "Name: Health Benefits, dtype: int64"
      ]
     },
     "execution_count": 609,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr['Health Benefits'].value_counts()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Economic Benefits\n",
    "- ECONOMIC BENEFITS:  Will the findings from your project lead to improvements in health care service cost and/or health care service delivery?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 610,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Economic Benefits  International (econ)  National (econ)  Local (econ)  \\\n",
       "0                No                 False            False         False   \n",
       "1                No                 False            False         False   \n",
       "2               Yes                 False             True         False   \n",
       "3               Yes                  True             True         False   \n",
       "4                No                 False            False         False   \n",
       "\n",
       "   General Public (econ)  Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "0                  False                            False            False   \n",
       "1                  False                            False            False   \n",
       "2                  False                            False            False   \n",
       "3                  False                            False             True   \n",
       "4                  False                            False            False   \n",
       "\n",
       "   Patient Families (econ)                      Economic Benefits Description  \n",
       "0                    False                                                NaN  \n",
       "1                    False                                                NaN  \n",
       "2                    False  The combination of cabozantinib with 13-cis-re...  \n",
       "3                     True  Oral cancer prevention and the consequent redu...  \n",
       "4                    False                                                NaN  "
      ]
     },
     "execution_count": 610,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get all columns related health economic benefits\n",
    "\n",
    "econ = pr.filter(regex=(r'econ|Econ'))\n",
    "econ = econ.loc[:, econ.columns[:9]]\n",
    "econ.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 611,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Reduced use of GCSF for supportive care for ch...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Potentially and in the long term. If our work ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>More effective therapies and predictive diagno...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of tyrosine kinase inhibi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The treatment paradigm being proposed has the ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>If gastric cancer can be detected at an earlie...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>If we can provide a scientific basis for treat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially i...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Economic Benefits  International (econ)  National (econ)  Local (econ)  \\\n",
       "2                Yes                 False             True         False   \n",
       "3                Yes                  True             True         False   \n",
       "22               Yes                  True             True          True   \n",
       "23               Yes                 False             True         False   \n",
       "27               Yes                 False            False         False   \n",
       "31               Yes                 False             True          True   \n",
       "44               Yes                 False            False         False   \n",
       "48               Yes                 False             True         False   \n",
       "49               Yes                  True            False         False   \n",
       "53               Yes                  True             True         False   \n",
       "56               Yes                 False            False         False   \n",
       "70               Yes                  True             True          True   \n",
       "81               Yes                 False             True          True   \n",
       "\n",
       "    General Public (econ)  Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "2                   False                            False            False   \n",
       "3                   False                            False             True   \n",
       "22                  False                             True             True   \n",
       "23                  False                            False            False   \n",
       "27                   True                            False            False   \n",
       "31                   True                             True             True   \n",
       "44                  False                            False             True   \n",
       "48                  False                            False            False   \n",
       "49                  False                            False            False   \n",
       "53                  False                             True             True   \n",
       "56                   True                            False             True   \n",
       "70                  False                             True             True   \n",
       "81                   True                             True             True   \n",
       "\n",
       "    Patient Families (econ)                      Economic Benefits Description  \n",
       "2                     False  The combination of cabozantinib with 13-cis-re...  \n",
       "3                      True  Oral cancer prevention and the consequent redu...  \n",
       "22                    False  Automated planning could reduce the time patie...  \n",
       "23                    False  Reduced use of GCSF for supportive care for ch...  \n",
       "27                    False  Potentially and in the long term. If our work ...  \n",
       "31                     True  The navigation intervention could potentially ...  \n",
       "44                    False  More effective therapies and predictive diagno...  \n",
       "48                    False       The combination of tyrosine kinase inhibi...  \n",
       "49                    False  The treatment paradigm being proposed has the ...  \n",
       "53                    False  If gastric cancer can be detected at an earlie...  \n",
       "56                    False  If we can provide a scientific basis for treat...  \n",
       "70                    False  Automated planning could reduce the time patie...  \n",
       "81                     True  The navigator intervention could potentially i...  "
      ]
     },
     "execution_count": 611,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "econ[~econ['Economic Benefits Description'].isna()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 612,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Economic Benefits\n",
      "No     86\n",
      "Yes    15\n",
      "Name: Economic Benefits, dtype: int64\n",
      "\n",
      "International (econ)\n",
      "False    96\n",
      "True      6\n",
      "Name: International (econ), dtype: int64\n",
      "\n",
      "National (econ)\n",
      "False    92\n",
      "True     10\n",
      "Name: National (econ), dtype: int64\n",
      "\n",
      "Local (econ)\n",
      "False    97\n",
      "True      5\n",
      "Name: Local (econ), dtype: int64\n",
      "\n",
      "General Public (econ)\n",
      "False    97\n",
      "True      5\n",
      "Name: General Public (econ), dtype: int64\n",
      "\n",
      "Healthcare Professionals (econ)\n",
      "False    96\n",
      "True      6\n",
      "Name: Healthcare Professionals (econ), dtype: int64\n",
      "\n",
      "Patients (econ)\n",
      "False    93\n",
      "True      9\n",
      "Name: Patients (econ), dtype: int64\n",
      "\n",
      "Patient Families (econ)\n",
      "False    99\n",
      "True      3\n",
      "Name: Patient Families (econ), dtype: int64\n",
      "\n",
      "Economic Benefits Description\n",
      "The combination of cabozantinib with 13-cis-retinoic acid as a therapeutic option for patients with relapsed or refractory neuroblastoma represents a lower cost, outpatient therapy to reduce the overall cost of treatment                                                                                                                                                                     1\n",
      "Oral cancer prevention and the consequent reduction in morbidity, mortality, and patient related costs                                                                                                                                                                                                                                                                                           1\n",
      "Automated planning could reduce the time patients spend under anesthesia, which reduces hospital resource usage and could reduce costs of brachytherapy procedures                                                                                                                                                                                                                               1\n",
      "Reduced use of GCSF for supportive care for children with medulloblastoma would serve to both reduce costs of care and improve outcomes for children with medulloblastoma worldwide.                                                                                                                                                                                                             1\n",
      "Potentially and in the long term. If our work leads to better risk projection and earlier detection, this can reduce costs associated with managing late stage disease.                                                                                                                                                                                                                          1\n",
      "The navigation intervention could potentially increase clinical trials accrual and benefit more patients by providing equal access.  By increasing minority participation in clinical trials, we can effectively and equally translate discoveries and treatment benefits. Our results will inform clinical care and the design of a multi-site randomized clinical trial in a larger sample.    1\n",
      "More effective therapies and predictive diagnostics.                                                                                                                                                                                                                                                                                                                                             1\n",
      "     The combination of tyrosine kinase inhibitors with 13-cis-retinoic acid as a therapeutic option for patients with relapsed or refractory neuroblastoma represents a lower cost, outpatient therapy to reduce the overall cost of treatment for children with neuroblastoma                                                                                                                  1\n",
      "The treatment paradigm being proposed has the potential to dramatically decrease morbidity of HNSCC treatment                                                                                                                                                                                                                                                                                    1\n",
      "If gastric cancer can be detected at an earlier stage, then patient survival will be improved.                                                                                                                                                                                                                                                                                                   1\n",
      "If we can provide a scientific basis for treatment efficacy, it can save patient time and healthcare expenditures by avoiding treatments that are unlikely to be effective and potentially tailor these therapies to individual patients.                                                                                                                                                        1\n",
      "Automated planning could reduce the time patients spend under anesthesia, which reduces hospital  resource usage and could reduce costs of  brachytherapy procedures                                                                                                                                                                                                                             1\n",
      "The navigator intervention could potentially increase clinical trials accrual and benefit more patients by providing equal access.  By increasing minority participation in clinical trials, we can effectively and equally translate discoveries and treatment benefits. Our results will inform clinical care and the design of a multi-site randomized clinical trial in a larger sample.     1\n",
      "Name: Economic Benefits Description, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Check columns values\n",
    "\n",
    "for col in econ.columns:\n",
    "    print(col)\n",
    "    print(econ[col].value_counts())\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 613,
   "metadata": {},
   "outputs": [],
   "source": [
    "# sanity check\n",
    "\n",
    "roi_ids = roi_adj['ID'].tolist()\n",
    "roi_ids.sort()\n",
    "\n",
    "pr_ids = pr['ID'].tolist()\n",
    "pr_ids.sort()\n",
    "\n",
    "for i in pr_ids:\n",
    "    if i not in roi_ids:\n",
    "        print(i)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 614,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>27.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.07.001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oral presentations:  1.Kallis, K., Jyoti Mayad...</td>\n",
       "      <td>Using the preliminary data collected with the ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Currently, under-resourced centers (particular...</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>I would use the funding to hire personnel to d...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Once automated treatment planning has been val...</td>\n",
       "      <td>I participated in 2018 as a walker, 2019-20 as...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The seed funding received from Padres Pedal th...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2020.04.008</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.semradonc.2020.05.009</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.08.010</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>94.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.07.001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oral presentations:  1. Kallis, K., Jyoti Maya...</td>\n",
       "      <td>Using the preliminary data collected with the ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Currently, under-resourced centers (particular...</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Hire personnel and test the automated brachyth...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Once automated treatment planning has been val...</td>\n",
       "      <td>Participated as a rider before COVID</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2020.04.008</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.semradonc.2020.05.009</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.08.010</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>95.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.07.001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oral presentations:  other publications (non-p...</td>\n",
       "      <td>Dr Meyers  Using the preliminary data collecte...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>To make brachy more automated and clinical</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Brachytherapy to increase cures in cervix cancer</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>To advance treatment planning in cevrical canc...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>To increase awareness and knowledge</td>\n",
       "      <td>rider</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>thank you!</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2020.04.008</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1016/j.semradonc.2020.05.009</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1016/j.brachy.2021.08.010</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      ID          Event Name Publication Status 4  \\\n",
       "22  27.0  Progress Report #1            Published   \n",
       "70  94.0  Progress Report #1            Published   \n",
       "71  95.0  Progress Report #1            Published   \n",
       "\n",
       "                    Fourth DOI # Publication Status 5 Fifth DOI #  \\\n",
       "22  10.1016/j.brachy.2021.07.001                  NaN         NaN   \n",
       "70  10.1016/j.brachy.2021.07.001                  NaN         NaN   \n",
       "71  10.1016/j.brachy.2021.07.001                  NaN         NaN   \n",
       "\n",
       "   Publication Status 6 Sixth DOI # Publication Status 7 Seventh DOI #  \\\n",
       "22                  NaN         NaN                  NaN           NaN   \n",
       "70                  NaN         NaN                  NaN           NaN   \n",
       "71                  NaN         NaN                  NaN           NaN   \n",
       "\n",
       "   Publication Status 8 Eighth DOI # Publication Status 9 Ninth DOI #  \\\n",
       "22                  NaN          NaN                  NaN         NaN   \n",
       "70                  NaN          NaN                  NaN         NaN   \n",
       "71                  NaN          NaN                  NaN         NaN   \n",
       "\n",
       "   Publication Status 10 Tenth DOI #  \\\n",
       "22                   NaN         NaN   \n",
       "70                   NaN         NaN   \n",
       "71                   NaN         NaN   \n",
       "\n",
       "                                  Pedal Non-Peer Pubs  \\\n",
       "22  Oral presentations:  1.Kallis, K., Jyoti Mayad...   \n",
       "70  Oral presentations:  1. Kallis, K., Jyoti Maya...   \n",
       "71  Oral presentations:  other publications (non-p...   \n",
       "\n",
       "                                Other Accomplishments Health Benefits  \\\n",
       "22  Using the preliminary data collected with the ...             Yes   \n",
       "70  Using the preliminary data collected with the ...             Yes   \n",
       "71  Dr Meyers  Using the preliminary data collecte...             Yes   \n",
       "\n",
       "    International  National  Local  General Public  Healthcare Professionals  \\\n",
       "22           True      True   True           False                      True   \n",
       "70           True      True   True           False                      True   \n",
       "71           True      True   True           False                      True   \n",
       "\n",
       "    Patients  Patient Families  Policy Influence  International (pol)  \\\n",
       "22      True             False              True                 True   \n",
       "70      True             False              True                 True   \n",
       "71     False             False              True                 True   \n",
       "\n",
       "    National (pol)  Local (pol)  General Public (pol)  \\\n",
       "22            True         True                 False   \n",
       "70            True         True                 False   \n",
       "71            True         True                  True   \n",
       "\n",
       "    Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "22                            True            True                   False   \n",
       "70                            True            True                   False   \n",
       "71                           False           False                   False   \n",
       "\n",
       "                          Policy Benefits Description Economic Benefits  \\\n",
       "22  These tools can help healthcare professionals ...               Yes   \n",
       "70  These tools can help healthcare professionals ...               Yes   \n",
       "71        To make brachy more automated and clinical                 No   \n",
       "\n",
       "    International (econ)  National (econ)  Local (econ)  \\\n",
       "22                  True             True          True   \n",
       "70                  True             True          True   \n",
       "71                 False            False         False   \n",
       "\n",
       "    General Public (econ)  Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "22                  False                             True             True   \n",
       "70                  False                             True             True   \n",
       "71                  False                            False            False   \n",
       "\n",
       "    Patient Families (econ)  \\\n",
       "22                    False   \n",
       "70                    False   \n",
       "71                    False   \n",
       "\n",
       "                        Economic Benefits Description Equity Benefits  \\\n",
       "22  Automated planning could reduce the time patie...             Yes   \n",
       "70  Automated planning could reduce the time patie...             Yes   \n",
       "71                                                NaN             Yes   \n",
       "\n",
       "    International (equity)  National (equity)  Local (equity)  \\\n",
       "22                    True               True            True   \n",
       "70                    True               True            True   \n",
       "71                    True               True            True   \n",
       "\n",
       "    General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "22                    False                              False   \n",
       "70                    False                              False   \n",
       "71                    False                              False   \n",
       "\n",
       "    Patients (equity)  Patient Families (equity)  \\\n",
       "22              False                      False   \n",
       "70              False                      False   \n",
       "71               True                      False   \n",
       "\n",
       "                          Equity Benefits Description  \\\n",
       "22  Currently, under-resourced centers (particular...   \n",
       "70  Currently, under-resourced centers (particular...   \n",
       "71  Brachytherapy to increase cures in cervix cancer    \n",
       "\n",
       "      Additional Funding Achieved First AFS Status  \\\n",
       "22  No additional funding sources              NaN   \n",
       "70  No additional funding sources              NaN   \n",
       "71  No additional funding sources              NaN   \n",
       "\n",
       "   First AFS Name and Project Title  First AFS Amount Second AFS Status  \\\n",
       "22                              NaN               NaN               NaN   \n",
       "70                              NaN               NaN               NaN   \n",
       "71                              NaN               NaN               NaN   \n",
       "\n",
       "   Second AFS Name and Project Title  Second AFS Amount Third AFS Status  \\\n",
       "22                               NaN                NaN              NaN   \n",
       "70                               NaN                NaN              NaN   \n",
       "71                               NaN                NaN              NaN   \n",
       "\n",
       "   Third AFS Name and Project Title  Third AGS Amount Fourth AFS Status  \\\n",
       "22                              NaN               NaN               NaN   \n",
       "70                              NaN               NaN               NaN   \n",
       "71                              NaN               NaN               NaN   \n",
       "\n",
       "   Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "22                               NaN                NaN   \n",
       "70                               NaN                NaN   \n",
       "71                               NaN                NaN   \n",
       "\n",
       "   Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "22                                                NaN                   \n",
       "70                                                NaN                   \n",
       "71                                                NaN                   \n",
       "\n",
       "   Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "22              NaN               NaN                             Yes   \n",
       "70              NaN               NaN                             Yes   \n",
       "71              NaN               NaN                             Yes   \n",
       "\n",
       "              Additional Funding Benefits Description  \\\n",
       "22  I would use the funding to hire personnel to d...   \n",
       "70  Hire personnel and test the automated brachyth...   \n",
       "71  To advance treatment planning in cevrical canc...   \n",
       "\n",
       "   Additional Pedal Funding Impact (clinical stages)  \\\n",
       "22                                               Yes   \n",
       "70                                               Yes   \n",
       "71                                               Yes   \n",
       "\n",
       "   Additional Funding Benefits Description (clinical stages)  \\\n",
       "22  Once automated treatment planning has been val...          \n",
       "70  Once automated treatment planning has been val...          \n",
       "71               To increase awareness and knowledge           \n",
       "\n",
       "                                Participated in Pedal  \\\n",
       "22  I participated in 2018 as a walker, 2019-20 as...   \n",
       "70               Participated as a rider before COVID   \n",
       "71                                             rider    \n",
       "\n",
       "   Further Research Contributions Success Stories  \\\n",
       "22                             No              No   \n",
       "70                             No              No   \n",
       "71                             No              No   \n",
       "\n",
       "   Major Scientific Breakthroughs  \\\n",
       "22                            NaN   \n",
       "70                            NaN   \n",
       "71                            NaN   \n",
       "\n",
       "                                  Additional Comments  Complete  \\\n",
       "22  The seed funding received from Padres Pedal th...      True   \n",
       "70                                                NaN      True   \n",
       "71                                         thank you!      True   \n",
       "\n",
       "   Publication Status 1                   First DOI # Publication Status 2  \\\n",
       "22            Published  10.1016/j.brachy.2020.04.008            Published   \n",
       "70            Published  10.1016/j.brachy.2020.04.008            Published   \n",
       "71            Published  10.1016/j.brachy.2020.04.008             Accepted   \n",
       "\n",
       "                       Second DOI # Publication Status 3  \\\n",
       "22  10.1016/j.semradonc.2020.05.009            Published   \n",
       "70  10.1016/j.semradonc.2020.05.009            Published   \n",
       "71  10.1016/j.semradonc.2020.05.009             Accepted   \n",
       "\n",
       "                     Third DOI #  \\\n",
       "22  10.1016/j.brachy.2021.08.010   \n",
       "70  10.1016/j.brachy.2021.08.010   \n",
       "71  10.1016/j.brachy.2021.08.010   \n",
       "\n",
       "                                        Project Title  \n",
       "22  Knowledge-based planning and treatment decisio...  \n",
       "70  Knowledge-based planning and treatment decisio...  \n",
       "71  Knowledge-based planning and treatment decisio...  "
      ]
     },
     "execution_count": 614,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr[pr['Project Title'].str.contains('Knowledge')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 615,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>27.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.07.001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oral presentations:  1.Kallis, K., Jyoti Mayad...</td>\n",
       "      <td>Using the preliminary data collected with the ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Currently, under-resourced centers (particular...</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>I would use the funding to hire personnel to d...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Once automated treatment planning has been val...</td>\n",
       "      <td>I participated in 2018 as a walker, 2019-20 as...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The seed funding received from Padres Pedal th...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2020.04.008</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.semradonc.2020.05.009</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.08.010</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>37.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>How many additional funding sources did you re...</td>\n",
       "      <td>List your presentations, abstracts, book chapt...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>see below in box</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>below</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>below</td>\n",
       "      <td>125000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>below</td>\n",
       "      <td>125000.0</td>\n",
       "      <td>below</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>1250000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Absolutely: Future CUREBOUND funding will be c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes, if the navigation intervention is effecti...</td>\n",
       "      <td>yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Missing Cancer Control and Population Sciences...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1200/EDBK_320499</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1001/jamanetworkopen.2021.9038</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1002/pbc.28296</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>51.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.Geron I, Savino AM, Fishman H, Tal N, Brown ...</td>\n",
       "      <td>Rell Sunn Award  Plenary Talk at AACR 2022  NA...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Adding genomics to the EMR in Epic.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>More effective therapies and predictive diagno...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Understanding ethnic and gender-related differ...</td>\n",
       "      <td>Three</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>LLS</td>\n",
       "      <td>600000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NASA</td>\n",
       "      <td>2000000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIDDK RO1</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>We would develop biomarkers for use in pediatr...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>It would help with development of Rebecsinib, ...</td>\n",
       "      <td>Yes as a rider.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Thank you.</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>69.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Turner MA, Amirfakhri S, Nishino H, Lwin TM, S...</td>\n",
       "      <td>GENOMICALLY SILENT REFRACTORY GASTRIC CANCER O...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The development of tumor specific probes for g...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>If gastric cancer can be detected at an earlie...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH/NCI Bouvet (PI) 1R01CA256973-01A1 \"Molecul...</td>\n",
       "      <td>2264206.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding well help establish more mo...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional research will advance the technolog...</td>\n",
       "      <td>No.</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.21873</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>77.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>94.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.07.001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oral presentations:  1. Kallis, K., Jyoti Maya...</td>\n",
       "      <td>Using the preliminary data collected with the ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Currently, under-resourced centers (particular...</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Hire personnel and test the automated brachyth...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Once automated treatment planning has been val...</td>\n",
       "      <td>Participated as a rider before COVID</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2020.04.008</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.semradonc.2020.05.009</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.08.010</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>112.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's reprot</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's reprot</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's reprot</td>\n",
       "      <td>None.  Dr. Aristizabal has presented on behalf...</td>\n",
       "      <td>None.  Dr. Aristizabal has presented on behalf...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially b...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially i...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially i...</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Future Curebound funding will be critical to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes, if the navigator intervention is effectiv...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Please see Dr. Aristizabal's report.  She is t...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID          Event Name Publication Status 4  \\\n",
       "22   27.0  Progress Report #1            Published   \n",
       "31   37.0  Progress Report #1          In progress   \n",
       "44   51.0  Progress Report #1                  NaN   \n",
       "53   69.0  Progress Report #1                  NaN   \n",
       "59   77.0  Progress Report #1                  NaN   \n",
       "70   94.0  Progress Report #1            Published   \n",
       "81  112.0  Progress Report #1            Published   \n",
       "\n",
       "                           Fourth DOI # Publication Status 5  \\\n",
       "22         10.1016/j.brachy.2021.07.001                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70         10.1016/j.brachy.2021.07.001                  NaN   \n",
       "81  Please see Dr. Aristizabal's report            Published   \n",
       "\n",
       "                            Fifth DOI # Publication Status 6  \\\n",
       "22                                  NaN                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70                                  NaN                  NaN   \n",
       "81  Please see Dr. Aristizabal's report            Published   \n",
       "\n",
       "                            Sixth DOI # Publication Status 7  \\\n",
       "22                                  NaN                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70                                  NaN                  NaN   \n",
       "81  Please see Dr. Aristizabal's report            Published   \n",
       "\n",
       "                          Seventh DOI # Publication Status 8  \\\n",
       "22                                  NaN                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70                                  NaN                  NaN   \n",
       "81  Please see Dr. Aristizabal's report            Published   \n",
       "\n",
       "                           Eighth DOI # Publication Status 9  \\\n",
       "22                                  NaN                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70                                  NaN                  NaN   \n",
       "81  Please see Dr. Aristizabal's reprot            Published   \n",
       "\n",
       "                            Ninth DOI # Publication Status 10  \\\n",
       "22                                  NaN                   NaN   \n",
       "31                                  NaN              Accepted   \n",
       "44                                  NaN                   NaN   \n",
       "53                                  NaN                   NaN   \n",
       "59                                  NaN                   NaN   \n",
       "70                                  NaN                   NaN   \n",
       "81  Please see Dr. Aristizabal's reprot             Published   \n",
       "\n",
       "                            Tenth DOI #  \\\n",
       "22                                  NaN   \n",
       "31                                  NaN   \n",
       "44                                  NaN   \n",
       "53                                  NaN   \n",
       "59                                  NaN   \n",
       "70                                  NaN   \n",
       "81  Please see Dr. Aristizabal's reprot   \n",
       "\n",
       "                                  Pedal Non-Peer Pubs  \\\n",
       "22  Oral presentations:  1.Kallis, K., Jyoti Mayad...   \n",
       "31  How many additional funding sources did you re...   \n",
       "44  1.Geron I, Savino AM, Fishman H, Tal N, Brown ...   \n",
       "53  Turner MA, Amirfakhri S, Nishino H, Lwin TM, S...   \n",
       "59                                                NaN   \n",
       "70  Oral presentations:  1. Kallis, K., Jyoti Maya...   \n",
       "81  None.  Dr. Aristizabal has presented on behalf...   \n",
       "\n",
       "                                Other Accomplishments Health Benefits  \\\n",
       "22  Using the preliminary data collected with the ...             Yes   \n",
       "31  List your presentations, abstracts, book chapt...             Yes   \n",
       "44  Rell Sunn Award  Plenary Talk at AACR 2022  NA...             Yes   \n",
       "53  GENOMICALLY SILENT REFRACTORY GASTRIC CANCER O...             Yes   \n",
       "59                                                NaN             Yes   \n",
       "70  Using the preliminary data collected with the ...             Yes   \n",
       "81  None.  Dr. Aristizabal has presented on behalf...             Yes   \n",
       "\n",
       "    International  National  Local  General Public  Healthcare Professionals  \\\n",
       "22           True      True   True           False                      True   \n",
       "31          False      True   True            True                      True   \n",
       "44           True      True   True            True                      True   \n",
       "53           True      True   True            True                      True   \n",
       "59           True      True   True           False                      True   \n",
       "70           True      True   True           False                      True   \n",
       "81          False      True   True            True                      True   \n",
       "\n",
       "    Patients  Patient Families  Policy Influence  International (pol)  \\\n",
       "22      True             False              True                 True   \n",
       "31      True              True              True                False   \n",
       "44      True              True              True                False   \n",
       "53      True             False              True                 True   \n",
       "59     False             False              True                 True   \n",
       "70      True             False              True                 True   \n",
       "81      True              True              True                False   \n",
       "\n",
       "    National (pol)  Local (pol)  General Public (pol)  \\\n",
       "22            True         True                 False   \n",
       "31            True         True                  True   \n",
       "44           False        False                 False   \n",
       "53            True        False                 False   \n",
       "59            True         True                 False   \n",
       "70            True         True                 False   \n",
       "81            True         True                  True   \n",
       "\n",
       "    Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "22                            True            True                   False   \n",
       "31                            True            True                    True   \n",
       "44                            True           False                   False   \n",
       "53                            True            True                   False   \n",
       "59                            True           False                   False   \n",
       "70                            True            True                   False   \n",
       "81                            True            True                    True   \n",
       "\n",
       "                          Policy Benefits Description Economic Benefits  \\\n",
       "22  These tools can help healthcare professionals ...               Yes   \n",
       "31  The navigation intervention could potentially ...               Yes   \n",
       "44                Adding genomics to the EMR in Epic.               Yes   \n",
       "53  The development of tumor specific probes for g...               Yes   \n",
       "59                                                NaN               Yes   \n",
       "70  These tools can help healthcare professionals ...               Yes   \n",
       "81  The navigator intervention could potentially b...               Yes   \n",
       "\n",
       "    International (econ)  National (econ)  Local (econ)  \\\n",
       "22                  True             True          True   \n",
       "31                 False             True          True   \n",
       "44                 False            False         False   \n",
       "53                  True             True         False   \n",
       "59                  True             True          True   \n",
       "70                  True             True          True   \n",
       "81                 False             True          True   \n",
       "\n",
       "    General Public (econ)  Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "22                  False                             True             True   \n",
       "31                   True                             True             True   \n",
       "44                  False                            False             True   \n",
       "53                  False                             True             True   \n",
       "59                  False                             True            False   \n",
       "70                  False                             True             True   \n",
       "81                   True                             True             True   \n",
       "\n",
       "    Patient Families (econ)  \\\n",
       "22                    False   \n",
       "31                     True   \n",
       "44                    False   \n",
       "53                    False   \n",
       "59                    False   \n",
       "70                    False   \n",
       "81                     True   \n",
       "\n",
       "                        Economic Benefits Description Equity Benefits  \\\n",
       "22  Automated planning could reduce the time patie...             Yes   \n",
       "31  The navigation intervention could potentially ...             Yes   \n",
       "44  More effective therapies and predictive diagno...             Yes   \n",
       "53  If gastric cancer can be detected at an earlie...              No   \n",
       "59                                                NaN              No   \n",
       "70  Automated planning could reduce the time patie...             Yes   \n",
       "81  The navigator intervention could potentially i...             Yes   \n",
       "\n",
       "    International (equity)  National (equity)  Local (equity)  \\\n",
       "22                    True               True            True   \n",
       "31                    True               True            True   \n",
       "44                   False              False           False   \n",
       "53                   False              False           False   \n",
       "59                   False              False           False   \n",
       "70                    True               True            True   \n",
       "81                   False               True            True   \n",
       "\n",
       "    General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "22                    False                              False   \n",
       "31                     True                               True   \n",
       "44                    False                              False   \n",
       "53                    False                              False   \n",
       "59                    False                              False   \n",
       "70                    False                              False   \n",
       "81                     True                               True   \n",
       "\n",
       "    Patients (equity)  Patient Families (equity)  \\\n",
       "22              False                      False   \n",
       "31               True                       True   \n",
       "44               True                      False   \n",
       "53              False                      False   \n",
       "59              False                      False   \n",
       "70              False                      False   \n",
       "81               True                       True   \n",
       "\n",
       "                          Equity Benefits Description  \\\n",
       "22  Currently, under-resourced centers (particular...   \n",
       "31  The navigation intervention could potentially ...   \n",
       "44  Understanding ethnic and gender-related differ...   \n",
       "53                                                NaN   \n",
       "59                                                NaN   \n",
       "70  Currently, under-resourced centers (particular...   \n",
       "81  The navigator intervention could potentially i...   \n",
       "\n",
       "      Additional Funding Achieved First AFS Status  \\\n",
       "22  No additional funding sources              NaN   \n",
       "31                           Five          Awarded   \n",
       "44                          Three          Awarded   \n",
       "53                            One          Awarded   \n",
       "59  No additional funding sources              NaN   \n",
       "70  No additional funding sources              NaN   \n",
       "81  No additional funding sources              NaN   \n",
       "\n",
       "                     First AFS Name and Project Title  First AFS Amount  \\\n",
       "22                                                NaN               NaN   \n",
       "31                                   see below in box         1000000.0   \n",
       "44                                                LLS          600000.0   \n",
       "53  NIH/NCI Bouvet (PI) 1R01CA256973-01A1 \"Molecul...         2264206.0   \n",
       "59                                                NaN               NaN   \n",
       "70                                                NaN               NaN   \n",
       "81                                                NaN               NaN   \n",
       "\n",
       "   Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "22               NaN                               NaN                NaN   \n",
       "31         Submitted                             below          1000000.0   \n",
       "44           Awarded                              NASA          2000000.0   \n",
       "53               NaN                               NaN                NaN   \n",
       "59               NaN                               NaN                NaN   \n",
       "70               NaN                               NaN                NaN   \n",
       "81               NaN                               NaN                NaN   \n",
       "\n",
       "   Third AFS Status Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "22              NaN                              NaN               NaN   \n",
       "31          Awarded                            below          125000.0   \n",
       "44          Awarded                        NIDDK RO1         1000000.0   \n",
       "53              NaN                              NaN               NaN   \n",
       "59              NaN                              NaN               NaN   \n",
       "70              NaN                              NaN               NaN   \n",
       "81              NaN                              NaN               NaN   \n",
       "\n",
       "   Fourth AFS Status Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "22               NaN                               NaN                NaN   \n",
       "31           Awarded                             below           125000.0   \n",
       "44               NaN                               NaN                NaN   \n",
       "53               NaN                               NaN                NaN   \n",
       "59               NaN                               NaN                NaN   \n",
       "70               NaN                               NaN                NaN   \n",
       "81               NaN                               NaN                NaN   \n",
       "\n",
       "   Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "22                                                NaN                   \n",
       "31                                              below                   \n",
       "44                                                NaN                   \n",
       "53                                                NaN                   \n",
       "59                                                NaN                   \n",
       "70                                                NaN                   \n",
       "81                                                NaN                   \n",
       "\n",
       "   Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "22              NaN               NaN                             Yes   \n",
       "31          Awarded         1250000.0                             Yes   \n",
       "44              NaN               NaN                             Yes   \n",
       "53              NaN               NaN                             Yes   \n",
       "59              NaN               NaN                              No   \n",
       "70              NaN               NaN                             Yes   \n",
       "81              NaN               NaN                             Yes   \n",
       "\n",
       "              Additional Funding Benefits Description  \\\n",
       "22  I would use the funding to hire personnel to d...   \n",
       "31  Absolutely: Future CUREBOUND funding will be c...   \n",
       "44  We would develop biomarkers for use in pediatr...   \n",
       "53  Additional funding well help establish more mo...   \n",
       "59                                                NaN   \n",
       "70  Hire personnel and test the automated brachyth...   \n",
       "81  Future Curebound funding will be critical to e...   \n",
       "\n",
       "   Additional Pedal Funding Impact (clinical stages)  \\\n",
       "22                                               Yes   \n",
       "31                                               Yes   \n",
       "44                                               Yes   \n",
       "53                                               Yes   \n",
       "59                                                No   \n",
       "70                                               Yes   \n",
       "81                                               Yes   \n",
       "\n",
       "   Additional Funding Benefits Description (clinical stages)  \\\n",
       "22  Once automated treatment planning has been val...          \n",
       "31  Yes, if the navigation intervention is effecti...          \n",
       "44  It would help with development of Rebecsinib, ...          \n",
       "53  Additional research will advance the technolog...          \n",
       "59                                                NaN          \n",
       "70  Once automated treatment planning has been val...          \n",
       "81  Yes, if the navigator intervention is effectiv...          \n",
       "\n",
       "                                Participated in Pedal  \\\n",
       "22  I participated in 2018 as a walker, 2019-20 as...   \n",
       "31                                                yes   \n",
       "44                                    Yes as a rider.   \n",
       "53                                                No.   \n",
       "59                                                NaN   \n",
       "70               Participated as a rider before COVID   \n",
       "81                                                Yes   \n",
       "\n",
       "   Further Research Contributions Success Stories  \\\n",
       "22                             No              No   \n",
       "31                            Yes             Yes   \n",
       "44                            Yes             Yes   \n",
       "53                             No              No   \n",
       "59                             No              No   \n",
       "70                             No              No   \n",
       "81                            Yes             Yes   \n",
       "\n",
       "   Major Scientific Breakthroughs  \\\n",
       "22                            NaN   \n",
       "31                            Yes   \n",
       "44                            Yes   \n",
       "53                            NaN   \n",
       "59                            NaN   \n",
       "70                            NaN   \n",
       "81                            Yes   \n",
       "\n",
       "                                  Additional Comments  Complete  \\\n",
       "22  The seed funding received from Padres Pedal th...      True   \n",
       "31  Missing Cancer Control and Population Sciences...      True   \n",
       "44                                         Thank you.      True   \n",
       "53                                                NaN      True   \n",
       "59                                                NaN      True   \n",
       "70                                                NaN      True   \n",
       "81  Please see Dr. Aristizabal's report.  She is t...      True   \n",
       "\n",
       "   Publication Status 1                          First DOI #  \\\n",
       "22            Published         10.1016/j.brachy.2020.04.008   \n",
       "31             Accepted                  10.1200/EDBK_320499   \n",
       "44                  NaN                                  NaN   \n",
       "53             Accepted                             10.21873   \n",
       "59                  NaN                                  NaN   \n",
       "70            Published         10.1016/j.brachy.2020.04.008   \n",
       "81            Published  Please see Dr. Aristizabal's report   \n",
       "\n",
       "   Publication Status 2                         Second DOI #  \\\n",
       "22            Published      10.1016/j.semradonc.2020.05.009   \n",
       "31             Accepted    10.1001/jamanetworkopen.2021.9038   \n",
       "44                  NaN                                  NaN   \n",
       "53          In progress                                  NaN   \n",
       "59                  NaN                                  NaN   \n",
       "70            Published      10.1016/j.semradonc.2020.05.009   \n",
       "81            Published  Please see Dr. Aristizabal's report   \n",
       "\n",
       "   Publication Status 3                          Third DOI #  \\\n",
       "22            Published         10.1016/j.brachy.2021.08.010   \n",
       "31             Accepted                    10.1002/pbc.28296   \n",
       "44                  NaN                                  NaN   \n",
       "53                  NaN                                  NaN   \n",
       "59                  NaN                                  NaN   \n",
       "70            Published         10.1016/j.brachy.2021.08.010   \n",
       "81            Published  Please see Dr. Aristizabal's report   \n",
       "\n",
       "                                        Project Title  \n",
       "22  Knowledge-based planning and treatment decisio...  \n",
       "31  Development and Implementation of a Peer-Navig...  \n",
       "44  Deciphering the role of RNA editing in leukemi...  \n",
       "53          Precision Interception of Gastric Cancers  \n",
       "59  A pilot trial to test the benefit of real time...  \n",
       "70  Knowledge-based planning and treatment decisio...  \n",
       "81  Development and Implementation of a Peer-Navig...  "
      ]
     },
     "execution_count": 615,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr[pr[\"Healthcare Professionals (pol)\"]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 616,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save cleaned dataframes to csv files in interim\n",
    "# Caution: examine directory before uncomment/run this cell to prevent duplicate\n",
    "# files or unintentional modifications to files\n",
    "\n",
    "wp = os.path.join('interim', 'tableau-datasets', '2022_Pedal_Prog_Rep.csv')\n",
    "pr.to_csv(wp)\n",
    "\n",
    "# wp = os.path.join('interim', '2022_Pedal_Progress_Report.csv')\n",
    "# prog_r.to_csv(wp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 617,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   34\n",
       "Novel approaches and new therapeutic platforms    66\n",
       "Immunotherapies and personalized vaccines         35\n",
       "Addressing cancer disparities                      3\n",
       "Pediatric cancers                                 46\n",
       "dtype: int64"
      ]
     },
     "execution_count": 617,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test = roi_adj[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "test.sum()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 622,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_35096\\1983725501.py:1: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   13\n",
       "Novel approaches and new therapeutic platforms    26\n",
       "Immunotherapies and personalized vaccines         14\n",
       "Addressing cancer disparities                      2\n",
       "Pediatric cancers                                 16\n",
       "dtype: int64"
      ]
     },
     "execution_count": 622,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test = roi_adj.groupby('Project Title').max()\n",
    "test = test[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "test.sum()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Fix mission pillars pie chart"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 627,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_35096\\4125477059.py:1: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Project Title</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Applying p38 MAPK inhibitors to tackle breast cancer metastasis</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cytotoxic Breast Cancer Treatment Effects on Aging</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decoding Colon Cancers Using Boolean Principles</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Detecting dysregulated genes in neuroblastoma using allele-specific expression</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Developing targeted therapy for Ewing sarcoma metastasis</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Epigenetic basis of platinum drug resistance in ovarian cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Epigenetic profiling of endometrial cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Functional Roles for Histidine Kinase Signaling in Neuroblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of therapeutic targets of B-ALL using Boolean logic</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Irreversible electroporation as an In Situ vaccine for pancreatic cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Knowledge-based planning and treatment decision-making for gynecologic brachytherapy</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Low Dose Chemotherapy for Immuno-activation in Lung Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Microbe-Associated Colorectal Cancer (M.A.C.S)</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Natural Killer Cells for Treatment of Medulloblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>New Therapies for Myeloid Leukemia</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novel Pathways Regulated by NME1 in Neuroblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novel kinase inhibitors in combination with retinoic acide for neuroblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Precision Interception of Gastric Cancers</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Responses of Melanoma Patients to Checkpoint Immunotherapy</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Science</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Small molecule screen for inhibitors of the GOLPH3 pathway</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting CD114 Signaling in Pediatric Medulloblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting FZD7 in human cancers</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting Stem Cell Signals in Cancer Development and Progression</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting cellular mechanotransduction in breast cancer metastasis</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting imatinib-resistant, KIT-negative cells in human GISTs</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Understanding and Targeting NRF2 in Pancreatic Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    Prevention and diagnostic tools  \\\n",
       "Project Title                                                                         \n",
       "A National Phase I Study of Cabozantinib in Com...                            False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                            False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                            False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                            False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                            False   \n",
       "A pilot trial to test the benefit of real time ...                            False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                            False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                            False   \n",
       "Applying p38 MAPK inhibitors to tackle breast c...                            False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                            False   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging                             True   \n",
       "Deciphering the role of RNA editing in leukemia...                            False   \n",
       "Decoding Colon Cancers Using Boolean Principles                                True   \n",
       "Defining the mechanisms of pancreatic cancer su...                             True   \n",
       "Demonstrating the Clinical Utility of Whole Exo...                             True   \n",
       "Detecting Correlates of Vaccine Responses in Al...                             True   \n",
       "Detecting dysregulated genes in neuroblastoma u...                            False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                            False   \n",
       "Development and Implementation of a Peer-Naviga...                            False   \n",
       "Discovery of non-coding oncogenic mutations in ...                            False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                            False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                             True   \n",
       "Epigenetic basis of platinum drug resistance in...                             True   \n",
       "Epigenetic profiling of endometrial cancer                                     True   \n",
       "Evaluation of carcinogen exposure via genome-wi...                             True   \n",
       "Examination of inhibitors of the ULK1 autophagy...                            False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                              False   \n",
       "Functional Roles for Histidine Kinase Signaling...                            False   \n",
       "Highly selective, synthetic, cleavage specifici...                             True   \n",
       "Identification of genes critical for the produc...                            False   \n",
       "Identification of regulatory programs for gliob...                            False   \n",
       "Identification of therapeutic targets of B-ALL ...                            False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                             True   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                            False   \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...                            False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                            False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                            False   \n",
       "Investigating the Efficacy of radium-223 with O...                            False   \n",
       "Irreversible electroporation as an In Situ vacc...                            False   \n",
       "KRAS Addiction and Protein Biomarkers of Respon...                            False   \n",
       "Knowledge-based planning and treatment decision...                             True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                            False   \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...                             True   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                                False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                            False   \n",
       "Neoantigen-specific T cell responses in excepti...                            False   \n",
       "New Therapies for Myeloid Leukemia                                            False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                             False   \n",
       "Novel kinase inhibitors in combination with ret...                            False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                            False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                            False   \n",
       "Precision Interception of Gastric Cancers                                     False   \n",
       "Protein Kinase C as a Novel Biomarker and Targe...                            False   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                            False   \n",
       "Science                                                                       False   \n",
       "Small molecule screen for inhibitors of the GOL...                            False   \n",
       "Stromal reprogramming to enhance the effectiven...                            False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                            False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                            False   \n",
       "Targeting FZD7 in human cancers                                               False   \n",
       "Targeting KRAS mutant lung cancer with biphosph...                            False   \n",
       "Targeting Stem Cell Signals in Cancer Developme...                            False   \n",
       "Targeting cellular mechanotransduction in breas...                            False   \n",
       "Targeting fibroblast heterogeneity to improve s...                            False   \n",
       "Targeting imatinib-resistant, KIT-negative cell...                            False   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...                            False   \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...                            False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                            False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                            False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                            False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                            False   \n",
       "\n",
       "                                                    Novel approaches and new therapeutic platforms  \\\n",
       "Project Title                                                                                        \n",
       "A National Phase I Study of Cabozantinib in Com...                                           False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                                           False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                                            True   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                                           False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                                           False   \n",
       "A pilot trial to test the benefit of real time ...                                           False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                                            True   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                                            True   \n",
       "Applying p38 MAPK inhibitors to tackle breast c...                                            True   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                                            True   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging                                           False   \n",
       "Deciphering the role of RNA editing in leukemia...                                           False   \n",
       "Decoding Colon Cancers Using Boolean Principles                                              False   \n",
       "Defining the mechanisms of pancreatic cancer su...                                           False   \n",
       "Demonstrating the Clinical Utility of Whole Exo...                                           False   \n",
       "Detecting Correlates of Vaccine Responses in Al...                                           False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                                           False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                                           False   \n",
       "Development and Implementation of a Peer-Naviga...                                           False   \n",
       "Discovery of non-coding oncogenic mutations in ...                                           False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                                           False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                                           False   \n",
       "Epigenetic basis of platinum drug resistance in...                                           False   \n",
       "Epigenetic profiling of endometrial cancer                                                   False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                                           False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                                            True   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                                             False   \n",
       "Functional Roles for Histidine Kinase Signaling...                                           False   \n",
       "Highly selective, synthetic, cleavage specifici...                                           False   \n",
       "Identification of genes critical for the produc...                                           False   \n",
       "Identification of regulatory programs for gliob...                                            True   \n",
       "Identification of therapeutic targets of B-ALL ...                                           False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                                           False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                                           False   \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...                                           False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                                           False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                                            True   \n",
       "Investigating the Efficacy of radium-223 with O...                                            True   \n",
       "Irreversible electroporation as an In Situ vacc...                                           False   \n",
       "KRAS Addiction and Protein Biomarkers of Respon...                                            True   \n",
       "Knowledge-based planning and treatment decision...                                           False   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                                           False   \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...                                           False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                                                True   \n",
       "Natural Killer Cells for Treatment of Medullobl...                                           False   \n",
       "Neoantigen-specific T cell responses in excepti...                                           False   \n",
       "New Therapies for Myeloid Leukemia                                                            True   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                                            False   \n",
       "Novel kinase inhibitors in combination with ret...                                           False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                                            True   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                                           False   \n",
       "Precision Interception of Gastric Cancers                                                     True   \n",
       "Protein Kinase C as a Novel Biomarker and Targe...                                            True   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                                           False   \n",
       "Science                                                                                      False   \n",
       "Small molecule screen for inhibitors of the GOL...                                            True   \n",
       "Stromal reprogramming to enhance the effectiven...                                            True   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                                            True   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                                           False   \n",
       "Targeting FZD7 in human cancers                                                              False   \n",
       "Targeting KRAS mutant lung cancer with biphosph...                                            True   \n",
       "Targeting Stem Cell Signals in Cancer Developme...                                            True   \n",
       "Targeting cellular mechanotransduction in breas...                                            True   \n",
       "Targeting fibroblast heterogeneity to improve s...                                            True   \n",
       "Targeting imatinib-resistant, KIT-negative cell...                                            True   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...                                            True   \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...                                            True   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                                           False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                                           False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                                           False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                                            True   \n",
       "\n",
       "                                                    Immunotherapies and personalized vaccines  \\\n",
       "Project Title                                                                                   \n",
       "A National Phase I Study of Cabozantinib in Com...                                      False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                                      False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                                      False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                                       True   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                                       True   \n",
       "A pilot trial to test the benefit of real time ...                                      False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                                      False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                                      False   \n",
       "Applying p38 MAPK inhibitors to tackle breast c...                                      False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                                      False   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging                                      False   \n",
       "Deciphering the role of RNA editing in leukemia...                                      False   \n",
       "Decoding Colon Cancers Using Boolean Principles                                         False   \n",
       "Defining the mechanisms of pancreatic cancer su...                                      False   \n",
       "Demonstrating the Clinical Utility of Whole Exo...                                      False   \n",
       "Detecting Correlates of Vaccine Responses in Al...                                      False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                                      False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                                      False   \n",
       "Development and Implementation of a Peer-Naviga...                                      False   \n",
       "Discovery of non-coding oncogenic mutations in ...                                      False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                                      False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                                      False   \n",
       "Epigenetic basis of platinum drug resistance in...                                      False   \n",
       "Epigenetic profiling of endometrial cancer                                              False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                                      False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                                      False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                                        False   \n",
       "Functional Roles for Histidine Kinase Signaling...                                      False   \n",
       "Highly selective, synthetic, cleavage specifici...                                      False   \n",
       "Identification of genes critical for the produc...                                       True   \n",
       "Identification of regulatory programs for gliob...                                      False   \n",
       "Identification of therapeutic targets of B-ALL ...                                      False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                                      False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                                      False   \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...                                       True   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                                       True   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                                      False   \n",
       "Investigating the Efficacy of radium-223 with O...                                      False   \n",
       "Irreversible electroporation as an In Situ vacc...                                       True   \n",
       "KRAS Addiction and Protein Biomarkers of Respon...                                      False   \n",
       "Knowledge-based planning and treatment decision...                                      False   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                                       True   \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...                                      False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                                          False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                                       True   \n",
       "Neoantigen-specific T cell responses in excepti...                                       True   \n",
       "New Therapies for Myeloid Leukemia                                                      False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                                       False   \n",
       "Novel kinase inhibitors in combination with ret...                                      False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                                      False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                                       True   \n",
       "Precision Interception of Gastric Cancers                                               False   \n",
       "Protein Kinase C as a Novel Biomarker and Targe...                                      False   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                                       True   \n",
       "Science                                                                                 False   \n",
       "Small molecule screen for inhibitors of the GOL...                                      False   \n",
       "Stromal reprogramming to enhance the effectiven...                                      False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                                      False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                                      False   \n",
       "Targeting FZD7 in human cancers                                                          True   \n",
       "Targeting KRAS mutant lung cancer with biphosph...                                      False   \n",
       "Targeting Stem Cell Signals in Cancer Developme...                                      False   \n",
       "Targeting cellular mechanotransduction in breas...                                      False   \n",
       "Targeting fibroblast heterogeneity to improve s...                                      False   \n",
       "Targeting imatinib-resistant, KIT-negative cell...                                      False   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...                                      False   \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...                                      False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                                      False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                                       True   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                                       True   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                                      False   \n",
       "\n",
       "                                                    Addressing cancer disparities  \\\n",
       "Project Title                                                                       \n",
       "A National Phase I Study of Cabozantinib in Com...                          False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                          False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                          False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                          False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                          False   \n",
       "A pilot trial to test the benefit of real time ...                          False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                          False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                          False   \n",
       "Applying p38 MAPK inhibitors to tackle breast c...                          False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                          False   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging                          False   \n",
       "Deciphering the role of RNA editing in leukemia...                          False   \n",
       "Decoding Colon Cancers Using Boolean Principles                             False   \n",
       "Defining the mechanisms of pancreatic cancer su...                          False   \n",
       "Demonstrating the Clinical Utility of Whole Exo...                          False   \n",
       "Detecting Correlates of Vaccine Responses in Al...                          False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                          False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                          False   \n",
       "Development and Implementation of a Peer-Naviga...                           True   \n",
       "Discovery of non-coding oncogenic mutations in ...                          False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                          False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                          False   \n",
       "Epigenetic basis of platinum drug resistance in...                          False   \n",
       "Epigenetic profiling of endometrial cancer                                  False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                          False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                          False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                            False   \n",
       "Functional Roles for Histidine Kinase Signaling...                          False   \n",
       "Highly selective, synthetic, cleavage specifici...                          False   \n",
       "Identification of genes critical for the produc...                          False   \n",
       "Identification of regulatory programs for gliob...                          False   \n",
       "Identification of therapeutic targets of B-ALL ...                          False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                          False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                          False   \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...                          False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                          False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                          False   \n",
       "Investigating the Efficacy of radium-223 with O...                          False   \n",
       "Irreversible electroporation as an In Situ vacc...                          False   \n",
       "KRAS Addiction and Protein Biomarkers of Respon...                          False   \n",
       "Knowledge-based planning and treatment decision...                          False   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                          False   \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...                          False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                              False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                          False   \n",
       "Neoantigen-specific T cell responses in excepti...                          False   \n",
       "New Therapies for Myeloid Leukemia                                          False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                           False   \n",
       "Novel kinase inhibitors in combination with ret...                          False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                          False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                          False   \n",
       "Precision Interception of Gastric Cancers                                   False   \n",
       "Protein Kinase C as a Novel Biomarker and Targe...                          False   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                          False   \n",
       "Science                                                                      True   \n",
       "Small molecule screen for inhibitors of the GOL...                          False   \n",
       "Stromal reprogramming to enhance the effectiven...                          False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                          False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                          False   \n",
       "Targeting FZD7 in human cancers                                             False   \n",
       "Targeting KRAS mutant lung cancer with biphosph...                          False   \n",
       "Targeting Stem Cell Signals in Cancer Developme...                          False   \n",
       "Targeting cellular mechanotransduction in breas...                          False   \n",
       "Targeting fibroblast heterogeneity to improve s...                          False   \n",
       "Targeting imatinib-resistant, KIT-negative cell...                          False   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...                          False   \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...                          False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                          False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                          False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                          False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                          False   \n",
       "\n",
       "                                                    Pediatric cancers  \n",
       "Project Title                                                          \n",
       "A National Phase I Study of Cabozantinib in Com...               True  \n",
       "A Novel Role for Histidine Kinase Activity in N...               True  \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...              False  \n",
       "A Phase 1b Safety and Feasibility Study of Pers...              False  \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...              False  \n",
       "A pilot trial to test the benefit of real time ...               True  \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...              False  \n",
       "An over-expressed GPCR in pancreatic cancer ass...              False  \n",
       "Applying p38 MAPK inhibitors to tackle breast c...              False  \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...              False  \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging              False  \n",
       "Deciphering the role of RNA editing in leukemia...               True  \n",
       "Decoding Colon Cancers Using Boolean Principles                 False  \n",
       "Defining the mechanisms of pancreatic cancer su...              False  \n",
       "Demonstrating the Clinical Utility of Whole Exo...              False  \n",
       "Detecting Correlates of Vaccine Responses in Al...              False  \n",
       "Detecting dysregulated genes in neuroblastoma u...               True  \n",
       "Developing targeted therapy for Ewing sarcoma m...               True  \n",
       "Development and Implementation of a Peer-Naviga...              False  \n",
       "Discovery of non-coding oncogenic mutations in ...               True  \n",
       "Elucidating the role of Syk kinase and Syk inhi...               True  \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...              False  \n",
       "Epigenetic basis of platinum drug resistance in...              False  \n",
       "Epigenetic profiling of endometrial cancer                      False  \n",
       "Evaluation of carcinogen exposure via genome-wi...              False  \n",
       "Examination of inhibitors of the ULK1 autophagy...              False  \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                 True  \n",
       "Functional Roles for Histidine Kinase Signaling...               True  \n",
       "Highly selective, synthetic, cleavage specifici...              False  \n",
       "Identification of genes critical for the produc...              False  \n",
       "Identification of regulatory programs for gliob...              False  \n",
       "Identification of therapeutic targets of B-ALL ...               True  \n",
       "Impact of Metformin on Clonal Hematopoiesis and...              False  \n",
       "Improved Echocardiographic Diagnosis of Anthrac...               True  \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...              False  \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...              False  \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...              False  \n",
       "Investigating the Efficacy of radium-223 with O...              False  \n",
       "Irreversible electroporation as an In Situ vacc...              False  \n",
       "KRAS Addiction and Protein Biomarkers of Respon...              False  \n",
       "Knowledge-based planning and treatment decision...              False  \n",
       "Low Dose Chemotherapy for Immuno-activation in ...              False  \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...              False  \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                  False  \n",
       "Natural Killer Cells for Treatment of Medullobl...              False  \n",
       "Neoantigen-specific T cell responses in excepti...              False  \n",
       "New Therapies for Myeloid Leukemia                              False  \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                True  \n",
       "Novel kinase inhibitors in combination with ret...               True  \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...              False  \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...              False  \n",
       "Precision Interception of Gastric Cancers                       False  \n",
       "Protein Kinase C as a Novel Biomarker and Targe...              False  \n",
       "Responses of Melanoma Patients to Checkpoint Im...              False  \n",
       "Science                                                         False  \n",
       "Small molecule screen for inhibitors of the GOL...              False  \n",
       "Stromal reprogramming to enhance the effectiven...              False  \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...              False  \n",
       "Targeting CD114 Signaling in Pediatric Medullob...               True  \n",
       "Targeting FZD7 in human cancers                                 False  \n",
       "Targeting KRAS mutant lung cancer with biphosph...              False  \n",
       "Targeting Stem Cell Signals in Cancer Developme...              False  \n",
       "Targeting cellular mechanotransduction in breas...              False  \n",
       "Targeting fibroblast heterogeneity to improve s...              False  \n",
       "Targeting imatinib-resistant, KIT-negative cell...              False  \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...              False  \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...              False  \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...               True  \n",
       "Transcriptomic, epigenomic profiling to reveal ...              False  \n",
       "UCSD-UCSF Specialized Program of Research Excel...              False  \n",
       "Understanding and Targeting NRF2 in Pancreatic ...              False  "
      ]
     },
     "execution_count": 627,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pillar_status = roi_adj.groupby('Project Title').max()[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "pillar_status"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 629,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False"
      ]
     },
     "execution_count": 629,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pillar_status.loc['Understanding and Targeting NRF2 in Pancreatic Cancer', 'Pediatric cancers']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 632,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "checked_titles = []\n",
    "def adj_pillar_cnt(row, pillar):\n",
    "    title = row['Project Title']\n",
    "    if title not in checked_titles:\n",
    "        checked_titles.append(title)\n",
    "        return pillar_status.loc[title, pillar]\n",
    "    else:\n",
    "        return False\n",
    "\n",
    "for pillar in pillar_status.columns:\n",
    "    checked_titles = []\n",
    "    roi_adj[pillar] = roi_adj.apply(adj_pillar_cnt, args=[pillar], axis=1)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 634,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>52.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The funding for this project and the data gene...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>131.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Obtaining funding is important for career adva...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.3</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding for this project enhanced innovative c...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>200.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>201.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      ID Event Name  Award ID  \\\n",
       "0   52.0    Initial      52.1   \n",
       "1  131.0    Initial      52.2   \n",
       "2  132.0    Initial      52.3   \n",
       "3  200.0    Initial     200.1   \n",
       "4  201.0    Initial     200.2   \n",
       "\n",
       "                                       Project Title   PI Institution  \\\n",
       "0  Discovery of non-coding oncogenic mutations in...   Salk Institute   \n",
       "1  Discovery of non-coding oncogenic mutations in...   Salk Institute   \n",
       "2  Discovery of non-coding oncogenic mutations in...  Rady Children's   \n",
       "3  Discovery of non-coding oncogenic mutations in...   Salk Institute   \n",
       "4  Discovery of non-coding oncogenic mutations in...   Salk Institute   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "1               NaN                            False   \n",
       "2               NaN                            False   \n",
       "3               NaN                            False   \n",
       "4               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "1                                           False   \n",
       "2                                           False   \n",
       "3                                           False   \n",
       "4                                           False   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "1                                      False                          False   \n",
       "2                                      False                          False   \n",
       "3                                      False                          False   \n",
       "4                                      False                          False   \n",
       "\n",
       "   Pediatric cancers      Specific Aims  \\\n",
       "0               True  Two Specific Aims   \n",
       "1              False  Two Specific Aims   \n",
       "2              False  Two Specific Aims   \n",
       "3              False  Two Specific Aims   \n",
       "4              False  Two Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Discover non-coding regulatory mutations in AL...   \n",
       "1  Discover non-coding regulatory mutations in AL...   \n",
       "2  Discover non-coding regulatory mutations in AL...   \n",
       "3  Discover non-coding regulatory mutations in AL...   \n",
       "4  Discover non-coding regulatory mutations in AL...   \n",
       "\n",
       "                                               Aim 2 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "1  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "2  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "3  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "4  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "1  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "2  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "3  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "4  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2017-06-01      2018-05-31  Complete      True   \n",
       "1        2017-06-01      2018-05-31  Complete      True   \n",
       "2        2017-06-01      2018-05-31  Complete      True   \n",
       "3        2017-06-01      2018-05-31  Complete       NaN   \n",
       "4        2017-06-01      2018-05-31  Complete       NaN   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                 False   \n",
       "1                   False                                 False   \n",
       "2                   False                                 False   \n",
       "3                     NaN                                   NaN   \n",
       "4                     NaN                                   NaN   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                           False   \n",
       "1                  False                           False   \n",
       "2                  False                           False   \n",
       "3                    NaN                             NaN   \n",
       "4                    NaN                             NaN   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                  False   \n",
       "1                   False                                  False   \n",
       "2                   False                                  False   \n",
       "3                     NaN                                    NaN   \n",
       "4                     NaN                                    NaN   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "1                    False               False                       False   \n",
       "2                    False               False                       False   \n",
       "3                      NaN                 NaN                         NaN   \n",
       "4                      NaN                 NaN                         NaN   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "1                     False                                    False   \n",
       "2                     False                                    False   \n",
       "3                       NaN                                      NaN   \n",
       "4                       NaN                                      NaN   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "1                False                                  False   \n",
       "2                False                                  False   \n",
       "3                  NaN                                    NaN   \n",
       "4                  NaN                                    NaN   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "1                                  False                           False   \n",
       "2                                  False                           False   \n",
       "3                                    NaN                             NaN   \n",
       "4                                    NaN                             NaN   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "1                    False   \n",
       "2                    False   \n",
       "3                      NaN   \n",
       "4                      NaN   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "1                                                Yes       \n",
       "2                                                Yes       \n",
       "3                                                NaN       \n",
       "4                                                NaN       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  The funding for this project and the data gene...                   NaN   \n",
       "1  Obtaining funding is important for career adva...                   NaN   \n",
       "2  Funding for this project enhanced innovative c...                   NaN   \n",
       "3                                                NaN                   NaN   \n",
       "4                                                NaN                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted First Clinical Trial  \\\n",
       "0                       0.0                  NaN   \n",
       "1                       0.0                  NaN   \n",
       "2                       0.0                  NaN   \n",
       "3                       0.0                  NaN   \n",
       "4                       0.0                  NaN   \n",
       "\n",
       "   First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                 NaN                   NaN   \n",
       "1                                 NaN                   NaN   \n",
       "2                                 NaN                   NaN   \n",
       "3                                 NaN                   NaN   \n",
       "4                                 NaN                   NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN              None            No   \n",
       "1                                  NaN              None            No   \n",
       "2                                  NaN              None            No   \n",
       "3                                  NaN               NaN           NaN   \n",
       "4                                  NaN               NaN           NaN   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              Two  \n",
       "1            NaN                              One  \n",
       "2            NaN                              Two  \n",
       "3            NaN                              NaN  \n",
       "4            NaN                              NaN  "
      ]
     },
     "execution_count": 634,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 640,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prevention and diagnostic tools                   13\n",
      "Novel approaches and new therapeutic platforms    26\n",
      "Immunotherapies and personalized vaccines         14\n",
      "Addressing cancer disparities                      2\n",
      "Pediatric cancers                                 16\n",
      "dtype: int64\n",
      "Prevention and diagnostic tools                   13\n",
      "Novel approaches and new therapeutic platforms    26\n",
      "Immunotherapies and personalized vaccines         14\n",
      "Addressing cancer disparities                      2\n",
      "Pediatric cancers                                 16\n",
      "dtype: int64\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_35096\\3773569758.py:3: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# sanity check\n",
    "\n",
    "test = roi_adj.groupby('Project Title').max()\n",
    "test = test[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "print(test.sum())\n",
    "\n",
    "test1 = roi_adj[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "print(test1.sum())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 641,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save cleaned dataframe to csv files in interim\n",
    "# Caution: examine directory before uncomment/run this cell to prevent duplicate\n",
    "# files or unintentional modifications to files\n",
    "\n",
    "wp = os.path.join('interim', 'tableau-datasets', '2022_Pedal_ROI.csv')\n",
    "roi_adj.to_csv(wp)\n",
    "\n",
    "# wp = os.path.join('interim', '2022_Pedal_Progress_Report.csv')\n",
    "# prog_r.to_csv(wp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 643,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Project Title</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "      <td>WIll better delineate the burden of clonal hem...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Potential to influence NCCN guidelines.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>E cigarette related policies</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>Adding genomics to the EMR in Epic.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "      <td>The development of tumor specific probes for g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>To make brachy more automated and clinical</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "      <td>The navigator intervention could potentially b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "      <td>These studies on the immune compartment may le...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        Project Title  \\\n",
       "9   Neoantigen-specific T cell responses in except...   \n",
       "19  Impact of Metformin on Clonal Hematopoiesis an...   \n",
       "22  Knowledge-based planning and treatment decisio...   \n",
       "31  Development and Implementation of a Peer-Navig...   \n",
       "35  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "42    Decoding Colon Cancers Using Boolean Principles   \n",
       "44  Deciphering the role of RNA editing in leukemi...   \n",
       "53          Precision Interception of Gastric Cancers   \n",
       "56  Neoantigen-specific T cell responses in except...   \n",
       "70  Knowledge-based planning and treatment decisio...   \n",
       "71  Knowledge-based planning and treatment decisio...   \n",
       "81  Development and Implementation of a Peer-Navig...   \n",
       "85  Investigating the Efficacy of radium-223 with ...   \n",
       "\n",
       "                          Policy Benefits Description  \n",
       "9   Our project could improve guidelines as to how...  \n",
       "19  WIll better delineate the burden of clonal hem...  \n",
       "22  These tools can help healthcare professionals ...  \n",
       "31  The navigation intervention could potentially ...  \n",
       "35            Potential to influence NCCN guidelines.  \n",
       "42                       E cigarette related policies  \n",
       "44                Adding genomics to the EMR in Epic.  \n",
       "53  The development of tumor specific probes for g...  \n",
       "56  Our project could improve guidelines as to how...  \n",
       "70  These tools can help healthcare professionals ...  \n",
       "71        To make brachy more automated and clinical   \n",
       "81  The navigator intervention could potentially b...  \n",
       "85  These studies on the immune compartment may le...  "
      ]
     },
     "execution_count": 643,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity check\n",
    "\n",
    "pr[~pr['Policy Benefits Description'].isna()][['Project Title', 'Policy Benefits Description']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.2"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
